<SEC-DOCUMENT>0001078782-17-000387.txt : 20170331
<SEC-HEADER>0001078782-17-000387.hdr.sgml : 20170331
<ACCEPTANCE-DATETIME>20170331130125
ACCESSION NUMBER:		0001078782-17-000387
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20161231
FILED AS OF DATE:		20170331
DATE AS OF CHANGE:		20170331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zivo Bioscience, Inc.
		CENTRAL INDEX KEY:			0001101026
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		IRS NUMBER:				870699977
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30415
		FILM NUMBER:		17729296

	BUSINESS ADDRESS:	
		STREET 1:		2804 ORCHARD LAKE ROAD, SUITE 202
		CITY:			KEEGO HARBOR
		STATE:			MI
		ZIP:			48320
		BUSINESS PHONE:		(248) 452 9866

	MAIL ADDRESS:	
		STREET 1:		2804 ORCHARD LAKE ROAD, SUITE 202
		CITY:			KEEGO HARBOR
		STATE:			MI
		ZIP:			48320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH ENHANCEMENT PRODUCTS INC
		DATE OF NAME CHANGE:	20040202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WESTERN GLORY HOLE INC
		DATE OF NAME CHANGE:	19991215
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>f10k123116_10k.htm
<DESCRIPTION>FORM 10-K ANNUAL REPORT
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Form 10-K Annual Report</TITLE>
<META NAME="author" CONTENT="Philip Rice">
<META NAME="date" CONTENT="03/28/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center>Washington D.C. 20549</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; font-size:12pt" align=center><B>FORM 10-K</B></P>
<P style="margin:0px" align=center><BR></P>
<A NAME="OLE_LINK5"></A><A NAME="OLE_LINK6"></A><P style="margin:0px" align=center>&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT>ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>
<P style="margin:0px" align=center>For the Fiscal Year ended December 31, 2016</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT><FONT style="color:#FFFFFF">.</FONT>TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>
<P style="margin:0px" align=center>For the transition period from _____ to _____</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: &nbsp;000-30415</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; font-size:14pt" align=center><B>Zivo Bioscience, Inc. </B></P>
<P style="margin:0px" align=center>(Name of Registrant as Specified in Its Charter)</P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=216 /><TD width=216 /></TR>
<TR><TD style="margin-top:0px" width=216><P style="margin:0px" align=center><B>Nevada</B></P>
</TD><TD style="margin-top:0px" width=216><P style="margin:0px" align=center><B>87-0699977</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=216><P style="margin:0px" align=center>(State or Other Jurisdiction</P>
<P style="margin:0px" align=center>of Incorporation or Organization)</P>
</TD><TD style="margin-top:0px" valign=top width=216><P style="margin:0px" align=center>(I.R.S. Employer</P>
<P style="margin:0px" align=center>Identification No.)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=434.4 /></TR>
<TR><TD style="margin-top:0px" valign=top width=434.4><P style="margin:0px" align=center><B>2804 Orchard Lake Rd., Suite 202, Keego Harbor, MI 48320</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=434.4><P style="margin:0px" align=center>(Address of Principal Executive Offices)</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>(248) 452 9866</B></P>
<P style="margin:0px" align=center>(Issuer&#146;s telephone number)</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>Securities registered under Section 12(b) of the Exchange Act:</B></P>
<P style="margin:0px" align=center>None</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Securities registered under Section 12(g) of the Exchange Act:</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><U>Common Stock, par value $.001 per share</U></P>
<P style="margin:0px" align=center>(Title of Class)</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</P>
<P style="margin:0px" align=right>Yes <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> No <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</P>
<P style="margin:0px" align=right>Yes <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> No <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</P>
<P style="margin:0px" align=right>Yes <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> No <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</P>
<P style="margin:0px" align=right>Yes <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> No <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant&#146;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. &nbsp;See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act (Check one).</P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=144.4 /><TD width=282.6 /><TD width=160.133 /><TD width=31.2 /></TR>
<TR><TD style="margin-top:0px" valign=top width=144.4><P style="margin:0px; text-indent:-0.667px">Large accelerated filer</P>
</TD><TD style="margin-top:0px" valign=top width=282.6><P style="margin:0px; text-indent:-0.667px; font-size:12pt">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; padding-bottom:0px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
</TD><TD style="margin-top:0px" valign=top width=160.133><P style="margin:0px; text-indent:-0.667px">Accelerated filer</P>
</TD><TD style="margin-top:0px" valign=top width=31.2><P style="margin:0px; text-indent:-0.667px; font-size:12pt">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; padding-bottom:0px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=144.4><P style="margin:0px; text-indent:-0.667px">Non-accelerated filer</P>
</TD><TD style="margin-top:0px" valign=top width=282.6><P style="margin:0px; text-indent:-0.667px; font-size:12pt">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; padding-bottom:0px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> <FONT style="font-size:10pt">(Do not check if a smaller reporting company)</FONT></P>
</TD><TD style="margin-top:0px" valign=top width=160.133><P style="margin:0px; text-indent:-0.667px">Smaller reporting company</P>
</TD><TD style="margin-top:0px" valign=top width=31.2><P style="margin:0px; text-indent:-0.667px; font-size:12pt">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; padding-bottom:0px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).</P>
<P style="margin:0px" align=right>Yes <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> No <FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;X </FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The aggregate market value of the issuer&#146;s voting and non-voting common equity held as of June 30, 2016 by non-affiliates of the issuer was $7,967,207 based on the closing price of the registrant&#146;s common stock on such date.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">As of March 29, 2017, there were 136,995,347 shares of $.001 par value common stock issued and outstanding<FONT style="color:#FF0000">.</FONT></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>2</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><B>FORM 10-K</B></P>
<P style="margin:0px" align=center><B>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>INDEX</B></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=71 /><TD width=538 /><TD width=21.6 /></TR>
<TR><TD style="margin-top:0px" width=71><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=538><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=21.6><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">PART I</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 1.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Business</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>5</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 1A.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Risk Factors</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>17</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 1B.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Unresolved Staff Comments</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>19</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 2.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Properties</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>19</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 3.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Legal Proceedings</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>19</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">PART II</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 5.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; padding-left:16.333px; text-indent:-17px">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>20</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 6.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Selected Financial Data</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>20</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 7.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>21</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 7A.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Quantitative and Qualitative Disclosures About Market Risk</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>24</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 8.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Financial Statements and Supplementary Data</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>24</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 9.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>24</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 9A</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Controls and Procedures.</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>24</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 9B.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Other Information</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>24</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">PART III</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 10.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Directors, Executive Officers and Corporate Governance.</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 11.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Executive Compensation</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 12.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 13.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Certain Relationships and Related Transactions, and Director Independence.</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 14.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Principal Accountant Fees and Services</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">PART IV</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">Item 15.</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">Exhibits and Financial Statement Schedules</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=71><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=538><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=21.6><P style="margin:0px" align=right>&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=609 colspan=2><P style="margin:0px; text-indent:-0.667px">SIGNATURES </P>
</TD><TD style="margin-top:0px" valign=top width=21.6><P style="margin:0px" align=right>26</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>3</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Some of the statements contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#146;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to statements regarding:</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">our ability to raise the funds we need to continue our operations;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">our goal to begin to generate revenues and become profitable;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">regulation of our product;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">market acceptance of our product and derivatives thereof;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">the results of current and future testing of our product;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">the anticipated performance and benefits of our product; </P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">the ability to generate licensing fees; and</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; clear:left; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px">our financial condition or results of operations.</P>
<P style="margin:0px; clear:left">&nbsp;</P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In some cases, you can identify forward-looking statements by terms such as &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;could&#148;, &#147;would&#148;, &#147;expects&#148;, &#147;plans&#148;, &#147;anticipates&#148;, &#147;believes&#148;, &#147;estimates&#148;, &#147;projects&#148;, &#147;predicts&#148;, &#147;potential&#148; and similar expressions intended to identify forward looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. We qualify all of our forward-looking statements by these cautionary statements.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>4</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>PART I</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Item 1. &nbsp;Business.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>General</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We were incorporated under the laws of the State of Nevada on March 28, 1983, under the name of &#147;L. Peck Enterprises, Inc.&#148; On May 27, 1999, we changed our name to &#147;Western Glory Hole, Inc.&#148; &nbsp;From 1990 until October 2003, we had no business operations; we were in the development stage and were seeking profitable business opportunities. &nbsp;On October 30, 2003, we acquired 100% of the outstanding shares of Health Enhancement Corporation (&#147;HEC&#148;) in exchange for 9,000,000 of our shares, making HEC our wholly-owned subsidiary. In connection with this transaction, we changed our name to Health Enhancement Products, Inc. &nbsp;On October 14, 2014, at the annual meeting of the Shareholders of the Company, a proposal was passed to change the name of the Company from Health Enhancement Products, Inc. to ZIVO Bioscience, Inc. (&#147;ZIVO&#148;). On October 30, 2014, the Financial Industry Regulatory Authority (&#147;FINRA&#148;) approved the name ZIVO Bioscience, Inc. for trading purposes and the symbol change to ZIVO effective November 10, 2014.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We acquired HEC in 2003 because we believed its unique and complex algal culture produced natural bioactive compounds that promoted health benefits. A production facility based in Scottsdale, AZ produced and marketed a liquid dietary supplement with marginal success beginning in 2003 until sales were suspended in January of 2012.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Our new management team, in place since December 2011, determined the sole focus for the near term was to move forward with a research-based product development program. &nbsp;From 2012 through 2016, we engaged fully in such activities, all as more fully explained herein. &nbsp;We are implementing a business model in which we would derive future income from licensing and selling natural bioactive ingredients that may be derived from or are initially based on the algae cultures. We expect that these planned new products will likely be sold to much larger, better-financed animal, food, dietary supplement and medical food manufacturers. &nbsp;The anticipated income streams are to be generated from a) royalties and advances for licensed natural bioactive ingredients, and b) bulk sales of such ingredients. These bulk ingredients will likely be made by contracted ingredient manufacturers and then sold by us to animal food, dietary supplement and medical food processors and/or name-brand marketers. Further, we expect to license our bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In January 2007, we established HEPI Pharmaceuticals, Inc. as our wholly owned subsidiary (&#147;HEPI Pharma&#148;). The purpose of HEPI Pharma was to develop potential pharmaceutical applications for the bioactive ingredients that may be derived from our algae cultures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In February 2013, we formed ZIVO Biologic, Inc., a Delaware corporation, for the purpose of manufacturing and commercialization of proprietary ingredients for non-medicinal animal health applications. Zivo Biologic is 100% owned by Zivo Bioscience, Inc.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In August 2013, we acquired the assets, consisting primarily of intellectual property rights, of Wellness Indicators, Inc. (&#147;Wellness&#148;), a Michigan corporation based in Illinois. &nbsp;Concurrently, we formed WellMetris, LLC (&#147;WellMetris&#148;) as a 100% owned entity of ZIVO. We acquired four patent applications as part of the transaction, in addition to engineering drawings, prototypes, chemical formulae, validation data, laboratory equipment and IT equipment. &nbsp;We assigned all of the intellectual property acquired to WellMetris with a stated value of $1,391,281. The mission of WellMetris is to develop, manufacture, market and sell Wellness Tests. The Wellness Tests are intended to provide individuals the information and opportunity to optimize their health and identify future health risks or to provide insurers, employers and healthcare providers timely information to intervene with wellness programs, fitness regimes or other preventative measures. During the period of time since we have owned WellMetris, we have filed / drafted an additional eight patent applications around the intellectual property acquired, as noted in the section &#147;Patents and Proprietary Rights.&#148; In the summer of 2014, we evaluated the circumstances related to the original four patent applications acquired and determined that that two of the existing patent applications could be improved and filed new patents applications to redefine and better protect our intellectual property than the original purchased patent applications. &nbsp;We have abandoned one of the initial four patent applications purchased, released two of the four applications purchased and substituted them with two new patent applications, and retained ownership of one of the four applications purchased, which has now converted to a national phase application. &nbsp;In connection with the abandoned patents, we have protected our rights with regards to the original patent applications purchased, however we determined we should record a loss on abandonment of $1,391,281 for the year ended December 31, 2014 as the initial value of the acquired patent applications pending resides in the newly filed / drafted eight patent applications. </P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>5</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify>Marketing and Sales</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>ZIVO Algal Products &amp; Derivatives</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The marketing and sale of all future products is subject to compliance with applicable regulations. Based on the findings from ongoing research, we intend to approach potential customers or licensees in the following market verticals. &nbsp;The products described throughout this document are still in the development stage, and subject to development risk. &nbsp;There can be no assurance that any of the products described below will prove to be effective, or if found to be effective, will be able to be produced in a commercially viable manner.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Animal Nutrition and Health</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>A 2007 pilot study in dairy cows indicated that our algal culture may be effective in fending off the onset, or significantly reducing symptoms, of bovine mastitis &#150; a condition that effectively stops milk production. According to the National Mastitis Council, the condition affects 10% of the U.S. dairy herd at any one time, costing producers approximately $1,100 per case. In the U.S. alone, production losses are nearly $3 billion. <I>Mycoplasma bovis</I> causes a highly contagious and potentially fatal form of bovine mastitis (an infection of the mammary gland), for which there currently is no treatment. &nbsp;In the cow&#146;s udder, mammary epithelial cells form an immunological barrier to protect the mammary gland. &nbsp;When bacteria or other pathogens break through this barrier, an infection sets in, affecting quality and quantity of milk produced. &nbsp;&nbsp;Our compounds showed promising early results for restoration of the immunological barrier in experiments conducted <I>in</I> <I>vitro</I>, as conducted by the Principal Researcher at the University of Wisconsin - Madison, Department of Dairy Science.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>On December 20, 2013, we entered into a Collaboration and Option Agreement (&#147;Agreement&#148;) with Zoetis, a global animal health company, in connection with the prevention, treatment, and management of bovine mastitis. &nbsp;In the Agreement, we granted to the counterparty an exclusive option to negotiate an exclusive license with us. &nbsp;Specifically, upon completion of a collaborative study (which is in process and will be completed upon adequate funding), the Agreement provides for a 90 day exclusivity period for evaluation of results and, based on the counterparty&#146;s desire for an exclusive license thereto, 90 days to conclude an exclusive license agreement.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>With respect to livestock and poultry applications, we intend to move on three related fronts &#150; working to bring an algal feed ingredient to market in the United States by amplifying the algae culture; working to produce a dietary supplement or feed additive for global consumption outside the U.S.; and, putting ourselves in a position to license the isolated bioactive molecules to a pharmaceutical or drug development company for synthetic development as a prescribed drug for production animal applications. &nbsp;The isolated bioactive molecules form the intellectual property of interest to Zoetis. The feed ingredient, feed additive and dietary supplement are intended for other potential collaborators.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The veterinarian who conducted the initial dairy cow <I>in vivo</I> study believes that the same autoimmune effect may be useful in combating bovine respiratory disease complex (&#147;BRDC&#148;), also known as &#147;shipping fever.&#148; BRDC typically occurs when beef cattle are shipped from the ranch to the feedlot prior to processing. According to the American Association of Beef Producers, cattle ranchers and feedlot operators attribute a 30% loss in body weight to BRDC when it occurs &#150; a $10 billion problem in the U.S. alone. We are planning a field study to validate several dosing modalities before offering a licensing option.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>A 2008 pilot study in dogs indicated that our algal culture may be effective in relieving the symptoms of osteoarthritis and soreness from overexertion. That same experiment with our amplified algae culture can be repeated in dogs, which if successful could allow a relatively rapid release to production and sales as a companion animal dietary supplement. According to the Nutrition Business Journal, the canine joint-health dietary supplement market segment tops $360 million annually in the U.S. alone. Estimates for the world market may be substantially higher, but such estimates are difficult to obtain. An <I>in vitro</I> tissue explant experiment conducted by the Comparative Orthopaedics Laboratory at University of Missouri found that direct stimulation of living canine joint tissue with our bioactive compounds protected cartilage from degradation by IL-1b, an inflammatory cytokine. If our product is proven to be effective <I>in vivo</I> and can be produced on an efficient basis, we intend to sell or license our product as a supplement ingredient to larger, well-established and profitable brand names in the pet industry. &nbsp;We have conducted other laboratory studies simulating the effects of canine osteoarthritis with positive results.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>6</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>With all of the above, the isolated bioactive molecules found in the amplified algae product may, subject to successful negotiations, be licensed to a pharmaceutical company for development as a synthetic prescription drug. We expect that the process of developing and testing such a drug could take years. &nbsp;Therefore, as is common practice, we intend to work toward negotiating a reasonable upfront licensing fee, milestone payments upon each successful conclusion of a development phase, followed by pre-market approval; and finally, a steady stream of royalties in the future. The other revenue streams generated by feed and supplement sales may begin to be realized in late 2017 or early 2018, but no assurance can be provided in that regard. Much of the research and licensing progress has been and will continue to be paced by the availability of capital funding and/or debt financing (see Item 7 &#150; Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations: Liquidity and Capital Resources). </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Functional Food Ingredient</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>According to NutraIngredients-USA, functional foods, or health foods, represent an estimated $20 billion business in the U.S. and a $28 billion business in Europe. The Middle East, although significantly smaller, is growing at a rate of 12-14% annually, followed closely by the newly-affluent in China and India. These foods typically are processed products that contain one or more staple foods augmented with a variety of performance-enhancing ingredients.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We intend to enter the food market with a healthy cholesterol and healthy immune response ingredient if and when the efficacy of our product can be demonstrated and it clears necessary regulatory hurdles. The timeframe is difficult to predict because of capital funding issues.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Dietary Supplement &amp; Nutraceutical</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The success of spirulina algae, dried kelp, Omega-3 fish oil, resveratrol, saw palmetto and similar supplements attests to the American public&#146;s obsession with &#145;natural&#146; products. The dietary supplement business is a $24 billion industry in the U.S. alone, and twice that the world over.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Rather than attempting to market a potential cholesterol related bioactive as a branded nutraceutical or supplement, we will endeavor to private-label the compound or finished product for larger, established marketers and retailers. If we are able to accomplish this, we believe this is a more efficient use of capital and resources while still retaining control of the intellectual property, the manufacturing process and pricing decisions. We do not intend to be placed in a position where our premier product application is commoditized and we must compete on price.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Medicinal Food</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Doctors prescribe medicinal foods prior to, during or after various medical procedures, including surgery, chemotherapy, radiation therapy and physical therapy. At times, medicinal foods are used to augment the effects of prescription drugs. These medicinal foods are expensive and typically reimbursed by health insurers.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe that this area has potential for us if we can demonstrate that various properties of the algal extract can be isolated and produced as a medicinal food or beverage prescribed by physicians. This is an FDA-regulated sector, but the standards are less stringent than pharmaceutical applications. &nbsp;Once again, under our new business model, if we are able to produce a commercial product in this area, we will endeavor to enter into a private-label arrangement with a larger strategic partner to produce and distribute this product application.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Pharmaceuticals</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe that we may be able to pursue prescription drug applications for our product. However, the process for developing a new prescription drug is costly, complex and time-consuming. It is an undertaking well beyond our current financial capabilities and one that may take years to achieve. If we pursue the development of a prescription drug, we will likely seek a partnership with a co-developer that will share in the risk and expense of the initial development process, and then share in any royalties resulting from the licensing or sale of any synthetic molecule and its homologs we are able to develop and license.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The first such step was the execution of the bovine mastitis Collaboration and Option Agreement with Zoetis. Part of our business plan is to execute agreements that may ultimately result in option payments, licenses fees and royalty payments across animal and human applications.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>7</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>WellMetris</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>WellMetris was formed for the purpose of developing, manufacturing, marketing, and selling tests that we believe will allow individuals and their care providers to optimize personal health and identify future health risks. &nbsp;The information obtained will also provide insurers, employers and healthcare providers timely information to intervene with wellness programs, fitness regimes or other preventative measures. &nbsp;We plan to develop and commercialize such tests in three phases:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase one (&#147;Phase One&#148;) or, alternately named Gen 1.0, we plan to develop and commercialize a series of tests, which are intended to measure indicators of good health and optimal metabolic function (collectively, the &#147;Phase One Test&#148;). &nbsp;The Phase One Test is being designed to measure biomarkers related to oxidative stress, inflammation, and antioxidant status to establish a metabolic assessment from which intervention can commence, and from which metabolic syndrome can be inferred.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase two (&#147;Phase Two&#148;) or alternately named Gen 1.5, we plan to develop and commercialize a testing technology focused on the positive or negative metabolic effects of metabolizing fat and muscle efficiency due to changes in diet, exertion, hydration and dietary supplements in a self-administered format that integrates with smartphone operating systems.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase three (&#147;Phase Three&#148;) or alternately named Gen 2.0, we plan to develop and commercialize additional tests intended to provide a more complete metabolic profile for an individual utilizing the metabolites present in urine. &nbsp;&nbsp;The Company believes the Gen 2.0 tests, in aggregate, will allow identification of healthy versus unhealthy bodily processes in real-time. This technology can also be applied to livestock and companion animals. As capital funding becomes available, the Company will move forward with finalizing its transition cow syndrome test, for which a provisional patent application has already been filed.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We are currently in Phase One of development as described above.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe there is a viable market for our Wellness Tests. &nbsp;More than 19% of Americans are afflicted with cardiovascular diseases, diabetes, autoimmune diseases and cancer. &nbsp;&nbsp;The Wellness Tests are intended to identify pre-conditions to such illnesses. &nbsp;Such identification may allow for early intervention and reduce incidence of such illnesses or forestall their onset. &nbsp;This is critically important to large employers, insurers and governmental agencies who are payers for health claims and are facing massive increases in premiums or cash outlays.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The WellMetris technology also incorporates sophisticated software to analyze, report, record and manage wellness and health data for large groups such as large employers, pension funds, accountable care organizations, state Medicaid agencies and their actuarial consultants, underwriters, re-insurers and wellness consultants. The software also contains tools to conduct meta-analysis of baseline health benchmarks and monitor the progress of pre-clinical intervention programs within large groups.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Due to funding issues, all development work has been halted until this entity is either sold, funded independently of ZIVO Bioscience, or spun out as a free-standing business.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Corporate Communications</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We maintain our website: www.zivobioscience.com and provide a toll free number (888) 871-6903. The content of our website is not a part of this Annual Report on Form 10-K and should not be construed as such.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>WellMetris maintains a separate website: www.wellmetris.com and provides the same toll free number as ZIVO Bioscience on its website.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Competition</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>ZIVO Algal Products &amp; Derivatives</P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Generic dietary supplements and functional food ingredients such as vitamins, Omega-3 and antioxidants are made and marketed in a fiercely competitive, price-sensitive market environment. Recently, several algae producers have made health claims for their proprietary algae strains, ranging from treatment for diabetes to controlling HIV symptoms. Proprietary products offered by some marketers are often dogged by unsubstantiated claims of product efficacy or present potential product safety issues, which in turn draw the attention of regulators. The optimal position for a supplement and ingredient maker is when pricing power can be exerted through well-protected intellectual property and further backed by well-documented safety and efficacy claims.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>8</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe that our primary competition will come from innovators in food technology such as DSM-Martek, Cognis, ConAgra, Cargill and Nestle, each of which has active M&amp;A efforts, a large scientific staff and a generous R&amp;D budget to develop supplements and ingredients for a wide range of applications. However, we intend to approach these very same competitors as potential strategic partners, in order to leverage their specific expertise in certain food and supplement categories where a mutually beneficial relationship can be established. &nbsp;There can be no assurance that this strategy will be effective.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>With respect to animal health, the companion animal dietary supplement segment, and specifically canine joint health, is made up almost exclusively of chondroitin/glutathione supplements, which have dominated that segment for more than a decade. This $360 million segment represents a potentially lucrative opportunity to introduce a completely new product if we are able to demonstrate superior benefits and produce a product at a comparable price.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Further, the animal health market as it pertains to mastitis in dairy cows, and specifically feed ingredients that exhibit beneficial properties, has been largely in the realm of yeast-based products. Only recently has there been a focus on algae-based alternatives, as promoted by Alltech with its $200 million expansion of an algae facility in Kentucky. In the U.S., feed ingredients cannot be promoted using any form of health claim, and dietary supplements for production animals are, to our knowledge, non-existent. However, outside the U.S., the use of dietary supplements is widespread, and we intend to market our refined ingredients to a worldwide market in partnership with a global brand name.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>WellMetris</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The biomedical and biotech fields are fiercely competitive. Many of the &#147;wellness&#148; tests available to the healthcare consumer or provider are not necessarily accurate nor reliable because some do not take into account urine concentration as normalized by creatinine or specific gravity, which changes markedly throughout the day. Blood-based wellness tests can be even less reliable because the biomarkers for oxidative stress and inflammation are extremely dynamic and will often change before the blood can be tested, casting doubt on the results.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Although we are not aware that competitors or competing products have entered the market recently, there is no guarantee that our products will be proven to be effective and commercially viable, or that a larger, better-financed competitor may not emerge once we begin promoting our products. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Raw Materials</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>ZIVO Algal Products &amp; Derivatives</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We produce our microbial mixture using third party facilities. At the close of 2016, we contracted Synthetic Genomics, Inc. to conduct commercial scale-up at a facility in Imperial Valley, California. We continue to use the AzCATI facility at Arizona State University to produce our microbial mixture for continued experimentation.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>WellMetris</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In tandem with seeking regulatory approval, we will need two physical components to deliver our services. &nbsp;A dedicated, custom reader device and a test comprised of eight (8) different chemistry tests on a single urine test panel housed in a proprietary disposable cartridge.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>The dedicated, custom reader device is manufactured by a third party to our specifications. &nbsp;We do not believe that there is a risk of supply, as there are several manufacturers available to produce the unit.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>The test panel and proprietary cartridge are manufactured by a third party to our specifications. &nbsp;We do not believe that there is a risk of supply, as there are several manufacturers available to produce the units.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Dependence on Customers</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As discussed above, we have readjusted the business model to focus in the near term on research and development in order to license our product and technology to third parties. &nbsp;At this time, there are no customers providing any revenue.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>9</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Production</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>ZIVO Algal Products &amp; Derivatives</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We produce our microbial mixture using third party laboratory facilities. &nbsp;At this time, we are only manufacturing the product for purposes of research and development programs that are currently underway. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>WellMetris</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As discussed above, we are using third parties to manufacture our custom reader device and test panel, which we are currently using for development purposes.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Patents and Proprietary Rights</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have rights in certain patent applications and trademarks. With respect to patents and trademarks, we have secured patent and federal trademark registrations in the U.S. Patent and Trademark Office (&#147;USPTO&#148;) as described below:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>U.S. Patent No. 7,807,622 issued October 5, 2010, relates to our proprietary complex algal culture. &nbsp;The title of the patent is: &#147;Composition and use of phyto-percolate for treatment of disease.&#148; &nbsp;This invention relates generally to a method of preparation of a phytopercolate that is derived from fresh water mixture including algae. The invention further relates to the potential use of the phyto-percolate in a variety of disease states. &nbsp;This patent was filed on November 30, 2006 and has a term of 20 years from the earliest claimed filing date (which may be subject to extension via Patent Term Adjustment and Patent Term Extension). </P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>U. S. Patent No. 8,586,053 issued November 19, 2013, relates to our proprietary algal culture. The title of the patent is: &#147;Composition and Use of Phytopercolate for Treatment of Disease.&#148; This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further relates to the use of the phyto-percolate in a variety of disease states. The phyto-percolate is believed to contain an activity that induces the reduction of soluble and insoluble fibrin. Further, the phyto-percolate is believed to reduce oxidative stress in the body. The patent was filed on April 20, 2006 and has a term of 20 years from the earliest claimed filing date. </P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>U.S. Patent No. 8,791,060 issued July 29, 2014, relates to our proprietary culture. Title of the patent is the same: &#147;Composition and Use of Phytopercolate for Treatment of disease.&#148; This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further describes proteolytic activity. &nbsp;The patent was filed on October 4, 2010 and has a term of 20 years from the earliest claimed filing date.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>U.S. Patent No. 9,486,005 relates to our proprietary culture. &nbsp;Title of the patent is: &#147;Agents and Mechanisms for Treating Hypercholesterolemia.&#148; &nbsp;This invention relates generally to a method of treating hypercholesterolemia in mammals, by administering an effective amount of microbial fermentation product and regulating genes involved in lipoprotein metabolism.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We also have an allowed pending trademark applications for &#147;ZIVO BIOSCIENCE,&#148; &#147;ZIVO BIOLOGIC,&#148; and ZIVO ZOOLOGIC&#148;. We may have other common law rights in other trademarks, trade names, service marks, and the like which will continue as long as we use those respective marks.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The following files have issued as patents, await examination or are in process:</P>
<P style="margin:0px"><BR></P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=0.533 /><TD width=357.733 /><TD width=58.467 /><TD width=0.533 /><TD width=116.333 /><TD width=191.467 /></TR>
<TR><TD style="margin-top:0px; border:1px solid #000000" valign=bottom width=358.267 colspan=2><P style="margin:0px; font-size:9pt" align=center><B>Title</B></P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=58.467><P style="margin:0px; font-size:9pt" align=center><B>Country</B></P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=116.867 colspan=2><P style="margin:0px; font-size:9pt" align=center><B>Patent/Application</B></P>
<P style="margin:0px; font-size:9pt" align=center><B>Number</B></P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=191.467><P style="margin:0px; font-size:9pt" align=center><B>Status</B></P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=358.267 colspan=2><P style="margin:0px; font-size:9pt">Composition and Use of Phytopercolate For Treatment of Disease</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=58.467><P style="margin:0px; font-size:9pt" align=center>U.S.</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.867 colspan=2><P style="margin:0px; font-size:9pt" align=center>7,807,622</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Issued Patent</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=358.267 colspan=2><P style="margin:0px; font-size:9pt">Composition and Use of Phytopercolate For Treatment of Disease</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=58.467><P style="margin:0px; font-size:9pt" align=center>Canada</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.867 colspan=2><P style="margin:0px; font-size:9pt" align=center>2,631,773</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Office action issued; response</P>
<P style="margin:0px; font-size:9pt" align=center>&nbsp;filed to foreign associate; </P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=358.267 colspan=2><P style="margin:0px; font-size:9pt">Composition and Method For Affecting Cytokines and NF-<font style='font-family:Arial Unicode MS,Times New Roman'>&#954;</font>B</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=58.467><P style="margin:0px; font-size:9pt" align=center>Canada</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.867 colspan=2><P style="margin:0px; font-size:9pt" align=center>PCT/US2010/056862 Canadian App. No.</P>
<P style="margin:0px; font-size:9pt" align=center>2,780,144</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Office action received 8/15/16; </P>
<P style="margin:0px; font-size:9pt" align=center>Awaiting examination </P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=0.533><P style="margin:0px; padding:0px; font-size:9pt">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition and Method For Affecting Cytokines and NF-<font style='font-family:Arial Unicode MS,Times New Roman'>&#954;</font>B</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59 colspan=2><P style="margin:0px; font-size:9pt" align=center>European</P>
<P style="margin:0px; font-size:9pt" align=center>Union</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>10830908.9</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Office action received; </P>
<P style="margin:0px; font-size:9pt" align=center>Response to office action filed</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=0.533><P style="margin:0px; padding:0px; font-size:9pt">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition and Method For Affecting Cytokines and NF-<font style='font-family:Arial Unicode MS,Times New Roman'>&#954;</font>B</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59 colspan=2><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US2010/056862</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>National stage filings completed</P>
</TD></TR>
</TABLE>
<DIV style="width:720px"><P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>10</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=357.733 /><TD width=59 /><TD width=116.333 /><TD width=191.467 /></TR>
<TR><TD style="margin-top:0px; border:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition and Method For Affecting Cytokines and NF-<font style='font-family:Arial Unicode MS,Times New Roman'>&#954;</font>B</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>14/558,516</P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Application filed; informational </P>
<P style="margin:0px; font-size:9pt" align=center>notice to applicant received; office </P>
<P style="margin:0px; font-size:9pt" align=center>action received; response filed</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition for Affecting Cytokines, Lactoferrin, and Serum Amyloid A</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>U.S.</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>61/834,842</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Application Filed 6/13/2013, </P>
<P style="margin:0px; font-size:9pt" align=center>non-provisional and</P>
<P style="margin:0px; font-size:9pt" align=center>PCT filed 6/13/14</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition for Affecting Cytokines, Lactoferrin and Serum Amyloid A</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US 14/42331</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>National stage filings completed</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Method of Cholesterol Regulation</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US11/ 25713</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>National Phase entered 8-22-12</P>
<P style="margin:0px; font-size:9pt" align=center>(US, JP, MX)</P>
<P style="margin:0px; font-size:9pt" align=center>National Phase entered 9-22-12 (EP)</P>
<P style="margin:0px; font-size:9pt" align=center>Canada extended National Phase </P>
<P style="margin:0px; font-size:9pt" align=center>DDD 8-22-13</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Agents and Mechanisms for Treating Hypercholesterolemia</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>Europe</P>
<P style="margin:0px; font-size:9pt" align=center>Union</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 11745434.8</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing Prosecution</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Stress and Inflammation Biomarker Urine Panel for Dairy Cows and Beef Cattle</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 61/835,282</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Converted to PCT 6/14/14</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Agents and Mechanisms for Treating Hypercholesterolemia</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>Canada</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 2,827,401</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing Prosecution</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Wellness Panel for Companion Animals</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 61/872,928</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Converted to PCT 9/3/14</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Wellness Panel</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 13/812,220</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing Prosecution</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Wellness Panel</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>61/367,486</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Converted to PCT</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Wellness Panel</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US11/44786</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>US National Phase entered</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Methods of modulating immune response and inflammatory response via administration of algal biomass</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US16/18105</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Filed: National stage filings</P>
<P style="margin:0px; font-size:9pt" align=center>&nbsp;due 8/16/17</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Nutritional support for animals via administration of an algal derived supplement</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>62/295,976</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Application filed Feb 16, 2016; </P>
<P style="margin:0px; font-size:9pt" align=center>Non-provisional and foreign/PCT </P>
<P style="margin:0px; font-size:9pt" align=center>due 2/16/17; converted to PCT</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Methods of modulating immune response and inflammatory response via administration of algal biomass</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 62,116,766</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Filed Feb 16, 2015; </P>
<P style="margin:0px; font-size:9pt" align=center>converted to PCT</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Smartphone urinalysis device</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 62 136,764</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Filed March, 23, 2015; </P>
<P style="margin:0px; font-size:9pt" align=center>&nbsp;converted to PCT</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Agents and Mechanisms for Treating Hypercholesterolemia</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US Div</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN15/330,830</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing prosecution</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Stress and Inflammation Biomarker Urine Panel for Dairy Cows and Beef Cattle</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>Intl.</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN14/42464</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing prosecution</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Wellness Panel for Companion Animals Smartphone Enabled Urinalysis Devise, software and Test Platform </P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US </P>
<P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN14/916,068</P>
<P style="margin:0px; font-size:9pt" align=center>PCT/US16/23702</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Undergoing prosecution</P>
<P style="margin:0px; font-size:9pt" align=center>US National Phase pending</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Sample Collection Device and Method for Urine and other Fluids</P>
<P style="margin:0px; font-size:9pt">&nbsp;&nbsp;</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>PCT</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>PCT/US/16/29725</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>US National Phase pending</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=357.733><P style="margin:0px; font-size:9pt">Composition for Affecting Cytokines, Lactoferrin, and Serum amyloid A</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=59><P style="margin:0px; font-size:9pt" align=center>US</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=116.333><P style="margin:0px; font-size:9pt" align=center>SN 14/898,091</P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=191.467><P style="margin:0px; font-size:9pt" align=center>Application filed 12/11/15; received notice of publication 5/5/16; office action response filed 12/21/16. </P>
</TD></TR>
</TABLE>
<DIV style="width:720px"><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Regulation</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><I><U>ZIVO Algal Products &amp; Derivatives</U></I></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">General Regulatory Framework</P>
<P style="margin:0px" align=justify>&nbsp;</P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In the United States and any foreign market we may choose to enter, our product(s) are subject to extensive governmental regulations.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>11</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In the United States, these laws, regulations and other constraints exist at the federal, state and local levels and at all levels of government in foreign jurisdictions. The majority of these regulations directly relate to (1) the formulation, clinical testing, manufacturing, packaging, labeling, distribution, sale and storage of our product(s) and (2) product claims and advertising, including claims and advertising by us, as well as claims and advertising by distributors for which we may be held responsible.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>U.S. product classification</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In the U.S., the formulation, testing, manufacturing, packaging, storing, labeling, promotion, advertising, distribution and sale of our product(s) are subject to regulation by various governmental agencies, primarily (1) the Food and Drug Administration (&#147;FDA&#148;) and (2) the Federal Trade Commission (&#147;FTC&#148;). &nbsp;Our activities also are regulated by various agencies of the states and localities and foreign countries in which our product(s) are manufactured, promoted, distributed and sold. The FDA, in particular, regulates the formulation, manufacture and labeling of conventional foods, dietary ingredients and dietary supplements (or nutraceuticals).</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The FDA is responsible for the oversight of all foods (including dietary supplements), drugs, cosmetics and medical devices in the United States. &nbsp;To the extent that we manufacture finished product(s) for sale to consumers (and in certain other limited circumstances where we sell our product as an ingredient), FDA regulations require us to comply with current good manufacturing practice (&#147;cGMP&#148;) regulations for the preparation, packing and storage of dietary supplements. &nbsp;This is a complex series of regulations that have posed significant compliance challenges to the supplement industry. &nbsp;&nbsp;To the extent that we supply our product(s) as ingredients for the use in foods or nutraceuticals, we would be required to comply with cGMP regulations for foods, as well as the provisions of the Food Safety Modernization Act of 2011 which require all companies involved in the production of food and food ingredients to develop and implement a Hazard Analysis and Critical Control Point (&#147;HACCP&#148;) program.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Dietary Supplement Health and Education Act of 1994 (DSHEA&#148;) revised the provisions of the Federal Food, Drug and Cosmetic Act (&#147;FFDCA&#148;) by recognizing &#147;dietary supplements&#148; as a distinct category of food and, we believe, is generally favorable to the dietary supplement industry. &nbsp;The legislation grandfathered, with some limitations, dietary ingredients that were on the market before October 15, 1994. &nbsp;A dietary supplement that contains a dietary ingredient that was not on the market before October 15, 1994 will require evidence of a history of use or other evidence of safety establishing that it is reasonably expected to be safe. &nbsp;To the extent that we offer for sale unique, proprietary ingredients we will be required to file with FDA evidence supporting the conclusion that we have a &#147;reasonable expectation&#148; that they will be safe for human consumption when used as directed. &nbsp;The FDA recently published an &#147;Advance Notice of Proposed Rulemaking&#148; which the nutraceutical industry believes will substantially increase the level of evidence required to satisfy the &#147;reasonable expectation&#148; standard.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>DSHEA provides for specific nutritional labeling requirements for dietary supplements. &nbsp;DSHEA permits substantiated, truthful and non-misleading statements of nutritional support to be made in labeling, such as statements describing general well-being from consumption of a nutraceutical ingredient or the role of a nutrient or dietary ingredient in affecting or maintaining structure or function of the body. &nbsp;A company making a statement of nutritional support must possess adequate substantiating scientific evidence for the statement, disclose on the label that the FDA has not reviewed the statement and that the product is not intended to mitigate, treat, cure or prevent disease, and notify the FDA of the statement within 30 days after its initial use. &nbsp;To the extent we produce finished product for use by consumers as nutraceuticals, we will be required to comply with these provisions of DSHEA.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Labeling and advertising regulations</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We may market one or more of our products as a conventional food or for use as an ingredient in conventional foods. &nbsp;Within the U.S., this category of products is subject to the Nutrition, Labeling and Education Act (&#147;NLEA&#148;) and regulations promulgated under the NLEA. The NLEA regulates health claims, ingredient labeling and nutrient content claims characterizing the level of a nutrient in the product. The ingredients added to conventional foods must either be generally recognized as safe by experts (&#147;GRAS&#148;) or be approved as food additives under FDA regulations.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The FTC, which exercises jurisdiction over the advertising of our product, has for years instituted enforcement actions against companies marketing supplements for alleged false, misleading or unsubstantiated advertising of some of their products. &nbsp;The FTC has specific guides for advertising claim substantiation as well as for the use of testimonials. &nbsp;As a general matter, companies making health related claims for their products or ingredients are required to possess well designed human clinical studies supporting such claims at the time they are made. &nbsp;Enforcement actions have often resulted in consent decrees and significant monetary payments by the companies involved. In addition, the FTC has increased its scrutiny of the use of testimonials which we have and may in the future utilize. </P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>12</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>International regulations of our product(s)</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In many foreign markets in which we may choose to offer our product(s) for sale, we may be required to obtain an approval, license or certification from the relevant country's ministry of health or comparable agency. &nbsp;This would hold true for jurisdictions such as Canada, the European Union, Japan, Australia and New Zealand. &nbsp;The approval process generally requires us to present each product and product ingredient to appropriate regulators for review of data supporting safety as well as substantiating any claims we may desire to make. We would also be required to comply with product labeling and packaging regulations that vary from country to country. Our failure to comply with these regulations could prevent our product(s) from being legally offered for sale. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>California Proposition 65</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>California&#146;s Safe Drinking Water and Toxic Enforcement Act of 1986, also known as Proposition 65, provides that no person in the course of doing business shall knowingly discharge or release a chemical known to the state to cause cancer or reproductive toxicity into water or into land where such chemical passes or probably will pass into any source of drinking water, without first giving clear and reasonable warning. &nbsp;Among other things, the statute covers all consumer goods (including foods) sold in the State of California. Prop. 65 allows private enforcement actions (sometimes called &#147;bounty hunter&#148; actions). &nbsp;Reports indicate that over 100 such actions have been commenced annually over the past 3 years against companies in the nutraceutical industry (e.g., lead content of calcium, lead content of ginseng, PCB in fish oil) alleging that their products are contaminated with heavy metals or other compounds that would trigger the warning requirements of the Act. &nbsp;While we intend to take appropriate steps to ensure that any of our products that we may market will be in compliance with the Act, given the nature of this statute and the extremely low tolerance limits it establishes (well below federal requirements), there is a risk that we, our contracted producer or a licensee could be found liable for the presence of miniscule amounts of a prohibited chemical in our product. &nbsp;Such liability could be significant.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>General</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>To the extent dictated by our research partners, we will produce research-only feedstock for chemical analysis, safety studies and efficacy studies compliant with applicable state and federal regulations. However, we will rely on our research partners to conduct their respective R&amp;D programs in a manner compliant with applicable regulation and law. Once a product concept has been fully developed, we intend to manufacture that product, either internally or on a contract basis. In either case, we intend to adhere to all state and federal regulations relative to the safety and efficacy of the product application, as well as relevant regulations covering the safe and consistent manufacture of that product.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><I>Compliance</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>In fall of 2016, we accelerated our efforts to achieve GRAS (Generally Recognized As Safe) status for the algal biomass, intended for use in humans, poultry, dogs and cattle. We contracted a well-regarded FDA consultant to map out the strategy and manage the process of developing product specifications, safety testing, publication of results and convening a GRAS panel for human use. In late 2016, as a result of a binding Letter of Intent with NutriQuest, an animal nutrition company based in Cedar Rapids, Iowa, the strategy expanded to accommodate a compliance track for poultry use as well.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As part of the accelerated effort, we contracted a number of well-regarded private and academic laboratories to establish a nutritional profile for the algal biomass, as well conduct various safety and toxicology tests required for the GRAS self-affirmation process. The tests, studies and validations will likely continue through most of 2017.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>WellMetris</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We are working to make the WellMetris testing systems compliant with existing FDA regulations and to that end have retained FDA counsel and a medical device consulting firm, which have advised us as to the most time and cost-efficient path to classification and approvals. &nbsp;This activity will continue upon availability of additional funding.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>13</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Research and Development</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>ZIVO</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Research</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Our algal culture has been subjected to product testing in its original form over several years, beginning in 2004. In spring of 2009, we undertook a research and development process with a view to fractioning the existing product into much smaller, concentrated groups of molecules with similar physical properties. These groups were then tested <I>in vivo</I> and <I>in vitro</I> with successful results noted in maintaining healthy cholesterol levels. &nbsp;A patent application describing a novel method of cholesterol regulation was submitted to the US Patent &amp; Trademark Office in spring of 2010 and a PCT filing was submitted in February of 2011.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Since January 2012 we continue to develop our research programs internally and direct outside academic researchers, private laboratories or contract research organizations to conduct experiments, tests and studies on our behalf. &nbsp;We spent approximately $800,000 for the year ended December 31, 2016 on research and development, as compared to $1 million in 2015. The resources were spent on external research, mainly to independent facilities involved in the analysis and validation of our bioactive compounds in various applications and animal models. To date, all of these amounts have been directly expensed as they have been incurred.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As of mid-March 2016, the Company has moved forward with the following R&amp;D activities:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>We are continuing work on a large-scale bovine mastitis study utilizing samples validated <I>in vitro</I> by the principal researcher at the University of Wisconsin - Madison and samples processed and validated by other researchers in the fall of 2016.. &nbsp;The pre-pilot and pilot arms of this study have been completed and the results gained thus far may shorten the primary arm of this bovine study, which is expected to commence upon available funding in early 2017</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>A study utilizing cadaver cartilage and joint tissue at the Comparative Orthopaedics Laboratory located at the University of Missouri showed positive early results for protective effects in canine joint health, using our natural bioactive compounds. The study will be repeated and expanded when capital funding is made available.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>A canine whole blood experiment was conducted at an international contract research organization to study the effects of our natural bioactive compounds on inflammatory cytokines and chemokines present in blood to assess whether a systemic or localized mechanism of action can be determined. &nbsp;Although the results trended in a positive direction, Company principals determined that a more definitive in vivo study would be more useful, pending capital funding.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>The ongoing elucidation and characterization of the natural bioactive compounds had undergone a data integrity review in early 2014. Further work to develop a more comprehensive understanding of the bioactives and developing a 3D model had been placed on hold since spring of 2014 pending available funding. In mid-March 2016, the Company re-activated the elucidation and characterization of the natural bioactive compounds as funding became available. The Center for Complex Carbohydrate Research at the University of Georgia was tasked with sample purification and preliminary analysis. Other laboratories were contracted to conduct bioassays to validate the bioactivity of the purified and isolated samples, with work ongoing at the close of 2016.</P>
<P style="margin:0px; clear:left" align=justify>&nbsp;</P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The purposes for these various tests and experiments are manifold: We are not only isolating bioactive molecules, but also testing the method of isolation and then validating that the isolated molecules retain their bioactivity across a select range of human and animal cell lines, and that these molecules exhibit no deleterious effects before they are introduced into humans or animals during <I>in vivo </I>studies. We must ensure that this does not occur occasionally, it is required for every production process, every safety validation process and every intended application, such as a canine dietary supplement that is mixed with food, as opposed to a canine dietary supplement that is administered in the form of a chewable caplet. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Further, as we now enter production scale-up, we are required to provide cGMP protocols and Quality Assurance (&#147;QA&#148;) protocols that show we can produce the algal biomass and/or the active ingredients safely, consistently and in defined quantities, and therefore rely on these same experiments and methods to substantiate our quality claims. These datasets form the basis for establishing the value of a license agreement. Therefore, every single license that we hope to issue requires its own data set and safety validation for the specific application being licensed. These datasets represent the core of the intellectual property that is being licensed.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>14</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Status of Culturing and Production</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Independent of identifying the bioactive compound(s) or validating their bioactivity and safety is the process and method of growing and maintaining the algal culture that gives rise to the bioactive compound(s) in the first place. This culture and its growing environment were developed decades ago. &nbsp;However, the method was not commercially viable, and the Company has expended considerable resources to develop a single-species, high-volume and commercially viable production methodology.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We made the decision to spread product development risk, resulting in the creation of a product platform strategy whereby four different forms could be developed for future marketing across several categories and applications:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>a) the raw algae biomass, which would naturally contain the beneficial compound(s); b) a more refined extraction which could be introduced into animal feed or supplements; c) the isolated natural molecule(s) which could be more appropriate for human consumption in food or supplements; and d) the synthetic version of any such natural molecule(s) which could be licensed to drug development companies or joint-ventured in a risk-sharing arrangement.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>To that end, we contracted with several experts in the field to coordinate isolation of the different organisms present in the culture, grow each of them separately and then subject them to the same life-cycle stressors as the original culture. The stated goal was to grow algae in bulk as a direct source of micro-nutrition and feed ingredient for production animals, namely beef cattle and dairy cows, as well as companion animal dietary supplementation. &nbsp;The production capability would be licensed to others. Per the business model, we have no intention of fielding a finished product, but rather empowering licensees to strike supply agreements with larger, better-financed brand names or licensing directly with such brand names. There can be no assurance that commercially viable products will be developed, or that they can be successfully and profitably manufactured and marketed.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Over the course of 2013 and 2014, our contracted researchers have been able to successfully isolate one or more algal species, scale up the production/output of the isolated species and still retain some of the key, desirable bioactive properties associated with the earlier, complex culture. Proof of concept growing techniques, including both pond and bioreactor modes, have shown that our target algal specie can be grown in commercially viable quantities, and the harvest time has been compressed from several months to several days&#146; time. We are uncertain if we can grow biomass in sufficient tonnage for livestock feed, but we believe that the current production methods will allow us to satisfy demand for a more refined extract introduced into animal supplements and, as a more purified substance, into human supplements.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In 2014, we tested the algal biomass and isolates derived from the aforementioned prototype growing facilities in dairy cows with successful results.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In 2015, we finalized development of Standard Operating Procedures (&#147;SOP&#146;s&#148;) in order to draft contractual terms with contract growers domestically and abroad. The SOP&#146;s form the basis for current Good Manufacturing Practice (&#147;cGMP&#148;) protocols to which contract growers and processors must adhere as part of the FDA&#146;s updated Food Safety Modernization Act of 2011 (&#147;FSMA&#148;) requirements, regardless of country of origin. In early 2016, we contracted with a Florida-based algae grower to scale-up production in a commercial setting. Due to weather problems, including Hurricane Matthew, the grower was unable to successfully deliver the biomass required. To remedy the situation, we identified and began contract negotiations in late October with Synthetic Genomics, Inc., (SGI) which operates an algae production facility in Imperial Valley, California, and concluded a tolling agreement in late December, 2016. SGI will also convert and upgrade the SOPs to cGMP level specifications so that we can meet compliance requirements. We conducted experiments in post-processing, such as spray-drying centrifugal water extraction and other techniques to better understand feed and food handling requirements. We interviewed FDA compliance consultants for animal feed applications and contracted the Burdock Group of Orlando, Florida in summer of 2016 to manage the compliance process on our behalf. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Looking Forward</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>A significant portion of our research efforts have been directed towards identifying a candidate &#147;class of compound&#148; and one or more &#147;active ingredients&#148;, as it relates to autoimmune and anti-inflammatory response. These are very broad categories and work is still required to fully describe the 3D structure of such compounds, as the actual structure is how the bioactivity exists and where the value is locked. One approach among several we&#146;ve taken is to create synthetic homologs, and from them deduce the composition and 3D structure of the naturally bioactive compounds. &nbsp;In early 2014, we determined that the synthetic approach was not yielding the hoped-for results and halted that particular effort. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>In mid-March 2016, we restarted the elucidation and characterization effort by contracting the Center for Complex Carbohydrate Research at the University of Georgia to begin sample purification, isolation and analyses, supported by bioassay validation conducted at several private labs.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>15</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Subject to the availability of sufficient funding, we estimate that we will, in fiscal 2017, be required to expend in excess of $3,000,000 on research and subsequent product development in order to complete the initiatives discussed herein. In addition to the activity in 2017, we plan to continue our research and development efforts in 2018 and beyond. &nbsp;These expenditures will need to be met from external funding sources. In the past, we have had difficulty raising funds from external sources. Thus, we may not be able to raise the funding required to continue our research and development activities. In the event that these sources are not available or adequate to meet our research needs, we will be unable to pursue our research activities, in which case our ability to substantiate the accumulated intellectual property with objective clinical support for its characterization, method of action and efficacy will continue to be impeded, thereby severely hindering our ability to generate licensing revenue (or otherwise commercialize our products) and adversely affect our operating results.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In the event that we are successful in raising the necessary capital, we will continue our current research program with our research partners, we will expand our investigations to include various experts and consultants on an as-needed basis and explore new product concepts and applications. Our current contracts with our research partners cover the following activities:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Ongoing isolation and characterization of individual natural molecules from various production formats in sufficient quantities for downstream analyses, experiments, standards development, FDA compliance, cGMP and QA protocols</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Ongoing validation of samples <I>in vivo</I> and <I>in vitro</I> to substantiate efficacy and safety for each specific application or claim, i.e., poultry immune health, canine osteoarthritis, canine joint health, porcine respiratory/reproductive syndrome, etc., to boost value for each specific license</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Synthetic development/validation of individual molecules to boost value of licenses</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Ongoing validation of samples in vivo and in vitro for standards development, FDA safety compliance, cGMP and QA protocols</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Product development initiatives such as the joint development project with NutriQuest to develop a successful poultry feed ingredient; a protein enhancement ingredient for fruit and vegan drinks and smoothies and a human dietary supplement formulation</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Ancillary development activities would occur in parallel with our research partners.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Development</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I><U>WellMetris</U></I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>WellMetris was initially focused on large-scale, programmatic applications of its testing and reporting platform. We are interested in supporting the intervention by wellness consultants or medical professionals in the lifestyle choices made by individuals covered by traditional health insurance plans, retiree medical benefits pools, employer-sponsored health initiatives and taxpayer-sponsored programs like Medicaid and the ACA (Affordable Care Act) or its replacement. &nbsp;These interventions, which are typically non-medical, have been shown to be successful in delaying the onset of chronic diseases such as diabetes or cardiovascular problems. We believe that targeting asymptomatic individuals and focusing intervention efforts on these individuals may have a positive result for wellness programs, and potentially lower premiums and health claims.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>At the close of 2015, the WellMetris product platform required additional prototype analyzers and additional dry chemistry reagent strips and cartridges to conduct pilot programs for potential customers, and to use the result of these pilot programs to help normalize data for the dry chemistry reagents as part of the FDA submission package. Such efforts are currently on hold, pending capital funding.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In early 2016 we refocused product development on self-monitoring of individual health, primarily focused on those individuals who purchase dietary supplements, join health clubs or are otherwise actively pursuing a healthy lifestyle. This involves miniaturizing some aspects of our test cartridge concept and creating a mobile application, thereby eliminating the need for the analyzer device. This is a significant undertaking, which will not commence until we realize revenues from our Phase 1 product launch or attract additional capital funding. However, incremental steps were taken in 2016 to finalize 3D models of the sample collection device and the assay carrier in preparation for finite element testing of each component sometime in 2017, pending available funding.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>16</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Compliance with Environmental Laws</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe that we are, in all material respects, in compliance with local, state, and federal environmental laws applicable to our production and waste disposal. The cost of this compliance activity to date has not been material, and has been absorbed within our general operations overhead.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Employees</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As of December 31, 2016 we had two full-time employees, positioned in executive management. In addition, we have three part-time people acting on a consulting basis as our Chief Science Officer; Director, Research &amp; Development; and Lead Scientist &amp; Clinical Coordinator. We believe that our employee relations are good. No employee is represented by a union.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Available Information</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Our website is http://zivobioscience.com/. Information on our website is not incorporated by reference into this Form 10-K and should not be considered part of this report or any other filing we make with the SEC. We file annual, quarterly and current reports, and other information with the Securities and Exchange Commission. &nbsp;&nbsp;Our filings with the SEC can be viewed at www.sec.gov.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 1A. &nbsp;Risk Factors.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>There is</I> <I>substantial doubt about our ability to continue as a going concern. </I>Our independent registered public accounting firm has issued an opinion on our consolidated financial statements which states that the consolidated financial statements were prepared assuming we will continue as a going concern and further states that our recurring losses from operations, stockholders&#146; deficit and inability to generate sufficient cash flow to meet our obligations and sustain our operations raise substantial doubt about our ability to continue as a going concern.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We are materially dependent on external sources for continued funding. </I>Unless and until we realize licensing and royalty revenues sufficient to cover our expenses, we will be reliant upon external sources to fund our continued operations. There is no guarantee that this funding will continue. If we are unable to raise additional funds, there will be a material adverse effect on our business, financial condition and results of operations.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We only have 450 million shares authorized for issuance. </I>As of December 31, 2016, we had <A NAME="OLE_LINK2"></A>136,745,347 shares outstanding. &nbsp;We also had contractual commitments to issue 145,605,722 additional shares as of December 31, 2016, consisting of 111,086,456 common shares issuable upon the conversion of convertible debentures and related accrued interest and 32,071,901 common shares issuable upon the exercise of outstanding warrants. &nbsp;This totals a potential 282,423,964 shares outstanding if all debentures were converted and warrants exercised. &nbsp;In order to increase the authorized shares to a higher number, we would need to amend our articles of incorporation, which would require shareholder approval. &nbsp;There is no guarantee that we will be able to obtain the shareholder approval necessary to amend our articles of incorporation to increase our authorized shares.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Our future success is dependent on our ability to establish strategic partnerships. </I>&nbsp;We do not have resources to pursue the development, manufacturing and marketing of products on our own, and we will need to rely on third parties for some of these activities. &nbsp;<I>&nbsp;</I>There is no guarantee that we will be able to successfully establish strategic partnerships.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>The ability to market our product is dependent upon the completion of proven, clinical research. </I>While we are currently undergoing studies to further identify the active ingredients in our products, there is no guarantee that the research will successfully achieve this goal. If our current research does not return the results we expect, our business prospects will be materially and adversely affected.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Government regulation of our products may adversely affect sales. </I>Nutraceutical and animal supplement products, although not subject to FDA approval, must follow strict guidelines in terms of production and advertising claims. Our ability to produce and successfully market our products is dependent upon adhering to these requirements. &nbsp;If we fail to comply with applicable government regulations concerning the production and marketing of our product, we could be subject to substantial fines and penalties, which would have a material adverse effect on our business.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We have a history of losses, we expect to continue to incur losses and we may not achieve or sustain profitability in the future. &nbsp;</I>We have incurred losses in each fiscal year of our existence. We cannot assure you that we will reach profitability in the future or at any specific time in the future or that, if and when we do become profitable, we will sustain profitability. If we are ultimately unable to generate sufficient revenue to meet our financial targets, become profitable and have sustainable positive cash flows, investors could lose their investment.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>17</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Competition from current competitors and new market entrants could adversely affect us. &nbsp;</I>We compete with a wide range of established companies in a variety of different markets, all of whom have substantially greater name recognition and resources than we do. We face or will face other specialized competitors if we are able to expand into new vertical markets. These competitors may be more efficient and successful than we are. &nbsp;If we fail to compete successfully, our operating results and financial condition will be materially adversely affected.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Changes in laws and/or regulations may cause our business to suffer. &nbsp;</I>The future success of our business depends upon our ability to meet regulatory requirements for the sale of our products. Increased enforcement of existing laws and regulations, as well as any laws, regulations, or changes that may be adopted or implemented in the future, could limit our ability to market our products.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>The loss of key employees and technical personnel or our inability to hire additional qualified personnel could have a material adverse effect on our business. &nbsp;</I>Our success depends in part upon the continued service of our senior management personnel. Our success will also depend on our future ability to attract and retain highly qualified technical, managerial and marketing personnel. The market for qualified personnel has historically been, and we expect that it will continue to be, intensely competitive. We cannot assure you that we will continue to be successful in attracting or retaining such personnel. The loss of certain key employees or our inability to attract and retain other qualified employees could have a material adverse effect on our business.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We could incur substantial costs as a result of any claim of infringement of another party's intellectual property rights. </I>In recent years, there has been significant litigation in the U.S. and elsewhere involving patents and other intellectual property rights. Companies are increasingly bringing and becoming subject to suits alleging infringement, misappropriation or other violations of patents, copyrights, trademarks, trade secrets or other intellectual property rights. These risks have been amplified by an increase in the number of third parties whose sole or primary business is to assert such claims. &nbsp;We could incur substantial costs in prosecuting or defending any intellectual property litigation. Additionally, the defense or prosecution of claims could be time-consuming and could divert our management's attention away from the execution of our business plan.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We cannot be certain that our products do not infringe the intellectual property rights of third parties. &nbsp;Claims of alleged infringement or misappropriation could be asserted against us by third parties in the future. &nbsp;We cannot be sure that we would prevail against any such asserted claim.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Moreover, any settlement or adverse judgment resulting from a claim could require us to pay substantial amounts or obtain a license to continue to use the technology that is the subject of the claim, or otherwise restrict or prohibit our use of the technology. We cannot assure you that we would be able to obtain a license from the third patty asserting the claim on commercially reasonable terms, that we would be able to develop alternative technology on a timely basis, or that we would be able to obtain a license to use a suitable alternative technology to permit us to continue offering, and our customers to continue using, our affected products or technology. In addition, we may be required to indemnify our customers for third-party intellectual property infringement claims, which would increase the cost to us. &nbsp;An adverse determination could also prevent us from offering our products or services to others. Infringement claims asserted with or without merit against us may have an adverse effect on our business, financial condition and results of operations.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>If we are required to make substantial payments or undertake any of the other actions noted above as a result of any intellectual property infringement claims against us or any obligation to indemnify our customers for such claims, such payments or costs could have a material adverse effect upon our business and financial results. &nbsp;Even if we are not a party to any litigation between a customer and a third party, an adverse outcome in any such litigation could make it more difficult for us to defend our technology in any subsequent litigation in which we are a named party. &nbsp;Moreover, such infringement claims with or without merit may harm our relationships with our existing customers and may deter others from dealing with us.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We may not be able to adequately protect our intellectual property rights and efforts to protect them may be costly and may substantially harm our business. &nbsp;</I>Our ability to compete effectively is dependent in part upon our ability to protect our intellectual property rights. &nbsp;While we hold one issued patent and pending patent applications covering certain elements of our technology, these patents, and, more generally, existing patent laws, may not provide adequate protection for portions of the technology that are important to our business. In addition, our pending patent applications may not result in issued patents.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>U.S. patent, copyright, trademark and trade secret laws offer us only limited protection and the laws of some foreign countries do not protect proprietary rights to the same extent. Accordingly, defense of our trademarks and proprietary technology may become an increasingly important issue as we seek to expand our product development into countries that provide a lower level of intellectual property protection than the U.S. Policing unauthorized use of our trademarks and technology is difficult and the steps we take may not prevent misappropriation of the trademarks or technology on which we rely. If competitors are able to use our trademarks or technology without recourse, our ability to compete would be harmed and our business would be materially and adversely affected.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>18</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We may elect to initiate litigation in the future to enforce or protect our proprietary rights or to determine the validity and scope of the rights of others. That litigation may not be ultimately successful and could result in substantial costs to us, the reduction or loss in intellectual property protection for our technology, the diversion of our management's attention and harm to our reputation, any of which could materially and adversely affect our business and results of operations.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>We do not anticipate paying any dividends on our common stock. </I>We do not anticipate paying any cash dividends on our common stock in the foreseeable future. &nbsp;If we do not pay cash dividends, you could receive a return on your investment in our common stock only if the market price of our common stock has increased when you sell your shares.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Substantial future sales of our common stock in the public market could cause our stock price to fall. &nbsp;</I>Sales of substantial amounts of our common stock in the public market, or the perception that these sales could occur, could cause the market price of our common stock to decline and impede our ability to raise capital through the issuance of additional equity securities. We have outstanding warrants and convertible debt that may result in substantially more outstanding shares, which could cause the price of our common stock to decline.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Sales Risk &#150; WellMetris products. </I>We have not finished developing our products or sold any products. &nbsp;We have only begun test marketing. &nbsp;We cannot be assured that there is a sufficient market demand for our products. &nbsp;In addition, while we are actively pursuing the relationships necessary to begin manufacturing and marketing the Wellness Tests, we have not yet finalized agreements with potential business partners, including third-party resellers, labs or distributors of the Wellness Tests. &nbsp;Failure to secure these critical alliances on reasonable terms could negatively impact us, our business and future plans.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Dependence on Manufacturers. </I>We do not own or operate, and currently do not plan to own or operate, manufacturing facilities for production of tests or devices which are critical to the successful operation of the business. We plan to target manufacturers and to form alliances for the mass production of our products, but we have no assurance that such alliances will be established. Furthermore, once we enter into such relationships, we may not have sufficient long-term agreements with any third-party manufacturers to ensure adequate supply and price controls. &nbsp;This may result in delays, quality control issues, additional expenses, and failure to meet demand or other customer obligations or needs.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>Failure of Manufacturers to Meet Design Specifications. &nbsp;</I>The success of our products is contingent upon one or more third parties manufacturing products according to design specifications. In practice, this is difficult to enforce and guarantee. As a result, we may never realize the expected efficiency, quality or sensitivity of our products and, as a result, may be required to continue research and development with another manufacturer. &nbsp;If a joint venture partner or contractor fails to meet design specifications, we will experience delays in commencing operations or delays in fulfilling orders in the future. Such delays could have a material adverse impact on our financial condition.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 1B. &nbsp;Unresolved Staff Comments.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Not required for smaller reporting companies.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 2. &nbsp;Facilities.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have leased 500 square feet in Bloomfield Hills, Michigan and 2,000 square feet in Keego Harbor, Michigan on a month to month basis to serve as the headquarters of our company. &nbsp;&nbsp;The monthly rent is $4,500.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 3. &nbsp;Legal Proceedings.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>From time to time we are involved in litigation incidental to our business.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>19</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><B>PART II</B></P>
<A NAME="_Toc418413160"></A><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Item 5. &nbsp;Market for Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Market Information</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Our common stock is quoted on the OTC Market (&#147;OTCQB&#148;) administered by the Financial Industry Regulatory Authority under the symbol &#147;ZIVO.&#148; The following table sets forth the range of high and low bid information as reported on the OTCQB by quarter for the last two fiscal years. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=201.6 /><TD width=84.8 /><TD width=86.4 /></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px"><B>Year ended December 31, 2015</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right><B><U>HIGH</U></B></P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right><B><U>LOW</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">First Quarter </P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>$ 0.11</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>$ 0.06</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Second Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.20</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.06</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Third Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.14</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.08</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Fourth Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.09</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.04</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px"><B>Year ended December 31, 2016</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right><B><U>HIGH</U></B></P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right><B><U>LOW</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">First Quarter </P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>$ 0.09</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>$ 0.04</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Second Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.09</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.05</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Third Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.07</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.04</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=201.6><P style="margin:0px">Fourth Quarter</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.12</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>0.05</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; text-indent:-0.667px">As of December 31, 2016 we had 145 shareholders of record.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have not paid any dividends on our common stock during the last two fiscal years, due to our need to retain all of our cash for operations. &nbsp;We do not anticipate paying any cash dividends on our common stock for the foreseeable future.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Recent Sales of Unregistered Securities.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the three months ended March 31, 2016, we issued 517,500 shares of common stock valued at $36,000 in connection with $1,000,000 of convertible debt financings in the first quarter.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the three months ended June 30, 2016, we issued 112,500 shares of common stock valued at $9,000 in connection with $250,000 of convertible debt financings in the second quarter.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the three months ended September 30, 2016, we issued 330,000 shares of common stock valued at $18,000 in connection with $500,000 of convertible debt financings in the third quarter. &nbsp;In addition, the Company also issued 3,500,000 shares of common stock, valued at $175,000, to an investor relations consulting firm.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the three months ended December 31, 2016, we issued 128,571 shares of common stock valued at $9,000 in connection with $250,000 of convertible debt financings in the fourth quarter.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company believes that the foregoing transactions were exempt from the registration requirements under Rule 506 of Regulation D promulgated under the Securities Act of 1933, as amended (&#147;the Act&#148;) or Section 4(2) under the Act, based on the following facts: in each case, there was no general solicitation, there was a limited number of investors, each of whom was an &#147;accredited investor&#148; (within the meaning of Regulation D under the &#147;1933 Act&#148;, as amended) and/or was (either alone or with his/her purchaser representative) sophisticated about business and financial matters, each such investor had the opportunity to ask questions of our management and to review our filings with the Securities and Exchange Commission, and all shares issued were subject to restrictions on transfer, so as to take reasonable steps to assure that the purchasers were not underwriters within the meaning of Section 2(11) under the 1933 Act.</P>
<A NAME="_Toc418413161"></A><P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 6. &nbsp;Selected Financial Data.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Not required for smaller reporting companies.</P>
<A NAME="_Toc418413162"></A><P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>20</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 7. Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Overview</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For ZIVO, we have put in place a business model in which we would derive future income from licensing and selling natural bioactive ingredients that may be derived from or are initially based on the algae cultures. We expect that these planned new products will likely be sold to much larger, better-financed animal, food, dietary supplement and medical food manufacturers. &nbsp;The anticipated income streams are to be generated from a) royalties and advances for licensed natural bioactive ingredients, and b) a toll on bulk sales of such ingredients. These bulk ingredients will likely be made by contracted ingredient manufacturers and then sold by us to animal food, dietary supplement and medical food processors and/or name-brand marketers. Further, we expect to license our bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For WellMetris, we are developing, with the intention to manufacture, market, and sell tests, that we believe will allow people to optimize their health and identify future health risks. &nbsp;We plan to develop and commercialize such tests in three phases:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase one (&#147;Phase One&#148;) or, alternately named Gen 1.0, we plan to develop and commercialize a series of tests, which are intended to measure indicators of good health and optimal metabolic function (collectively, the &#147;Phase One Test&#148;). &nbsp;The Phase One Test is being designed to measure biomarkers related to oxidative stress, inflammation, and antioxidant status to establish a metabolic assessment from which intervention can commence, and from which metabolic syndrome can be inferred.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase two (&#147;Phase Two&#148;) or alternately named Gen 1.5, we plan to develop and commercialize a testing technology focused on the positive or negative metabolic effects of metabolizing fat and muscle efficiency due to changes in diet, exertion, hydration and dietary supplements in a self-administered format that integrates with smartphone operating systems.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; font-family:Symbol; float:left">&#183;</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>In phase three (&#147;Phase Three&#148;) or alternately named Gen 2.0, we plan to develop and commercialize additional tests intended to provide a more complete metabolic profile for an individual utilizing the metabolites present in urine. The Company believes the Gen 2.0 tests, in aggregate, will allow identification of healthy versus unhealthy bodily processes in real-time. This technology can also be applied to livestock and companion animals. As capital funding becomes available, the Company will move forward with product development.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We believe there is a viable market for our Wellness Tests. &nbsp;More than 19% of Americans are afflicted with cardiovascular diseases, diabetes, autoimmune diseases and cancer. &nbsp;&nbsp;The Wellness Tests are intended to identify pre-conditions to such illnesses. &nbsp;Such identification may allow for early intervention and reduce incidence of such illnesses or forestall their onset. &nbsp;This is critically important to large employers, insurers and governmental agencies who are payers for health claims and are facing massive increases in premiums or cash outlays.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The WellMetris technology also incorporates sophisticated software to analyze, report, record and manage wellness and health data for large groups such as large employers, pension funds, accountable care organizations, state Medicaid agencies and their actuarial consultants, underwriters, re-insurers and wellness consultants. The software also contains tools to conduct meta-analysis of baseline health benchmarks and monitor the progress of pre-clinical intervention programs within large groups.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Since 2004, we have been incurring significant operating losses and negative cash flow. We experienced only nominal sales of our algal product, which was pulled from the market in January of 2012, and have relied primarily on the sale of company securities and shareholder loans to fund operations. &nbsp;&nbsp;We are also experiencing an ongoing and substantial working capital deficiency. We have had difficulty raising capital from third parties. In March of 2017, we successfully raised capital to fund operations and research for the first half of 2017. If we are unable to obtain additional funding in the near term, we may be unable to continue as a going concern, in which case you would likely suffer a total loss of your investment in our company. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Results of Operations for Years Ended December 31, 2016 and 2015</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Sales</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We had no sales for the years ended December 31, 2016 and 2015.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Cost of Sales</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company had no Costs of Sales for the years ended December 31, 2016 and 2015. As noted above, we ceased all sales activities as of January 2012.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>21</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Selling Expenses</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company had no Selling Expenses for the years ended December 31, 2016 and 2015. &nbsp;As noted above, we ceased all sales activities as of January 2012.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>General and Administrative Expenses</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>General and administrative expenses decreased approximately $131,000 to $832,000 in 2016 compared to $963,000 in 2015. &nbsp;General and administrative expenses decreased in the following areas: a reduction of WellMetris operating expenses of $108,000, travel expenses of $22,000 and an overall reduction in office expenses. &nbsp;Our decrease in general and administrative expenses was due to our difficulty in raising capital.</P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>&nbsp;</B></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Professional Fees and Consulting Expense</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Professional fees and consulting expense increased approximately $809,000 to $1,869,000 in 2016 compared to $1,060,000 in 2015. Professional fees and consulting expense were increased in 2016 due to the following: an increase of $824,000 in the use of an Investor Relations Firm and use of financial consultants (of the total expense in 2016 related to these activities of $1,378,000, $1,291,000 was a non-cash expense in the forms of stock and warrants issued for services rendered), an increase of $19,000 in filing and listing fees, and an increase in legal and accounting fees of $24,000 offset by a reduction in Board of Director Fess of $57,000 (of the total expense in 2016 related to these activities of $110,000, $70,000 was a non-cash expense in the form of warrants issued for services rendered).</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Research and Development Expenses</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Research and development expenses decreased approximately $244,000 to $789,000 in 2016 compared to $1,033,000 in 2015 for the comparable period. The decrease in research and development for 2016 can be attributed to a decrease in available funding. We expect external research and development to increase in 2017 as we pursue additional external trials, subject to the availability of sufficient funding, which we do not currently have.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Other Income (Expenses)</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2016, we recorded approximately $1,376,000 relating to amortization of bond discount as compared to $2,048,000<FONT style="font-size:12pt"> </FONT>for the year ended December 31, 2015, a $642,000 decrease. &nbsp;The decrease is due to a reduction of in amortization of bond discounts based on the timing of the discounts. &nbsp;The discounts are amortized over a two year period, and a number of periods rolled out during 2016. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2016, we recorded approximately $135,000 in amortization of deferred finance costs as compared to $85,000 in 2015. &nbsp;The increase of $50,000 is due to additional funding received in 2016 which incurred finance costs which are amortized over a two year period. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2016, we recorded approximately $72,000 in finance costs paid in stock and warrants as compared to $96,000 in 2015. &nbsp;The decrease of $24,000 was due to a lower funding level combined with a lower stock price which is used to calculate the finance costs.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the year ended December 31, 2016, we recorded approximately $986,000 in interest expense as compared to $720,000 in 2015. The increase of $266,000 is due to the increased debt the Company incurred in 2016.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Liquidity and Capital Resources</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The consolidated financial statements contained in this report have been prepared on a &#147;going concern&#148; basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the reasons discussed herein, there is a significant risk that we will be unable to continue as a going concern, in which case, you would likely suffer a total loss of your investment in our company.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>22</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As of March 31, 2017, we had cash in the bank of $1,005,000. We have incurred significant net losses since inception, including a net loss of approximately $6,060,000 during the year ended December 31, 2016. We have, since inception, consistently incurred negative cash flow from operations. During the year ended December 31, 2016, we incurred negative cash flows from operations of approximately $2,543,000. As of December 31, 2016, we had a working capital deficiency of $10,662,057 and a stockholders&#146; deficiency of $13,621,235. Although we recently raised a limited amount of capital, we have a near term need for significant additional capital.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2016, our operating activities used approximately $2,543,000 in cash, compared with $2,297,000 in cash during the comparable prior period. &nbsp;The approximate $247,000 decrease in cash used by our operating activities was due primarily to the following (all of which are approximated): a $270,000 increase in net loss, a $427,000 change (decrease) in accounts payable, a $20,000 change (decrease) in prepaid expenses, a $14,000 change in due to related party (decrease), and a $265,000 change in accrued interest (increase), offset by a $24,000 decrease in financing costs (a non-cash expense item), a $135,000 decrease in accrued liabilities, a $464,000 decrease in amortization and depreciation (a non-cash expense item) and an increase of $836,000 in stocks and warrants issued for services rendered &nbsp;(a non-cash expense item).</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the years ended December 31, 2016 and 2015, there were no investing activities.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the years ended December 31, 2016 and 2015, our financing activities generated $3,034,000 and $2,312,000 in cash, respectively. The difference of $722,000 was primarily related to a net increase of proceeds of $1,183,000 from issuance of convertible debentures (with loans payable converted into convertible debentures), offset by a decrease of $287,000 in loans from related parties, a decrease of $48,000 from the proceeds of sales of common stocks and deferred finance costs of $125,000.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the fourth quarter of 2011, we entered into an agreement with HEP Investments, LLC (&#147;HEP&#148;) under which HEP agreed to purchase convertible notes in the aggregate principal amount of $2,000,000. &nbsp;Through 2016, we amended this agreement to provide for funding up to $17,500,000. &nbsp;As of the date of this filing, HEP had advanced a total of $14 million pursuant to this arrangement. &nbsp;HEP&#146;s convertible notes are secured by all our assets.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Although we raised a limited amount of capital during 2016, we continue to experience a shortage of capital, which is materially and adversely affecting our ability to run our business. As noted above, we have been largely dependent upon external sources for funding. We have in the past had difficulty in raising capital from external sources. &nbsp;We are still heavily reliant upon external financing for the continuation of our research and development program.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We estimate that we will require approximately $5,000,000 in cash over the next 12 months in order to fund our normal operations and to fund our research and development initiatives. Based on this cash requirement, we have a near term need for additional funding. Historically, we have had substantial difficulty raising funds from external sources; however, we recently were able to raise a limited amount of capital from outside sources. If we are unable to raise the required capital, we will be forced to curtail our business operations, including our research and development activities. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Seasonality</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Based on our business model implemented at the beginning of 2012, anticipated income streams are to be generated from the following:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For ZIVO</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:72px; width:96.133px; float:left">a)</P>
<P style="margin:0px; padding-left:96.133px; text-indent:-2px" align=justify>royalties and advances for licensed natural bioactive ingredients, isolated natural compounds and synthetic variants thereof,</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; padding-left:96.133px" align=justify>and </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:72.133px; width:96px; float:left">b) </P>
<P style="margin:0px; text-indent:-2px" align=justify>bulk sales of such ingredients;</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For WellMetris</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>The selling of wellness tests and data services related to medical records management and analysis/compilation of data gathered on behalf of payers. For insurers, the primary selling season is November through April of any given year.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We do not anticipate that these will be affected by seasonality.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>23</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Staffing</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have conducted all of our activities since inception with a minimum level of qualified staff. &nbsp;We currently do not expect a significant increase in staff.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Off-Balance Sheet arrangements</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have no off-Balance Sheet arrangements that would create contingent or other forms of liability.</P>
<A NAME="_Toc418413163"></A><P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 7A. &nbsp;Quantitative and Qualitative Disclosures about Market Risk.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Not required for smaller reporting companies.</P>
<A NAME="_Toc418413164"></A><P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 8. &nbsp;Financial Statements and Supplementary Data.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Reference is made to the Consolidated Financial Statements, the Reports thereon, and the Notes thereto, commencing on page F-1 of this report, which Consolidated Financial Statements, Reports, Notes and data are incorporated herein by reference.</P>
<A NAME="_Toc418413165"></A><P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 9. &nbsp;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>None.</P>
<P style="margin:0px" align=justify><BR></P>
<A NAME="_Toc418413166"></A><P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 9A. &nbsp;Controls and Procedures.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:2px; width:48px; float:left"><B><I>(a)</I></B></P>
<P style="margin:0px; padding-left:2px; text-indent:-2px" align=justify><B><I>Evaluation of Disclosure Controls and Procedures.</I></B> Based on their evaluation as of December 31, 2016, our Chief Financial Officer has concluded that our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), were effective as of the end of the period covered by this report to ensure that the information required to be disclosed by us in this Annual Report on Form 10-K was recorded, processed, summarized and reported within the time periods specified in the SEC&#146;s rules and instructions for Form 10-K. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Financial Officer, to allow timely decisions regarding required disclosure.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:2px; width:48px; float:left"><B><I>(b)</I></B></P>
<P style="margin:0px; padding-left:2px; text-indent:-2px" align=justify><B><I>Management&#146;s Annual Report on Internal Control Over Financial Reporting.</I></B> Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined by Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of the Company&#146;s internal control over financial reporting as of December 31, 2016. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in <I>Internal Control-Integrated Framework</I>. Based on our assessment of those criteria, management believes that the Company maintained effective internal control over financial reporting as of December 31, 2016.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify><I>This annual report does not include an attestation report of the Company&#146;s registered public accounting firm regarding internal control over financial reporting. Management&#146;s report was not subject to attestation by the Company&#146;s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management&#146;s report in this annual report.</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><I>This Management&#146;s report is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, unless we specifically state in a future filing that such report is to be considered filed.</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left"><B><I>(c)</I></B></P>
<P style="margin:0px; text-indent:-2px" align=justify><B><I>Changes in Internal Control over Financial Reporting</I></B><FONT style="color:#FF0000"><B><I>.</I></B></FONT><FONT style="color:#FF0000"> </FONT>There were no changes in our internal control over financial reporting (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the year ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</P>
<A NAME="_Toc418413167"></A><P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 9B. &nbsp;Other Information.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">None. &nbsp;</P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>24</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px; text-indent:332px"><B>PART III</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify><B>Item 10. &nbsp;Directors, Executive Officers and Corporate Governance.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Directors and Executive Officers</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Incorporated by reference to the Registrant&#146;s 2016 Proxy Statement to be filed within 120 days after the Registrant&#146;s fiscal year end.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Code of Ethics</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have adopted a Code of Ethics and Business Conduct that defines the standard of conduct expected of our officers, directors and employees. We will upon request and without charge provide a copy of our Code of Ethics. Requests should be directed to Principal Accounting Officer, Zivo Bioscience, Inc., 2804 Orchard Lake Road, Suite 202, Keego Harbor, MI 48320.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 11. &nbsp;Executive Compensation</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Incorporated by reference to the Registrant&#146;s 2016 Proxy Statement to be filed within 120 days after the Registrant&#146;s fiscal year end.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 12. &nbsp;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Incorporated by reference to the Registrant&#146;s 2016 Proxy Statement to be filed within 120 days after the Registrant&#146;s fiscal year end.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 13. &nbsp;Certain Relationships and Related Transactions, and Director Independence.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Incorporated by reference to the Registrant&#146;s 2016 Proxy Statement to be filed within 120 days after the Registrant&#146;s fiscal year end.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 14. &nbsp;Principal Accountant Fees and Services</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Incorporated by reference to the Registrant&#146;s 2016 Proxy Statement to be filed within 120 days after the Registrant&#146;s fiscal year end.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>PART IV</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Item 15. &nbsp;Exhibits and Financial Statement Schedules.</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>(a) (1) (2) <I>Financial Statements</I>.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Financial Statements are listed in the Index to Consolidated Financial Statements on page F-1 of this report.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>All schedules have been omitted because they are not applicable or the required information is included in the Consolidated Financial Statements or Notes thereto.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>(3) <I>Exhibits</I>.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Exhibit Index and required Exhibits immediately following the Signatures to this Form 10-K are filed as part of, or hereby incorporated by reference into, this Form 10-K.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>25</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><B>SIGNATURES</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>ZIVO BIOSCIENCE, INC.</B></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=390 /><TD width=147.2 /></TR>
<TR><TD style="margin-top:0px" valign=top width=390><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=147.2><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=390><P style="margin:0px">Date: &nbsp;March 31, 2017</P>
</TD><TD style="margin-top:0px" valign=top width=147.2><P style="margin:0px">By: &nbsp;<I><U>/s/ Philip M. Rice II</U></I></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=390><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=147.2><P style="margin:0px">Philip M. Rice II</P>
<P style="margin:0px">Chief Financial Officer</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/Andrew Dahl</U></I></P>
<P style="margin:0px; text-indent:-0.667px">Andrew Dahl, Principal</P>
<P style="margin:0px; text-indent:-0.667px">Executive Officer</P>
<P style="margin:0px; text-indent:-0.667px">CEO, President</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/ Philip M. Rice II</U></I></P>
<P style="margin:0px; text-indent:-0.667px">Principal Financial Officer, </P>
<P style="margin:0px; text-indent:-0.667px">Chief Financial Officer, Director</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/Christopher Maggiore</U></I></P>
<P style="margin:0px; text-indent:-0.667px">Christopher Maggiore, Director</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/Nola Masterson</U></I></P>
<P style="margin:0px; text-indent:-0.667px">Nola Masterson, Director</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/John Payne</U></I></P>
<P style="margin:0px; text-indent:-0.667px">John Payne, Director</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">By: <I><U>/s/Robert Rondeau</U></I></P>
<P style="margin:0px; text-indent:-0.667px">Robert Rondeau, Director</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>26</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><B>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Board of Directors and Stockholders</P>
<P style="margin:0px; text-indent:-0.667px"><B>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We have audited the accompanying consolidated balance sheets of Zivo Bioscience, Inc. and Subsidiaries (the &#147;Company&#148;) as of December 31, 2016 and 2015 and the related consolidated statements of operations, stockholders&#146; deficiency and cash flows for each of the two years in the period ended December 31, 2016. These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. Also, an audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Zivo Bioscience, Inc. and Subsidiaries at December 31, 2016 and 2015, and the results of their operations and their cash flows for each of the two years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has incurred significant operating losses for the years ended December 31, 2016 and 2015 and, as of December 31, 2016, has a significant working capital and stockholders&#146; deficiency. These factors raise substantial doubt about the Company&#146;s ability to continue as a going concern. Management&#146;s plans regarding those matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:240px" align=center><I><U>/s/ WOLINETZ, LAFAZAN &amp; COMPANY, P.C. </U></I></P>
<P style="margin:0px; padding-left:240px" align=center>WOLINETZ, LAFAZAN &amp; COMPANY, P.C.</P>
<P style="margin:0px; text-indent:-0.667px">Rockville Centre, New York</P>
<P style="margin:0px; text-indent:-0.667px">March 31, 2017</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-1</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=452 /><TD width=16.4 /><TD width=85.333 /><TD width=18.267 /><TD width=84.4 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=656.4 colspan=5><P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=656.4 colspan=5><P style="margin:0px" align=center>CONSOLIDATED BALANCE SHEET</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=18.267><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px" align=center>ASSETS</P>
</TD><TD style="margin-top:0px" valign=top width=16.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2015</P>
</TD><TD style="margin-top:0px" valign=top width=18.267><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2016</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=18.267><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">CURRENT ASSETS:</P>
</TD><TD style="margin-top:0px" valign=top width=16.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=18.267><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Cash</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>16,589</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>506,986</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Prepaid Expenses</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>12,341</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>13,437</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:0.6px">Total Current Assets</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>28,930</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>520,423</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">PROPERTY AND EQUIPMENT, NET</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>43,750</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>18,750</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">OTHER ASSETS:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px; font-size:9pt">Deferred Finance Costs, net</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px; font-size:9pt" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px; font-size:9pt" align=right>198,119</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">TOTAL ASSETS</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=85.333><P style="margin:0px" align=right>72,680</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=84.4><P style="margin:0px" align=right>737,292</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px" align=center>LIABILITIES AND STOCKHOLDERS' DEFICIT</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">CURRENT LIABILITIES:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Accounts Payable</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; font-size:9pt" align=right>1,114,426</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>666,365</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Due to Related Party</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>211,233</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>319,234</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Loans Payable, Related Parties</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>337,107</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>245,979</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:20px; text-indent:-12px">Convertible Debentures Payable, less discount of $385,190 and $500,490 at December 31, 2015 and 2016, respectively</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>1,224,510</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>6,886,710</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Accrued Interest</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>1,673,386</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>2,659,574</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:8px">Accrued Liabilities &#150; Other</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>410,248</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>404,618</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px">Total Current Liabilities</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>4,970,910</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>11,182,480</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">LONG TERM LIABILITIES:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:20px; text-indent:-12px">Convertible Debenture Payable, less discount of $<A NAME="OLE_LINK1"></A>1,458,741 and $ 73,953 at December 31, 2015 and 2016, respectively</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>4,598,759</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>3,176,047</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px">Total Long Term Liabilities</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>4,598,759</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>3,176,047</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">TOTAL LIABILITIES</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>9,569,669</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>14,358,527</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">COMMITMENTS AND CONTINGENCIES</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">STOCKHOLDERS' DEFICIT:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:14px; text-indent:-6px">Common stock, $.001 par value, 450,000,000 shares authorized; 132,156,776 and <A NAME="OLE_LINK11"></A>136,745,347 issued and outstanding at December 31, 2015 and 2016, respectively</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>132,157</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>136,745</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:14px; text-indent:-6px">Additional Paid-In Capital</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>38,085,266</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px" align=right>40,016,059</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; padding-left:14px; text-indent:-6px">Accumulated Deficit</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=85.333><P style="margin:0px" align=right>(47,714,412)</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>(53,774,039)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px">Total Stockholders' Deficit</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=85.333><P style="margin:0px" align=right>(9,496,989)</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.4><P style="margin:0px" align=right>(13,621,235)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-top:1px solid #000000" valign=bottom width=85.333><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=452><P style="margin:0px; text-indent:-0.667px">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=85.333><P style="margin:0px" align=right>72,680</P>
</TD><TD style="margin-top:0px" valign=bottom width=18.267><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=84.4><P style="margin:0px" align=right>737,292</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>The accompanying notes are an integral part of these financial statements</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-2</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=320.4 /><TD width=16 /><TD width=86.4 /><TD width=16 /><TD width=86.4 /></TR>
<TR><TD style="margin-top:0px" width=525.2 colspan=5><P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=525.2 colspan=5><P style="margin:0px" align=center>CONSOLIDATED STATEMENTS OF OPERATIONS</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=320.4><P style="margin:0px; text-indent:-0.667px">`</P>
</TD><TD style="margin-top:0px" width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=center>For the year</P>
<P style="margin:0px" align=center>ended</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=center>For the year</P>
<P style="margin:0px" align=center>ended</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>&nbsp;2015</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>&nbsp;2016</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">REVENUES:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">COSTS AND EXPENSES:</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">General and Administrative</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>963,296</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>832,239</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Professional Fees and Consulting Expense</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>1,059,633</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>1,869,234</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Research and Development</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>1,033,351</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>788,971</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px">Total Costs and Expenses</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>3,056,280</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>3,490,444</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">LOSS FROM OPERATIONS</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(3,056,280)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(3,490,444)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">OTHER INCOME (EXPENSE):</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Other Income</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>34,927</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Amortization of Bond Discount</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(1,866,842)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(1,376,182)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Amortization of Deferred Finance Costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(26,813)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Financing Costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(84,645)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(108,000)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Finance Costs Paid in Stocks and Warrants</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(95,580)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(72,000)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Interest Expense &#150; Related Parties</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(718,311)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>(950,698)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; padding-left:8.4px">Interest Expense</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(2,400)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(35,490)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px">Total Other Income (Expense)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(2,732,851)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(2,569,183)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">NET INCOME (LOSS)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(5,789,131)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(<A NAME="OLE_LINK3"></A><A NAME="OLE_LINK4"></A>6,059,627)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px; text-indent:-0.667px">BASIC AND DILUTED LOSS PER SHARE</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(0.04)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(0.05)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=320.4><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">WEIGHTED AVERAGE</P>
<P style="margin:0px; text-indent:-0.667px">&nbsp;&nbsp;BASIC AND DILUTED SHARES OUTSTANDING</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>130,945,979</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>133,844,254</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>The accompanying notes are an integral part of these financial statements</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-3</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=309.2 /><TD width=75 /><TD width=14.4 /><TD width=52.4 /><TD width=13.6 /><TD width=68.533 /><TD width=12.8 /><TD width=77.8 /><TD width=15.2 /><TD width=70.6 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=709.533 colspan=10><P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=709.533 colspan=10><P style="margin:0px" align=center>CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=709.533 colspan=10><P style="margin:0px" align=center>FOR THE PERIOD JANUARY 1, 2015 THROUGH DECEMBER 31, 2016</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=141.8 colspan=3><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=141.8 colspan=3 rowspan=2><P style="margin:0px" align=center>Common Stock</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=center>Additional</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=center>Paid in</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=center>Accumulated</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=75><P style="margin:0px" align=center>Shares</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=52.4><P style="margin:0px" align=center>Amount</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=68.533><P style="margin:0px" align=center>Capital</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=77.8><P style="margin:0px" align=center>Deficit</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=70.6><P style="margin:0px" align=center>Total</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Balance, January 1, 2015</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>128,773,859</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>128,774</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>35,427,339</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>(41,925,281)</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>(6,369,168)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants to board of directors</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>126,679</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>126,679</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants for services</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>321,845</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>321,845</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants for services &#150; related party</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>16,053</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>16,053</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of common stock for services</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>961,539</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>962</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>75,190</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>76,151</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of common stock and warrants pursuant to private placements</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>970,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>970</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>47,530</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>48,500</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Common stock issued on conversion of 1% Convertible Debt</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>100,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>100</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>(100)</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Common stock issued on conversion of 11% Convertible Debt</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>500,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>500</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>59,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>60,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Discounts on issuance of 11% convertible debentures</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>1,916,501</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>1,916,501</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Warrants issued for financing costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>21,150</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>21,150</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Common stock issued for financing costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>851,378</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>851</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>73,579</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>74,430</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Net income</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=68.533><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=77.8><P style="margin:0px" align=right>(5,789,131)</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=70.6><P style="margin:0px" align=right>(5,789,131)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Balance, December 31, 2015</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=75><P style="margin:0px" align=right>132,156,776</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=52.4><P style="margin:0px" align=right>132,157</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=68.533><P style="margin:0px" align=right>38,085,266</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=77.8><P style="margin:0px" align=right>(47,714,412)</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=70.6><P style="margin:0px" align=right>(9,496,989)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants to board of directors</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>69,712</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>69,712</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants for services</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>1,116,444</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>1,116,444</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of warrants for services &#150; related party</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>15,601</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>15,601</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Issuance of common stock for services</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>3,500,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>3,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>171,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>175,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Discounts on issuance of 11% convertible debentures</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>106,693</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>106,693</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Warrants issued for financing costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>99,931</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>99,931</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Common stock issued for financing costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>1,088,571</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>1,088</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>70,912</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>72,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Settlement of Litigation &#150; related party</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px" align=right>280,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px" align=right>280,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Net loss</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=75><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=52.4><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=68.533><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=77.8><P style="margin:0px" align=right>(6,059,627)</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=70.6><P style="margin:0px" align=right>(6,059,627)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px; padding-left:16.4px; text-indent:-12px">Balance, December 31, 2016</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=75><P style="margin:0px" align=right>136,745,347</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=52.4><P style="margin:0px" align=right>136,745</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=68.533><P style="margin:0px" align=right>40,016,059</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=77.8><P style="margin:0px" align=right>(53,774,039)</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=70.6><P style="margin:0px" align=right>(13,621,235)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=309.2><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=75><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=14.4><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.4><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=68.533><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=77.8><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=15.2><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=70.6><P style="margin:0px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center>The accompanying notes are an integral part of these consolidated financial statements.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-4</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=393 /><TD width=8.533 /><TD width=79.6 /><TD width=16 /><TD width=81.867 /></TR>
<TR><TD style="margin-top:0px" width=579 colspan=5><P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=579 colspan=5><P style="margin:0px" align=center>CONSOLIDATED STATEMENT OF CASH FLOWS</P>
</TD></TR>
<TR><TD style="margin-top:0px" width=393><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=8.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=79.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=81.867><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=8.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=center>For the</P>
<P style="margin:0px" align=center>year ended</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=center>For the</P>
<P style="margin:0px" align=center>year ended</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=8.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2015</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2016</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px"><B>Cash Flows from Operating Activities:</B></P>
</TD><TD style="margin-top:0px" valign=top width=8.533><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Net Loss</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>(5,789,131)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>(6,059,627)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Adjustments to reconcile net income (loss) to net cash used in operating activities:</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Stocks and warrants issued for services rendered</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>397,997</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>1,291,444</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Issuance of warrants for services &#150; related party</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>16,053</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>15,601</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Warrants issued for Directors&#146; Fees</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>126,679</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>69,713</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Stocks and warrants issued for financing costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>95,580</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>72,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Amortization of deferred finance costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>26,813</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Amortization of bond discount</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>1,866,842</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>1,376,181</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Depreciation expense</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>25,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>25,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Changes in assets and liabilities:</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">(Increase) decrease in prepaid expenses</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>19,383</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>(1,096)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">(Decrease) in accounts payable</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>(21,430)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>(448,061)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Increase in due to related party</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>121,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>108,001</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Increase in accrued interest</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>720,711</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>986,188</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Increase (decrease) in accrued liabilities</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>123,929</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>(5,630)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Net Cash (Used) in Operating Activities</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>(2,296,887)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>(2,543,473)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:7.533px"><B>Cash Flows from Investing Activities:</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Net Cash (Used) in Investing Activities</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:7.533px"><B>Cash Flow from Financing Activities:</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Proceeds (payments) from loans payable, related parties</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>196,093</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>(91,130)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Deferred Finance Costs</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>(125,000)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Proceeds from issuance of 11% convertible debentures</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>2,067,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>3,250,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:13.533px">Proceeds from sale of common stock and exercise of warrants</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>48,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Net Cash Provided by Financing Activities</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>2,312,093</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>3,033,870</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:7.533px">Increase in Cash</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px" align=right>15,206</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px" align=right>490,397</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Cash at Beginning of Period</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.6><P style="margin:0px" align=right>1,383</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=81.867><P style="margin:0px" align=right>16,589</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Cash at End of Period</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=79.6><P style="margin:0px" align=right>16,589</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=81.867><P style="margin:0px" align=right>506,986</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:7.533px">Supplemental Disclosures of Cash Flow Information:</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:7.533px">Cash paid during the period for:</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=81.867><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:19.533px">Interest</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=79.6><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=81.867><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=393><P style="margin:0px; padding-left:19.533px">Income taxes</P>
</TD><TD style="margin-top:0px" valign=bottom width=8.533><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=79.6><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=81.867><P style="margin:0px" align=right>-</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>The accompanying notes are an integral part of these consolidated financial statements.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-5</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
<P style="margin:0px" align=center>CONSOLIDATED STATEMENT OF CASH FLOWS (<I>Continued)</I></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Supplemental Schedule of Non-Cash Investing and Financing Activities:</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>For the Year Ended December 31, 2016:</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended March 31, 2016, the Company recorded $49,630 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended June 30, 2016, the Company recorded $17,439 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended September 30, 2016, the Company recorded $24,218 in discounts on 11% convertible debentures, and issued 900,000 common stock warrants, valued at $50,371 as Deferred Finance Costs. These warrants are exercisable at $.10 per share and expire five (5) years from the date of issuance.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended December 31, 2016, the Company recorded $15,407 in discounts on 11% convertible debentures, and the Company issued 975,000 common stock warrants, valued at $49,560 as Deferred Finance Costs. These warrants are exercisable at $.10 per share and expire five (5) years from the date of issuance. In addition, the Company reduced its 11% Convertible Debt, due to a related party by $280,000 to offset an award received in settlement of litigation against the related party.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>For the Year Ended December 31, 2015:</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended March 31, 2015, the Company recorded $211,501 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended June 30, 2015, the Company recorded $705,000 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended June 30, 2015, the holder of 11% Convertible Debentures, converted $30,000 into 250,000 shares of the Company's common stock.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended September 30, 2015, the Company recorded $500,000 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended September 30, 2015, the holder of 11% Convertible Debentures, converted $30,000 into 250,000 shares of the Company's common stock.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the quarter ended December 31, 2015, the Company recorded $500,000 in discounts on 11% convertible debentures.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>The accompanying notes are an integral part of these consolidated financial statements.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-6</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center>ZIVO BIOSCIENCE, INC. AND SUBSIDIARIES</P>
<P style="margin:0px" align=center>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>NOTE 1 &#150; DESCRIPTION OF BUSINESS</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The business model of Zivo Bioscience, Inc. and Subsidiaries (Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc.) (collectively the &#147;Company&#148;) is as follows: 1) to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement and medical food manufacturers (currently, the Company's focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially), and 2) developing, manufacturing, marketing, and selling tests that the Company believes will allow people to optimize their health and identify future health risks.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 2 &#150; BASIS OF PRESENTATION </B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Going Concern</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company had a net loss of $6,059,627 and $5,789,131 during the years ended December 31, 2016 and 2015, respectively.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In addition, the Company had a working capital deficiency of $10,662,057 and a stockholders&#146; deficiency of $13,621,235 at December 31, 2016. These factors raise substantial doubt about the Company's ability to continue as a going concern.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company&#146;s existing stockholders.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company is attempting to address its lack of liquidity by raising additional funds, either in the form of debt or equity or some combination thereof. &nbsp;There can be no assurances that the Company will be able to raise the additional funds it requires.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2016, the Company received proceeds of $3,250,000 from the issuance of 11% convertible debt.</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=justify><B>NOTE 3 &#150; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Principles of Consolidation</U> -</B> The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Accounting Estimates</U> - </B>The Company&#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates. &nbsp;Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. &nbsp;&nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Cash and Cash Equivalents</U> -</B> For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31, 2016, the Company did not have any cash equivalents.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-7</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Property and Equipment</U> &#150; </B>Property and equipment consists of furniture and office equipment, and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets, generally five to seven years. &nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Deferred Financing Costs</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &nbsp;Amortization of deferred financing costs amounted to $26,813 and $-0- for the years ended December 31, 2016 and 2015.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Revenue Recognition</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104, &#147;Revenue Recognition&#148; (&#147;SAB No. 104&#148;), which superseded Staff Accounting Bulletin No. 101, &#147;Revenue Recognition in Financial Statements&#148; (&#147;SAB No. 101&#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Shipping and Handling Costs</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Shipping and handling costs are expensed as incurred. For the years ended December 31, 2016 and 2015 no shipping and handling costs were incurred.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Research and Development</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Research and development costs are expensed as incurred. The majority of the Company's research and development costs consist of clinical study expenses. These consist of fees, charges, and related expenses incurred in the conduct of clinical studies conducted with Company products by independent outside contractors. External clinical studies expenses were approximately $789,000 and $1,033,000 for the years ended December 31, 2016 and 2015, respectively. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Income Taxes</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses, and it is more likely than not that some portion or all of the deferred tax assets will not be realized, a full valuation allowance has been established. In addition, utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &#147;change in ownership&#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Stock Based Compensation</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We account for stock-based compensation in accordance with FASB ASC 718, <I>Compensation &#150; Stock Compensation. &nbsp;</I>Under the provisions of FASB ASC 718, stock-based compensation cost is estimated at the grant date based on the award&#146;s fair value and is recognized as expense over the requisite service period. &nbsp;The Company generally issues grants to its employees, consultants and board members. &nbsp;At the date of grant, the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-8</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During 2016 and 2015, warrants were granted to employees, directors and consultants of the Company. &nbsp;As a result of these grants, the Company recorded compensation expense of $1,201,758 and $464,577 during the years ended December 31, 2016 and 2015 respectively.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=130.4 /><TD width=100.8 /><TD width=12 /><TD width=93.6 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=206.4 colspan=3><P style="margin:0px" align=center>Year Ended December 31,</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=100.8><P style="margin:0px" align=center>2016</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=93.6><P style="margin:0px" align=center>2015</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">Expected volatility</P>
</TD><TD style="margin-top:0px" valign=bottom width=100.8><P style="margin:0px" align=center>158.53% to 173.53%</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=93.6><P style="margin:0px" align=center>128.36% to 155.43%</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">Expected dividends</P>
</TD><TD style="margin-top:0px" valign=bottom width=100.8><P style="margin:0px" align=center>0%</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=93.6><P style="margin:0px" align=center>0%</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">Expected term</P>
</TD><TD style="margin-top:0px" valign=bottom width=100.8><P style="margin:0px" align=center>5 years</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=93.6><P style="margin:0px" align=center>3 to 5 years</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=130.4><P style="margin:0px; text-indent:-0.667px">Risk free rate</P>
</TD><TD style="margin-top:0px" valign=bottom width=100.8><P style="margin:0px" align=center>.71% to 1.04%</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=93.6><P style="margin:0px" align=center>.51% to 1.75%</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company&#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Income (Loss) Per Share</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Basic loss per share is computed by dividing the Company&#146;s net loss by the weighted average number of common shares outstanding during the period presented. Diluted loss per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &nbsp;Potentially dilutive securities as of December 31, 2016, consisted of 111,086,456 common shares from convertible debentures and related accrued interest and 32,071,901 common shares from outstanding warrants. Potentially dilutive securities as of December 31, 2015, consisted of 73,883,330 common shares from convertible debentures and related accrued interest and 14,705,818 common shares from outstanding warrants. &nbsp;&nbsp;For 2016 and 2015, diluted and basic weighted average shares were the same, as potentially dilutive shares are anti-dilutive.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Advertising Costs</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Advertising costs are charged to operations when incurred. &nbsp;There were no Advertising Costs during the years 2016 and 2015.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Concentrations of Credit Risk</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&#147;FDIC&#148;) limit of $250,000 at times during the year.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Reclassifications</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Future Impact of Recently Issued Accounting Standards</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>In May 2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), &#147;<I>Revenue from Contracts with Customers.</I>&#148;<I> </I>ASU 2014-09 superseded the revenue recognition requirements in &#147;Revenue Recognition (Topic 605),&#148; and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&#146;s financial position or results of operations.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-9</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify>In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) &#147;Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40).&#148; &nbsp;The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. &nbsp;Early application is permitted. &nbsp;This Update had no effect on the Company&#146;s financial position and results of operations for the year ended December 31, 2016.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued, but not yet effective, accounting standards been adopted in the current period.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 4 &#150; PROPERTY AND EQUIPMENT</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Property and equipment at December 31, 2016 and 2015 consist of the following:</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=216.8 /><TD width=16 /><TD width=86.4 /><TD width=16 /><TD width=86.4 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=top width=86.4><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2016</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=top width=86.4><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2015</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=86.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">Furniture &amp; fixtures</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>20,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>20,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">Equipment</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>80,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>80,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>100,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px" align=right>100,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">Less accumulated depreciation and amortization</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(81,250)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=86.4><P style="margin:0px" align=right>(56,250)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=86.4><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=216.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>18,750</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=86.4><P style="margin:0px" align=right>43,750</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Depreciation and amortization was $25,000 and $25,000 for the years ended December 31, 2016 and 2015, respectively.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>NOTE 5 &#150; DUE TO RELATED PARTY</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As of December 31, 2016 and 2015, the Company owed HEP Investments, a related party, cumulative balances of $319,234 and $211,234, respectively. &nbsp;The basis for the payable is a 5.4% cash finance fee for monies invested in the Company in the form of convertible debt. &nbsp;For the years ended December 31, 2016 and 2015, the Company incurred finance costs related to these transactions of $108,000 and $111,820, respectively.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 6 &#150; LOAN PAYABLE, RELATED PARTIES</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>During the year ended December 31, 2015, Mr. Christopher Maggiore, a director and a significant shareholder of the Company, had advanced the Company a total of $156,405, which remained unpaid as of December 31, 2015. &nbsp;During 2016, Mr. Maggiore advanced the Company an additional $20,000, for a total advanced as of December 31, 2016 of $176,405. &nbsp;The Company has agreed to pay 11% interest on this loan. During the years ended December 31, 2016 and 2015, the Company recorded interest on this indebtedness of $20,396 and $19,835, respectively.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>For the year ended December 31, 2015, Officers had advanced the Company $2,000, which amount remained unpaid as of December 31, 2015. &nbsp;This amount was repaid in 2016.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the year ended December 31, 2015, HEP Investments, LLC loaned the Company $2,246,202 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,067,500 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $178,702 as of December 31, 2015. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the year ended December 31, 2016, HEP Investments loaned the Company $1,890,872 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,000,000 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $69,574 as of December 31, 2016. &nbsp;&nbsp;</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-10</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 7 &#150; CONVERTIBLE DEBT</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>HEP Investments, LLC &#150; Related Party</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On December 2, 2011, the Company and HEP Investments, LLC, a Michigan limited liability company (&#147;Lender&#148;), entered into the following documents, effective as of December 1, 2011, as amended through September 30, 2016:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>(i) a Loan Agreement under which the Lender has agreed to advance up to $17,500,000 to the Company, subject to certain conditions, (ii) a Convertible Secured Promissory Note in the principal amount of $17,500,000 (&#147;Note&#148;) and (iii) a Security Agreement, under which the Company granted the Lender a security interest in all of its assets, (iv) an Intellectual Property security agreement under which the Company and its subsidiaries granted the Lender a security interest in all their respective intellectual properties, including patents, in each case order to secure their respective obligations to the Lender under the Note and related documents and &nbsp;(v) enter into a Registration Rights Agreement with respect to all the shares of common stock issuable to the Lender in connection with the Loan transaction. &nbsp;In addition, the Company&#146;s subsidiaries have guaranteed the Company&#146;s obligations under the Note. The Company has also made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Company&#146;s senior management, without the prior written consent of the Lender. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the year ended December 31, 2015, the Company recorded a debt discount, related to the $2,067,500 of Notes described previously (Note 6), in the amount of $1,916,501, to reflect the beneficial conversion feature of the convertible debt and fair value of the warrants pursuant to Emerging Issues Task Force (&#147;EITF&#148;) 00-27: Application of EITF 98-5, &#147;Accounting for Convertible Securities with Beneficial Conversion Features on Contingently Adjustable Conversion Rates,&#148; to certain convertible instruments. In accordance with EITF 00-27, the Company valued the beneficial conversion feature and recorded the amount of $1,773,078 as a reduction to the carrying amount of the convertible debt and as an addition to paid-in capital. Additionally, the relative fair value of the warrants was calculated and recorded at $143,423 as a further reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of discounts was $1,866,842 for the year ended December 31, 2015. &nbsp;The $2,067,500 of Notes are convertible at $.10 per share.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>During the year ended December 31, 2016, the Company recorded debt discounts, related to the $2,000,000 of Notes described previously (Note 6), in the amount of $106,693, to reflect the relative fair value of the related warrants as a reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of the debt discounts was $1,376,181 for the years ended December 31, 2016. &nbsp;The $2,000,000 of Notes are convertible at $.10 per share. As discussed in Note 13 &#150; Settlement of Litigation &#150; Related Party, the Lender reduced the principal of the debt by $280,000 (at $.12 per share) relating to a settlement with the Company.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As of December 31, 2016, amounts advanced under the Note are convertible into the Company&#146;s restricted common stock according to the following schedule: (A) $4,152,200 at $.10 per share, (B) $2,320,000 at $.12 per share, (C) $1,285,000 at $.15 per share, (D) $640,000 at $.22 per share, and (E) $750,000 at $.30 per share, (ii) bear interest at the rate of 11% per annum. &nbsp;The Seventh Amended and Restated Senior Secured Convertible Promissory Note (effective December 31, 2015) resets the Due Dates of Tranches 1 through 13 (totaling $3,740,000) to October 14, 2017. The Eighth Amended and Restated Senior Secured Convertible Promissory Note (effective September 30, 2016) resets the Due Dates of Tranches 14 through 16 (totaling $1,369,700) to January 31, 2017. The remaining Tranches 17 to 30, totaling $4,067,500, are due on varying anniversary dates ranging from February 28, 2017 through August 25, 2018. &nbsp;Accrued interest must be paid on the first and second anniversary of the Note. &nbsp;&nbsp;The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148; As of December 31, 2016 and December 31, 2015, unpaid interest due was $2,502,367 and $1,572,065, respectively and is included in accrued liabilities. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>In 2015, the Lender converted $60,000 of the debt (at $.12 per share). Any Note that has not yet matured may be prepaid upon sixty days written notice, provided that the Company shall be required to pay a prepayment premium equal to 5% of the amount repaid.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-11</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify><B>Paulson Investment Company, LLC - Related Debt</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On August 24, 2016, the Company entered into a Placement Agent Agreement with Paulson Investment Company, LLC (Paulson). &nbsp;This agreement provides that Paulson can provide up to $2 million in financings through &#147;accredited investors&#148; (as defined by Regulation D of the Securities Act of 1933, as amended). &nbsp;As of December 31, 2016, the Company received funding of $1,250,000 through seven (7) individual loans (the &#147;New Lenders&#148;). &nbsp;Each loan includes a (i) a Loan Agreement of the individual loan, (ii) a Convertible Secured Promissory Note (&#147;New Lenders Notes&#148;) in the principal amount of the loan, (iii) a Security Agreement under which the Company granted the Lender a security interest in all of its assets and (iv) an Intercreditor Agreement with HEP Investments, LLC (HEP) whereby HEP and the New Lenders agree to participate in all collateral a <I>pari passu </I>basis. &nbsp;The loans have a two year term and mature in September 2018 ($600,000) and October 2018 ($650,000). &nbsp;Paulson receives a 10% cash finance fee for monies invested in the Company in the form of convertible debt, along with 5 year, $.10 warrants equal to 15% of the number of common shares for which the debt is convertible into at $.10 per share.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>The New Lenders Notes are convertible into the Company&#146;s restricted common stock at $.10 per share and bear interest at the rate of 11% per annum. &nbsp;The New Lenders Notes must be repaid as follows: &nbsp;accrued interest must be paid on the first and second anniversary of the Note and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Other Debt</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>In September 2014, the Lender of the 1% convertible debentures agreed to rolling 30 day extensions until notice is given to the Company to the contrary. &nbsp;The Company determined that the modification of these Notes is not a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148;</P>
<P style="margin:0px" align=justify><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=286.4 /><TD width=16 /><TD width=80.8 /><TD width=16 /><TD width=84.8 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">Convertible debt consists of the following:</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=80.8><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2016</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.8><P style="margin:0px" align=center>December 31,</P>
<P style="margin:0px" align=center>2015</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">1% Convertible notes payable, due January 2017</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px" align=right>240,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>240,000</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px" align=justify>11% Convertible note payable &#150; HEP Investments, LLC, a related party, net of unamortized discount of $574,443 and $1,843,931, respectively, due at various dates ranging from January 2017 to October 2018</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px" align=right>8,572,757</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>5,583,269</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>11% Convertible note payable &#150; New Lenders; placed by Paulson, due at various dates ranging from September 2018 to October 2018</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=80.8><P style="margin:0px" align=right>1,250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.8><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px" align=right>10,062,757</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>5,823,269</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">Less: Current portion</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=80.8><P style="margin:0px" align=right>6,886,710</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.8><P style="margin:0px" align=right>1,224,510</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=80.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=286.4><P style="margin:0px; text-indent:-0.667px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long term portion</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=80.8><P style="margin:0px" align=right>3,176,047</P>
</TD><TD style="margin-top:0px" valign=bottom width=16><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=84.8><P style="margin:0px" align=right>4,598,759</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-12</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>NOTE 8 - STOCKHOLDERS&#146; DEFICIENCY</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Board of Directors fees</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2015, at an exercise price of $.09 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $3,664 using the Black Scholes pricing model relying on the following assumptions: volatility 128.38%; annual rate of dividends 0%; discount rate 0.68%. &nbsp;In addition, Mr. Rice is entitled to receive $10,000 for each annual term served.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2015, at an exercise price of $.15 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $6,185 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 1.09%. &nbsp;In addition, Mr. Cox is entitled to receive $10,000 for each annual term served.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to John B. Payne in July, 2015, at an exercise price of $.09 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $4,876 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 0. 109%. &nbsp;In addition, Mr. Payne is entitled to receive $10,000 for each annual term served.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On September 10, 2015, the board of directors amended its policy for the compensation of its directors. The Board granted to each of its five (5) Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.10 per share. The warrants have a term of five years and vest immediately. The unvested portion of the previously granted warrants were cancelled due to the Company&#146;s change to a program where all director warrant grants are made once per year at the same time. In addition, each director is entitled to receive $10,000 for each annual term served. &nbsp;As such, Mr. Cox&#146;s unvested warrant of 36,986 shares, Ms. Masterson&#146;s warrant of 959 shares, Mr. Payne&#146;s warrant of 42,740 shares and Mr. Rice&#146;s unvested warrant of 15,890 shares, were cancelled.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 125,000 shares of common stock to Robert O. Rondeau, a new Director, in March 2016, at an exercise price of $.09 per share. &nbsp;The warrants have a term of five years and vest immediately. &nbsp;The warrants were valued at $10,588 using the Black Scholes pricing model relying on the following assumptions: volatility 168.01%; annual rate of dividends 0%; discount rate 0.97%. &nbsp;In addition, Mr. Rondeau will receive $10,000 for each annual term served, paid quarterly.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On September 10, 2016, the board of directors granted to each of its Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.05 per share. The warrants have a term of five years and vest immediately. The warrants were valued at $59,125 using the Black Scholes pricing model relying on the following assumptions: volatility 171.58%; annual rate of dividends 0%; discount rate 0.79%. &nbsp;In addition, each director is entitled to receive $10,000 for each annual term served.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>The Company recorded directors&#146; fees of $109,713 and $166,679 for the years ended December 31, 2016 and 2015, respectively, representing the cash fees and the value of the vested warrants described above.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>Stock Based Compensation</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On April 23, 2015, the Company issued 500,000 shares of common stock valued at $30,000, to an investor relations consulting firm. On April 15, 2015, the Company issued warrants to purchase 1,875,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &nbsp;The warrants were valued at $133,862 using the Black Scholes pricing model relying on the following assumptions: volatility 143.36%; annual rate of dividends 0%; discount rate 0.15%.<FONT style="font-size:12pt"> </FONT>On June 26, 2015, the Company issued warrants to purchase 1,250,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &nbsp;The warrants were valued at $151,443 using the Black Scholes pricing model relying on the following assumptions: volatility 150.93%; annual rate of dividends 0%; discount rate 1.75%.<FONT style="font-size:12pt"> </FONT>On August 1, 2015, the Company issued 461,539 shares of common stock valued at $46,154, to an investor relations consulting firm. On September 10, 2015, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.10 with a term of five years to four of its consultants (100,000 warrants per consultant) working in research and development. &nbsp;The warrants have a term of five years and are fully vested. &nbsp;The warrants were valued at $36,540 using the Black Scholes pricing model relying on the following assumptions: volatility 152.53%; annual rate of dividends 0%; discount rate 0. 075%.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-13</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify>On May 19, 2016, the Company issued warrants to purchase 14,500,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to agreements with financial consultants. &nbsp;The warrants were valued at $1,095,063 using the Black Scholes pricing model relying on the following assumptions: volatility 170.07%; annual rate of dividends 0%; discount rate 0.89%.<FONT style="font-size:12pt"> </FONT>&nbsp;On September 19, 2016, the Company issued 3,500,000 shares of common stock, valued at $175,000, to an investor relations consulting firm. &nbsp;On November 17, 2016, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.09 with a term of 5 years pursuant to agreements with financial consultants. &nbsp;The warrants were valued at $21,381 using the Black Scholes pricing model relying on the following assumptions: volatility 173.41%; annual rate of dividends 0%; discount rate 1.04%.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>Stock Issuances</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On January 14, 2015, the Company received proceeds of $30,000 from the issuance of 600,000 shares of common stock. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On January 23, 2015, the Company received proceeds of $13,500 from the issuance of 270,000 shares of common stock. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On February 17, 2015, the Company received proceeds of $5,000 from the issuance of 100,000 shares of common stock. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On February 27, 2015, in connection with the issuance of $227,500 in principal of an 11% Convertible Debenture, the Company issued 81,900 shares of common stock valued at $8,190 and a warrant to purchase 227,500 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.3%; annual rate of dividends 0%; discount rate 0.63%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On March 27, 2015, in connection with the issuance of $135,000 in principal of an 11% Convertible Debenture, the Company issued 151,329 shares of common stock valued at $13,050 and a warrant to purchase 135,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.9%; annual rate of dividends 0%; discount rate 0.61%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On April 17, 2015, in connection with the issuance of $217,800 in principal of an 11% Convertible Debenture, the Company issued 112,011 shares of common stock valued at $7,841 and a warrant to purchase 217,800 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $13,326 using the Black Scholes pricing model relying on the following assumptions: volatility 143.3%; annual rate of dividends 0%; discount rate 1.31%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On May 1, 2015, in connection with the issuance of $237,200 in principal of an 11% Convertible Debenture, the Company issued 121,989 shares of common stock valued at $8,539 and a warrant to purchase 237,200 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $14,531 using the Black Scholes pricing model relying on the following assumptions: volatility 143.7%; annual rate of dividends 0%; discount rate 1.50%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On June 26, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 69,231 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $30,012 using the Black Scholes pricing model relying on the following assumptions: volatility 150.9%; annual rate of dividends 0%; discount rate 1.75%. See Note 7 &#150; Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On July 7, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 90,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $22,972 using the Black Scholes pricing model relying on the following assumptions: volatility 150.8%; annual rate of dividends 0%; discount rate 1.55%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On September 2, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 81,818 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $25,221 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.72%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On October 8, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.8%; annual rate of dividends 0%; discount rate 0.65%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-14</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify>On October 29, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On January 27, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $8,018 using the Black Scholes pricing model relying on the following assumptions: volatility 158.1%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On March 1, 2016, in connection with the issuance of $750,000 in principal of an 11% Convertible Debenture, the Company issued 337,500 shares of common stock valued at $27,000 and a warrant to purchase 750,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $44,371 using the Black Scholes pricing model relying on the following assumptions: volatility 167.7%; annual rate of dividends 0%; discount rate 0.85%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On May 16, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,746 using the Black Scholes pricing model relying on the following assumptions: volatility 170.1%; annual rate of dividends 0%; discount rate 0.79%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On July 26, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $11,523 using the Black Scholes pricing model relying on the following assumptions: volatility 170.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On August 25, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 150,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $13,939 using the Black Scholes pricing model relying on the following assumptions: volatility 170.8%; annual rate of dividends 0%; discount rate 0.78%. See Note 7 - Convertible Debt. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On October 20, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 128,571 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $16,419 using the Black Scholes pricing model relying on the following assumptions: volatility 173.2%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Executive Compensation</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>As compensation for serving as Chief Financial Officer, the Company, quarterly, will issue warrants to purchase 50,000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner, at which time such warrants would vest. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>On April 6, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.085. The warrants were valued at $3,800 using the Black Scholes pricing model relying on the following assumptions: volatility 143.17%; annual rate of dividends 0%; discount rate 1.31%. On May 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,582 using the Black Scholes pricing model relying on the following assumptions: volatility 143.464%; annual rate of dividends 0%; discount rate 1.57%. &nbsp;On August 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.11. The warrants were valued at $5,019 using the Black Scholes pricing model relying on the following assumptions: volatility 152.05%; annual rate of dividends 0%; discount rate 0.72%. &nbsp;On November 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,652 using the Black Scholes pricing model relying on the following assumptions: volatility 151.81%; annual rate of dividends 0%; discount rate 1.2%.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-15</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px" align=justify>On March 29, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,771 using the Black Scholes pricing model relying on the following assumptions: volatility 169.28%; annual rate of dividends 0%; discount rate 0.78%.<FONT style="font-size:12pt"> &nbsp;</FONT>On May 13, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,777 using the Black Scholes pricing model relying on the following assumptions: volatility 170.23%; annual rate of dividends 0%; discount rate 0.76%. &nbsp;On August 12, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.07. &nbsp;The warrants were valued at $3,307 using the Black Scholes pricing model relying on the following assumptions: volatility 170.83%; annual rate of dividends 0%; discount rate 0.71%. &nbsp;On November 14, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.10. &nbsp;The warrants were valued at $4,745 using the Black Scholes pricing model relying on the following assumptions: volatility 173.53%; annual rate of dividends 0%; discount rate 1.00%.<FONT style="font-size:12pt"> &nbsp;</FONT></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>Common Stock Warrants</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>A summary of the status of the Company&#146;s warrants is presented below.</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=177.6 /><TD width=16.8 /><TD width=64.8 /><TD width=16.8 /><TD width=79.2 /><TD width=16.8 /><TD width=64.8 /><TD width=16.8 /><TD width=84.8 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=160.8 colspan=3><P style="margin:0px" align=center><B>December 31, 2016</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=166.4 colspan=3><P style="margin:0px" align=center><B>December 31, 2015</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=center>Number of</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px" align=center>Weighted</P>
<P style="margin:0px" align=center>Average</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=center>Number of</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=center>Weighted</P>
<P style="margin:0px" align=center>Average</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=64.8><P style="margin:0px" align=center>Warrants</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.2><P style="margin:0px" align=center>Exercise Price</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=64.8><P style="margin:0px" align=center>Warrants</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.8><P style="margin:0px" align=center>Exercise Price</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Outstanding, beginning of year</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>14,705,818</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px" align=right>0.13</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>9,053,005</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.16</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Issued</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>20,350,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px" align=right>0.08</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>7,192,500</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.09</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Exercised</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>0</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>0</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>-</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Cancelled</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>0</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px" align=right>-</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px" align=right>(96,575)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px" align=right>0.14</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Expired</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=64.8><P style="margin:0px" align=right>(2,983,917)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=79.2><P style="margin:0px" align=right>0.14</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=64.8><P style="margin:0px" align=right>(1,443,112)</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=84.8><P style="margin:0px" align=right>0.13</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=79.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=64.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=84.8><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=177.6><P style="margin:0px; text-indent:-0.667px">Outstanding, end of period</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=64.8><P style="margin:0px" align=right>32,071,901</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=79.2><P style="margin:0px" align=right>0.10</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=64.8><P style="margin:0px" align=right>14,705,818</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=84.8><P style="margin:0px" align=right>0.13</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">Warrants outstanding and exercisable by price range as of December 31, 2016 were as follows:</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=16.8 /><TD width=67.2 /><TD width=12 /><TD width=60 /><TD width=12 /><TD width=76 /><TD width=20.8 /><TD width=52.8 /><TD width=13.6 /><TD width=60 /><TD width=16.8 /><TD width=53.6 /></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=227.2 colspan=5><P style="margin:0px" align=center><B>Outstanding Warrants</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=196.8 colspan=5><P style="margin:0px" align=center><B>Exercisable Warrants</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=center>Average</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=center>Weighted</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=center>Weighted</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=center>Remaining</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=center>Average</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=67.2><P style="margin:0px" align=center>Range of</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px" align=center>Number</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=76><P style="margin:0px" align=center>Contractual Life in Years</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=52.8><P style="margin:0px" align=center>Exercise Price</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px" align=center>Number</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=53.6><P style="margin:0px" align=center>Exercise Price</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" width=67.2><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=12><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=76><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=52.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=13.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=60><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=16.8><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.05</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>1,250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>4.70</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.05</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>1,250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.05</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.08</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>18,625,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>4.23</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.08</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>18,625,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.08</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.09</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>309,110</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>3.11</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.09</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>309,110</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.09</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.10</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>7,327,200</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>3.99</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.10</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>7,327,200</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.10</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.12</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>99,041</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>2.17</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.12</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>99,041</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.12</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.14</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>2.62</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.14</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.14</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.15</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>2,485,274</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.30</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.15</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>2,485,274</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.15</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.17</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>2.25</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.17</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.17</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.19</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>100,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.46</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.19</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>100,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.19</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.20</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>0.33</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.20</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.20</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.22</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>269,276</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.75</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.22</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>269,276</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.22</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.25</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>707,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.52</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.25</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>707,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.25</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.30</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.90</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.30</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.30</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.33</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px" align=right>1.50</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.33</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px" align=right>250,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px" align=right>0.33</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px" align=right>0.38</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=76><P style="margin:0px" align=right>0.01</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px" align=right>0.38</P>
</TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px" align=right>50,000</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=bottom width=53.6><P style="margin:0px" align=right>0.38</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=76><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=60><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=53.6><P style="margin:0px; padding:0px">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=67.2><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=60><P style="margin:0px" align=right>32,071,901</P>
</TD><TD style="margin-top:0px" valign=bottom width=12><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=76><P style="margin:0px" align=right>1.79</P>
</TD><TD style="margin-top:0px" valign=bottom width=20.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=52.8><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px" valign=bottom width=13.6><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=60><P style="margin:0px" align=right>32,071,901</P>
</TD><TD style="margin-top:0px" valign=bottom width=16.8><P style="margin:0px" align=right>$</P>
</TD><TD style="margin-top:0px; border-bottom:3px double #000000" valign=bottom width=53.6><P style="margin:0px" align=right>0.10</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-16</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px"><B>NOTE 9 - OTHER INCOME (EXPENSE)</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>On July 15, 2014, the Company settled a dispute with one of its vendors. &nbsp;The settlement agreement calls for the Company to make 10 payments of $6,250. &nbsp;If the payments are not made timely, a total liability of $97,463 out of the gross amount recorded on the Company&#146;s books of $191,146 will be due. &nbsp;During the year ended December 31, 2015, the Company met its obligation for timely payments and recognized an additional $34,963 (the difference between the $97,463 remaining liability and the agreed upon payments of $62,500) as &quot;Other Income&quot; on its Statement of Operations the year ended December 31, 2015.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>NOTE 10- COMMITMENTS AND CONTINGENCIES</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px"><B>Employment Agreement</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>The Company&#146;s Chief Executive Officer, Andrew Dahl, is serving under the terms of an employment agreement dated December 16, 2011 as amended August 11, 2016. Under the agreement Mr. Dahl serves as CEO for one year terms, subject to automatic renewal, unless either party terminates the Agreement on sixty days&#146; notice prior to the expiration of the term of the agreement. &nbsp;Mr. Dahl is compensated as follows: &nbsp;he receives an annual base salary of $240,000. &nbsp;In addition, Mr. Dahl is entitled to monthly bonus compensation equal to 2% of the Company&#146;s revenue, but only to the extent that such bonus amount exceeds his base salary for the month in question. &nbsp;In addition, Mr. Dahl will be entitled to warrants having an exercise price of $.25 per share, upon the attainment of specified milestones as follows: 1) Warrants for 500,000 shares upon identification of bio-active agents in the Company&#146;s product and filing of a patent with respect thereto, 2) Warrants for 500,000 shares upon entering into a business contract under which the Company receives at least $500,000 in cash payments, 3) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement with a research company to develop &nbsp;medicinal or pharmaceutical applications (where the partner provides at least $2 million in cash or in-kind outlays), 4) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement for nutraceutical or dietary supplement applications (where the partner provides at least $2 million in cash or in-kind outlays), 5) Warrants for 1,000,000 shares upon the Company entering into a pharmaceutical development agreement. &nbsp;Further, as it relates to Company&#146;s wholly-owned subsidiary, WellMetris, LLC (&#147;WellMetris&#148;), in the event the Company ceases to own a controlling interest in WellMetris for any reason whatsoever, the Company shall cause WellMetris to grant Mr. Dahl warrants to purchase a seven percent (7%) equity interest in WellMetris at the time outside funding is closed and/or at the time an event occurs whereby the Company relinquishes majority control of WellMetris. &nbsp;Such Warrant shall be priced at the per-unit or per-share price at the time of the applicable closing or change of control with respect to WellMetris. &nbsp;As of December 31, 2016, none of the milestones referred to had been achieved and there has been no notice of contract termination.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Legal Contingencies</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>We may become a party to litigation in the normal course of business. &nbsp;In the opinion of management, there are no legal matters involving us that would have a material adverse effect upon our financial condition, results of operation or cash flows.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Workers&#146; Compensation</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company does not carry workers&#146; compensation insurance, which covers on the job injury.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 11 - RELATED PARTY TRANSACTIONS</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Due to Related Party</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>See Note 5 Due to Related Party for disclosure of payable to related Party. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Loan Payable &#150; Related Party</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>See Note 6 Loan Payable &#150; Related Parties for disclosure of loans payable to related Parties </P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-17</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Executive Compensation</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>See Note 8 &#150; Stockholder&#146; Deficiency for disclosure of compensation to the Chief Financial Officer. </P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B><U>Employment Agreement</U></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>See Note 10 &#150; Commitments and Contingencies for disclosure of the Employment Agreement with the Chief Executive Officer.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 12 - INCOME TAXES</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>At December 31, 2016 the Company had available net-operating loss carry-forwards for Federal tax purposes of approximately $39,732,000, which may be applied against future taxable income, if any, at various dates from 2016 through 2036. Certain significant changes in ownership of the Company may restrict the future utilization of these tax loss carry-forwards.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>At December 31, 2016 the Company had a deferred tax asset of approximately $15,893,000 representing the benefit of its net operating loss carry-forwards. The Company has not recognized the tax benefit because realization of the tax benefit is uncertain and thus a valuation allowance has been fully provided against the deferred tax asset. &nbsp;The difference between the Federal and State Statutory Rate of 40% and the Company&#146;s effective tax rate of 0% is due to an increase in the valuation allowance of approximately $3,693,000 in 2016.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>NOTE 13 &#150; SETTLEMENT OF LITIGATION - RELATED PARTY</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>On July 15, 2015, a shareholder of the Company (&#147;Shareholder&#148;) brought action against HEP Investment alleging certain technical violations of Section 16(b) of the Securities Act of 1934, as amended. &nbsp;On March 3, 2017, without admitting any liability whatsoever, HEP Investment settled with the Shareholder by agreeing to reduce the Company&#146;s debt owed to HEP Investment by $280,000. Related to this debt reduction, the Company will pay to the Shareholder&#146;s legal counsel $60,000 and 250,000 shares of the Company&#146;s common stock valued at $22,500. &nbsp;The Company considered the settlement to be a Type 1 subsequent event and recorded legal fees of $82,500 on the Statement of Operations and recorded the settlement amount of $280,000 as a reduction of convertible debt owed to HEP Investments and an increase to Additional Paid-In Capital.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>NOTE 14 &#150; SUBSEQUENT EVENTS </B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>CONVERTIBLE DEBT: HEP Investments, LLC</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify><B>Debt Modification</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>On March 1, 2017, the Company and HEP Investments, LLC (&#147;Lender&#148;), entered into the following documents, effective as of March 1, 2017: (i) Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total of $17,500,000 to the Company, subject to certain conditions, and (ii) a Ninth Amended and Restated Senior Secured Convertible Promissory Note. &nbsp;The Eighth Amendment to Loan Agreement amends and restates the Seventh Amendment to Loan Agreement, which was entered into with the Lender on December 31, 2015 and disclosed in the Company&#146;s Form 8-K Current Report filed on January 7, 2016. &nbsp;The Ninth Amended and Restated Senior Secured Convertible Promissory Note resets the total outstanding debt as of March 1, 2017 and provides for a maturity date of September 30, 2018. &nbsp;The total outstanding debt as of March 1, 2017 is $12,982,203. &nbsp;This amount includes unpaid principal of $9,427,200, interest outstanding as of February 28, 2017 of $2,955,003 and restructuring and legal fees of $600,000.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company, as consideration for the extension of the maturity date to September 30, 2018, agreed to provide for the conversion of the $12,982,203 Convertible Promissory Note into the Company&#146;s restricted common stock at $.10 per share, with interest at the rate of 11% per annum.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The related indebtedness represented by this note shall be paid to the Lender in monthly installments of interest only beginning on July 1, 2017 and continuing on the first day of each month thereafter.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Based on the above, the total shares of common stock, if the Lender converted the complete $12,982,203 convertible debt, would be 129,822,030 shares, not including any future interest charges which may be converted into common stock.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>Amounts advanced under the Note are secured by all the Company&#146;s assets.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>F-18</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company has agreed to pay the following fees in connection with the Loan transaction (when the final $4,517,797 in funding is achieved): (i) a $361,602 closing fee, consisting of $216,961 in cash, and $144,641 paid in shares of common stock, which will be accomplished by the issuance of common stock valued at various amounts based on the timing of the funding and the related stock price. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company has made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Registrant&#146;s senior management. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; text-indent:-0.667px" align=justify>The Company determined that the modification of these Notes was a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148; &nbsp;As such, the Company will recognize a loss on extinguishment.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>11% Convertible Debt - HEP Investments, LLC</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On March 31, 2017, HEP Investments LLC (&#147;Lender&#148;) funded an additional of $1,000,000. &nbsp;Due to this additional funding, the Company issued to the Lender a $1,000,000, 11% convertible note and warrants to purchase 1,000,000 shares of common stock, at an exercise price of $.10 for a term of five years. &nbsp;The terms of the debt are in described in Note 7 - Convertible Debt.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><B>Stock Based Compensation</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>On February 27, 2017, the Company issued warrants to purchase 500,000 shares of common stock at an exercise price of $.10 with a term of 5 years pursuant to an agreement with a financial consultant. &nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>F-19</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center><B>EXHIBIT INDEX</B></P>
<P style="margin:0px"><BR></P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=53.6 /><TD width=654.4 /><TD width=26.4 /></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px"><B>Exhibit</B></P>
<P style="margin:0px"><B>Number</B></P>
</TD><TD style="margin-top:0px" valign=bottom width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px"><B>&nbsp;&nbsp;&nbsp;&nbsp;Title</B></P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px; text-indent:-0.667px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">3.13</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Articles of Incorporation of Health Enhancement Products, Inc., as amended</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(1)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">3.11</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amendment to Articles of Incorporation of the Company, dated July 24, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(2)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">3.12 &nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended Articles of Incorporation dated October 16, 2014 for name change</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(3)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">3.1 &nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Certificate to Amendment of Articles of Incorporation of Incorporation dated November 14, 2016 </P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(4)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">3.2</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended and restated By-laws of the Company</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(5)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.04</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Security Agreement with HEP Investments, LLC ($100K loan) dated September 8, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(6)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.05</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Senior Secured Note with HEP Investments, LLC ($100K loan) dated September 8, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(7)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.06</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Loan Agreement with HEP Investments, LLC ($2M loan) dated December 2, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(8)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.07</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Senior Secured Note with HEP Investments, LLC ($2M loan) dated December 2, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(9)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.08</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Security Agreement with HEP Investments, LLC ($2M loan) dated December 2, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(10)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.09</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">IP Security Agreement with HEP Investments, LLC ($2M loan) dated December 2, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(11)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.10</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Investor Rights Agreement with Venture Group, LLC ($500K loan) dated November 8, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(12)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.14</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Subscription Agreement with Venture Group, LLC ($500K loan) dated January 26, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(13)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.15</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Subordinated Convertible Note with Venture Group, LLC ($500K loan) dated January 27, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(14)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.16</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Warrant Agreement with Venture Group, LLC ($500K loan) dated January 26, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(15)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.17</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Security Agreement with Venture Group, LLC ($500K loan) dated January 26, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(16)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.18</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Termination Agreement with Venture Group, LLC ($500K loan) dated January 26, 2012 (terminating agreements with Venture Group, LLC dated November 8, 2011)</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(17)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.19</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Termination Agreement with Oxford Holdings, LLC, dated January 26, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(18)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.20</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">License Agreement between Zus Health LLC and the Company dated September 2, 2010</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(19)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.21</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Lease Agreement between the Company and BCO, LLC dated February 28, 2011</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(20)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.24</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended and Restated Senior Secured Convertible Promissory Note and the First Amendment to Loan Agreement with HEP Investments, LLC dated April 15, 2013</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(21)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.25</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Asset Purchase Agreement with Essex Angel Capital Inc. dated April 15, 2013</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(22)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.26</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Second Amendment to Loan Agreement with HEP Investments, LLC dated December 16, 2013</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(23)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.27</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Third Amendment to Loan Agreement with HEP Investments, LLC dated March 17, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(24)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.28</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Third Amendment to Loan Agreement with HEP Investments, LLC dated July 1, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(25)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.29</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Fourth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated July 1, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(26)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.30</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Change of Control Agreement dated August 10, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(27)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.31</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Fourth Amendment to Loan Agreement with HEP Investments, LLC dated December 1, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(28)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.32</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Fifth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated December 1, 2014</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(29)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.33</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Fifth Amendment to Loan Agreement with HEP Investments, LLC dated April 28, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(30)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.34</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Sixth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated April 28, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(31)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.35</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended and Restated Change of Control Agreement dated April 9, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(32)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.36</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Sixth Amendment to Loan Agreement with HEP Investments, LLC dated December 31, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(33)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.37</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Seventh Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated December 31, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(34)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.38</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended and Restated Change of Control Agreement dated December 31, 2015</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(35)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.39</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Amended and Restated Employment Agreement with Andrew Dahl, the Registrant&#146;s CEO</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(36)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.40</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Seventh Amendment to Loan Agreement with HEP Investments, LLC dated September 30, 2016</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(37)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.41</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Eighth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated September 30, 2016</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(38)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.42</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Eighth Amendment to Loan Agreement with HEP Investments, LLC dated March 1, 2017</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(39)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">10.43</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Ninth Amended and Restated Senior Secured Convertible Promissory Note with HEP Investments, LLC dated March 1, 2017</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>(40)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">14.1</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Code of Ethics</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>*</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">21</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Subsidiaries of the Registrant</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>*</P>
</TD></TR>
</TABLE>
<DIV style="width:720px"><P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>1</P>
<P style="margin:0px"><BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=53.6 /><TD width=654.4 /><TD width=26.4 /></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">31.1</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>*</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">31.2</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>*</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">32.1</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Certification of the Principal Executive Officer pursuant to U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center>*</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=53.6><P style="margin:0px; text-indent:-0.667px">32.2</P>
</TD><TD style="margin-top:0px" valign=top width=654.4><P style="margin:0px; padding-left:6.4px; text-indent:-7.067px">Certification of the Principal Financial Officer pursuant to U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</P>
</TD><TD style="margin-top:0px" valign=top width=26.4><P style="margin:0px" align=center><B>*</B></P>
</TD></TR>
</TABLE>
<DIV style="width:720px"><P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:-0.667px">*Filed herewith</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; float:left">(1)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 3.13 to the Registrant&#146;s Form 8K filed with the Commission on June 29, 2015 and incorporated herein by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(2) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 3.11 to the Registrant&#146;s Form 10Q filed with the Commission on March 25, 2013 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(3) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 3.12 to the Registrant&#146;s Form 10Q filed with the Commission on November 14, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(4)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 3.1 to the Registrant&#146;s Form 10Q filed with the Commission on November 14, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(5) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 3.2 to the Registrant&#146;s Form 10Q filed with the Commission on May 17, 2010 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(6) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.04 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(7) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.05 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(8) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.06 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(9) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.07 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(10) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.08 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(11) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.09 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(12) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.10 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(13) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.14 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference. </P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(14) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.15 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(15) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.16 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(16) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.17 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(17) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.18 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(18) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.19 to Form 10K filed with the Commission on March 30, 2012 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(19) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.20 to Form 10K filed with the Commission on April 15, 2011 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(20) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.21 to Form 10Q filed with the Commission on August 22, 2011 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(21) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.24 to Form 10Q filed with the Commission on May 16, 2013 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(22) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.25 to Form 10Q filed with the Commission on May 16, 2013 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(23) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.26 to Form 10K filed with the Commission on March 31, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(24) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.27 to Form 10K filed with the Commission on March 31, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(25) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.28 to Form 10K filed with the Commission on March 31, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(26) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.29 to Form 10K filed with the Commission on March 31, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(27) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.30 to Form 10Q filed with the Commission on August 14, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(28) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.31 to Form 8K filed with the Commission on December 26, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(29) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.32 to Form 8K filed with the Commission on December 26, 2014 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(30) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.33 to Form 8K filed with the Commission on May 1, 2015 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(31) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.34 to Form 8K filed with the Commission on May 1, 2015 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(32) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.35 to Form 8K filed with the Commission on April 9, 2015 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(33) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.36 to Form 8K filed with the Commission on January 7, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(34) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.37 to Form 8K filed with the Commission on January 7, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(35) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.38 to Form 8K filed with the Commission on January 7, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(36) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.39 to Form 10Q filed with the Commission on August 12, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(37) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.40 to Form 8K filed with the Commission on October 5, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(38) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.41 to Form 8K filed with the Commission on October 5, 2016 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(39) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.42 to Form 8K filed with the Commission on March 6, 2017 and incorporated by this reference.</P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; font-size:9pt; clear:left; float:left">(40) </P>
<P style="margin:0px; padding-left:48px; text-indent:-2px; font-size:9pt">Filed as Exhibit 10.43 to Form 8K filed with the Commission on March 6, 2017 and incorporated by this reference.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>2</P>
<P style="margin:0px"><BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: DD47AA80 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>f10k123116_ex31z1.htm
<DESCRIPTION>EXHIBIT 31.1 SECTION 302 CERTIFICATION
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 31.1 Section 302 Certification</TITLE>
<META NAME="author" CONTENT="Philip Rice">
<META NAME="date" CONTENT="03/28/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px" align=right><BR></P>
<P style="margin:0px" align=right><B>Exhibit 31.1</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>Certification Pursuant to pursuant to Rule 13a-14(a) or Rule 15d-14(a) </B></P>
<P style="margin:0px" align=center><B>of the Securities Exchange Act of 1934, as amended</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">I, Andrew D. Dahl, certify that:</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>1. I have reviewed this Annual report on Form 10-K of Zivo Bioscience, Inc. (the &#147;Company&#148;);</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>4. The Registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">a)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure the material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly through the period in which this report is being prepared;</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">b)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">c)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations, and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">d)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify>5. The registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of registrant&#146;s board of directors (or persons performing the equivalent function):</P>
<P style="margin:0px" align=justify>&nbsp;</P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">a)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">b)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Date: &nbsp;March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><I><U>/s/ Andrew D. Dahl</U></I><U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P style="margin:0px">Andrew D. Dahl </P>
<P style="margin:0px">Chief Executive Officer</P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 1163268B -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>f10k123116_ex31z2.htm
<DESCRIPTION>EXHIBIT 31.2 SECTION 302 CERTIFICATION
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 31.2 Section 302 Certification</TITLE>
<META NAME="author" CONTENT="Philip Rice">
<META NAME="date" CONTENT="03/28/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px" align=right><BR></P>
<P style="margin:0px" align=right><B>Exhibit 31.2</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Certification Pursuant to pursuant to Rule 13a-14(a) or Rule 15d-14(a) </B></P>
<P style="margin:0px" align=center><B>of the Securities Exchange Act of 1934, as amended</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">I, Philip M. Rice II certify that:</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>1. I have reviewed this Annual report on Form 10-K of Zivo Bioscience, Inc. (the &#147;Company&#148;);</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>4. The Registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">a)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure the material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly through the period in which this report is being prepared;</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">b)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">c)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations, and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">d)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify>5. The registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of registrant&#146;s board of directors (or persons performing the equivalent function):</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">a)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; text-indent:24px; width:48px; float:left">b)</P>
<P style="margin:0px; padding-left:48px; text-indent:-2px" align=justify>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Date: March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><I><U>/s/ Philip M. Rice II &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I></P>
<P style="margin:0px">Philip M. Rice II </P>
<P style="margin:0px">Chief Financial Officer</P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 309F60B7 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>f10k123116_ex32z1.htm
<DESCRIPTION>EXHIBIT 32.1 SECTION 906 CERTIFICATION
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 32.1 Section 906 Certification</TITLE>
<META NAME="author" CONTENT="Philip Rice">
<META NAME="date" CONTENT="03/28/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px" align=right><BR></P>
<P style="margin:0px" align=right><B>Exhibit 32.1</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>CERTIFICATION PURSUANT TO</B></P>
<P style="margin:0px" align=center><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>
<P style="margin:0px" align=center><B>(Subsections (a) and (b) of Section 1350,</B></P>
<P style="margin:0px" align=center><B>Chapter 63 of Title 18, United States Code)</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>In connection with the Annual Report of Zivo Bioscience, Inc., a Nevada corporation (the &#147;Company&#148;), on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission (the &#147;Report&#148;), I, Andrew D. Dahl, Chief Administrative Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350), that to the best of my knowledge and belief:</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:24px" align=justify>(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:24px" align=justify>(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Date: March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><I><U>/s/ Andrew D. Dahl</U></I><U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P style="margin:0px">Andrew D. Dahl </P>
<P style="margin:0px">Chief Executive Officer</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO ZIVO BIOSCIENCE, INC. AND WILL BE RETAINED BY ZIVO BIOSCIENCE, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 160BC964 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>f10k123116_ex32z2.htm
<DESCRIPTION>EXHIBIT 32.2 SECTION 906 CERTIFICATION
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 32.2 Section 906 Certification</TITLE>
<META NAME="author" CONTENT="Philip Rice">
<META NAME="date" CONTENT="03/28/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:720px"><P style="margin:0px" align=right><BR></P>
<P style="margin:0px" align=right><B>Exhibit 32.2</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>CERTIFICATION PURSUANT TO</B></P>
<P style="margin:0px" align=center><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>
<P style="margin:0px" align=center><B>(Subsections (a) and (b) of Section 1350,</B></P>
<P style="margin:0px" align=center><B>Chapter 63 of Title 18, United States Code)</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>In connection with the Annual Report of Zivo Bioscience, Inc., a Nevada corporation (the &#147;Company&#148;), on Form 10-K for the period ended December 31, 2016 as filed with the Securities and Exchange Commission (the &#147;Report&#148;), I, Philip M. Rice II, Chief Accounting Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350), that to the best of my knowledge and belief:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:24px" align=justify>(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:24px" align=justify>(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Date: March 31, 2017</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><I><U>/s/ Philip M. Rice II</U></I><U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P style="margin:0px">Philip M. Rice II </P>
<P style="margin:0px">Chief Financial Officer</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO ZIVO BIOSCIENCE, INC. AND WILL BE RETAINED BY ZIVO BIOSCIENCE, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: F342E5B3 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>zivo-20161231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.zivobioscience.com/20161231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDBALANCESHEET"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet' xlink:label='us-gaap_DeferredFinanceCostsNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_DeferredFinanceCostsNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_Liabilities' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_StockholdersEquity' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>zivo-20161231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.zivobioscience.com/20161231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDBALANCESHEET"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalUnitsMember' xlink:label='us-gaap_CapitalUnitsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_CapitalUnitsMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_AdditionalPaidInCapitalMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_RetainedEarningsMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding' xlink:label='us-gaap_SharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesOutstanding' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance' xlink:label='fil_Balance'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance1' xlink:label='fil_Balance1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance1' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsToBoardOfDirectors' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices' xlink:label='fil_IssuanceOfWarrantsForServices'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServices' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServicesRelatedParty' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:label='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' xlink:label='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:label='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountsOnIssuanceOfConvertibleDebentures' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts' xlink:label='fil_WarrantsIssuedForFinancingCosts'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsIssuedForFinancingCosts' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts' xlink:label='fil_CommonStockIssuedForFinancingCosts'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedForFinancingCosts' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetIncome' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsToBoardOfDirectors1' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices1' xlink:label='fil_IssuanceOfWarrantsForServices1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServices1' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServicesRelatedParty1' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockForServices' xlink:label='fil_IssuanceOfCommonStockForServices'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfCommonStockForServices' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountsOnIssuanceOfConvertibleDebentures1' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts1' xlink:label='fil_WarrantsIssuedForFinancingCosts1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsIssuedForFinancingCosts1' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts1' xlink:label='fil_CommonStockIssuedForFinancingCosts1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedForFinancingCosts1' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetLoss' use='optional' order='22.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureDESCRIPTIONOFBUSINESS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureBASISOFPRESENTATION"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosurePROPERTYANDEQUIPMENT"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureDUETORELATEDPARTY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureLOANPAYABLERELATEDPARTIES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureCONVERTIBLEDEBT"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSTOCKHOLDERSDEFICIENCY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureOTHERINCOMEEXPENSE"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureCOMMITMENTSANDCONTINGENCIES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureRELATEDPARTYTRANSACTIONS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureINCOMETAXES"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSUBSEQUENTEVENTS"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureAccountingPoliciesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureFairValueOfWarrantsEstimatedTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureScheduleOfPropertyAndEquipmentTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureScheduleOfConvertibleDebtTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureStockholdersWarrantsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_BasisOfPresentationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_FairValueAssumptionsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PropertyAndEquipmentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PropertyAndEquipmentDepreciationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DueToRelatedPartyDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_LoanPayableRelatedPartiesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtHEPInvestmentsLLCDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DeferredDebtDiscountAndOtherDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_HEPInvestmentsLLCRestrictedCommonSharesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PaulsonInvestmentRelatedDebtDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtConsistsOfTheFollowingDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtParentheticalsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_BoardOfDirectorsFeesTextualDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DirectorsFeesDuringThePeriodDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockBasedCompensationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockIssuancesInTheYear2015Details"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockIssuancesInTheYear2016Details"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ExecutiveCompensationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_WarrantsOutstandingAndExercisableByPriceRangeDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_OtherIncomeExpenseDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CommitmentAndContingenciesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_IncomeTaxDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SettlementOfLitigationRelatedPartyDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails"/>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SubsequentEventsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>zivo-20161231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2016-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://www.zivobioscience.com/20161231' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='zivo-20161231.xsd' />
	<us-gaap:Cash decimals='INF' contextRef='E15' unitRef='USD'>16589</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E16' unitRef='USD'>506986</us-gaap:Cash>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E15' unitRef='USD'>12341</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E16' unitRef='USD'>13437</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E15' unitRef='USD'>28930</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E16' unitRef='USD'>520423</us-gaap:AssetsCurrent>
	<us-gaap:DeferredFinanceCostsNet decimals='INF' contextRef='E15' unitRef='USD'>0</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:DeferredFinanceCostsNet decimals='INF' contextRef='E16' unitRef='USD'>198119</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:Assets decimals='INF' contextRef='E15' unitRef='USD'>72680</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E16' unitRef='USD'>737292</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E15' unitRef='USD'>1114426</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16' unitRef='USD'>666365</us-gaap:AccountsPayableCurrent>
	<us-gaap:DueToRelatedPartiesCurrent decimals='INF' contextRef='E15' unitRef='USD'>211233</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>319234</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:LoansPayableCurrent decimals='INF' contextRef='E15' unitRef='USD'>337107</us-gaap:LoansPayableCurrent>
	<us-gaap:LoansPayableCurrent decimals='INF' contextRef='E16' unitRef='USD'>245979</us-gaap:LoansPayableCurrent>
	<us-gaap:ConvertibleDebtCurrent decimals='INF' contextRef='E15' unitRef='USD'>1224510</us-gaap:ConvertibleDebtCurrent>
	<us-gaap:ConvertibleDebtCurrent decimals='INF' contextRef='E16' unitRef='USD'>6886710</us-gaap:ConvertibleDebtCurrent>
	<us-gaap:InterestPayableCurrent decimals='INF' contextRef='E15' unitRef='USD'>1673386</us-gaap:InterestPayableCurrent>
	<us-gaap:InterestPayableCurrent decimals='INF' contextRef='E16' unitRef='USD'>2659574</us-gaap:InterestPayableCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent decimals='INF' contextRef='E15' unitRef='USD'>410248</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>404618</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E15' unitRef='USD'>4970910</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>11182480</us-gaap:LiabilitiesCurrent>
	<us-gaap:ConvertibleDebtNoncurrent decimals='INF' contextRef='E15' unitRef='USD'>4598759</us-gaap:ConvertibleDebtNoncurrent>
	<us-gaap:ConvertibleDebtNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>3176047</us-gaap:ConvertibleDebtNoncurrent>
	<us-gaap:LiabilitiesNoncurrent decimals='INF' contextRef='E15' unitRef='USD'>4598759</us-gaap:LiabilitiesNoncurrent>
	<us-gaap:LiabilitiesNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>3176047</us-gaap:LiabilitiesNoncurrent>
	<us-gaap:Liabilities decimals='INF' contextRef='E15' unitRef='USD'>9569669</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E16' unitRef='USD'>14358527</us-gaap:Liabilities>
	<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E15' unitRef='USD' />
	<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E16' unitRef='USD' />
	<us-gaap:CommonStockValue decimals='INF' contextRef='E15' unitRef='USD'>132157</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E16' unitRef='USD'>136745</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E15' unitRef='USD'>38085266</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16' unitRef='USD'>40016059</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E15' unitRef='USD'>-47714412</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E16' unitRef='USD'>-53774039</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E15' unitRef='USD'>-9496989</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E16' unitRef='USD'>-13621235</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E15' unitRef='USD'>72680</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E16' unitRef='USD'>737292</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 1 &amp;#150; DESCRIPTION OF BUSINESS&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The business model of Zivo Bioscience, Inc. and Subsidiaries (Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc.) (collectively the &amp;#147;Company&amp;#148;) is as follows: 1) to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement and medical food manufacturers (currently, the Company&apos;s focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially), and 2) developing, manufacturing, marketing, and selling tests that the Company believes will allow people to optimize their health and identify future health risks.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
	<us-gaap:BasisOfAccounting contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 2 &amp;#150; BASIS OF PRESENTATION &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Going Concern&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company had a net loss of $6,059,627 and $5,789,131 during the years ended December 31, 2016 and 2015, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;In addition, the Company had a working capital deficiency of $10,662,057 and a stockholders&amp;#146; deficiency of $13,621,235 at December 31, 2016. These factors raise substantial doubt about the Company&apos;s ability to continue as a going concern.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company&amp;#146;s existing stockholders.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company is attempting to address its lack of liquidity by raising additional funds, either in the form of debt or equity or some combination thereof. &amp;nbsp;There can be no assurances that the Company will be able to raise the additional funds it requires.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;During the year ended December 31, 2016, the Company received proceeds of $3,250,000 from the issuance of 11% convertible debt.&lt;/p&gt;</us-gaap:BasisOfAccounting>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 3 &amp;#150; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/b&gt;&lt;b&gt; -&lt;/b&gt; The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Accounting Estimates&lt;/u&gt;&lt;/b&gt;&lt;b&gt; - &lt;/b&gt;The Company&amp;#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &amp;nbsp;Actual results could differ from those estimates. &amp;nbsp;Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. &amp;nbsp;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/b&gt;&lt;b&gt; -&lt;/b&gt; For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31, 2016, the Company did not have any cash equivalents.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/b&gt;&lt;b&gt; &amp;#150; &lt;/b&gt;Property and equipment consists of furniture and office equipment, and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets, generally five to seven years. &amp;nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Deferred Financing Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &amp;nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &amp;nbsp;Amortization of deferred financing costs amounted to $26,813 and $-0- for the years ended December 31, 2016 and 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104, &amp;#147;Revenue Recognition&amp;#148; (&amp;#147;SAB No. 104&amp;#148;), which superseded Staff Accounting Bulletin No. 101, &amp;#147;Revenue Recognition in Financial Statements&amp;#148; (&amp;#147;SAB No. 101&amp;#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Shipping and Handling Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Shipping and handling costs are expensed as incurred. For the years ended December 31, 2016 and 2015 no shipping and handling costs were incurred.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Research and development costs are expensed as incurred. The majority of the Company&apos;s research and development costs consist of clinical study expenses. These consist of fees, charges, and related expenses incurred in the conduct of clinical studies conducted with Company products by independent outside contractors. External clinical studies expenses were approximately $789,000 and $1,033,000 for the years ended December 31, 2016 and 2015, respectively. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &amp;nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses, and it is more likely than not that some portion or all of the deferred tax assets will not be realized, a full valuation allowance has been established. In addition, utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &amp;#147;change in ownership&amp;#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Stock Based Compensation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;We account for stock-based compensation in accordance with FASB ASC 718, &lt;i&gt;Compensation &amp;#150; Stock Compensation. &amp;nbsp;&lt;/i&gt;Under the provisions of FASB ASC 718, stock-based compensation cost is estimated at the grant date based on the award&amp;#146;s fair value and is recognized as expense over the requisite service period. &amp;nbsp;The Company generally issues grants to its employees, consultants and board members. &amp;nbsp;At the date of grant, the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &amp;nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;During 2016 and 2015, warrants were granted to employees, directors and consultants of the Company. &amp;nbsp;As a result of these grants, the Company recorded compensation expense of $1,201,758 and $464,577 during the years ended December 31, 2016 and 2015 respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;206&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected volatility&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;158.53% to 173.53%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;128.36% to 155.43%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected dividends&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected term&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;5 years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;3 to 5 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Risk free rate&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.71% to 1.04%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.51% to 1.75%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company&amp;#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&amp;#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Income (Loss) Per Share&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Basic loss per share is computed by dividing the Company&amp;#146;s net loss by the weighted average number of common shares outstanding during the period presented. Diluted loss per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &amp;nbsp;Potentially dilutive securities as of December 31, 2016, consisted of 111,086,456 common shares from convertible debentures and related accrued interest and 32,071,901 common shares from outstanding warrants. Potentially dilutive securities as of December 31, 2015, consisted of 73,883,330 common shares from convertible debentures and related accrued interest and 14,705,818 common shares from outstanding warrants. &amp;nbsp;&amp;nbsp;For 2016 and 2015, diluted and basic weighted average shares were the same, as potentially dilutive shares are anti-dilutive.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Advertising Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Advertising costs are charged to operations when incurred. &amp;nbsp;There were no Advertising Costs during the years 2016 and 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Concentrations of Credit Risk&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &amp;nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&amp;#147;FDIC&amp;#148;) limit of $250,000 at times during the year.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Future Impact of Recently Issued Accounting Standards&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;In May 2014, the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), &amp;#147;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&amp;#148;&lt;i&gt; &lt;/i&gt;ASU 2014-09 superseded the revenue recognition requirements in &amp;#147;Revenue Recognition (Topic 605),&amp;#148; and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &amp;nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&amp;#146;s financial position or results of operations.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) &amp;#147;Presentation of Financial Statements &amp;#150; Going Concern (Subtopic 205-40).&amp;#148; &amp;nbsp;The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. &amp;nbsp;Early application is permitted. &amp;nbsp;This Update had no effect on the Company&amp;#146;s financial position and results of operations for the year ended December 31, 2016.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued, but not yet effective, accounting standards been adopted in the current period.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<fil:FairValueOfWarrantsEstimatedTablesTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;206&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected volatility&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;158.53% to 173.53%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;128.36% to 155.43%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected dividends&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected term&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;5 years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;3 to 5 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Risk free rate&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.71% to 1.04%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.51% to 1.75%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</fil:FairValueOfWarrantsEstimatedTablesTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Property and equipment at December 31, 2016 and 2015 consist of the following:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Equipment&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;80,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;80,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(81,250)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(56,250)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,750&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;43,750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 4 &amp;#150; PROPERTY AND EQUIPMENT&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Property and equipment at December 31, 2016 and 2015 consist of the following:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Furniture &amp;amp; fixtures&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Equipment&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;80,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;80,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(81,250)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(56,250)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;216&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,750&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;86&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;43,750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Depreciation and amortization was $25,000 and $25,000 for the years ended December 31, 2016 and 2015, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 5 &amp;#150; DUE TO RELATED PARTY&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As of December 31, 2016 and 2015, the Company owed HEP Investments, a related party, cumulative balances of $319,234 and $211,234, respectively. &amp;nbsp;The basis for the payable is a 5.4% cash finance fee for monies invested in the Company in the form of convertible debt. &amp;nbsp;For the years ended December 31, 2016 and 2015, the Company incurred finance costs related to these transactions of $108,000 and $111,820, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:LongTermDebtTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 6 &amp;#150; LOAN PAYABLE, RELATED PARTIES&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;During the year ended December 31, 2015, Mr. Christopher Maggiore, a director and a significant shareholder of the Company, had advanced the Company a total of $156,405, which remained unpaid as of December 31, 2015. &amp;nbsp;During 2016, Mr. Maggiore advanced the Company an additional $20,000, for a total advanced as of December 31, 2016 of $176,405. &amp;nbsp;The Company has agreed to pay 11% interest on this loan. During the years ended December 31, 2016 and 2015, the Company recorded interest on this indebtedness of $20,396 and $19,835, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;For the year ended December 31, 2015, Officers had advanced the Company $2,000, which amount remained unpaid as of December 31, 2015. &amp;nbsp;This amount was repaid in 2016.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;During the year ended December 31, 2015, HEP Investments, LLC loaned the Company $2,246,202 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,067,500 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $178,702 as of December 31, 2015. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;During the year ended December 31, 2016, HEP Investments loaned the Company $1,890,872 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,000,000 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $69,574 as of December 31, 2016. &amp;nbsp;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 12pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 7 &amp;#150; CONVERTIBLE DEBT&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;HEP Investments, LLC &amp;#150; Related Party&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On December 2, 2011, the Company and HEP Investments, LLC, a Michigan limited liability company (&amp;#147;Lender&amp;#148;), entered into the following documents, effective as of December 1, 2011, as amended through September 30, 2016:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;(i) a Loan Agreement under which the Lender has agreed to advance up to $17,500,000 to the Company, subject to certain conditions, (ii) a Convertible Secured Promissory Note in the principal amount of $17,500,000 (&amp;#147;Note&amp;#148;) and (iii) a Security Agreement, under which the Company granted the Lender a security interest in all of its assets, (iv) an Intellectual Property security agreement under which the Company and its subsidiaries granted the Lender a security interest in all their respective intellectual properties, including patents, in each case order to secure their respective obligations to the Lender under the Note and related documents and &amp;nbsp;(v) enter into a Registration Rights Agreement with respect to all the shares of common stock issuable to the Lender in connection with the Loan transaction. &amp;nbsp;In addition, the Company&amp;#146;s subsidiaries have guaranteed the Company&amp;#146;s obligations under the Note. The Company has also made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Company&amp;#146;s senior management, without the prior written consent of the Lender. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;During the year ended December 31, 2015, the Company recorded a debt discount, related to the $2,067,500 of Notes described previously (Note 6), in the amount of $1,916,501, to reflect the beneficial conversion feature of the convertible debt and fair value of the warrants pursuant to Emerging Issues Task Force (&amp;#147;EITF&amp;#148;) 00-27: Application of EITF 98-5, &amp;#147;Accounting for Convertible Securities with Beneficial Conversion Features on Contingently Adjustable Conversion Rates,&amp;#148; to certain convertible instruments. In accordance with EITF 00-27, the Company valued the beneficial conversion feature and recorded the amount of $1,773,078 as a reduction to the carrying amount of the convertible debt and as an addition to paid-in capital. Additionally, the relative fair value of the warrants was calculated and recorded at $143,423 as a further reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of discounts was $1,866,842 for the year ended December 31, 2015. &amp;nbsp;The $2,067,500 of Notes are convertible at $.10 per share.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;During the year ended December 31, 2016, the Company recorded debt discounts, related to the $2,000,000 of Notes described previously (Note 6), in the amount of $106,693, to reflect the relative fair value of the related warrants as a reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of the debt discounts was $1,376,181 for the years ended December 31, 2016. &amp;nbsp;The $2,000,000 of Notes are convertible at $.10 per share. As discussed in Note 13 &amp;#150; Settlement of Litigation &amp;#150; Related Party, the Lender reduced the principal of the debt by $280,000 (at $.12 per share) relating to a settlement with the Company.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As of December 31, 2016, amounts advanced under the Note are convertible into the Company&amp;#146;s restricted common stock according to the following schedule: (A) $4,152,200 at $.10 per share, (B) $2,320,000 at $.12 per share, (C) $1,285,000 at $.15 per share, (D) $640,000 at $.22 per share, and (E) $750,000 at $.30 per share, (ii) bear interest at the rate of 11% per annum. &amp;nbsp;The Seventh Amended and Restated Senior Secured Convertible Promissory Note (effective December 31, 2015) resets the Due Dates of Tranches 1 through 13 (totaling $3,740,000) to October 14, 2017. The Eighth Amended and Restated Senior Secured Convertible Promissory Note (effective September 30, 2016) resets the Due Dates of Tranches 14 through 16 (totaling $1,369,700) to January 31, 2017. The remaining Tranches 17 to 30, totaling $4,067,500, are due on varying anniversary dates ranging from February 28, 2017 through August 25, 2018. &amp;nbsp;Accrued interest must be paid on the first and second anniversary of the Note. &amp;nbsp;&amp;nbsp;The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50, &amp;#147;Modifications and Extinguishments.&amp;#148; As of December 31, 2016 and December 31, 2015, unpaid interest due was $2,502,367 and $1,572,065, respectively and is included in accrued liabilities. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;In 2015, the Lender converted $60,000 of the debt (at $.12 per share). Any Note that has not yet matured may be prepaid upon sixty days written notice, provided that the Company shall be required to pay a prepayment premium equal to 5% of the amount repaid.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Paulson Investment Company, LLC - Related Debt&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On August 24, 2016, the Company entered into a Placement Agent Agreement with Paulson Investment Company, LLC (Paulson). &amp;nbsp;This agreement provides that Paulson can provide up to $2 million in financings through &amp;#147;accredited investors&amp;#148; (as defined by Regulation D of the Securities Act of 1933, as amended). &amp;nbsp;As of December 31, 2016, the Company received funding of $1,250,000 through seven (7) individual loans (the &amp;#147;New Lenders&amp;#148;). &amp;nbsp;Each loan includes a (i) a Loan Agreement of the individual loan, (ii) a Convertible Secured Promissory Note (&amp;#147;New Lenders Notes&amp;#148;) in the principal amount of the loan, (iii) a Security Agreement under which the Company granted the Lender a security interest in all of its assets and (iv) an Intercreditor Agreement with HEP Investments, LLC (HEP) whereby HEP and the New Lenders agree to participate in all collateral a &lt;i&gt;pari passu &lt;/i&gt;basis. &amp;nbsp;The loans have a two year term and mature in September 2018 ($600,000) and October 2018 ($650,000). &amp;nbsp;Paulson receives a 10% cash finance fee for monies invested in the Company in the form of convertible debt, along with 5 year, $.10 warrants equal to 15% of the number of common shares for which the debt is convertible into at $.10 per share.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;The New Lenders Notes are convertible into the Company&amp;#146;s restricted common stock at $.10 per share and bear interest at the rate of 11% per annum. &amp;nbsp;The New Lenders Notes must be repaid as follows: &amp;nbsp;accrued interest must be paid on the first and second anniversary of the Note and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Other Debt&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;In September 2014, the Lender of the 1% convertible debentures agreed to rolling 30 day extensions until notice is given to the Company to the contrary. &amp;nbsp;The Company determined that the modification of these Notes is not a substantial modification in accordance with ASC 470-50, &amp;#147;Modifications and Extinguishments.&amp;#148;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Convertible debt consists of the following:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;1% Convertible notes payable, due January 2017&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;240,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;240,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;11% Convertible note payable &amp;#150; HEP Investments, LLC, a related party, net of unamortized discount of $574,443 and $1,843,931, respectively, due at various dates ranging from January 2017 to October 2018&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;8,572,757&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;5,583,269&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;11% Convertible note payable &amp;#150; New Lenders; placed by Paulson, due at various dates ranging from September 2018 to October 2018&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;10,062,757&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;5,823,269&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Less: Current portion&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;6,886,710&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,224,510&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Long term portion&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,176,047&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4,598,759&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 12pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:ConvertibleDebtTableTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Convertible debt consists of the following:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;December 31,&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;1% Convertible notes payable, due January 2017&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;240,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;240,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;11% Convertible note payable &amp;#150; HEP Investments, LLC, a related party, net of unamortized discount of $574,443 and $1,843,931, respectively, due at various dates ranging from January 2017 to October 2018&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;8,572,757&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;5,583,269&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;11% Convertible note payable &amp;#150; New Lenders; placed by Paulson, due at various dates ranging from September 2018 to October 2018&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;10,062,757&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;5,823,269&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Less: Current portion&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;6,886,710&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,224,510&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;286&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Long term portion&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;80&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,176,047&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4,598,759&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 12pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 8 - STOCKHOLDERS&amp;#146; DEFICIENCY&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Board of Directors fees&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2015, at an exercise price of $.09 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &amp;nbsp;The warrants were valued at $3,664 using the Black Scholes pricing model relying on the following assumptions: volatility 128.38%; annual rate of dividends 0%; discount rate 0.68%. &amp;nbsp;In addition, Mr. Rice is entitled to receive $10,000 for each annual term served.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2015, at an exercise price of $.15 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &amp;nbsp;The warrants were valued at $6,185 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 1.09%. &amp;nbsp;In addition, Mr. Cox is entitled to receive $10,000 for each annual term served.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to John B. Payne in July, 2015, at an exercise price of $.09 per share. &amp;nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &amp;nbsp;The warrants were valued at $4,876 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 0. 109%. &amp;nbsp;In addition, Mr. Payne is entitled to receive $10,000 for each annual term served.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On September 10, 2015, the board of directors amended its policy for the compensation of its directors. The Board granted to each of its five (5) Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.10 per share. The warrants have a term of five years and vest immediately. The unvested portion of the previously granted warrants were cancelled due to the Company&amp;#146;s change to a program where all director warrant grants are made once per year at the same time. In addition, each director is entitled to receive $10,000 for each annual term served. &amp;nbsp;As such, Mr. Cox&amp;#146;s unvested warrant of 36,986 shares, Ms. Masterson&amp;#146;s warrant of 959 shares, Mr. Payne&amp;#146;s warrant of 42,740 shares and Mr. Rice&amp;#146;s unvested warrant of 15,890 shares, were cancelled.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 125,000 shares of common stock to Robert O. Rondeau, a new Director, in March 2016, at an exercise price of $.09 per share. &amp;nbsp;The warrants have a term of five years and vest immediately. &amp;nbsp;The warrants were valued at $10,588 using the Black Scholes pricing model relying on the following assumptions: volatility 168.01%; annual rate of dividends 0%; discount rate 0.97%. &amp;nbsp;In addition, Mr. Rondeau will receive $10,000 for each annual term served, paid quarterly.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On September 10, 2016, the board of directors granted to each of its Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.05 per share. The warrants have a term of five years and vest immediately. The warrants were valued at $59,125 using the Black Scholes pricing model relying on the following assumptions: volatility 171.58%; annual rate of dividends 0%; discount rate 0.79%. &amp;nbsp;In addition, each director is entitled to receive $10,000 for each annual term served.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;The Company recorded directors&amp;#146; fees of $109,713 and $166,679 for the years ended December 31, 2016 and 2015, respectively, representing the cash fees and the value of the vested warrants described above.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Stock Based Compensation&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On April 23, 2015, the Company issued 500,000 shares of common stock valued at $30,000, to an investor relations consulting firm. On April 15, 2015, the Company issued warrants to purchase 1,875,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &amp;nbsp;The warrants were valued at $133,862 using the Black Scholes pricing model relying on the following assumptions: volatility 143.36%; annual rate of dividends 0%; discount rate 0.15%. On June 26, 2015, the Company issued warrants to purchase 1,250,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &amp;nbsp;The warrants were valued at $151,443 using the Black Scholes pricing model relying on the following assumptions: volatility 150.93%; annual rate of dividends 0%; discount rate 1.75%. On August 1, 2015, the Company issued 461,539 shares of common stock valued at $46,154, to an investor relations consulting firm. On September 10, 2015, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.10 with a term of five years to four of its consultants (100,000 warrants per consultant) working in research and development. &amp;nbsp;The warrants have a term of five years and are fully vested. &amp;nbsp;The warrants were valued at $36,540 using the Black Scholes pricing model relying on the following assumptions: volatility 152.53%; annual rate of dividends 0%; discount rate 0. 075%.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On May 19, 2016, the Company issued warrants to purchase 14,500,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to agreements with financial consultants. &amp;nbsp;The warrants were valued at $1,095,063 using the Black Scholes pricing model relying on the following assumptions: volatility 170.07%; annual rate of dividends 0%; discount rate 0.89%. &amp;nbsp;On September 19, 2016, the Company issued 3,500,000 shares of common stock, valued at $175,000, to an investor relations consulting firm. &amp;nbsp;On November 17, 2016, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.09 with a term of 5 years pursuant to agreements with financial consultants. &amp;nbsp;The warrants were valued at $21,381 using the Black Scholes pricing model relying on the following assumptions: volatility 173.41%; annual rate of dividends 0%; discount rate 1.04%.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Stock Issuances&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On January 14, 2015, the Company received proceeds of $30,000 from the issuance of 600,000 shares of common stock. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On January 23, 2015, the Company received proceeds of $13,500 from the issuance of 270,000 shares of common stock. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On February 17, 2015, the Company received proceeds of $5,000 from the issuance of 100,000 shares of common stock. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On February 27, 2015, in connection with the issuance of $227,500 in principal of an 11% Convertible Debenture, the Company issued 81,900 shares of common stock valued at $8,190 and a warrant to purchase 227,500 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.3%; annual rate of dividends 0%; discount rate 0.63%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On March 27, 2015, in connection with the issuance of $135,000 in principal of an 11% Convertible Debenture, the Company issued 151,329 shares of common stock valued at $13,050 and a warrant to purchase 135,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.9%; annual rate of dividends 0%; discount rate 0.61%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On April 17, 2015, in connection with the issuance of $217,800 in principal of an 11% Convertible Debenture, the Company issued 112,011 shares of common stock valued at $7,841 and a warrant to purchase 217,800 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $13,326 using the Black Scholes pricing model relying on the following assumptions: volatility 143.3%; annual rate of dividends 0%; discount rate 1.31%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On May 1, 2015, in connection with the issuance of $237,200 in principal of an 11% Convertible Debenture, the Company issued 121,989 shares of common stock valued at $8,539 and a warrant to purchase 237,200 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $14,531 using the Black Scholes pricing model relying on the following assumptions: volatility 143.7%; annual rate of dividends 0%; discount rate 1.50%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On June 26, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 69,231 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $30,012 using the Black Scholes pricing model relying on the following assumptions: volatility 150.9%; annual rate of dividends 0%; discount rate 1.75%. See Note 7 &amp;#150; Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On July 7, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 90,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $22,972 using the Black Scholes pricing model relying on the following assumptions: volatility 150.8%; annual rate of dividends 0%; discount rate 1.55%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On September 2, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 81,818 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $25,221 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.72%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On October 8, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.8%; annual rate of dividends 0%; discount rate 0.65%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On October 29, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On January 27, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $8,018 using the Black Scholes pricing model relying on the following assumptions: volatility 158.1%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On March 1, 2016, in connection with the issuance of $750,000 in principal of an 11% Convertible Debenture, the Company issued 337,500 shares of common stock valued at $27,000 and a warrant to purchase 750,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $44,371 using the Black Scholes pricing model relying on the following assumptions: volatility 167.7%; annual rate of dividends 0%; discount rate 0.85%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On May 16, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $18,746 using the Black Scholes pricing model relying on the following assumptions: volatility 170.1%; annual rate of dividends 0%; discount rate 0.79%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On July 26, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $11,523 using the Black Scholes pricing model relying on the following assumptions: volatility 170.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On August 25, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 150,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $13,939 using the Black Scholes pricing model relying on the following assumptions: volatility 170.8%; annual rate of dividends 0%; discount rate 0.78%. See Note 7 - Convertible Debt. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On October 20, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 128,571 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &amp;nbsp;The warrants were valued at $16,419 using the Black Scholes pricing model relying on the following assumptions: volatility 173.2%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Executive Compensation&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;As compensation for serving as Chief Financial Officer, the Company, quarterly, will issue warrants to purchase 50,000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner, at which time such warrants would vest. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;On April 6, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.085. The warrants were valued at $3,800 using the Black Scholes pricing model relying on the following assumptions: volatility 143.17%; annual rate of dividends 0%; discount rate 1.31%. On May 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,582 using the Black Scholes pricing model relying on the following assumptions: volatility 143.464%; annual rate of dividends 0%; discount rate 1.57%. &amp;nbsp;On August 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.11. The warrants were valued at $5,019 using the Black Scholes pricing model relying on the following assumptions: volatility 152.05%; annual rate of dividends 0%; discount rate 0.72%. &amp;nbsp;On November 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &amp;nbsp;The warrants were valued at $3,652 using the Black Scholes pricing model relying on the following assumptions: volatility 151.81%; annual rate of dividends 0%; discount rate 1.2%.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On March 29, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &amp;nbsp;The warrants were valued at $3,771 using the Black Scholes pricing model relying on the following assumptions: volatility 169.28%; annual rate of dividends 0%; discount rate 0.78%. &amp;nbsp;On May 13, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &amp;nbsp;The warrants were valued at $3,777 using the Black Scholes pricing model relying on the following assumptions: volatility 170.23%; annual rate of dividends 0%; discount rate 0.76%. &amp;nbsp;On August 12, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.07. &amp;nbsp;The warrants were valued at $3,307 using the Black Scholes pricing model relying on the following assumptions: volatility 170.83%; annual rate of dividends 0%; discount rate 0.71%. &amp;nbsp;On November 14, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.10. &amp;nbsp;The warrants were valued at $4,745 using the Black Scholes pricing model relying on the following assumptions: volatility 173.53%; annual rate of dividends 0%; discount rate 1.00%. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Common Stock Warrants&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;A summary of the status of the Company&amp;#146;s warrants is presented below.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;160&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:120pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;December 31, 2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;166&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:124.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Outstanding, beginning of year&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;14,705,818&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;9,053,005&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Issued&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,350,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,192,500&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Exercised&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Cancelled&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(96,575)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expired&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(2,983,917)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(1,443,112)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Outstanding, end of period&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;14,705,818&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Warrants outstanding and exercisable by price range as of December 31, 2016 were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;227&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:170.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Outstanding Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;196&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:147pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Exercisable Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Remaining&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Range of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Contractual Life in Years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4.70&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,625,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4.23&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,625,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;309,110&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3.11&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;309,110&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,327,200&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3.99&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,327,200&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;99,041&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;99,041&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.62&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2,485,274&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2,485,274&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.46&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;269,276&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.75&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;269,276&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;707,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.52&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;707,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.90&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.50&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.01&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.79&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;A summary of the status of the Company&amp;#146;s warrants is presented below.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;160&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:120pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;December 31, 2016&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;166&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:124.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Warrants&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Outstanding, beginning of year&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;14,705,818&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;9,053,005&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.16&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Issued&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;20,350,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,192,500&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Exercised&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Cancelled&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;-&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(96,575)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expired&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(2,983,917)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(1,443,112)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;177&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Outstanding, end of period&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;79&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;64&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;14,705,818&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;84&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
	<fil:WarrantsOutstandingAndExercisableTableTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Warrants outstanding and exercisable by price range as of December 31, 2016 were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;227&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:170.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Outstanding Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;196&quot; colspan=&quot;5&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:147pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Exercisable Warrants&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Weighted&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Remaining&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Average&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Range of&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Contractual Life in Years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Number&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4.70&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1,250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.05&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,625,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;4.23&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;18,625,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;309,110&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3.11&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;309,110&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.09&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,327,200&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3.99&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;7,327,200&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;99,041&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;99,041&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.62&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.14&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2,485,274&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2,485,274&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.15&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;2.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.17&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.46&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;100,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.20&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;269,276&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.75&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;269,276&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.22&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;707,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.52&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;707,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.25&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.90&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.30&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.50&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;250,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.01&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;50,000&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.38&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;67&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;76&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;1.79&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;20&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;52&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;13&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;60&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;32,071,901&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;53&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;0.10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 12pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</fil:WarrantsOutstandingAndExercisableTableTextBlock>
	<us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 9 - OTHER INCOME (EXPENSE)&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;On July 15, 2014, the Company settled a dispute with one of its vendors. &amp;nbsp;The settlement agreement calls for the Company to make 10 payments of $6,250. &amp;nbsp;If the payments are not made timely, a total liability of $97,463 out of the gross amount recorded on the Company&amp;#146;s books of $191,146 will be due. &amp;nbsp;During the year ended December 31, 2015, the Company met its obligation for timely payments and recognized an additional $34,963 (the difference between the $97,463 remaining liability and the agreed upon payments of $62,500) as &quot;Other Income&quot; on its Statement of Operations the year ended December 31, 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 10- COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Employment Agreement&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;The Company&amp;#146;s Chief Executive Officer, Andrew Dahl, is serving under the terms of an employment agreement dated December 16, 2011 as amended August 11, 2016. Under the agreement Mr. Dahl serves as CEO for one year terms, subject to automatic renewal, unless either party terminates the Agreement on sixty days&amp;#146; notice prior to the expiration of the term of the agreement. &amp;nbsp;Mr. Dahl is compensated as follows: &amp;nbsp;he receives an annual base salary of $240,000. &amp;nbsp;In addition, Mr. Dahl is entitled to monthly bonus compensation equal to 2% of the Company&amp;#146;s revenue, but only to the extent that such bonus amount exceeds his base salary for the month in question. &amp;nbsp;In addition, Mr. Dahl will be entitled to warrants having an exercise price of $.25 per share, upon the attainment of specified milestones as follows: 1) Warrants for 500,000 shares upon identification of bio-active agents in the Company&amp;#146;s product and filing of a patent with respect thereto, 2) Warrants for 500,000 shares upon entering into a business contract under which the Company receives at least $500,000 in cash payments, 3) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement with a research company to develop &amp;nbsp;medicinal or pharmaceutical applications (where the partner provides at least $2 million in cash or in-kind outlays), 4) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement for nutraceutical or dietary supplement applications (where the partner provides at least $2 million in cash or in-kind outlays), 5) Warrants for 1,000,000 shares upon the Company entering into a pharmaceutical development agreement. &amp;nbsp;Further, as it relates to Company&amp;#146;s wholly-owned subsidiary, WellMetris, LLC (&amp;#147;WellMetris&amp;#148;), in the event the Company ceases to own a controlling interest in WellMetris for any reason whatsoever, the Company shall cause WellMetris to grant Mr. Dahl warrants to purchase a seven percent (7%) equity interest in WellMetris at the time outside funding is closed and/or at the time an event occurs whereby the Company relinquishes majority control of WellMetris. &amp;nbsp;Such Warrant shall be priced at the per-unit or per-share price at the time of the applicable closing or change of control with respect to WellMetris. &amp;nbsp;As of December 31, 2016, none of the milestones referred to had been achieved and there has been no notice of contract termination.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Legal Contingencies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;We may become a party to litigation in the normal course of business. &amp;nbsp;In the opinion of management, there are no legal matters involving us that would have a material adverse effect upon our financial condition, results of operation or cash flows.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Workers&amp;#146; Compensation&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company does not carry workers&amp;#146; compensation insurance, which covers on the job injury.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<fil:RelatedPartyTransactionsTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 11 - RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Due to Related Party&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;See Note 5 Due to Related Party for disclosure of payable to related Party. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Loan Payable &amp;#150; Related Party&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;See Note 6 Loan Payable &amp;#150; Related Parties for disclosure of loans payable to related Parties &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 12pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Executive Compensation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;See Note 8 &amp;#150; Stockholder&amp;#146; Deficiency for disclosure of compensation to the Chief Financial Officer. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Employment Agreement&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;See Note 10 &amp;#150; Commitments and Contingencies for disclosure of the Employment Agreement with the Chief Executive Officer.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</fil:RelatedPartyTransactionsTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 12 - INCOME TAXES&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;At December 31, 2016 the Company had available net-operating loss carry-forwards for Federal tax purposes of approximately $39,732,000, which may be applied against future taxable income, if any, at various dates from 2016 through 2036. Certain significant changes in ownership of the Company may restrict the future utilization of these tax loss carry-forwards.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;At December 31, 2016 the Company had a deferred tax asset of approximately $15,893,000 representing the benefit of its net operating loss carry-forwards. The Company has not recognized the tax benefit because realization of the tax benefit is uncertain and thus a valuation allowance has been fully provided against the deferred tax asset. &amp;nbsp;The difference between the Federal and State Statutory Rate of 40% and the Company&amp;#146;s effective tax rate of 0% is due to an increase in the valuation allowance of approximately $3,693,000 in 2016.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:LegalMattersAndContingenciesTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 13 &amp;#150; SETTLEMENT OF LITIGATION - RELATED PARTY&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;On July 15, 2015, a shareholder of the Company (&amp;#147;Shareholder&amp;#148;) brought action against HEP Investment alleging certain technical violations of Section 16(b) of the Securities Act of 1934, as amended. &amp;nbsp;On March 3, 2017, without admitting any liability whatsoever, HEP Investment settled with the Shareholder by agreeing to reduce the Company&amp;#146;s debt owed to HEP Investment by $280,000. Related to this debt reduction, the Company will pay to the Shareholder&amp;#146;s legal counsel $60,000 and 250,000 shares of the Company&amp;#146;s common stock valued at $22,500. &amp;nbsp;The Company considered the settlement to be a Type 1 subsequent event and recorded legal fees of $82,500 on the Statement of Operations and recorded the settlement amount of $280,000 as a reduction of convertible debt owed to HEP Investments and an increase to Additional Paid-In Capital.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;NOTE 14 &amp;#150; SUBSEQUENT EVENTS &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;CONVERTIBLE DEBT: HEP Investments, LLC&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;Debt Modification&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;On March 1, 2017, the Company and HEP Investments, LLC (&amp;#147;Lender&amp;#148;), entered into the following documents, effective as of March 1, 2017: (i) Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total of $17,500,000 to the Company, subject to certain conditions, and (ii) a Ninth Amended and Restated Senior Secured Convertible Promissory Note. &amp;nbsp;The Eighth Amendment to Loan Agreement amends and restates the Seventh Amendment to Loan Agreement, which was entered into with the Lender on December 31, 2015 and disclosed in the Company&amp;#146;s Form 8-K Current Report filed on January 7, 2016. &amp;nbsp;The Ninth Amended and Restated Senior Secured Convertible Promissory Note resets the total outstanding debt as of March 1, 2017 and provides for a maturity date of September 30, 2018. &amp;nbsp;The total outstanding debt as of March 1, 2017 is $12,982,203. &amp;nbsp;This amount includes unpaid principal of $9,427,200, interest outstanding as of February 28, 2017 of $2,955,003 and restructuring and legal fees of $600,000.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company, as consideration for the extension of the maturity date to September 30, 2018, agreed to provide for the conversion of the $12,982,203 Convertible Promissory Note into the Company&amp;#146;s restricted common stock at $.10 per share, with interest at the rate of 11% per annum.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The related indebtedness represented by this note shall be paid to the Lender in monthly installments of interest only beginning on July 1, 2017 and continuing on the first day of each month thereafter.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Based on the above, the total shares of common stock, if the Lender converted the complete $12,982,203 convertible debt, would be 129,822,030 shares, not including any future interest charges which may be converted into common stock.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Amounts advanced under the Note are secured by all the Company&amp;#146;s assets.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company has agreed to pay the following fees in connection with the Loan transaction (when the final $4,517,797 in funding is achieved): (i) a $361,602 closing fee, consisting of $216,961 in cash, and $144,641 paid in shares of common stock, which will be accomplished by the issuance of common stock valued at various amounts based on the timing of the funding and the related stock price. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company has made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Registrant&amp;#146;s senior management. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company determined that the modification of these Notes was a substantial modification in accordance with ASC 470-50, &amp;#147;Modifications and Extinguishments.&amp;#148; &amp;nbsp;As such, the Company will recognize a loss on extinguishment.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;11% Convertible Debt - HEP Investments, LLC&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;On March 31, 2017, HEP Investments LLC (&amp;#147;Lender&amp;#148;) funded an additional of $1,000,000. &amp;nbsp;Due to this additional funding, the Company issued to the Lender a $1,000,000, an 11% convertible note and warrants to purchase 1,000,000 shares of common stock, at an exercise price of $.10 for a term of five years. &amp;nbsp;The terms of the debt are in described in Note 7 - Convertible Debt.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Stock Based Compensation&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;On February 27, 2017, the Company issued warrants to purchase 500,000 shares of common stock at an exercise price of $.10 with a term of 5 years pursuant to an agreement with a financial consultant. &amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:ConsolidationPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/b&gt;&lt;b&gt; -&lt;/b&gt; The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
	<us-gaap:UseOfEstimates contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Accounting Estimates&lt;/u&gt;&lt;/b&gt;&lt;b&gt; - &lt;/b&gt;The Company&amp;#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &amp;nbsp;Actual results could differ from those estimates. &amp;nbsp;Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. &amp;nbsp;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/b&gt;&lt;b&gt; -&lt;/b&gt; For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31, 2016, the Company did not have any cash equivalents.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/b&gt;&lt;b&gt; &amp;#150; &lt;/b&gt;Property and equipment consists of furniture and office equipment, and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets, generally five to seven years. &amp;nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:DeferredChargesPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Deferred Financing Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &amp;nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &amp;nbsp;Amortization of deferred financing costs amounted to $26,813 and $-0- for the years ended December 31, 2016 and 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
	<us-gaap:RevenueRecognitionPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104, &amp;#147;Revenue Recognition&amp;#148; (&amp;#147;SAB No. 104&amp;#148;), which superseded Staff Accounting Bulletin No. 101, &amp;#147;Revenue Recognition in Financial Statements&amp;#148; (&amp;#147;SAB No. 101&amp;#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
	<us-gaap:ShippingAndHandlingCostPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Shipping and Handling Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Shipping and handling costs are expensed as incurred. For the years ended December 31, 2016 and 2015 no shipping and handling costs were incurred.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ShippingAndHandlingCostPolicyTextBlock>
	<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Research and development costs are expensed as incurred. The majority of the Company&apos;s research and development costs consist of clinical study expenses. These consist of fees, charges, and related expenses incurred in the conduct of clinical studies conducted with Company products by independent outside contractors. External clinical studies expenses were approximately $789,000 and $1,033,000 for the years ended December 31, 2016 and 2015, respectively. &lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &amp;nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses, and it is more likely than not that some portion or all of the deferred tax assets will not be realized, a full valuation allowance has been established. In addition, utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &amp;#147;change in ownership&amp;#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Stock Based Compensation&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;We account for stock-based compensation in accordance with FASB ASC 718, &lt;i&gt;Compensation &amp;#150; Stock Compensation. &amp;nbsp;&lt;/i&gt;Under the provisions of FASB ASC 718, stock-based compensation cost is estimated at the grant date based on the award&amp;#146;s fair value and is recognized as expense over the requisite service period. &amp;nbsp;The Company generally issues grants to its employees, consultants and board members. &amp;nbsp;At the date of grant, the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &amp;nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;During 2016 and 2015, warrants were granted to employees, directors and consultants of the Company. &amp;nbsp;As a result of these grants, the Company recorded compensation expense of $1,201,758 and $464,577 during the years ended December 31, 2016 and 2015 respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot;&gt; &lt;tr&gt; &lt;td width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt; &lt;td width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;206&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2016&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;2015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected volatility&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;158.53% to 173.53%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;128.36% to 155.43%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected dividends&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Expected term&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;5 years&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;3 to 5 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;bottom&quot; width=&quot;130&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Risk free rate&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;100&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.71% to 1.04%&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;12&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;93&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.51% to 1.75%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company&amp;#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&amp;#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Income (Loss) Per Share&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Basic loss per share is computed by dividing the Company&amp;#146;s net loss by the weighted average number of common shares outstanding during the period presented. Diluted loss per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &amp;nbsp;Potentially dilutive securities as of December 31, 2016, consisted of 111,086,456 common shares from convertible debentures and related accrued interest and 32,071,901 common shares from outstanding warrants. Potentially dilutive securities as of December 31, 2015, consisted of 73,883,330 common shares from convertible debentures and related accrued interest and 14,705,818 common shares from outstanding warrants. &amp;nbsp;&amp;nbsp;For 2016 and 2015, diluted and basic weighted average shares were the same, as potentially dilutive shares are anti-dilutive.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:AdvertisingCostsPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Advertising Costs&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Advertising costs are charged to operations when incurred. &amp;nbsp;There were no Advertising Costs during the years 2016 and 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
	<us-gaap:ConcentrationRiskCreditRisk contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Concentrations of Credit Risk&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &amp;nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&amp;#147;FDIC&amp;#148;) limit of $250,000 at times during the year.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
	<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef='Y16'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;&lt;b&gt;&lt;u&gt;Future Impact of Recently Issued Accounting Standards&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;In May 2014, the Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), &amp;#147;&lt;i&gt;Revenue from Contracts with Customers.&lt;/i&gt;&amp;#148;&lt;i&gt; &lt;/i&gt;ASU 2014-09 superseded the revenue recognition requirements in &amp;#147;Revenue Recognition (Topic 605),&amp;#148; and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &amp;nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&amp;#146;s financial position or results of operations.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) &amp;#147;Presentation of Financial Statements &amp;#150; Going Concern (Subtopic 205-40).&amp;#148; &amp;nbsp;The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. &amp;nbsp;Early application is permitted. &amp;nbsp;This Update had no effect on the Company&amp;#146;s financial position and results of operations for the year ended December 31, 2016.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt;text-indent:-0.5pt&apos;&gt;Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued, but not yet effective, accounting standards been adopted in the current period.&lt;/p&gt; &lt;p style=&apos;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<fil:NetLoss1 decimals='INF' contextRef='Y16' unitRef='USD'>6059627</fil:NetLoss1>
	<fil:NetLoss1 decimals='INF' contextRef='D150102_151231' unitRef='USD'>5789131</fil:NetLoss1>
	<fil:WorkingCapitalDeficiency1 decimals='INF' contextRef='Y16' unitRef='USD'>10662057</fil:WorkingCapitalDeficiency1>
	<fil:StockholdersDeficiency decimals='INF' contextRef='Y16' unitRef='USD'>13621235</fil:StockholdersDeficiency>
	<fil:ProceedsFromIssuanceOfConvertibleDebentures decimals='INF' contextRef='Y16' unitRef='USD'>3250000</fil:ProceedsFromIssuanceOfConvertibleDebentures>
	<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF' contextRef='E15' unitRef='USD'>385190</us-gaap:DebtInstrumentUnamortizedDiscount>
	<us-gaap:DebtInstrumentUnamortizedDiscount decimals='INF' contextRef='E16' unitRef='USD'>500490</us-gaap:DebtInstrumentUnamortizedDiscount>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet decimals='INF' contextRef='E15' unitRef='USD'>1458741</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet decimals='INF' contextRef='E16' unitRef='USD'>73953</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E15' unitRef='Shares'>450000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16' unitRef='Shares'>450000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E15' unitRef='Shares'>132156776</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16' unitRef='Shares'>136745347</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E15' unitRef='Shares'>132156776</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16' unitRef='Shares'>136745347</us-gaap:CommonStockSharesOutstanding>
	<fil:ResearchAndDevelopmentCosts decimals='INF' contextRef='Y16' unitRef='USD'>789000</fil:ResearchAndDevelopmentCosts>
	<fil:ResearchAndDevelopmentCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>1033000</fil:ResearchAndDevelopmentCosts>
	<fil:StockBasedCompensationExpense decimals='INF' contextRef='Y16' unitRef='USD'>1201758</fil:StockBasedCompensationExpense>
	<fil:StockBasedCompensationExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>464577</fil:StockBasedCompensationExpense>
	<fil:CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest decimals='INF' contextRef='Y16' unitRef='USD'>111086456</fil:CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest>
	<fil:CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest decimals='INF' contextRef='D150102_151231' unitRef='USD'>73883330</fil:CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest>
	<fil:CommonSharesFromOutstandingWarrants decimals='INF' contextRef='Y16' unitRef='USD'>32071901</fil:CommonSharesFromOutstandingWarrants>
	<fil:CommonSharesFromOutstandingWarrants decimals='INF' contextRef='D150102_151231' unitRef='USD'>14705818</fil:CommonSharesFromOutstandingWarrants>
	<us-gaap:AdvertisingExpense decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:AdvertisingExpense>
	<us-gaap:AdvertisingExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:AdvertisingExpense>
	<fil:CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1 decimals='INF' contextRef='Y16' unitRef='USD'>250000</fil:CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1>
	<fil:CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1 decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</fil:CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum decimals='INF' contextRef='Y16' unitRef='Pure'>1.5853</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum decimals='INF' contextRef='D150102_151231' unitRef='Pure'>1.2836</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum decimals='INF' contextRef='Y16' unitRef='Pure'>1.7353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum decimals='INF' contextRef='D150102_151231' unitRef='Pure'>1.5543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate decimals='INF' contextRef='Y16' unitRef='Pure'>0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate decimals='INF' contextRef='D150102_151231' unitRef='Pure'>0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum decimals='INF' contextRef='Y16' unitRef='Pure'>0.0071</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum decimals='INF' contextRef='D150102_151231' unitRef='Pure'>0.0051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum decimals='INF' contextRef='Y16' unitRef='Pure'>0.0104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum decimals='INF' contextRef='D150102_151231' unitRef='Pure'>0.0175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
	<us-gaap:FurnitureAndFixturesGross decimals='INF' contextRef='E16' unitRef='USD'>20000</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:FurnitureAndFixturesGross decimals='INF' contextRef='E15' unitRef='USD'>20000</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:MachineryAndEquipmentGross decimals='INF' contextRef='E16' unitRef='USD'>80000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='INF' contextRef='E15' unitRef='USD'>80000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E16' unitRef='USD'>100000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E15' unitRef='USD'>100000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='INF' contextRef='E16' unitRef='USD'>-81250</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='INF' contextRef='E15' unitRef='USD'>-56250</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16' unitRef='USD'>18750</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E15' unitRef='USD'>43750</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:Depreciation decimals='INF' contextRef='Y16' unitRef='USD'>25000</us-gaap:Depreciation>
	<us-gaap:Depreciation decimals='INF' contextRef='D150102_151231' unitRef='USD'>25000</us-gaap:Depreciation>
	<fil:CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances decimals='INF' contextRef='E16' unitRef='USD'>319234</fil:CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances>
	<fil:CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances decimals='INF' contextRef='E15' unitRef='USD'>211234</fil:CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances>
	<fil:CashFinanceFee decimals='INF' contextRef='E16' unitRef='Pure'>0.0540</fil:CashFinanceFee>
	<fil:CompanyIncurredFinanceCosts decimals='INF' contextRef='E16' unitRef='USD'>108000</fil:CompanyIncurredFinanceCosts>
	<fil:CompanyIncurredFinanceCosts decimals='INF' contextRef='E15' unitRef='USD'>111820</fil:CompanyIncurredFinanceCosts>
	<fil:AmountAdvancedByChrisMaggioreASignificantShareholder decimals='INF' contextRef='Y16' unitRef='USD'>0</fil:AmountAdvancedByChrisMaggioreASignificantShareholder>
	<fil:AmountAdvancedByChrisMaggioreASignificantShareholder decimals='INF' contextRef='D150102_151231' unitRef='USD'>156405</fil:AmountAdvancedByChrisMaggioreASignificantShareholder>
	<fil:MrMaggioreAdvancedTheCompanyAnAdditionalAmount decimals='INF' contextRef='Y16' unitRef='USD'>20000</fil:MrMaggioreAdvancedTheCompanyAnAdditionalAmount>
	<fil:MrMaggioreAdvancedTheCompanyAnAdditionalAmount decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</fil:MrMaggioreAdvancedTheCompanyAnAdditionalAmount>
	<fil:TotalOutstandingBalanceOfAdvance decimals='INF' contextRef='Y16' unitRef='USD'>0</fil:TotalOutstandingBalanceOfAdvance>
	<fil:TotalOutstandingBalanceOfAdvance decimals='INF' contextRef='D150102_151231' unitRef='USD'>176405</fil:TotalOutstandingBalanceOfAdvance>
	<fil:CompanyAgreedToPayInterestOnLoan decimals='INF' contextRef='Y16' unitRef='Pure'>0.1100</fil:CompanyAgreedToPayInterestOnLoan>
	<fil:CompanyAgreedToPayInterestOnLoan decimals='INF' contextRef='D150102_151231' unitRef='Pure'>0.1100</fil:CompanyAgreedToPayInterestOnLoan>
	<fil:AccruedInterestOnIndebtednessTotaled decimals='INF' contextRef='Y16' unitRef='USD'>20396</fil:AccruedInterestOnIndebtednessTotaled>
	<fil:AccruedInterestOnIndebtednessTotaled decimals='INF' contextRef='D150102_151231' unitRef='USD'>19835</fil:AccruedInterestOnIndebtednessTotaled>
	<fil:AmountAdvancedByOfficers decimals='INF' contextRef='Y16' unitRef='USD'>0</fil:AmountAdvancedByOfficers>
	<fil:AmountAdvancedByOfficers decimals='INF' contextRef='D150102_151231' unitRef='USD'>2000</fil:AmountAdvancedByOfficers>
	<fil:HepInvestmentsLlcLoanedTheCompany decimals='INF' contextRef='Y16' unitRef='USD'>1890872</fil:HepInvestmentsLlcLoanedTheCompany>
	<fil:HepInvestmentsLlcLoanedTheCompany decimals='INF' contextRef='D150102_151231' unitRef='USD'>2246202</fil:HepInvestmentsLlcLoanedTheCompany>
	<fil:LoansWereConvertedToConvertibleSecuredPromissoryNotes decimals='INF' contextRef='Y16' unitRef='USD'>2000000</fil:LoansWereConvertedToConvertibleSecuredPromissoryNotes>
	<fil:LoansWereConvertedToConvertibleSecuredPromissoryNotes decimals='INF' contextRef='D150102_151231' unitRef='USD'>2067500</fil:LoansWereConvertedToConvertibleSecuredPromissoryNotes>
	<fil:ConvertibleSecuredPromissoryNotes decimals='INF' contextRef='Y16' unitRef='Pure'>0.1100</fil:ConvertibleSecuredPromissoryNotes>
	<fil:ConvertibleSecuredPromissoryNotes decimals='INF' contextRef='D150102_151231' unitRef='Pure'>0.1100</fil:ConvertibleSecuredPromissoryNotes>
	<fil:RemainingBalanceInLoansPayableToRelatedParties decimals='INF' contextRef='Y16' unitRef='USD'>69574</fil:RemainingBalanceInLoansPayableToRelatedParties>
	<fil:RemainingBalanceInLoansPayableToRelatedParties decimals='INF' contextRef='D150102_151231' unitRef='USD'>178702</fil:RemainingBalanceInLoansPayableToRelatedParties>
	<fil:AdvanceAgreedUnderLoanAgreement1 decimals='INF' contextRef='E16' unitRef='USD'>17500000</fil:AdvanceAgreedUnderLoanAgreement1>
	<fil:ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1 decimals='INF' contextRef='E16' unitRef='USD'>17500000</fil:ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1>
	<fil:AdvancedAmountOfConvertibleSecuredPromissoryNote decimals='INF' contextRef='E16' unitRef='USD'>8677200</fil:AdvancedAmountOfConvertibleSecuredPromissoryNote>
	<fil:CompanySRestrictedCommonStockValueScheduleA010PerShare decimals='INF' contextRef='E16' unitRef='USD'>4152200</fil:CompanySRestrictedCommonStockValueScheduleA010PerShare>
	<fil:CompanySRestrictedCommonStockValueScheduleB012PerShare decimals='INF' contextRef='E16' unitRef='USD'>2320000</fil:CompanySRestrictedCommonStockValueScheduleB012PerShare>
	<fil:CompanySRestrictedCommonStockValueScheduleC015PerShare decimals='INF' contextRef='E16' unitRef='USD'>1285000</fil:CompanySRestrictedCommonStockValueScheduleC015PerShare>
	<fil:CompanySRestrictedCommonStockValueScheduleD022PerShare decimals='INF' contextRef='E16' unitRef='USD'>640000</fil:CompanySRestrictedCommonStockValueScheduleD022PerShare>
	<fil:CompanySRestrictedCommonStockValueScheduleE030PerShare decimals='INF' contextRef='E16' unitRef='USD'>750000</fil:CompanySRestrictedCommonStockValueScheduleE030PerShare>
	<fil:ConvertibleNote2BearsInterestRate decimals='INF' contextRef='E16' unitRef='Pure'>0.1100</fil:ConvertibleNote2BearsInterestRate>
	<fil:ConvertiblePromissoryNoteTotaling decimals='INF' contextRef='E16' unitRef='USD'>3740000</fil:ConvertiblePromissoryNoteTotaling>
	<fil:ConvertiblePromissoryNoteTranches14Through16Totaling decimals='INF' contextRef='E16' unitRef='USD'>1369700</fil:ConvertiblePromissoryNoteTranches14Through16Totaling>
	<fil:RemainingTranches17To30Totaling decimals='INF' contextRef='E16' unitRef='USD'>4067500</fil:RemainingTranches17To30Totaling>
	<fil:UnpaidInterestDue decimals='INF' contextRef='E16' unitRef='USD'>2502367</fil:UnpaidInterestDue>
	<fil:UnpaidInterestDue decimals='INF' contextRef='E15' unitRef='USD'>1572065</fil:UnpaidInterestDue>
	<fil:LenderConvertedTheDebt decimals='INF' contextRef='E16' unitRef='USD'>60000</fil:LenderConvertedTheDebt>
	<fil:LenderConvertedTheDebtPerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.12</fil:LenderConvertedTheDebtPerShare>
	<fil:CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid decimals='INF' contextRef='E16' unitRef='Pure'>0.0500</fil:CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid>
	<fil:N1ConvertibleNotesPayableDueApril2016 decimals='INF' contextRef='E16' unitRef='USD'>240000</fil:N1ConvertibleNotesPayableDueApril2016>
	<fil:N1ConvertibleNotesPayableDueApril2016 decimals='INF' contextRef='E15' unitRef='USD'>240000</fil:N1ConvertibleNotesPayableDueApril2016>
	<fil:N11ConvertibleNotePayableHepInvestmentsLlc decimals='INF' contextRef='E16' unitRef='USD'>8572757</fil:N11ConvertibleNotePayableHepInvestmentsLlc>
	<fil:N11ConvertibleNotePayableHepInvestmentsLlc decimals='INF' contextRef='E15' unitRef='USD'>5583269</fil:N11ConvertibleNotePayableHepInvestmentsLlc>
	<fil:N11ConvertibleNotePayableNewLenders decimals='INF' contextRef='E16' unitRef='USD'>1250000</fil:N11ConvertibleNotePayableNewLenders>
	<fil:N11ConvertibleNotePayableNewLenders decimals='INF' contextRef='E15' unitRef='USD'>0</fil:N11ConvertibleNotePayableNewLenders>
	<us-gaap:ConvertibleNotesPayable decimals='INF' contextRef='E16' unitRef='USD'>10062757</us-gaap:ConvertibleNotesPayable>
	<us-gaap:ConvertibleNotesPayable decimals='INF' contextRef='E15' unitRef='USD'>5823269</us-gaap:ConvertibleNotesPayable>
	<fil:LessCurrentPortion decimals='INF' contextRef='E16' unitRef='USD'>6886710</fil:LessCurrentPortion>
	<fil:LessCurrentPortion decimals='INF' contextRef='E15' unitRef='USD'>1224510</fil:LessCurrentPortion>
	<fil:LongTermPortion decimals='INF' contextRef='E16' unitRef='USD'>3176047</fil:LongTermPortion>
	<fil:LongTermPortion decimals='INF' contextRef='E15' unitRef='USD'>4598269</fil:LongTermPortion>
	<fil:N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc decimals='INF' contextRef='E16' unitRef='USD'>574443</fil:N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc>
	<fil:N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc decimals='INF' contextRef='E15' unitRef='USD'>1843931</fil:N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150131' unitRef='Shares'>50000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='E15Q2' unitRef='Shares'>50000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150731' unitRef='Shares'>50000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150910' unitRef='Shares'>250000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='E16Q1' unitRef='Shares'>125000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:GrantedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I160910' unitRef='Shares'>250000</fil:GrantedWarrantsToPurchaseSharesOfCommonStock>
	<fil:ExercisePricePerShare decimals='INF' contextRef='I150131' unitRef='UsdPerShare'>0.09</fil:ExercisePricePerShare>
	<fil:ExercisePricePerShare decimals='INF' contextRef='E15Q2' unitRef='UsdPerShare'>0.15</fil:ExercisePricePerShare>
	<fil:ExercisePricePerShare decimals='INF' contextRef='I150731' unitRef='UsdPerShare'>0.09</fil:ExercisePricePerShare>
	<fil:ExercisePricePerShare decimals='INF' contextRef='I150910' unitRef='UsdPerShare'>0.10</fil:ExercisePricePerShare>
	<fil:ExercisePricePerShare decimals='INF' contextRef='E16Q1' unitRef='UsdPerShare'>0.09</fil:ExercisePricePerShare>
	<fil:ExercisePricePerShare decimals='INF' contextRef='I160910' unitRef='UsdPerShare'>0.05</fil:ExercisePricePerShare>
	<fil:WarrantsTermInYears decimals='INF' contextRef='I150131' unitRef='Pure'>3</fil:WarrantsTermInYears>
	<fil:WarrantsTermInYears decimals='INF' contextRef='E15Q2' unitRef='Pure'>3</fil:WarrantsTermInYears>
	<fil:WarrantsTermInYears decimals='INF' contextRef='I150731' unitRef='Pure'>3</fil:WarrantsTermInYears>
	<fil:WarrantsTermInYears decimals='INF' contextRef='I150910' unitRef='Pure'>5</fil:WarrantsTermInYears>
	<fil:WarrantsTermInYears decimals='INF' contextRef='E16Q1' unitRef='Pure'>5</fil:WarrantsTermInYears>
	<fil:WarrantsTermInYears decimals='INF' contextRef='I160910' unitRef='Pure'>5</fil:WarrantsTermInYears>
	<fil:WarrantsVestedOnTheGrantDate decimals='INF' contextRef='I150131' unitRef='Shares'>12500</fil:WarrantsVestedOnTheGrantDate>
	<fil:WarrantsVestedOnTheGrantDate decimals='INF' contextRef='E15Q2' unitRef='Shares'>12500</fil:WarrantsVestedOnTheGrantDate>
	<fil:WarrantsVestedOnTheGrantDate decimals='INF' contextRef='I150731' unitRef='Shares'>12500</fil:WarrantsVestedOnTheGrantDate>
	<fil:RemainingWarrants decimals='INF' contextRef='I150131' unitRef='Shares'>37500</fil:RemainingWarrants>
	<fil:RemainingWarrants decimals='INF' contextRef='E15Q2' unitRef='Shares'>37500</fil:RemainingWarrants>
	<fil:RemainingWarrants decimals='INF' contextRef='I150731' unitRef='Shares'>37500</fil:RemainingWarrants>
	<fil:RemainingWarrantsShallVestQuarterly decimals='INF' contextRef='I150131' unitRef='Shares'>12500</fil:RemainingWarrantsShallVestQuarterly>
	<fil:RemainingWarrantsShallVestQuarterly decimals='INF' contextRef='E15Q2' unitRef='Shares'>12500</fil:RemainingWarrantsShallVestQuarterly>
	<fil:RemainingWarrantsShallVestQuarterly decimals='INF' contextRef='I150731' unitRef='Shares'>12500</fil:RemainingWarrantsShallVestQuarterly>
	<fil:WarrantsWereValuedUsingTheBlackScholesPricingModel decimals='INF' contextRef='I150131' unitRef='USD'>3664</fil:WarrantsWereValuedUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedUsingTheBlackScholesPricingModel decimals='INF' contextRef='E15Q2' unitRef='USD'>6185</fil:WarrantsWereValuedUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedUsingTheBlackScholesPricingModel decimals='INF' contextRef='I150731' unitRef='USD'>4876</fil:WarrantsWereValuedUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedUsingTheBlackScholesPricingModel decimals='INF' contextRef='E16Q1' unitRef='USD'>10588</fil:WarrantsWereValuedUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedUsingTheBlackScholesPricingModel decimals='INF' contextRef='I160910' unitRef='USD'>59125</fil:WarrantsWereValuedUsingTheBlackScholesPricingModel>
	<fil:InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed decimals='INF' contextRef='I150131' unitRef='USD'>10000</fil:InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed>
	<fil:InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed decimals='INF' contextRef='E15Q2' unitRef='USD'>10000</fil:InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed>
	<fil:MrRiceSUnvestedWarrant decimals='INF' contextRef='I150910' unitRef='Shares'>15890</fil:MrRiceSUnvestedWarrant>
	<fil:MrCoxSUnvestedWarrant decimals='INF' contextRef='I150910' unitRef='Shares'>36986</fil:MrCoxSUnvestedWarrant>
	<fil:InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed decimals='INF' contextRef='E16Q1' unitRef='USD'>10000</fil:InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed>
	<fil:InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed decimals='INF' contextRef='I160910' unitRef='USD'>10000</fil:InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed>
	<fil:InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed decimals='INF' contextRef='I150910' unitRef='USD'>10000</fil:InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed>
	<fil:MsMastersonSUnvestedWarrant1 decimals='INF' contextRef='I150910' unitRef='Shares'>959</fil:MsMastersonSUnvestedWarrant1>
	<fil:MrPayneSUnvestedWarrant1 decimals='INF' contextRef='I150910' unitRef='Shares'>42740</fil:MrPayneSUnvestedWarrant1>
	<fil:DirectorsFees decimals='INF' contextRef='Y16' unitRef='USD'>109713</fil:DirectorsFees>
	<fil:DirectorsFees decimals='INF' contextRef='D150102_151231' unitRef='USD'>166679</fil:DirectorsFees>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I150415' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I150626' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I150910' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160519' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I161117' unitRef='UsdPerShare'>0.09</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I150415' unitRef='Shares'>1875000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I150626' unitRef='Shares'>1250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I150910' unitRef='Shares'>400000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160519' unitRef='Shares'>14500000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I161117' unitRef='Shares'>400000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I150415' unitRef='USD'>133862</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I150626' unitRef='USD'>151443</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I150910' unitRef='USD'>36540</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160519' unitRef='USD'>1095063</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I161117' unitRef='USD'>21381</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<us-gaap:Revenues decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:Revenues>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>963296</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y16' unitRef='USD'>832239</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='D150102_151231' unitRef='USD'>1059633</us-gaap:ProfessionalFees>
	<us-gaap:ProfessionalFees decimals='INF' contextRef='Y16' unitRef='USD'>1869234</us-gaap:ProfessionalFees>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>1033351</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y16' unitRef='USD'>788971</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:CostsAndExpenses decimals='INF' contextRef='D150102_151231' unitRef='USD'>3056280</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses decimals='INF' contextRef='Y16' unitRef='USD'>3490444</us-gaap:CostsAndExpenses>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='D150102_151231' unitRef='USD'>-3056280</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='Y16' unitRef='USD'>-3490444</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherIncome decimals='INF' contextRef='D150102_151231' unitRef='USD'>34927</us-gaap:OtherIncome>
	<us-gaap:OtherIncome decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:OtherIncome>
	<us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments decimals='INF' contextRef='D150102_151231' unitRef='USD'>-1866842</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
	<us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments decimals='INF' contextRef='Y16' unitRef='USD'>-1376182</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
	<us-gaap:AmortizationOfDebtDiscountPremium decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfDebtDiscountPremium decimals='INF' contextRef='Y16' unitRef='USD'>-26813</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:PaymentsOfFinancingCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>-84645</us-gaap:PaymentsOfFinancingCosts>
	<us-gaap:PaymentsOfFinancingCosts decimals='INF' contextRef='Y16' unitRef='USD'>-108000</us-gaap:PaymentsOfFinancingCosts>
	<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims decimals='INF' contextRef='D150102_151231' unitRef='USD'>-95580</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
	<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims decimals='INF' contextRef='Y16' unitRef='USD'>-72000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
	<us-gaap:InterestExpenseRelatedParty decimals='INF' contextRef='D150102_151231' unitRef='USD'>-718311</us-gaap:InterestExpenseRelatedParty>
	<us-gaap:InterestExpenseRelatedParty decimals='INF' contextRef='Y16' unitRef='USD'>-950698</us-gaap:InterestExpenseRelatedParty>
	<us-gaap:InterestExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>-2400</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='Y16' unitRef='USD'>-35490</us-gaap:InterestExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>-2732851</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='Y16' unitRef='USD'>-2569183</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D150102_151231' unitRef='UsdPerShare'>-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y16' unitRef='UsdPerShare'>-0.05</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D150102_151231' unitRef='Shares'>130945979</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y16' unitRef='Shares'>133844254</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:SharesOutstanding decimals='INF' contextRef='B15_StEqComps-CapUnits' unitRef='Shares'>128773859</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding decimals='INF' contextRef='B15_StEqComps-CommonStock' unitRef='Shares'>128774</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding decimals='INF' contextRef='B15_StEqComps-AddPaidInCap' unitRef='Shares'>35427339</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding decimals='INF' contextRef='B15_StEqComps-RetainedEarnings' unitRef='Shares'>-41925281</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding decimals='INF' contextRef='B15' unitRef='Shares'>-6369168</us-gaap:SharesOutstanding>
	<fil:IssuanceOfWarrantsToBoardOfDirectors decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsToBoardOfDirectors>
	<fil:IssuanceOfWarrantsToBoardOfDirectors decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>126679</fil:IssuanceOfWarrantsToBoardOfDirectors>
	<fil:IssuanceOfWarrantsToBoardOfDirectors decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsToBoardOfDirectors>
	<fil:IssuanceOfWarrantsToBoardOfDirectors decimals='INF' contextRef='D150102_151231' unitRef='USD'>126679</fil:IssuanceOfWarrantsToBoardOfDirectors>
	<fil:IssuanceOfWarrantsForServices decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsForServices>
	<fil:IssuanceOfWarrantsForServices decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>321845</fil:IssuanceOfWarrantsForServices>
	<fil:IssuanceOfWarrantsForServices decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsForServices>
	<fil:IssuanceOfWarrantsForServices decimals='INF' contextRef='D150102_151231' unitRef='USD'>321845</fil:IssuanceOfWarrantsForServices>
	<fil:IssuanceOfWarrantsForServicesRelatedParty decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsForServicesRelatedParty>
	<fil:IssuanceOfWarrantsForServicesRelatedParty decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>16053</fil:IssuanceOfWarrantsForServicesRelatedParty>
	<fil:IssuanceOfWarrantsForServicesRelatedParty decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsForServicesRelatedParty>
	<fil:IssuanceOfWarrantsForServicesRelatedParty decimals='INF' contextRef='D150102_151231' unitRef='USD'>16053</fil:IssuanceOfWarrantsForServicesRelatedParty>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D150102_151231_StEqComps-CapUnits' unitRef='Shares'>961539</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='Shares'>962</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='Shares'>75190</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='Shares'>0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements decimals='INF' contextRef='D150102_151231_StEqComps-CapUnits' unitRef='Shares'>970000</fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements>
	<fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='Shares'>970</fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements>
	<fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='Shares'>47530</fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements>
	<fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='Shares'>0</fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements>
	<fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements decimals='INF' contextRef='D150102_151231' unitRef='Shares'>48500</fil:IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements>
	<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities decimals='INF' contextRef='D150102_151231_StEqComps-CapUnits' unitRef='Shares'>100000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
	<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='Shares'>100</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
	<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='Shares'>-100</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
	<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='Shares'>0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
	<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities decimals='INF' contextRef='D150102_151231' unitRef='Shares'>0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
	<fil:CommonStockIssuedOnConversionOf1ConvertibleDebt decimals='INF' contextRef='D150102_151231_StEqComps-CapUnits' unitRef='Shares'>500000</fil:CommonStockIssuedOnConversionOf1ConvertibleDebt>
	<fil:CommonStockIssuedOnConversionOf1ConvertibleDebt decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='Shares'>500</fil:CommonStockIssuedOnConversionOf1ConvertibleDebt>
	<fil:CommonStockIssuedOnConversionOf1ConvertibleDebt decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='Shares'>59500</fil:CommonStockIssuedOnConversionOf1ConvertibleDebt>
	<fil:CommonStockIssuedOnConversionOf1ConvertibleDebt decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='Shares'>0</fil:CommonStockIssuedOnConversionOf1ConvertibleDebt>
	<fil:CommonStockIssuedOnConversionOf1ConvertibleDebt decimals='INF' contextRef='D150102_151231' unitRef='Shares'>60000</fil:CommonStockIssuedOnConversionOf1ConvertibleDebt>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:DiscountsOnIssuanceOfConvertibleDebentures>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>1916501</fil:DiscountsOnIssuanceOfConvertibleDebentures>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:DiscountsOnIssuanceOfConvertibleDebentures>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures decimals='INF' contextRef='D150102_151231' unitRef='USD'>1916501</fil:DiscountsOnIssuanceOfConvertibleDebentures>
	<fil:WarrantsIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:WarrantsIssuedForFinancingCosts>
	<fil:WarrantsIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>21150</fil:WarrantsIssuedForFinancingCosts>
	<fil:WarrantsIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:WarrantsIssuedForFinancingCosts>
	<fil:WarrantsIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>21150</fil:WarrantsIssuedForFinancingCosts>
	<fil:CommonStockIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-CapUnits' unitRef='Shares'>851378</fil:CommonStockIssuedForFinancingCosts>
	<fil:CommonStockIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='Shares'>851</fil:CommonStockIssuedForFinancingCosts>
	<fil:CommonStockIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='Shares'>73579</fil:CommonStockIssuedForFinancingCosts>
	<fil:CommonStockIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='Shares'>0</fil:CommonStockIssuedForFinancingCosts>
	<fil:CommonStockIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231' unitRef='Shares'>74430</fil:CommonStockIssuedForFinancingCosts>
	<fil:NetIncome decimals='INF' contextRef='D150102_151231_StEqComps-CommonStock' unitRef='USD'>0</fil:NetIncome>
	<fil:NetIncome decimals='INF' contextRef='D150102_151231_StEqComps-AddPaidInCap' unitRef='USD'>0</fil:NetIncome>
	<fil:NetIncome decimals='INF' contextRef='D150102_151231_StEqComps-RetainedEarnings' unitRef='USD'>-5789131</fil:NetIncome>
	<fil:NetIncome decimals='INF' contextRef='D150102_151231' unitRef='USD'>-5789131</fil:NetIncome>
	<fil:Balance decimals='INF' contextRef='E15_StEqComps-CapUnits' unitRef='Shares'>132156776</fil:Balance>
	<fil:Balance decimals='INF' contextRef='E15_StEqComps-CommonStock' unitRef='Shares'>132157</fil:Balance>
	<fil:Balance decimals='INF' contextRef='E15_StEqComps-AddPaidInCap' unitRef='Shares'>38085266</fil:Balance>
	<fil:Balance decimals='INF' contextRef='E15_StEqComps-RetainedEarnings' unitRef='Shares'>-47714412</fil:Balance>
	<fil:Balance decimals='INF' contextRef='E15' unitRef='Shares'>-9496989</fil:Balance>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D150102_151231' unitRef='USD'>-5789131</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y16' unitRef='USD'>-6059627</us-gaap:NetIncomeLoss>
	<fil:StocksAndWarrantsIssuedForServicesRendered decimals='INF' contextRef='D150102_151231' unitRef='USD'>397997</fil:StocksAndWarrantsIssuedForServicesRendered>
	<fil:StocksAndWarrantsIssuedForServicesRendered decimals='INF' contextRef='Y16' unitRef='USD'>1291444</fil:StocksAndWarrantsIssuedForServicesRendered>
	<fil:IssuanceOfWarrantsForServicesRelatedParty2 decimals='INF' contextRef='D150102_151231' unitRef='USD'>16053</fil:IssuanceOfWarrantsForServicesRelatedParty2>
	<fil:IssuanceOfWarrantsForServicesRelatedParty2 decimals='INF' contextRef='Y16' unitRef='USD'>15601</fil:IssuanceOfWarrantsForServicesRelatedParty2>
	<fil:WarrantsIssuedForDirectorsFees decimals='INF' contextRef='D150102_151231' unitRef='USD'>126679</fil:WarrantsIssuedForDirectorsFees>
	<fil:WarrantsIssuedForDirectorsFees decimals='INF' contextRef='Y16' unitRef='USD'>69713</fil:WarrantsIssuedForDirectorsFees>
	<fil:StocksAndWarrantsIssuedForFinancingCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>95580</fil:StocksAndWarrantsIssuedForFinancingCosts>
	<fil:StocksAndWarrantsIssuedForFinancingCosts decimals='INF' contextRef='Y16' unitRef='USD'>72000</fil:StocksAndWarrantsIssuedForFinancingCosts>
	<fil:AmortizationOfDeferredFinanceCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</fil:AmortizationOfDeferredFinanceCosts>
	<fil:AmortizationOfDeferredFinanceCosts decimals='INF' contextRef='Y16' unitRef='USD'>26813</fil:AmortizationOfDeferredFinanceCosts>
	<fil:AmortizationOfBondDiscount decimals='INF' contextRef='D150102_151231' unitRef='USD'>1866842</fil:AmortizationOfBondDiscount>
	<fil:AmortizationOfBondDiscount decimals='INF' contextRef='Y16' unitRef='USD'>1376181</fil:AmortizationOfBondDiscount>
	<us-gaap:DepreciationAmortizationAndAccretionNet decimals='INF' contextRef='D150102_151231' unitRef='USD'>25000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet decimals='INF' contextRef='Y16' unitRef='USD'>25000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:IncreaseDecreaseInPrepaidExpense decimals='INF' contextRef='D150102_151231' unitRef='USD'>19383</us-gaap:IncreaseDecreaseInPrepaidExpense>
	<us-gaap:IncreaseDecreaseInPrepaidExpense decimals='INF' contextRef='Y16' unitRef='USD'>-1096</us-gaap:IncreaseDecreaseInPrepaidExpense>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='D150102_151231' unitRef='USD'>-21430</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='Y16' unitRef='USD'>-448061</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInDueFromRelatedParties decimals='INF' contextRef='D150102_151231' unitRef='USD'>121500</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
	<us-gaap:IncreaseDecreaseInDueFromRelatedParties decimals='INF' contextRef='Y16' unitRef='USD'>108001</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
	<us-gaap:IncreaseDecreaseInInterestPayableNet decimals='INF' contextRef='D150102_151231' unitRef='USD'>720711</us-gaap:IncreaseDecreaseInInterestPayableNet>
	<us-gaap:IncreaseDecreaseInInterestPayableNet decimals='INF' contextRef='Y16' unitRef='USD'>986188</us-gaap:IncreaseDecreaseInInterestPayableNet>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D150102_151231' unitRef='USD'>123929</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='Y16' unitRef='USD'>-5630</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D150102_151231' unitRef='USD'>-2296887</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='Y16' unitRef='USD'>-2543473</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties decimals='INF' contextRef='D150102_151231' unitRef='USD'>196093</us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties>
	<us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties decimals='INF' contextRef='Y16' unitRef='USD'>-91130</us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties>
	<fil:DeferredFinanceCosts decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</fil:DeferredFinanceCosts>
	<fil:DeferredFinanceCosts decimals='INF' contextRef='Y16' unitRef='USD'>-125000</fil:DeferredFinanceCosts>
	<us-gaap:ProceedsFromConvertibleDebt decimals='INF' contextRef='D150102_151231' unitRef='USD'>2067500</us-gaap:ProceedsFromConvertibleDebt>
	<us-gaap:ProceedsFromConvertibleDebt decimals='INF' contextRef='Y16' unitRef='USD'>3250000</us-gaap:ProceedsFromConvertibleDebt>
	<us-gaap:ProceedsFromSaleOfTreasuryStock decimals='INF' contextRef='D150102_151231' unitRef='USD'>48500</us-gaap:ProceedsFromSaleOfTreasuryStock>
	<us-gaap:ProceedsFromSaleOfTreasuryStock decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:ProceedsFromSaleOfTreasuryStock>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D150102_151231' unitRef='USD'>2312093</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='Y16' unitRef='USD'>3033870</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='D150102_151231' unitRef='USD'>15206</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='Y16' unitRef='USD'>490397</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='B15' unitRef='USD'>1383</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E15' unitRef='USD'>16589</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E16' unitRef='USD'>506986</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:InterestPaidNet decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:InterestPaidNet>
	<us-gaap:InterestPaidNet decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:InterestPaidNet>
	<us-gaap:IncomeTaxesPaid decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid decimals='INF' contextRef='Y16' unitRef='USD'>0</us-gaap:IncomeTaxesPaid>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150423' unitRef='Shares'>500000</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150801' unitRef='Shares'>461539</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I160919' unitRef='Shares'>3500000</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150227' unitRef='Shares'>227500</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150327' unitRef='Shares'>135000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150417' unitRef='Shares'>217800</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150501' unitRef='Shares'>237200</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150707' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150902' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I151008' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I151029' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160127' unitRef='USD'>8018</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160301' unitRef='USD'>44371</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160516' unitRef='USD'>18746</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160726' unitRef='USD'>11523</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160825' unitRef='USD'>13939</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I161020' unitRef='USD'>16419</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:IssuedSharesOfCommonStockValue decimals='INF' contextRef='I150423' unitRef='USD'>30000</fil:IssuedSharesOfCommonStockValue>
	<fil:IssuedSharesOfCommonStockValue decimals='INF' contextRef='I150801' unitRef='USD'>46154</fil:IssuedSharesOfCommonStockValue>
	<fil:IssuedSharesOfCommonStockValue decimals='INF' contextRef='I160919' unitRef='USD'>175000</fil:IssuedSharesOfCommonStockValue>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150415' unitRef='Shares'>1875000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150626' unitRef='Shares'>1250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150910' unitRef='Shares'>400000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I160519' unitRef='Shares'>14500000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I161117' unitRef='Shares'>400000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice decimals='INF' contextRef='I150415' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice decimals='INF' contextRef='I150626' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice decimals='INF' contextRef='I150910' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice decimals='INF' contextRef='I160519' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice decimals='INF' contextRef='I161117' unitRef='UsdPerShare'>0.09</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice>
	<fil:TermInYears decimals='INF' contextRef='I150415' unitRef='Pure'>5</fil:TermInYears>
	<fil:TermInYears decimals='INF' contextRef='I150626' unitRef='Pure'>5</fil:TermInYears>
	<fil:TermInYears decimals='INF' contextRef='I150910' unitRef='Pure'>5</fil:TermInYears>
	<fil:TermInYears decimals='INF' contextRef='I160519' unitRef='Pure'>5</fil:TermInYears>
	<fil:TermInYears decimals='INF' contextRef='I161117' unitRef='Pure'>5</fil:TermInYears>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel decimals='INF' contextRef='I150415' unitRef='USD'>133862</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel decimals='INF' contextRef='I150626' unitRef='USD'>151443</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel decimals='INF' contextRef='I150910' unitRef='USD'>36540</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel decimals='INF' contextRef='I160519' unitRef='USD'>1095063</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel decimals='INF' contextRef='I161117' unitRef='USD'>21381</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel>
	<fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150114' unitRef='USD'>30000</fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock>
	<fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150123' unitRef='USD'>13500</fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock>
	<fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150217' unitRef='USD'>5000</fil:ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock>
	<fil:IssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150114' unitRef='Shares'>600000</fil:IssuanceOfSharesOfCommonStock>
	<fil:IssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150123' unitRef='Shares'>270000</fil:IssuanceOfSharesOfCommonStock>
	<fil:IssuanceOfSharesOfCommonStock decimals='INF' contextRef='I150217' unitRef='Shares'>100000</fil:IssuanceOfSharesOfCommonStock>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150227' unitRef='USD'>227500</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150327' unitRef='USD'>135000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150417' unitRef='USD'>217800</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150501' unitRef='USD'>237200</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150626' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150707' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I150902' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I151008' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture decimals='INF' contextRef='I151029' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150227' unitRef='Shares'>81900</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150327' unitRef='Shares'>151329</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150417' unitRef='Shares'>112011</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150501' unitRef='Shares'>121989</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150626' unitRef='Shares'>69231</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150707' unitRef='Shares'>90000</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I150902' unitRef='Shares'>81818</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I151008' unitRef='Shares'>112500</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStock1 decimals='INF' contextRef='I151029' unitRef='Shares'>112500</fil:IssuedSharesOfCommonStock1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150227' unitRef='USD'>8190</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150327' unitRef='USD'>13050</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150417' unitRef='USD'>7841</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150501' unitRef='USD'>8539</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150626' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150707' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I150902' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I151008' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedSharesOfCommonStockValue1 decimals='INF' contextRef='I151029' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150227' unitRef='Shares'>227500</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150327' unitRef='Shares'>135000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150417' unitRef='Shares'>217800</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150501' unitRef='Shares'>237200</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150626' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150707' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I150902' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I151008' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock1 decimals='INF' contextRef='I151029' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150227' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150327' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150417' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150501' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150626' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150707' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I150902' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I151008' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1 decimals='INF' contextRef='I151029' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150227' unitRef='USD'>21150</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150327' unitRef='USD'>21150</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150417' unitRef='USD'>13326</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150501' unitRef='USD'>14531</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150626' unitRef='USD'>30012</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150707' unitRef='USD'>22972</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I150902' unitRef='USD'>25221</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I151008' unitRef='USD'>18065</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1 decimals='INF' contextRef='I151029' unitRef='USD'>18065</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I160127' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I160301' unitRef='USD'>750000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I160516' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I160726' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I160825' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1 decimals='INF' contextRef='I161020' unitRef='USD'>250000</fil:IssuanceInPrincipalOfAn11ConvertibleDebenture1>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I160127' unitRef='Shares'>180000</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I160301' unitRef='Shares'>337500</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I160516' unitRef='Shares'>112500</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I160726' unitRef='Shares'>180000</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I160825' unitRef='Shares'>150000</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStock2 decimals='INF' contextRef='I161020' unitRef='Shares'>128571</fil:IssuedSharesOfCommonStock2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I160127' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I160301' unitRef='USD'>27000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I160516' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I160726' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I160825' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedSharesOfCommonStockValue2 decimals='INF' contextRef='I161020' unitRef='USD'>9000</fil:IssuedSharesOfCommonStockValue2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160127' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160301' unitRef='Shares'>750000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160516' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160726' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I160825' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStock2 decimals='INF' contextRef='I161020' unitRef='Shares'>250000</fil:IssuedWarrantsToPurchaseSharesOfCommonStock2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160127' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160301' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160516' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160726' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I160825' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2 decimals='INF' contextRef='I161020' unitRef='UsdPerShare'>0.10</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160127' unitRef='USD'>8018</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160301' unitRef='USD'>44371</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160516' unitRef='USD'>18746</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160726' unitRef='USD'>11523</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I160825' unitRef='USD'>13939</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2 decimals='INF' contextRef='I161020' unitRef='USD'>16419</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel2>
	<fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150406' unitRef='Shares'>50000</fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I150513' unitRef='Shares'>50000</fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I160329' unitRef='Shares'>50000</fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='I160513' unitRef='Shares'>50000</fil:CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3 decimals='INF' contextRef='I150406' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3 decimals='INF' contextRef='I150513' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3 decimals='INF' contextRef='I160329' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3>
	<fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3 decimals='INF' contextRef='I160513' unitRef='UsdPerShare'>0.08</fil:IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I150406' unitRef='USD'>3800</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I150513' unitRef='USD'>3582</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160329' unitRef='USD'>3771</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3 decimals='INF' contextRef='I160513' unitRef='USD'>3777</fil:WarrantsWereValuedAtUsingTheBlackScholesPricingModel3>
	<fil:NumberOfWarrantsIssued decimals='INF' contextRef='E16' unitRef='Shares'>20350000</fil:NumberOfWarrantsIssued>
	<fil:NumberOfWarrantsIssued decimals='INF' contextRef='E15' unitRef='Shares'>7192500</fil:NumberOfWarrantsIssued>
	<fil:NumberOfWarrantsExercised decimals='INF' contextRef='E16' unitRef='Shares'>0</fil:NumberOfWarrantsExercised>
	<fil:NumberOfWarrantsExercised decimals='INF' contextRef='E15' unitRef='Shares'>0</fil:NumberOfWarrantsExercised>
	<fil:NumberOfWarrantsCancelled decimals='INF' contextRef='E16' unitRef='Shares'>0</fil:NumberOfWarrantsCancelled>
	<fil:NumberOfWarrantsCancelled decimals='INF' contextRef='E15' unitRef='Shares'>-96575</fil:NumberOfWarrantsCancelled>
	<fil:NumberOfWarrantsExpired decimals='INF' contextRef='E16' unitRef='Shares'>-2983917</fil:NumberOfWarrantsExpired>
	<fil:NumberOfWarrantsExpired decimals='INF' contextRef='E15' unitRef='Shares'>-1443112</fil:NumberOfWarrantsExpired>
	<fil:NumberOfWarrantsOutstanding1 decimals='INF' contextRef='E16' unitRef='Shares'>32071901</fil:NumberOfWarrantsOutstanding1>
	<fil:NumberOfWarrantsOutstanding1 decimals='INF' contextRef='E15' unitRef='Shares'>14705818</fil:NumberOfWarrantsOutstanding1>
	<fil:OutstandingBeginningOfYear decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.13</fil:OutstandingBeginningOfYear>
	<fil:OutstandingBeginningOfYear decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.16</fil:OutstandingBeginningOfYear>
	<fil:WeightedAverageExercisePriceIssued decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.08</fil:WeightedAverageExercisePriceIssued>
	<fil:WeightedAverageExercisePriceIssued decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.09</fil:WeightedAverageExercisePriceIssued>
	<fil:WeightedAverageExercisePriceExercised decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0</fil:WeightedAverageExercisePriceExercised>
	<fil:WeightedAverageExercisePriceExercised decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0</fil:WeightedAverageExercisePriceExercised>
	<fil:WeightedAverageExercisePriceCancelled decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0</fil:WeightedAverageExercisePriceCancelled>
	<fil:WeightedAverageExercisePriceCancelled decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.14</fil:WeightedAverageExercisePriceCancelled>
	<fil:WeightedAverageExercisePriceExpired decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.14</fil:WeightedAverageExercisePriceExpired>
	<fil:WeightedAverageExercisePriceExpired decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.13</fil:WeightedAverageExercisePriceExpired>
	<fil:OutstandingEndOfPeriod decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.10</fil:OutstandingEndOfPeriod>
	<fil:OutstandingEndOfPeriod decimals='INF' contextRef='E15' unitRef='UsdPerShare'>0.13</fil:OutstandingEndOfPeriod>
	<fil:PriceRange005 decimals='INF' contextRef='E16' unitRef='Shares'>1250000</fil:PriceRange005>
	<fil:PriceRange008 decimals='INF' contextRef='E16' unitRef='Shares'>18625000</fil:PriceRange008>
	<fil:PriceRange009 decimals='INF' contextRef='E16' unitRef='Shares'>309110</fil:PriceRange009>
	<fil:PriceRange010 decimals='INF' contextRef='E16' unitRef='Shares'>7327200</fil:PriceRange010>
	<fil:PriceRange012 decimals='INF' contextRef='E16' unitRef='Shares'>99041</fil:PriceRange012>
	<fil:PriceRange014 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:PriceRange014>
	<fil:PriceRange015 decimals='INF' contextRef='E16' unitRef='Shares'>2485274</fil:PriceRange015>
	<fil:PriceRange017 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:PriceRange017>
	<fil:PriceRange019 decimals='INF' contextRef='E16' unitRef='Shares'>100000</fil:PriceRange019>
	<fil:PriceRange020 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:PriceRange020>
	<fil:PriceRange022 decimals='INF' contextRef='E16' unitRef='Shares'>269276</fil:PriceRange022>
	<fil:PriceRange025 decimals='INF' contextRef='E16' unitRef='Shares'>707000</fil:PriceRange025>
	<fil:PriceRange030 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:PriceRange030>
	<fil:PriceRange033 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:PriceRange033>
	<fil:PriceRange038 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:PriceRange038>
	<fil:TotalWarrantsOutstandingNumber decimals='INF' contextRef='E16' unitRef='Shares'>32071901</fil:TotalWarrantsOutstandingNumber>
	<fil:PriceRange005InYears decimals='INF' contextRef='E16' unitRef='Pure'>4.70</fil:PriceRange005InYears>
	<fil:PriceRange008InYears decimals='INF' contextRef='E16' unitRef='Pure'>4.23</fil:PriceRange008InYears>
	<fil:PriceRange009InYears decimals='INF' contextRef='E16' unitRef='Pure'>3.11</fil:PriceRange009InYears>
	<fil:PriceRange010InYears decimals='INF' contextRef='E16' unitRef='Pure'>3.99</fil:PriceRange010InYears>
	<fil:PriceRange012InYears decimals='INF' contextRef='E16' unitRef='Pure'>2.17</fil:PriceRange012InYears>
	<fil:PriceRange014InYears decimals='INF' contextRef='E16' unitRef='Pure'>2.62</fil:PriceRange014InYears>
	<fil:PriceRange015InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.30</fil:PriceRange015InYears>
	<fil:PriceRange017InYears decimals='INF' contextRef='E16' unitRef='Pure'>2.25</fil:PriceRange017InYears>
	<fil:PriceRange019InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.46</fil:PriceRange019InYears>
	<fil:PriceRange020InYears decimals='INF' contextRef='E16' unitRef='Pure'>0.33</fil:PriceRange020InYears>
	<fil:PriceRange022InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.75</fil:PriceRange022InYears>
	<fil:PriceRange025InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.52</fil:PriceRange025InYears>
	<fil:PriceRange030InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.90</fil:PriceRange030InYears>
	<fil:PriceRange033InYears decimals='INF' contextRef='E16' unitRef='Pure'>1.50</fil:PriceRange033InYears>
	<fil:PriceRange038InYears decimals='INF' contextRef='E16' unitRef='Pure'>0.01</fil:PriceRange038InYears>
	<fil:TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears decimals='INF' contextRef='E16' unitRef='Pure'>1.79</fil:TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears>
	<fil:ExercisePrice005 decimals='INF' contextRef='E16' unitRef='Shares'>1250000</fil:ExercisePrice005>
	<fil:ExercisePrice008 decimals='INF' contextRef='E16' unitRef='Shares'>18625000</fil:ExercisePrice008>
	<fil:ExercisePrice009 decimals='INF' contextRef='E16' unitRef='Shares'>309110</fil:ExercisePrice009>
	<fil:ExercisePrice010 decimals='INF' contextRef='E16' unitRef='Shares'>7327200</fil:ExercisePrice010>
	<fil:ExercisePrice012 decimals='INF' contextRef='E16' unitRef='Shares'>99041</fil:ExercisePrice012>
	<fil:ExercisePrice014 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:ExercisePrice014>
	<fil:ExercisePrice015 decimals='INF' contextRef='E16' unitRef='Shares'>2485274</fil:ExercisePrice015>
	<fil:ExercisePrice017 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:ExercisePrice017>
	<fil:ExercisePrice019 decimals='INF' contextRef='E16' unitRef='Shares'>100000</fil:ExercisePrice019>
	<fil:ExercisePrice020 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:ExercisePrice020>
	<fil:ExercisePrice022 decimals='INF' contextRef='E16' unitRef='Shares'>269276</fil:ExercisePrice022>
	<fil:ExercisePrice025 decimals='INF' contextRef='E16' unitRef='Shares'>707000</fil:ExercisePrice025>
	<fil:ExercisePrice030 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:ExercisePrice030>
	<fil:ExercisePrice033 decimals='INF' contextRef='E16' unitRef='Shares'>250000</fil:ExercisePrice033>
	<fil:ExercisePrice038 decimals='INF' contextRef='E16' unitRef='Shares'>50000</fil:ExercisePrice038>
	<fil:TotalExercisableWarrants decimals='INF' contextRef='E16' unitRef='Shares'>32071901</fil:TotalExercisableWarrants>
	<fil:WeightedAverageExercisePrice005 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.05</fil:WeightedAverageExercisePrice005>
	<fil:WeightedAverageExercisePrice008 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.08</fil:WeightedAverageExercisePrice008>
	<fil:WeightedAverageExercisePrice009 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.09</fil:WeightedAverageExercisePrice009>
	<fil:WeightedAverageExercisePrice010 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.10</fil:WeightedAverageExercisePrice010>
	<fil:WeightedAverageExercisePrice012 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.12</fil:WeightedAverageExercisePrice012>
	<fil:WeightedAverageExercisePrice014 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.14</fil:WeightedAverageExercisePrice014>
	<fil:WeightedAverageExercisePrice015 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.15</fil:WeightedAverageExercisePrice015>
	<fil:WeightedAverageExercisePrice017 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.17</fil:WeightedAverageExercisePrice017>
	<fil:WeightedAverageExercisePrice019 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.19</fil:WeightedAverageExercisePrice019>
	<fil:WeightedAverageExercisePrice020 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.20</fil:WeightedAverageExercisePrice020>
	<fil:WeightedAverageExercisePrice022 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.22</fil:WeightedAverageExercisePrice022>
	<fil:WeightedAverageExercisePrice025 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.25</fil:WeightedAverageExercisePrice025>
	<fil:WeightedAverageExercisePrice030 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.30</fil:WeightedAverageExercisePrice030>
	<fil:WeightedAverageExercisePrice033 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.33</fil:WeightedAverageExercisePrice033>
	<fil:WeightedAverageExercisePrice038 decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.38</fil:WeightedAverageExercisePrice038>
	<fil:TotalExercisableWarrantsWeightedAverageExercisePrice decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.10</fil:TotalExercisableWarrantsWeightedAverageExercisePrice>
	<fil:AnnualBaseSalary decimals='INF' contextRef='I111216' unitRef='USD'>240000</fil:AnnualBaseSalary>
	<fil:PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation decimals='INF' contextRef='I111216' unitRef='Pure'>0.0200</fil:PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation>
	<fil:ExercisePricePerShareWarrantsEntitled decimals='INF' contextRef='I111216' unitRef='UsdPerShare'>0.25</fil:ExercisePricePerShareWarrantsEntitled>
	<fil:WarrantForSharesUponIdentificationOfBioActiveAgents decimals='INF' contextRef='I111216' unitRef='Shares'>500000</fil:WarrantForSharesUponIdentificationOfBioActiveAgents>
	<fil:WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract decimals='INF' contextRef='I111216' unitRef='Shares'>500000</fil:WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract>
	<fil:ReceivesInCashPayments decimals='INF' contextRef='I111216' unitRef='USD'>500000</fil:ReceivesInCashPayments>
	<fil:WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement decimals='INF' contextRef='I111216' unitRef='Shares'>1000000</fil:WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement>
	<fil:PartnerProvidesAtleastInCashOrInKindOutlays decimals='INF' contextRef='I111216' unitRef='USD'>2000000</fil:PartnerProvidesAtleastInCashOrInKindOutlays>
	<fil:WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1 decimals='INF' contextRef='I111216' unitRef='Shares'>1000000</fil:WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1>
	<fil:WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement decimals='INF' contextRef='I111216' unitRef='Shares'>1000000</fil:WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement>
	<fil:SettlementAgreementCallsForTheCompanyToMake10Payments decimals='INF' contextRef='I140715' unitRef='USD'>6250</fil:SettlementAgreementCallsForTheCompanyToMake10Payments>
	<fil:TotalLiabilityOutOfTheGrossAmount decimals='INF' contextRef='I140715' unitRef='USD'>97463</fil:TotalLiabilityOutOfTheGrossAmount>
	<fil:AmountRecordedOnTheCompanySBooks decimals='INF' contextRef='I140715' unitRef='USD'>191146</fil:AmountRecordedOnTheCompanySBooks>
	<fil:RecognizedAsOtherIncomeForThePeriodEndingSeptember302014 decimals='INF' contextRef='E14Q3' unitRef='USD'>93683</fil:RecognizedAsOtherIncomeForThePeriodEndingSeptember302014>
	<fil:RecognizedAsOtherIncomeForThePeriodEndingSeptember302014 decimals='INF' contextRef='E15' unitRef='USD'>34963</fil:RecognizedAsOtherIncomeForThePeriodEndingSeptember302014>
	<us-gaap:OperatingLossCarryforwards decimals='INF' contextRef='E16' unitRef='USD'>39732000</us-gaap:OperatingLossCarryforwards>
	<us-gaap:DeferredTaxAssetsNet decimals='INF' contextRef='E16' unitRef='USD'>15893000</us-gaap:DeferredTaxAssetsNet>
	<fil:FederalAndStateStatutoryRate decimals='INF' contextRef='E16' unitRef='Pure'>0.4000</fil:FederalAndStateStatutoryRate>
	<fil:EffectiveTaxRate decimals='INF' contextRef='E16' unitRef='Pure'>0.0000</fil:EffectiveTaxRate>
	<fil:IncreaseInTheValuationAllowance decimals='INF' contextRef='E16' unitRef='USD'>3693000</fil:IncreaseInTheValuationAllowance>
	<fil:DebtOwedToHepInvestment decimals='INF' contextRef='I170303' unitRef='USD'>280000</fil:DebtOwedToHepInvestment>
	<fil:PayToTheShareholderSLegalCounsel decimals='INF' contextRef='I170303' unitRef='USD'>60000</fil:PayToTheShareholderSLegalCounsel>
	<fil:SharesOfTheCompanySCommonStock decimals='INF' contextRef='I170303' unitRef='Shares'>250000</fil:SharesOfTheCompanySCommonStock>
	<fil:SharesOfTheCompanySCommonStockValued decimals='INF' contextRef='I170303' unitRef='USD'>22500</fil:SharesOfTheCompanySCommonStockValued>
	<fil:RecordedLegalFees decimals='INF' contextRef='I170303' unitRef='USD'>82500</fil:RecordedLegalFees>
	<fil:RecordedTheSettlementAmount decimals='INF' contextRef='I170303' unitRef='USD'>280000</fil:RecordedTheSettlementAmount>
	<fil:UnamortizedDiscount decimals='INF' contextRef='E16' unitRef='USD'>574443</fil:UnamortizedDiscount>
	<fil:UnamortizedDiscount decimals='INF' contextRef='E15' unitRef='USD'>1843931</fil:UnamortizedDiscount>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D150102_151231' unitRef='Shares'>76151</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<fil:IssuanceOfWarrantsToBoardOfDirectors1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsToBoardOfDirectors1>
	<fil:IssuanceOfWarrantsToBoardOfDirectors1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>69712</fil:IssuanceOfWarrantsToBoardOfDirectors1>
	<fil:IssuanceOfWarrantsToBoardOfDirectors1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsToBoardOfDirectors1>
	<fil:IssuanceOfWarrantsToBoardOfDirectors1 decimals='INF' contextRef='Y16' unitRef='USD'>69712</fil:IssuanceOfWarrantsToBoardOfDirectors1>
	<fil:IssuanceOfWarrantsForServices1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsForServices1>
	<fil:IssuanceOfWarrantsForServices1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>1116444</fil:IssuanceOfWarrantsForServices1>
	<fil:IssuanceOfWarrantsForServices1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsForServices1>
	<fil:IssuanceOfWarrantsForServices1 decimals='INF' contextRef='Y16' unitRef='USD'>1116444</fil:IssuanceOfWarrantsForServices1>
	<fil:IssuanceOfWarrantsForServicesRelatedParty1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:IssuanceOfWarrantsForServicesRelatedParty1>
	<fil:IssuanceOfWarrantsForServicesRelatedParty1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>15601</fil:IssuanceOfWarrantsForServicesRelatedParty1>
	<fil:IssuanceOfWarrantsForServicesRelatedParty1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:IssuanceOfWarrantsForServicesRelatedParty1>
	<fil:IssuanceOfWarrantsForServicesRelatedParty1 decimals='INF' contextRef='Y16' unitRef='USD'>15601</fil:IssuanceOfWarrantsForServicesRelatedParty1>
	<fil:IssuanceOfCommonStockForServices decimals='INF' contextRef='Y16_StEqComps-CapUnits' unitRef='Shares'>3500000</fil:IssuanceOfCommonStockForServices>
	<fil:IssuanceOfCommonStockForServices decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='Shares'>3500</fil:IssuanceOfCommonStockForServices>
	<fil:IssuanceOfCommonStockForServices decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='Shares'>171500</fil:IssuanceOfCommonStockForServices>
	<fil:IssuanceOfCommonStockForServices decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='Shares'>0</fil:IssuanceOfCommonStockForServices>
	<fil:IssuanceOfCommonStockForServices decimals='INF' contextRef='Y16' unitRef='Shares'>175000</fil:IssuanceOfCommonStockForServices>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:DiscountsOnIssuanceOfConvertibleDebentures1>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>106693</fil:DiscountsOnIssuanceOfConvertibleDebentures1>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:DiscountsOnIssuanceOfConvertibleDebentures1>
	<fil:DiscountsOnIssuanceOfConvertibleDebentures1 decimals='INF' contextRef='Y16' unitRef='USD'>106693</fil:DiscountsOnIssuanceOfConvertibleDebentures1>
	<fil:WarrantsIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:WarrantsIssuedForFinancingCosts1>
	<fil:WarrantsIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>99931</fil:WarrantsIssuedForFinancingCosts1>
	<fil:WarrantsIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>0</fil:WarrantsIssuedForFinancingCosts1>
	<fil:WarrantsIssuedForFinancingCosts1 decimals='INF' contextRef='Y16' unitRef='USD'>99931</fil:WarrantsIssuedForFinancingCosts1>
	<fil:CommonStockIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-CapUnits' unitRef='Shares'>1088571</fil:CommonStockIssuedForFinancingCosts1>
	<fil:CommonStockIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='Shares'>1088</fil:CommonStockIssuedForFinancingCosts1>
	<fil:CommonStockIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='Shares'>70912</fil:CommonStockIssuedForFinancingCosts1>
	<fil:CommonStockIssuedForFinancingCosts1 decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='Shares'>0</fil:CommonStockIssuedForFinancingCosts1>
	<fil:CommonStockIssuedForFinancingCosts1 decimals='INF' contextRef='Y16' unitRef='Shares'>72000</fil:CommonStockIssuedForFinancingCosts1>
	<fil:NetLoss decimals='INF' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:NetLoss>
	<fil:NetLoss decimals='INF' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>0</fil:NetLoss>
	<fil:NetLoss decimals='INF' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>-6059627</fil:NetLoss>
	<fil:NetLoss decimals='INF' contextRef='Y16' unitRef='USD'>-6059627</fil:NetLoss>
	<fil:Balance1 decimals='INF' contextRef='E16_StEqComps-CapUnits' unitRef='Shares'>136745347</fil:Balance1>
	<fil:Balance1 decimals='INF' contextRef='E16_StEqComps-CommonStock' unitRef='Shares'>136745</fil:Balance1>
	<fil:Balance1 decimals='INF' contextRef='E16_StEqComps-AddPaidInCap' unitRef='Shares'>40016059</fil:Balance1>
	<fil:Balance1 decimals='INF' contextRef='E16_StEqComps-RetainedEarnings' unitRef='Shares'>-53774039</fil:Balance1>
	<fil:Balance1 decimals='INF' contextRef='E16' unitRef='Shares'>-13621235</fil:Balance1>
	<fil:CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt decimals='INF' contextRef='Y16' unitRef='USD'>106693</fil:CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt>
	<fil:CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt decimals='INF' contextRef='D150102_151231' unitRef='USD'>1916501</fil:CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt>
	<fil:ValueOfTheNotesOnWhichDebtDiscountWasRecorded decimals='INF' contextRef='Y16' unitRef='USD'>2000000</fil:ValueOfTheNotesOnWhichDebtDiscountWasRecorded>
	<fil:ValueOfTheNotesOnWhichDebtDiscountWasRecorded decimals='INF' contextRef='D150102_151231' unitRef='USD'>2067500</fil:ValueOfTheNotesOnWhichDebtDiscountWasRecorded>
	<fil:CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital decimals='INF' contextRef='Y16' unitRef='USD'>0</fil:CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital>
	<fil:CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital decimals='INF' contextRef='D150102_151231' unitRef='USD'>1773078</fil:CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital>
	<fil:TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded decimals='INF' contextRef='Y16' unitRef='USD'>0</fil:TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded>
	<fil:TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded decimals='INF' contextRef='D150102_151231' unitRef='USD'>143423</fil:TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded>
	<fil:AmortizationOfDebtDiscounts decimals='INF' contextRef='Y16' unitRef='USD'>1376181</fil:AmortizationOfDebtDiscounts>
	<fil:AmortizationOfDebtDiscounts decimals='INF' contextRef='D150102_151231' unitRef='USD'>1866842</fil:AmortizationOfDebtDiscounts>
	<fil:RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare decimals='INF' contextRef='Y16' unitRef='USD'>280000</fil:RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare>
	<fil:RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare decimals='INF' contextRef='D150102_151231' unitRef='USD'>0</fil:RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare>
	<fil:PaulsonCanProvideFinancingsThroughAccreditedInvestors decimals='INF' contextRef='I160824' unitRef='USD'>2000000</fil:PaulsonCanProvideFinancingsThroughAccreditedInvestors>
	<fil:CompanyReceivedFunding4IndividualLoans decimals='INF' contextRef='I160824' unitRef='USD'>600000</fil:CompanyReceivedFunding4IndividualLoans>
	<fil:PaulsonReceivesACashFinanceFee decimals='INF' contextRef='I160824' unitRef='Pure'>0.1000</fil:PaulsonReceivesACashFinanceFee>
	<fil:DebtIsConvertiblePerShare decimals='INF' contextRef='I160824' unitRef='UsdPerShare'>0.10</fil:DebtIsConvertiblePerShare>
	<fil:NewLendersAdvancedPaulsonNotes1 decimals='INF' contextRef='E16' unitRef='USD'>1250000</fil:NewLendersAdvancedPaulsonNotes1>
	<fil:CompanySRestrictedCommonStockPerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.10</fil:CompanySRestrictedCommonStockPerShare>
	<fil:NewLendersAdvancedPaulsonNotesInterestRate decimals='INF' contextRef='E16' unitRef='Pure'>0.1100</fil:NewLendersAdvancedPaulsonNotesInterestRate>
	<dei:DocumentType contextRef='Y16'>10-K</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='Y16'>2016-12-31</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='Y16'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='Y16'>Zivo Bioscience, Inc.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='Y16'>0001101026</dei:EntityCentralIndexKey>
	<dei:TradingSymbol contextRef='Y16'>zivo</dei:TradingSymbol>
	<dei:CurrentFiscalYearEndDate contextRef='Y16'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='I170329' unitRef='Shares'>136995347</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityPublicFloat decimals='INF' contextRef='E16Q2' unitRef='USD'>7967207</dei:EntityPublicFloat>
	<dei:EntityFilerCategory contextRef='Y16'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='Y16'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='Y16'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='Y16'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='Y16'>2016</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='Y16'>FY</dei:DocumentFiscalPeriodFocus>
	<fil:EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal decimals='INF' contextRef='E15' unitRef='USD'>17500000</fil:EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal>
	<fil:TotalOutstandingDebtAsOfMarch12017 decimals='INF' contextRef='E16' unitRef='USD'>12982203</fil:TotalOutstandingDebtAsOfMarch12017>
	<fil:UnpaidPrincipal decimals='INF' contextRef='E16' unitRef='USD'>9427200</fil:UnpaidPrincipal>
	<fil:InterestOutstandingAsOfFebruary282017 decimals='INF' contextRef='E16' unitRef='USD'>2955003</fil:InterestOutstandingAsOfFebruary282017>
	<fil:RestructuringAndLegalFees decimals='INF' contextRef='E16' unitRef='USD'>600000</fil:RestructuringAndLegalFees>
	<fil:ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare decimals='INF' contextRef='E16' unitRef='Shares'>12982203</fil:ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare>
	<fil:TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt decimals='INF' contextRef='E16' unitRef='Shares'>129822030</fil:TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt>
	<fil:HepInvestmentsLlcLenderFundedAnAdditionalLoan decimals='INF' contextRef='E17Q1' unitRef='USD'>1000000</fil:HepInvestmentsLlcLenderFundedAnAdditionalLoan>
	<fil:CompanyIssuedToTheLenderForAggregateConsiderationOf decimals='INF' contextRef='E17Q1' unitRef='USD'>1000000</fil:CompanyIssuedToTheLenderForAggregateConsiderationOf>
	<fil:WarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='E17Q1' unitRef='Shares'>1000000</fil:WarrantsToPurchaseSharesOfCommonStock>
	<fil:CommonStockAtAtAnExercisePricePerShare decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>0.10</fil:CommonStockAtAtAnExercisePricePerShare>
	<fil:CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt decimals='INF' contextRef='E17Q1' unitRef='USD'>1000000</fil:CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt>
	<fil:ConvertibleNotesAccrueInterestAtTheRatePerAnnum decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.1100</fil:ConvertibleNotesAccrueInterestAtTheRatePerAnnum>
	<fil:CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount decimals='INF' contextRef='E16' unitRef='USD'>0</fil:CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount>
	<fil:OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10 decimals='INF' contextRef='E16' unitRef='Shares'>500000</fil:OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10>
	<fil:AdditionalAmountFundedByHepInvestmentsLlc decimals='INF' contextRef='E17Q1' unitRef='USD'>1000000</fil:AdditionalAmountFundedByHepInvestmentsLlc>
	<fil:Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock decimals='INF' contextRef='E17Q1' unitRef='Shares'>1000000</fil:Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock>
	<fil:Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>0.10</fil:Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice>
	<fil:TermInYears1 decimals='INF' contextRef='E17Q1' unitRef='Pure'>5</fil:TermInYears1>
	<context id='Y16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='E16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-06-30</instant>
		</period>
	</context>
	<context id='I170329'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2017-03-29</instant>
		</period>
	</context>
	<context id='E15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='D150102_151231'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<startDate>2015-01-02</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='I160824'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-08-24</instant>
		</period>
	</context>
	<context id='I150131'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-01-31</instant>
		</period>
	</context>
	<context id='E15Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-06-30</instant>
		</period>
	</context>
	<context id='I150731'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-07-31</instant>
		</period>
	</context>
	<context id='I150910'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-09-10</instant>
		</period>
	</context>
	<context id='E16Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-03-31</instant>
		</period>
	</context>
	<context id='I160910'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-09-10</instant>
		</period>
	</context>
	<context id='I150423'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-04-23</instant>
		</period>
	</context>
	<context id='I150415'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-04-15</instant>
		</period>
	</context>
	<context id='I150626'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-06-26</instant>
		</period>
	</context>
	<context id='I150801'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-08-01</instant>
		</period>
	</context>
	<context id='I160519'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-05-19</instant>
		</period>
	</context>
	<context id='I160919'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-09-19</instant>
		</period>
	</context>
	<context id='I161117'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-11-17</instant>
		</period>
	</context>
	<context id='B15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-01-01</instant>
		</period>
	</context>
	<context id='Y16_StEqComps-CapUnits'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CapitalUnitsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='E16_StEqComps-CapUnits'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CapitalUnitsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='B15_StEqComps-CapUnits'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CapitalUnitsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-01-01</instant>
		</period>
	</context>
	<context id='B15_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-01-01</instant>
		</period>
	</context>
	<context id='B15_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-01-01</instant>
		</period>
	</context>
	<context id='B15_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-01-01</instant>
		</period>
	</context>
	<context id='D150102_151231_StEqComps-CapUnits'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CapitalUnitsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-02</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='D150102_151231_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-02</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='D150102_151231_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-02</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='D150102_151231_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-02</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='E15_StEqComps-CapUnits'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CapitalUnitsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='I150114'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-01-14</instant>
		</period>
	</context>
	<context id='I150123'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-01-23</instant>
		</period>
	</context>
	<context id='I150217'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-02-17</instant>
		</period>
	</context>
	<context id='I150227'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-02-27</instant>
		</period>
	</context>
	<context id='I150327'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-03-27</instant>
		</period>
	</context>
	<context id='I150417'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-04-17</instant>
		</period>
	</context>
	<context id='I150501'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-05-01</instant>
		</period>
	</context>
	<context id='I150707'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-07-07</instant>
		</period>
	</context>
	<context id='I150902'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-09-02</instant>
		</period>
	</context>
	<context id='I151008'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-10-08</instant>
		</period>
	</context>
	<context id='I151029'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-10-29</instant>
		</period>
	</context>
	<context id='I160127'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-01-27</instant>
		</period>
	</context>
	<context id='I160301'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-03-01</instant>
		</period>
	</context>
	<context id='I160516'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-05-16</instant>
		</period>
	</context>
	<context id='I160726'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-07-26</instant>
		</period>
	</context>
	<context id='I160825'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-08-25</instant>
		</period>
	</context>
	<context id='I161020'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-10-20</instant>
		</period>
	</context>
	<context id='I150406'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-04-06</instant>
		</period>
	</context>
	<context id='I150513'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2015-05-13</instant>
		</period>
	</context>
	<context id='I160329'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-03-29</instant>
		</period>
	</context>
	<context id='I160513'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2016-05-13</instant>
		</period>
	</context>
	<context id='I111216'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2011-12-16</instant>
		</period>
	</context>
	<context id='I140715'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2014-07-15</instant>
		</period>
	</context>
	<context id='E14Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2014-09-30</instant>
		</period>
	</context>
	<context id='I170303'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2017-03-03</instant>
		</period>
	</context>
	<context id='E17Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001101026</identifier>
		</entity>
		<period>
			<instant>2017-03-31</instant>
		</period>
	</context>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>zivo-20161231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.zivobioscience.com/20161231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' xlink:label='fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recognized as other income for the period ending September 30, 2014</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Recognized as other income for the period ending September 30, 2014</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' xlink:to='lab_fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementAgreementCallsForTheCompanyToMake10Payments' xlink:label='fil_SettlementAgreementCallsForTheCompanyToMake10Payments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SettlementAgreementCallsForTheCompanyToMake10Payments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Settlement agreement calls for the Company to make 10 payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SettlementAgreementCallsForTheCompanyToMake10Payments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Settlement agreement calls for the Company to make 10 payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SettlementAgreementCallsForTheCompanyToMake10Payments' xlink:to='lab_fil_SettlementAgreementCallsForTheCompanyToMake10Payments'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice015' xlink:label='fil_WeightedAverageExercisePrice015'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice015' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.15</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice015' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.15</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice015' xlink:to='lab_fil_WeightedAverageExercisePrice015'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice012' xlink:label='fil_ExercisePrice012'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice012' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.12</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice012' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.12</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice012' xlink:to='lab_fil_ExercisePrice012'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange009InYears' xlink:label='fil_PriceRange009InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange009InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.09 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange009InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.09, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange009InYears' xlink:to='lab_fil_PriceRange009InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceExpired' xlink:label='fil_WeightedAverageExercisePriceExpired'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceExpired' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Expired</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceExpired' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePriceExpired' xlink:to='lab_fil_WeightedAverageExercisePriceExpired'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsIssued' xlink:label='fil_NumberOfWarrantsIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsIssued' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsIssued' xlink:to='lab_fil_NumberOfWarrantsIssued'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price {3}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue2' xlink:label='fil_IssuedSharesOfCommonStockValue2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock value {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued shares of common stock value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders&apos; equity.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStockValue2' xlink:to='lab_fil_IssuedSharesOfCommonStockValue2'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LenderConvertedTheDebtPerShare' xlink:label='fil_LenderConvertedTheDebtPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LenderConvertedTheDebtPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lender Converted the debt per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LenderConvertedTheDebtPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Lender Converted the debt per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LenderConvertedTheDebtPerShare' xlink:to='lab_fil_LenderConvertedTheDebtPerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' xlink:label='fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Secured Promissory Note in the initial principal amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Secured Promissory Note in the initial principal amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' xlink:to='lab_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:label='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summary of Significant Accounting Policies (Narrative) Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company raised net proceeds from from the issuance of convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:to='lab_fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockholdersDeficiency' xlink:label='fil_StockholdersDeficiency'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockholdersDeficiency' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; deficiency</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockholdersDeficiency' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of stockholders&apos; equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockholdersDeficiency' xlink:to='lab_fil_StockholdersDeficiency'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:label='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Summary of the status of warrants (Tables)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:to='lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:label='us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Reclassifications</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:to='lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OtherIncomeAndExpensesAbstract1' xlink:label='fil_OtherIncomeAndExpensesAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherIncomeAndExpensesAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OTHER INCOME (EXPENSE): {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherIncomeAndExpensesAbstract1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>OTHER INCOME (EXPENSE):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherIncomeAndExpensesAbstract1' xlink:to='lab_fil_OtherIncomeAndExpensesAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid' xlink:label='us-gaap_IncomeTaxesPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesPaid' xlink:to='lab_us-gaap_IncomeTaxesPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties' xlink:label='us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds (payments) from loans payable, related parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties' xlink:to='lab_us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in assets and liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants for services - related party {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance of warrants for services - related party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees, related parties as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:to='lab_fil_IssuanceOfWarrantsForServicesRelatedParty1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts' xlink:label='fil_WarrantsIssuedForFinancingCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsIssuedForFinancingCosts' xlink:to='lab_fil_WarrantsIssuedForFinancingCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of common stock for services</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:to='lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding' xlink:label='us-gaap_SharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharesOutstanding' xlink:to='lab_us-gaap_SharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued $1,000,000 11% convertible note and warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued $1,000,000 11% convertible note and warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' xlink:to='lab_fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' xlink:label='fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company recorded a deferred debt discount, related to the $1,000,000 Note, in the amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company recorded a deferred debt discount, related to the $1,000,000 Note, in the amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' xlink:to='lab_fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' xlink:label='fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Promissory Note into the Company&apos;s restricted common stock at $.10 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Promissory Note into the Company&apos;s restricted common stock at $.10 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' xlink:to='lab_fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EmploymentAgreementDetailsAbstract' xlink:label='fil_EmploymentAgreementDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EmploymentAgreementDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Employment Agreement Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='lab_fil_EmploymentAgreementDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice030' xlink:label='fil_WeightedAverageExercisePrice030'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice030' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.30</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice030' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.30</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice030' xlink:to='lab_fil_WeightedAverageExercisePrice030'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice020' xlink:label='fil_ExercisePrice020'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice020' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.20</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice020' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.20</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice020' xlink:to='lab_fil_ExercisePrice020'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice010' xlink:label='fil_ExercisePrice010'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice010' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.10</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice010' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.10</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice010' xlink:to='lab_fil_ExercisePrice010'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:label='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding Warrants Average Weighted Remaining Contractual Life in Years</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Number of Warrants Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='lab_fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingBeginningOfYear' xlink:label='fil_OutstandingBeginningOfYear'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingBeginningOfYear' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding Beginning Of Year</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingBeginningOfYear' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingBeginningOfYear' xlink:to='lab_fil_OutstandingBeginningOfYear'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MsMastersonSUnvestedWarrant1' xlink:label='fil_MsMastersonSUnvestedWarrant1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MsMastersonSUnvestedWarrant1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ms. Masterson&apos;s unvested warrant</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MsMastersonSUnvestedWarrant1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Ms. Masterson&apos;s unvested warrant</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MsMastersonSUnvestedWarrant1' xlink:to='lab_fil_MsMastersonSUnvestedWarrant1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' xlink:label='fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In addition, Mr. Cox is entitled to receive $10,000 for each annual term served</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mr. Cox is entitled to receive $10,000 for each annual term served.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' xlink:to='lab_fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingTranches17To30Totaling' xlink:label='fil_RemainingTranches17To30Totaling'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingTranches17To30Totaling' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Remaining Tranches 17 to 30, totaling</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingTranches17To30Totaling' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Remaining Tranches 17 to 30, totaling</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RemainingTranches17To30Totaling' xlink:to='lab_fil_RemainingTranches17To30Totaling'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleA010PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule A 0.10 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule A 0.10 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockValueScheduleA010PerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ResearchAndDevelopmentCosts' xlink:label='fil_ResearchAndDevelopmentCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ResearchAndDevelopmentCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and development costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ResearchAndDevelopmentCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity&apos;s use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ResearchAndDevelopmentCosts' xlink:to='lab_fil_ResearchAndDevelopmentCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:label='us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Based Compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:to='lab_us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConsolidationPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principles of Consolidation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConsolidationPolicyTextBlock' xlink:to='lab_us-gaap_ConsolidationPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ChangesInEquityAbstract' xlink:label='fil_ChangesInEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ChangesInEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ChangesInEquityAbstract' xlink:to='lab_fil_ChangesInEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent' xlink:label='us-gaap_PrepaidExpenseCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PrepaidExpenseCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PrepaidExpenseCurrent' xlink:to='lab_us-gaap_PrepaidExpenseCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SharesOfTheCompanySCommonStock' xlink:label='fil_SharesOfTheCompanySCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares of the Company&apos;s common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfTheCompanySCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares of the Company&apos;s common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesOfTheCompanySCommonStock' xlink:to='lab_fil_SharesOfTheCompanySCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:label='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant for shares upon the Company entering into a co-development agreement {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrant for shares upon the Company entering into a co-development agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrant for shares upon the Company entering into a co-development agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:to='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' xlink:label='fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant for shares to be issued upon upon entering into a business contract</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrant for shares to be issued upon upon entering into a business contract</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' xlink:to='lab_fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange033InYears' xlink:label='fil_PriceRange033InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange033InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.33 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange033InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.33, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange033InYears' xlink:to='lab_fil_PriceRange033InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange020InYears' xlink:label='fil_PriceRange020InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange020InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.20 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange020InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.20, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange020InYears' xlink:to='lab_fil_PriceRange020InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalWarrantsOutstandingNumber' xlink:label='fil_TotalWarrantsOutstandingNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsOutstandingNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Warrants outstanding number</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsOutstandingNumber' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Number of Warrants Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalWarrantsOutstandingNumber' xlink:to='lab_fil_TotalWarrantsOutstandingNumber'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceCancelled' xlink:label='fil_WeightedAverageExercisePriceCancelled'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceCancelled' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cancelled</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceCancelled' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePriceCancelled' xlink:to='lab_fil_WeightedAverageExercisePriceCancelled'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExecutiveCompensationAbstract' xlink:label='fil_ExecutiveCompensationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExecutiveCompensationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Executive Compensation</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExecutiveCompensationAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The cash inflow from the additional capital contribution to the entity.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExecutiveCompensationAbstract' xlink:to='lab_fil_ExecutiveCompensationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TermInYears' xlink:label='fil_TermInYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TermInYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Term (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TermInYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Term (in years)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TermInYears' xlink:to='lab_fil_TermInYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock' xlink:label='fil_IssuedSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStock' xlink:to='lab_fil_IssuedSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' xlink:label='fil_WarrantsWereValuedUsingTheBlackScholesPricingModel'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants were valued using the Black Scholes pricing model</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants were valued using the Black Scholes pricing model</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' xlink:to='lab_fil_WarrantsWereValuedUsingTheBlackScholesPricingModel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RestrictedCommonSharesDetailsAbstract' xlink:label='fil_RestrictedCommonSharesDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RestrictedCommonSharesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Restricted Common Shares Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='lab_fil_RestrictedCommonSharesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleSecuredPromissoryNotes' xlink:label='fil_ConvertibleSecuredPromissoryNotes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleSecuredPromissoryNotes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Secured Promissory Notes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleSecuredPromissoryNotes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Secured Promissory Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleSecuredPromissoryNotes' xlink:to='lab_fil_ConvertibleSecuredPromissoryNotes'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyIncurredFinanceCosts' xlink:label='fil_CompanyIncurredFinanceCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIncurredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company incurred finance costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIncurredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company incurred finance costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyIncurredFinanceCosts' xlink:to='lab_fil_CompanyIncurredFinanceCosts'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WorkingCapitalDeficiency1' xlink:label='fil_WorkingCapitalDeficiency1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WorkingCapitalDeficiency1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Working capital deficiency</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WorkingCapitalDeficiency1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Working capital deficiency</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WorkingCapitalDeficiency1' xlink:to='lab_fil_WorkingCapitalDeficiency1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract' xlink:label='us-gaap_SubsequentEventsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SUBSEQUENT EVENTS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsAbstract' xlink:to='lab_us-gaap_SubsequentEventsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementOfLitigationRelatedPartyAbstract' xlink:label='fil_SettlementOfLitigationRelatedPartyAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SettlementOfLitigationRelatedPartyAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SETTLEMENT OF LITIGATION - RELATED PARTY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SettlementOfLitigationRelatedPartyAbstract' xlink:to='lab_fil_SettlementOfLitigationRelatedPartyAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BasisOfAccounting' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BasisOfAccounting' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>BASIS OF PRESENTATION</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BasisOfAccounting' xlink:to='lab_us-gaap_BasisOfAccounting'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetLoss' xlink:to='lab_fil_NetLoss'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discounts on issuance of convertible debentures {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Discounts on issuance of convertible debentures</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Discounts on issuance of convertible debentures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:to='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COSTS AND EXPENSES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='lab_us-gaap_OperatingExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent' xlink:label='us-gaap_ConvertibleDebtNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConvertibleDebtNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Debenture Payable, less discount of $1,458,741 and $ 73,953 at December 31, 2015 and 2016, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConvertibleDebtNoncurrent' xlink:to='lab_us-gaap_ConvertibleDebtNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdditionalAmountFundedByHepInvestmentsLlc' xlink:label='fil_AdditionalAmountFundedByHepInvestmentsLlc'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdditionalAmountFundedByHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional amount funded by HEP Investments LLC</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdditionalAmountFundedByHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Additional amount funded by HEP Investments LLC</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdditionalAmountFundedByHepInvestmentsLlc' xlink:to='lab_fil_AdditionalAmountFundedByHepInvestmentsLlc'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InterestOutstandingAsOfFebruary282017' xlink:label='fil_InterestOutstandingAsOfFebruary282017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOutstandingAsOfFebruary282017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest outstanding as of February 28, 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InterestOutstandingAsOfFebruary282017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Interest outstanding as of February 28, 2017</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InterestOutstandingAsOfFebruary282017' xlink:to='lab_fil_InterestOutstandingAsOfFebruary282017'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtOwedToHepInvestment' xlink:label='fil_DebtOwedToHepInvestment'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtOwedToHepInvestment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt owed to HEP Investment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtOwedToHepInvestment' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Debt owed to HEP Investment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DebtOwedToHepInvestment' xlink:to='lab_fil_DebtOwedToHepInvestment'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EffectiveTaxRate' xlink:label='fil_EffectiveTaxRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EffectiveTaxRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective tax rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EffectiveTaxRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EffectiveTaxRate' xlink:to='lab_fil_EffectiveTaxRate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ReceivesInCashPayments' xlink:label='fil_ReceivesInCashPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivesInCashPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Receives in cash payments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivesInCashPayments' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Receives in cash payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReceivesInCashPayments' xlink:to='lab_fil_ReceivesInCashPayments'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice010' xlink:label='fil_WeightedAverageExercisePrice010'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice010' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.10</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice010' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.10</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice010' xlink:to='lab_fil_WeightedAverageExercisePrice010'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice017' xlink:label='fil_ExercisePrice017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.17</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.17</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice017' xlink:to='lab_fil_ExercisePrice017'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingWarrantsNumberAbstract' xlink:label='fil_OutstandingWarrantsNumberAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingWarrantsNumberAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding Warrants Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='lab_fil_OutstandingWarrantsNumberAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model {3}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:to='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' xlink:label='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance in principal of an 11% Convertible Debenture</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issuance in principal of an 11% Convertible Debenture</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' xlink:to='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BoardOfDirectorsFeesDetailsAbstract' xlink:label='fil_BoardOfDirectorsFeesDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BoardOfDirectorsFeesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Board Of Directors Fees Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_BoardOfDirectorsFeesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount advanced by Chris Maggiore, a significant shareholder</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='lab_fil_BoardOfDirectorsFeesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NewLendersAdvancedPaulsonNotes1' xlink:label='fil_NewLendersAdvancedPaulsonNotes1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NewLendersAdvancedPaulsonNotes1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>New Lenders advanced Paulson Notes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NewLendersAdvancedPaulsonNotes1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>New Lenders advanced Paulson Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NewLendersAdvancedPaulsonNotes1' xlink:to='lab_fil_NewLendersAdvancedPaulsonNotes1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingBalanceInLoansPayableToRelatedParties' xlink:label='fil_RemainingBalanceInLoansPayableToRelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingBalanceInLoansPayableToRelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Remaining balance in loans payable to related parties</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingBalanceInLoansPayableToRelatedParties' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Remaining balance in loans payable to related parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RemainingBalanceInLoansPayableToRelatedParties' xlink:to='lab_fil_RemainingBalanceInLoansPayableToRelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Depreciation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation expense {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Depreciation' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Depreciation expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Depreciation' xlink:to='lab_us-gaap_Depreciation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Expected volatility maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' xlink:label='fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common shares from convertible debentures and related accrued interest</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Common shares from convertible debentures and related accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' xlink:to='lab_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock' xlink:label='us-gaap_DeferredChargesPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredChargesPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Financing Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredChargesPolicyTextBlock' xlink:to='lab_us-gaap_DeferredChargesPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTransactionsTextBlock' xlink:label='fil_RelatedPartyTransactionsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionsTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyTransactionsTextBlock' xlink:to='lab_fil_RelatedPartyTransactionsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyDisclosuresAbstract' xlink:label='fil_RelatedPartyDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>DUE TO RELATED PARTY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyDisclosuresAbstract' xlink:to='lab_fil_RelatedPartyDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>PROPERTY AND EQUIPMENT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:label='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>DESCRIPTION OF BUSINESS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>DESCRIPTION OF BUSINESS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:to='lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet' xlink:label='us-gaap_IncreaseDecreaseInInterestPayableNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInterestPayableNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase in accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInInterestPayableNet' xlink:to='lab_us-gaap_IncreaseDecreaseInInterestPayableNet'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts1' xlink:label='fil_WarrantsIssuedForFinancingCosts1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants issued for financing costs {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsIssuedForFinancingCosts1' xlink:to='lab_fil_WarrantsIssuedForFinancingCosts1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' xlink:label='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued on conversion of 1% Convertible Debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' xlink:to='lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated Deficit {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsMember' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accumulated Deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsMember' xlink:to='lab_us-gaap_RetainedEarningsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CURRENT ASSETS:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockAtAtAnExercisePricePerShare' xlink:label='fil_CommonStockAtAtAnExercisePricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAtAtAnExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, at at an exercise price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAtAtAnExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Common stock, at at an exercise price per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockAtAtAnExercisePricePerShare' xlink:to='lab_fil_CommonStockAtAtAnExercisePricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' xlink:label='fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' xlink:to='lab_fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice012' xlink:label='fil_WeightedAverageExercisePrice012'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice012' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.12</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice012' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.12</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice012' xlink:to='lab_fil_WeightedAverageExercisePrice012'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice009' xlink:label='fil_ExercisePrice009'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice009' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.09</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice009' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.09</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice009' xlink:to='lab_fil_ExercisePrice009'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange015InYears' xlink:label='fil_PriceRange015InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange015InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.15 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange015InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.15, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange015InYears' xlink:to='lab_fil_PriceRange015InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange012' xlink:label='fil_PriceRange012'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange012' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.12</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange012' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.12</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange012' xlink:to='lab_fil_PriceRange012'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsExpired' xlink:label='fil_NumberOfWarrantsExpired'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsExpired' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants Expired</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsExpired' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Expired</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsExpired' xlink:to='lab_fil_NumberOfWarrantsExpired'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsAbstract' xlink:label='fil_NumberOfWarrantsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='lab_fil_NumberOfWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DirectorsFees' xlink:label='fil_DirectorsFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DirectorsFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Directors&apos; fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DirectorsFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of expense incurred during the period as Director&apos;s fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DirectorsFees' xlink:to='lab_fil_DirectorsFees'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleDebtParentheticalsAbstract' xlink:label='fil_ConvertibleDebtParentheticalsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleDebtParentheticalsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible debt Parentheticals</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleDebtParentheticalsAbstract' xlink:to='lab_fil_ConvertibleDebtParentheticalsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnpaidInterestDue' xlink:label='fil_UnpaidInterestDue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnpaidInterestDue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unpaid interest due</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnpaidInterestDue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Unpaid interest due</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnpaidInterestDue' xlink:to='lab_fil_UnpaidInterestDue'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' xlink:label='fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&quot;FDIC&quot;) limit.</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>ConcentrationsOfCreditRiskAbstract</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' xlink:to='lab_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockBasedCompensationExpense' xlink:label='fil_StockBasedCompensationExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockBasedCompensationExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock based compensation expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockBasedCompensationExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers&apos; compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockBasedCompensationExpense' xlink:to='lab_fil_StockBasedCompensationExpense'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' xlink:label='fil_ScheduleOfConvertibleDebtTableTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' xlink:to='lab_fil_ScheduleOfConvertibleDebtTableTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Future Impact of Recently Issued Accounting Standards</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and Cash Equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:to='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CashPaidDuringThePeriodForAbstract' xlink:label='fil_CashPaidDuringThePeriodForAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashPaidDuringThePeriodForAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid during the period for:</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashPaidDuringThePeriodForAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashPaidDuringThePeriodForAbstract' xlink:to='lab_fil_CashPaidDuringThePeriodForAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense' xlink:label='us-gaap_IncreaseDecreaseInPrepaidExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Increase) decrease in prepaid expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInPrepaidExpense' xlink:to='lab_us-gaap_IncreaseDecreaseInPrepaidExpense'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfBondDiscount' xlink:label='fil_AmortizationOfBondDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfBondDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of bond discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfBondDiscount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The sum of the periodic adjustments of the differences between securities&apos; face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizationOfBondDiscount' xlink:to='lab_fil_AmortizationOfBondDiscount'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockForServices' xlink:label='fil_IssuanceOfCommonStockForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfCommonStockForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of common stock for services {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfCommonStockForServices' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance of common stock for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfCommonStockForServices' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of common stock and warrants issued pursuant to private placements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfCommonStockForServices' xlink:to='lab_fil_IssuanceOfCommonStockForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfFinancingCosts' xlink:label='us-gaap_PaymentsOfFinancingCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsOfFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Financing Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsOfFinancingCosts' xlink:to='lab_us-gaap_PaymentsOfFinancingCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract' xlink:label='us-gaap_RevenuesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenuesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>REVENUES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenuesAbstract' xlink:to='lab_us-gaap_RevenuesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Par Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent' xlink:label='us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued Liabilities - Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsAbstract' xlink:label='us-gaap_OtherAssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OTHER ASSETS:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssetsAbstract' xlink:to='lab_us-gaap_OtherAssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' xlink:label='fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total shares of common stock, if the Lender converted the complete convertible debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total shares of common stock, if the Lender converted the complete convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' xlink:to='lab_fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncomeTaxDetailsAbstract' xlink:label='fil_IncomeTaxDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAX Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Settlement agreement calls for the Company to make 10 payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='lab_fil_IncomeTaxDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice020' xlink:label='fil_WeightedAverageExercisePrice020'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice020' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.20</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice020' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.20</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice020' xlink:to='lab_fil_WeightedAverageExercisePrice020'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice030' xlink:label='fil_ExercisePrice030'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice030' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.30</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice030' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.30</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice030' xlink:to='lab_fil_ExercisePrice030'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice008' xlink:label='fil_ExercisePrice008'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice008' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.08</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice008' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.08</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice008' xlink:to='lab_fil_ExercisePrice008'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange015' xlink:label='fil_PriceRange015'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange015' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.15</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange015' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.15</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange015' xlink:to='lab_fil_PriceRange015'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange008' xlink:label='fil_PriceRange008'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange008' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.08</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange008' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.08</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange008' xlink:to='lab_fil_PriceRange008'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceAbstract' xlink:label='fil_WeightedAverageExercisePriceAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='lab_fil_WeightedAverageExercisePriceAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' xlink:to='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsTermInYears' xlink:label='fil_WarrantsTermInYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsTermInYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants term (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsTermInYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Term of warrants in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsTermInYears' xlink:to='lab_fil_WarrantsTermInYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnamortizedDiscount' xlink:label='fil_UnamortizedDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unamortized discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnamortizedDiscount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount, after accumulated amortization, of debt discount.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnamortizedDiscount' xlink:to='lab_fil_UnamortizedDiscount'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotePayableHepInvestmentsLlc' xlink:label='fil_N11ConvertibleNotePayableHepInvestmentsLlc'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotePayableHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>11% Convertible note payable - HEP Investments, LLC,</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotePayableHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N11ConvertibleNotePayableHepInvestmentsLlc' xlink:to='lab_fil_N11ConvertibleNotePayableHepInvestmentsLlc'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' xlink:label='fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Paulson can provide financings through accredited investors</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Paulson can provide financings through &quot;accredited investors</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' xlink:to='lab_fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:label='fil_DeferredDebtDiscountAndOtherDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Debt Discount and Other details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='lab_fil_DeferredDebtDiscountAndOtherDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountAdvancedByChrisMaggioreASignificantShareholder' xlink:label='fil_AmountAdvancedByChrisMaggioreASignificantShareholder'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountAdvancedByChrisMaggioreASignificantShareholder' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amount advanced by Chris Maggiore, a significant shareholder</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountAdvancedByChrisMaggioreASignificantShareholder' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount advanced by Chris Maggiore, a significant shareholder</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmountAdvancedByChrisMaggioreASignificantShareholder' xlink:to='lab_fil_AmountAdvancedByChrisMaggioreASignificantShareholder'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:label='fil_LoanPayableRelatedPartiesDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loan Payable, Related Parties Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='lab_fil_LoanPayableRelatedPartiesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonSharesFromOutstandingWarrants' xlink:label='fil_CommonSharesFromOutstandingWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesFromOutstandingWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common shares from outstanding warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonSharesFromOutstandingWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Common shares from convertible debentures and related accrued interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonSharesFromOutstandingWarrants' xlink:to='lab_fil_CommonSharesFromOutstandingWarrants'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash (Used) in Operating Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discounts on issuance of convertible debentures</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Discounts on issuance of convertible debentures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:to='lab_fil_DiscountsOnIssuanceOfConvertibleDebentures'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments' xlink:label='us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of Bond Discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments' xlink:to='lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL LIABILITIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet' xlink:label='us-gaap_DeferredFinanceCostsNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredFinanceCostsNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Finance Costs, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredFinanceCostsNet' xlink:to='lab_us-gaap_DeferredFinanceCostsNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Cash' xlink:to='lab_us-gaap_Cash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:label='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>11% Convertible Debt - HEP Investments, LLC</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Paulson can provide financings through &quot;accredited investors</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:to='lab_fil_N11ConvertibleDebtHepInvestmentsLlcAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet' xlink:label='us-gaap_DeferredTaxAssetsNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company had a deferred tax asset</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsNet' xlink:to='lab_us-gaap_DeferredTaxAssetsNet'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePricePerShareWarrantsEntitled' xlink:label='fil_ExercisePricePerShareWarrantsEntitled'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePricePerShareWarrantsEntitled' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise price per share warrants entitled</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePricePerShareWarrantsEntitled' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Exercise price per share warrants entitled</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePricePerShareWarrantsEntitled' xlink:to='lab_fil_ExercisePricePerShareWarrantsEntitled'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice014' xlink:label='fil_WeightedAverageExercisePrice014'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice014' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.14</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice014' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.14</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice014' xlink:to='lab_fil_WeightedAverageExercisePrice014'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice038' xlink:label='fil_ExercisePrice038'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice038' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.38</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice038' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.38</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice038' xlink:to='lab_fil_ExercisePrice038'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange010InYears' xlink:label='fil_PriceRange010InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange010InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.10 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange010InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.10, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange010InYears' xlink:to='lab_fil_PriceRange010InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange017' xlink:label='fil_PriceRange017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.17</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.17</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange017' xlink:to='lab_fil_PriceRange017'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceExercised' xlink:label='fil_WeightedAverageExercisePriceExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceExercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePriceExercised' xlink:to='lab_fil_WeightedAverageExercisePriceExercised'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:label='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance in principal of an 11% Convertible Debenture {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance in principal of an 11% Convertible Debenture</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issuance in principal of an 11% Convertible Debenture</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:to='lab_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock1' xlink:label='fil_IssuedSharesOfCommonStock1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStock1' xlink:to='lab_fil_IssuedSharesOfCommonStock1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DirectorsFeesDuringThePeriodAbstract' xlink:label='fil_DirectorsFeesDuringThePeriodAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DirectorsFeesDuringThePeriodAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Directors fees- During the period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DirectorsFeesDuringThePeriodAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount which Mr. Rondeau entitled to receive for each annual term served.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DirectorsFeesDuringThePeriodAbstract' xlink:to='lab_fil_DirectorsFeesDuringThePeriodAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrRiceSUnvestedWarrant' xlink:label='fil_MrRiceSUnvestedWarrant'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrRiceSUnvestedWarrant' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mr. Rice&apos;s unvested warrant</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrRiceSUnvestedWarrant' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mr. Rice&apos;s unvested warrant</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MrRiceSUnvestedWarrant' xlink:to='lab_fil_MrRiceSUnvestedWarrant'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleNotesPayable' xlink:label='us-gaap_ConvertibleNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConvertibleNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Convertible notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConvertibleNotesPayable' xlink:to='lab_us-gaap_ConvertibleNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyReceivedFunding4IndividualLoans' xlink:label='fil_CompanyReceivedFunding4IndividualLoans'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedFunding4IndividualLoans' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company received funding (4) individual loans</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyReceivedFunding4IndividualLoans' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company received funding (4) individual loans</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyReceivedFunding4IndividualLoans' xlink:to='lab_fil_CompanyReceivedFunding4IndividualLoans'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleD022PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -D 0.22 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -D 0.22 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockValueScheduleD022PerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' xlink:label='fil_AdvancedAmountOfConvertibleSecuredPromissoryNote'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advanced amount of Convertible Secured Promissory Note</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Advances of Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity&apos;s common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' xlink:to='lab_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcLoanedTheCompany' xlink:label='fil_HepInvestmentsLlcLoanedTheCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcLoanedTheCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>HEP Investments, LLC loaned the Company</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcLoanedTheCompany' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>HEP Investments, LLC loaned the Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_HepInvestmentsLlcLoanedTheCompany' xlink:to='lab_fil_HepInvestmentsLlcLoanedTheCompany'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' xlink:label='fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mr. Maggiore advanced the Company an additional amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mr. Maggiore advanced the Company an additional amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' xlink:to='lab_fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Property and Equipment {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Schedule of Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtAbstract' xlink:label='fil_DebtAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LOAN PAYABLE, RELATED PARTIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DebtAbstract' xlink:to='lab_fil_DebtAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DescriptionOfBusinessAbstract' xlink:label='fil_DescriptionOfBusinessAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DescriptionOfBusinessAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>DESCRIPTION OF BUSINESS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DescriptionOfBusinessAbstract' xlink:to='lab_fil_DescriptionOfBusinessAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash at Beginning of Period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Cash at Beginning of Period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Cash at End of Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet' xlink:label='us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationAmortizationAndAccretionNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationAmortizationAndAccretionNet' xlink:to='lab_us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StocksAndWarrantsIssuedForServicesRendered' xlink:label='fil_StocksAndWarrantsIssuedForServicesRendered'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StocksAndWarrantsIssuedForServicesRendered' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stocks and warrants issued for services rendered</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StocksAndWarrantsIssuedForServicesRendered' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StocksAndWarrantsIssuedForServicesRendered' xlink:to='lab_fil_StocksAndWarrantsIssuedForServicesRendered'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance1' xlink:label='fil_Balance1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued which are neither cancelled nor held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Balance1' xlink:to='lab_fil_Balance1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapitalMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional Paid in Capital {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapitalMember' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Additional Paid in Capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapitalMember' xlink:to='lab_us-gaap_AdditionalPaidInCapitalMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockMember' xlink:to='lab_us-gaap_CommonStockMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:label='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finance Costs Paid in Stocks and Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:to='lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome' xlink:label='us-gaap_OtherIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncome' xlink:to='lab_us-gaap_OtherIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated Deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableCurrent' xlink:label='us-gaap_LoansPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LoansPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loans Payable, Related Parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LoansPayableCurrent' xlink:to='lab_us-gaap_LoansPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Current Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_WarrantsToPurchaseSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsToPurchaseSharesOfCommonStock' xlink:to='lab_fil_WarrantsToPurchaseSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards' xlink:label='us-gaap_OperatingLossCarryforwards'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLossCarryforwards' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net-operating loss carry-forwards for Federal tax</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLossCarryforwards' xlink:to='lab_us-gaap_OperatingLossCarryforwards'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PartnerProvidesAtleastInCashOrInKindOutlays' xlink:label='fil_PartnerProvidesAtleastInCashOrInKindOutlays'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PartnerProvidesAtleastInCashOrInKindOutlays' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Partner provides atleast in cash or in-kind outlays</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PartnerProvidesAtleastInCashOrInKindOutlays' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Partner provides atleast in cash or in-kind outlays</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PartnerProvidesAtleastInCashOrInKindOutlays' xlink:to='lab_fil_PartnerProvidesAtleastInCashOrInKindOutlays'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice005' xlink:label='fil_ExercisePrice005'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice005' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.05</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice005' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.05</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice005' xlink:to='lab_fil_ExercisePrice005'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' xlink:label='fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' xlink:to='lab_fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange005InYears' xlink:label='fil_PriceRange005InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange005InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.05 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange005InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.05, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange005InYears' xlink:to='lab_fil_PriceRange005InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStock' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue' xlink:label='fil_IssuedSharesOfCommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Aggregate par or stated value of issued nonredeemable common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStockValue' xlink:to='lab_fil_IssuedSharesOfCommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteTranches14Through16Totaling' xlink:label='fil_ConvertiblePromissoryNoteTranches14Through16Totaling'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteTranches14Through16Totaling' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Promissory Note Tranches 14 through 16 Totaling</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteTranches14Through16Totaling' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Promissory Note Tranches 14 through 16 Totaling</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertiblePromissoryNoteTranches14Through16Totaling' xlink:to='lab_fil_ConvertiblePromissoryNoteTranches14Through16Totaling'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleB012PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule B 0.12 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule B 0.12 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockValueScheduleB012PerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdvanceAgreedUnderLoanAgreement1' xlink:label='fil_AdvanceAgreedUnderLoanAgreement1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvanceAgreedUnderLoanAgreement1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advance agreed under the loan agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AdvanceAgreedUnderLoanAgreement1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Advance agreed under loan agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AdvanceAgreedUnderLoanAgreement1' xlink:to='lab_fil_AdvanceAgreedUnderLoanAgreement1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AccruedInterestOnIndebtednessTotaled' xlink:label='fil_AccruedInterestOnIndebtednessTotaled'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterestOnIndebtednessTotaled' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued interest on indebtedness totaled</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccruedInterestOnIndebtednessTotaled' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Accrued interest on indebtedness totaled</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccruedInterestOnIndebtednessTotaled' xlink:to='lab_fil_AccruedInterestOnIndebtednessTotaled'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense' xlink:label='us-gaap_AdvertisingExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdvertisingExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advertising costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdvertisingExpense' xlink:to='lab_us-gaap_AdvertisingExpense'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BasisOfPresentationDetailsAbstract' xlink:label='fil_BasisOfPresentationDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BasisOfPresentationDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basis of Presentation Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BasisOfPresentationDetailsAbstract' xlink:to='lab_fil_BasisOfPresentationDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock' xlink:label='us-gaap_ConvertibleDebtTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConvertibleDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Convertible debt {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConvertibleDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Schedule of Convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConvertibleDebtTableTextBlock' xlink:to='lab_us-gaap_ConvertibleDebtTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockholdersDeficiency1Abstract' xlink:label='fil_StockholdersDeficiency1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockholdersDeficiency1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS&apos; DEFICIENCY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockholdersDeficiency1Abstract' xlink:to='lab_fil_StockholdersDeficiency1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract' xlink:label='us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentAbstract' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock' xlink:label='us-gaap_ProceedsFromSaleOfTreasuryStock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromSaleOfTreasuryStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from sale of common stock and exercise of warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromSaleOfTreasuryStock' xlink:to='lab_us-gaap_ProceedsFromSaleOfTreasuryStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flows from Investing Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants for services - related party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees, related parties as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:to='lab_fil_IssuanceOfWarrantsForServicesRelatedParty'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Table]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AmortizationOfDebtDiscountPremium' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of Deferred Finance Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AmortizationOfDebtDiscountPremium' xlink:to='lab_us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CURRENT LIABILITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SharesOfTheCompanySCommonStockValued' xlink:label='fil_SharesOfTheCompanySCommonStockValued'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfTheCompanySCommonStockValued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares of the Company&apos;s common stock valued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_SharesOfTheCompanySCommonStockValued' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Shares of the Company&apos;s common stock valued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SharesOfTheCompanySCommonStockValued' xlink:to='lab_fil_SharesOfTheCompanySCommonStockValued'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountRecordedOnTheCompanySBooks' xlink:label='fil_AmountRecordedOnTheCompanySBooks'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountRecordedOnTheCompanySBooks' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amount recorded on the Company&apos;s books</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountRecordedOnTheCompanySBooks' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount recorded on the Company&apos;s books</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmountRecordedOnTheCompanySBooks' xlink:to='lab_fil_AmountRecordedOnTheCompanySBooks'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalLiabilityOutOfTheGrossAmount' xlink:label='fil_TotalLiabilityOutOfTheGrossAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLiabilityOutOfTheGrossAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liability out of the gross amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalLiabilityOutOfTheGrossAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total liability out of the gross amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalLiabilityOutOfTheGrossAmount' xlink:to='lab_fil_TotalLiabilityOutOfTheGrossAmount'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice025' xlink:label='fil_ExercisePrice025'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice025' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.25</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice025' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.25</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice025' xlink:to='lab_fil_ExercisePrice025'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange022InYears' xlink:label='fil_PriceRange022InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange022InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.22 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange022InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.22, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange022InYears' xlink:to='lab_fil_PriceRange022InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange010' xlink:label='fil_PriceRange010'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange010' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.10</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange010' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.10</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange010' xlink:to='lab_fil_PriceRange010'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingEndOfPeriod' xlink:label='fil_OutstandingEndOfPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEndOfPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Outstanding End Of Period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OutstandingEndOfPeriod' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OutstandingEndOfPeriod' xlink:to='lab_fil_OutstandingEndOfPeriod'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue1' xlink:label='fil_IssuedSharesOfCommonStockValue1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock value {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued shares of common stock value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStockValue1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued shares of common stock value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStockValue1' xlink:to='lab_fil_IssuedSharesOfCommonStockValue1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotePayableNewLenders' xlink:label='fil_N11ConvertibleNotePayableNewLenders'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotePayableNewLenders' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>11% Convertible note payable - New Lenders</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotePayableNewLenders' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N11ConvertibleNotePayableNewLenders' xlink:to='lab_fil_N11ConvertibleNotePayableNewLenders'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' xlink:label='fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Value of the notes on which debt discount was recorded</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Value of the notes on which debt discount was recorded</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' xlink:to='lab_fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DueToRelatedPartyDetailsAbstract' xlink:label='fil_DueToRelatedPartyDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DueToRelatedPartyDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Due to Related Party Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DueToRelatedPartyDetailsAbstract' xlink:to='lab_fil_DueToRelatedPartyDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Expected volatility minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PotentiallyDilutiveSecuritiesAbstract' xlink:label='fil_PotentiallyDilutiveSecuritiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PotentiallyDilutiveSecuritiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Potentially dilutive securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PotentiallyDilutiveSecuritiesAbstract' xlink:to='lab_fil_PotentiallyDilutiveSecuritiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ScheduleOfPropertyAndEquipmentAbstract' xlink:label='fil_ScheduleOfPropertyAndEquipmentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfPropertyAndEquipmentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfPropertyAndEquipmentAbstract' xlink:to='lab_fil_ScheduleOfPropertyAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Taxes, Policy</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxPolicyTextBlock' xlink:to='lab_us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncomeTaxesAbstract' xlink:label='fil_IncomeTaxesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncomeTaxesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncomeTaxesAbstract' xlink:to='lab_fil_IncomeTaxesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BasisOfPresentationAbstract' xlink:label='fil_BasisOfPresentationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_BasisOfPresentationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIS OF PRESENTATION</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_BasisOfPresentationAbstract' xlink:to='lab_fil_BasisOfPresentationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>BASIC AND DILUTED LOSS PER SHARE</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDiluted' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet' xlink:label='us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discount on Convertible Debenture Payable Non-Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet' xlink:to='lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecordedLegalFees' xlink:label='fil_RecordedLegalFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecordedLegalFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recorded legal fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecordedLegalFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RecordedLegalFees' xlink:to='lab_fil_RecordedLegalFees'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PayToTheShareholderSLegalCounsel' xlink:label='fil_PayToTheShareholderSLegalCounsel'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PayToTheShareholderSLegalCounsel' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pay to the Shareholder&apos;s legal counsel</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PayToTheShareholderSLegalCounsel' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Pay to the Shareholder&apos;s legal counsel</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PayToTheShareholderSLegalCounsel' xlink:to='lab_fil_PayToTheShareholderSLegalCounsel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice019' xlink:label='fil_WeightedAverageExercisePrice019'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice019' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.19</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice019' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.19</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice019' xlink:to='lab_fil_WeightedAverageExercisePrice019'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalExercisableWarrants' xlink:label='fil_TotalExercisableWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalExercisableWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total exercisable warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalExercisableWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total exercisable warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalExercisableWarrants' xlink:to='lab_fil_TotalExercisableWarrants'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice022' xlink:label='fil_ExercisePrice022'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice022' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.22</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice022' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.22</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice022' xlink:to='lab_fil_ExercisePrice022'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange017InYears' xlink:label='fil_PriceRange017InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange017InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.17 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange017InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.17, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange017InYears' xlink:to='lab_fil_PriceRange017InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange030' xlink:label='fil_PriceRange030'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange030' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.30</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange030' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.30</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange030' xlink:to='lab_fil_PriceRange030'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceIssued' xlink:label='fil_WeightedAverageExercisePriceIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePriceIssued' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePriceIssued' xlink:to='lab_fil_WeightedAverageExercisePriceIssued'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock2' xlink:label='fil_IssuedSharesOfCommonStock2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued shares of common stock {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedSharesOfCommonStock2' xlink:to='lab_fil_IssuedSharesOfCommonStock2'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingWarrantsShallVestQuarterly' xlink:label='fil_RemainingWarrantsShallVestQuarterly'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingWarrantsShallVestQuarterly' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Remaining warrants shall vest quarterly</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingWarrantsShallVestQuarterly' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants remaining that shall vest quarterly.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RemainingWarrantsShallVestQuarterly' xlink:to='lab_fil_RemainingWarrantsShallVestQuarterly'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_GrantedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_GrantedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrantedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Granted warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrantedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants granted to purchase shares of common stock.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GrantedWarrantsToPurchaseSharesOfCommonStock' xlink:to='lab_fil_GrantedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' xlink:label='fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>11% Convertible notes payable unamortized discount HEP Investments, LLC</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' xlink:to='lab_fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LongTermPortion' xlink:label='fil_LongTermPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long term portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongTermPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongTermPortion' xlink:to='lab_fil_LongTermPortion'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LessCurrentPortion' xlink:label='fil_LessCurrentPortion'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less: Current portion</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LessCurrentPortion' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LessCurrentPortion' xlink:to='lab_fil_LessCurrentPortion'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteTotaling' xlink:label='fil_ConvertiblePromissoryNoteTotaling'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteTotaling' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Promissory Note Totaling</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePromissoryNoteTotaling' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Promissory Note Totaling</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertiblePromissoryNoteTotaling' xlink:to='lab_fil_ConvertiblePromissoryNoteTotaling'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' xlink:label='fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>The relative fair value of the warrants was calculated and recorded</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company valued the beneficial conversion feature and recorded the amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' xlink:to='lab_fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcDetailsAbstract' xlink:label='fil_HepInvestmentsLlcDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>HEP Investments, LLC Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Advance agreed under loan agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_HepInvestmentsLlcDetailsAbstract' xlink:to='lab_fil_HepInvestmentsLlcDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Risk free rate minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_STOCKHOLDERSWARRANTSAbstract' xlink:label='fil_STOCKHOLDERSWARRANTSAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_STOCKHOLDERSWARRANTSAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders Warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_STOCKHOLDERSWARRANTSAbstract' xlink:to='lab_fil_STOCKHOLDERSWARRANTSAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy' xlink:label='us-gaap_ResearchAndDevelopmentExpensePolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpensePolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and Development {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpensePolicy' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Research and Development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ResearchAndDevelopmentExpensePolicy' xlink:to='lab_us-gaap_ResearchAndDevelopmentExpensePolicy'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONVERTIBLE DEBT {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>CONVERTIBLE DEBT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtDisclosureTextBlock' xlink:to='lab_us-gaap_DebtDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet' xlink:label='us-gaap_InterestPaidNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaidNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaidNet' xlink:to='lab_us-gaap_InterestPaidNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalCashFlowInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Supplemental Disclosures of Cash Flow Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='lab_us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Decrease) in accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:label='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued on conversion of 11% Convertible Debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:to='lab_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses' xlink:label='us-gaap_CostsAndExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostsAndExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Costs and Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostsAndExpenses' xlink:to='lab_us-gaap_CostsAndExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS&apos; DEFICIT:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' xlink:label='fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock as financing cost related to the issuance of the 11% convertible debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Common stock as financing cost related to the issuance of the 11% convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' xlink:to='lab_fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnpaidPrincipal' xlink:label='fil_UnpaidPrincipal'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnpaidPrincipal' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unpaid principal</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnpaidPrincipal' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Unpaid principal</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnpaidPrincipal' xlink:to='lab_fil_UnpaidPrincipal'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecordedTheSettlementAmount' xlink:label='fil_RecordedTheSettlementAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecordedTheSettlementAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recorded the settlement amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RecordedTheSettlementAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Recorded the settlement amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RecordedTheSettlementAmount' xlink:to='lab_fil_RecordedTheSettlementAmount'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncreaseInTheValuationAllowance' xlink:label='fil_IncreaseInTheValuationAllowance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreaseInTheValuationAllowance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase in the valuation allowance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreaseInTheValuationAllowance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncreaseInTheValuationAllowance' xlink:to='lab_fil_IncreaseInTheValuationAllowance'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FederalAndStateStatutoryRate' xlink:label='fil_FederalAndStateStatutoryRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FederalAndStateStatutoryRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Federal and State Statutory Rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FederalAndStateStatutoryRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FederalAndStateStatutoryRate' xlink:to='lab_fil_FederalAndStateStatutoryRate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice008' xlink:label='fil_WeightedAverageExercisePrice008'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice008' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.08</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice008' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.05</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice008' xlink:to='lab_fil_WeightedAverageExercisePrice008'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange025InYears' xlink:label='fil_PriceRange025InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange025InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.25 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange025InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.25, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange025InYears' xlink:to='lab_fil_PriceRange025InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange020' xlink:label='fil_PriceRange020'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange020' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.20</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange020' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.20</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange020' xlink:to='lab_fil_PriceRange020'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange014' xlink:label='fil_PriceRange014'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange014' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.14</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange014' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.14</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange014' xlink:to='lab_fil_PriceRange014'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsExercised' xlink:label='fil_NumberOfWarrantsExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsExercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Exercised</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsExercised' xlink:to='lab_fil_NumberOfWarrantsExercised'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:label='fil_StockIssuancesInTheYear2015DetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issuances in the year 2015 Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='lab_fil_StockIssuancesInTheYear2015DetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockBasedCompensationAbstract' xlink:label='fil_StockBasedCompensationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockBasedCompensationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Based Compensation:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='lab_fil_StockBasedCompensationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' xlink:label='fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In addition, each director is entitled to receive each annual term served</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>In addition, each director is entitled to receive each annual term served</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' xlink:to='lab_fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' xlink:label='fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In addition, Mr. Rice entitled to receive for each annual term served</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount which Mr. Rice entitled to receive for each annual term served.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' xlink:to='lab_fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonReceivesACashFinanceFee' xlink:label='fil_PaulsonReceivesACashFinanceFee'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaulsonReceivesACashFinanceFee' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Paulson receives a cash finance fee</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaulsonReceivesACashFinanceFee' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Paulson receives a cash finance fee</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaulsonReceivesACashFinanceFee' xlink:to='lab_fil_PaulsonReceivesACashFinanceFee'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LenderConvertedTheDebt' xlink:label='fil_LenderConvertedTheDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LenderConvertedTheDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Lender Converted the debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LenderConvertedTheDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Lender Converted the debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LenderConvertedTheDebt' xlink:to='lab_fil_LenderConvertedTheDebt'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleNote2BearsInterestRate' xlink:label='fil_ConvertibleNote2BearsInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNote2BearsInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible note (2) bears interest rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNote2BearsInterestRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>ConvertibleNote2BearsInterestRate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNote2BearsInterestRate' xlink:to='lab_fil_ConvertibleNote2BearsInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Less accumulated depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:to='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FurnitureAndFixturesGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Furniture and fixtures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FurnitureAndFixturesGross' xlink:to='lab_us-gaap_FurnitureAndFixturesGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommitmentAndContingenciesAbstract' xlink:label='fil_CommitmentAndContingenciesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentAndContingenciesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommitmentAndContingenciesAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommitmentAndContingenciesAbstract' xlink:to='lab_fil_CommitmentAndContingenciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LOAN PAYABLE, RELATED PARTIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtTextBlock' xlink:to='lab_us-gaap_LongTermDebtTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flow from Financing Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to reconcile net income (loss) to net cash used in operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts' xlink:label='fil_CommonStockIssuedForFinancingCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued for financing costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockIssuedForFinancingCosts' xlink:to='lab_fil_CommonStockIssuedForFinancingCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract' xlink:label='us-gaap_NonoperatingIncomeExpenseAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NonoperatingIncomeExpenseAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OTHER INCOME (EXPENSE):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='lab_us-gaap_NonoperatingIncomeExpenseAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LOSS FROM OPERATIONS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DueToRelatedPartiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Due to Related Party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DueToRelatedPartiesCurrent' xlink:to='lab_us-gaap_DueToRelatedPartiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AnnualBaseSalary' xlink:label='fil_AnnualBaseSalary'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AnnualBaseSalary' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Annual base salary</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AnnualBaseSalary' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Annual base salary</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AnnualBaseSalary' xlink:to='lab_fil_AnnualBaseSalary'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice025' xlink:label='fil_WeightedAverageExercisePrice025'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice025' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.25</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice025' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.25</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice025' xlink:to='lab_fil_WeightedAverageExercisePrice025'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice014' xlink:label='fil_ExercisePrice014'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice014' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.14</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice014' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.14</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice014' xlink:to='lab_fil_ExercisePrice014'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange012InYears' xlink:label='fil_PriceRange012InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange012InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.12 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange012InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.12, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange012InYears' xlink:to='lab_fil_PriceRange012InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange022' xlink:label='fil_PriceRange022'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange022' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.22</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange022' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.22</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange022' xlink:to='lab_fil_PriceRange022'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrCoxSUnvestedWarrant' xlink:label='fil_MrCoxSUnvestedWarrant'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrCoxSUnvestedWarrant' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mr. Cox&apos;s unvested warrant</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrCoxSUnvestedWarrant' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mr. Cox&apos;s unvested warrant</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MrCoxSUnvestedWarrant' xlink:to='lab_fil_MrCoxSUnvestedWarrant'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsVestedOnTheGrantDate' xlink:label='fil_WarrantsVestedOnTheGrantDate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsVestedOnTheGrantDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants vested on the grant date</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsVestedOnTheGrantDate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants vested on the grant date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsVestedOnTheGrantDate' xlink:to='lab_fil_WarrantsVestedOnTheGrantDate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfDebtDiscounts' xlink:label='fil_AmortizationOfDebtDiscounts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfDebtDiscounts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of debt discounts</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfDebtDiscounts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizationOfDebtDiscounts' xlink:to='lab_fil_AmortizationOfDebtDiscounts'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' xlink:label='fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company recorded debt discount in the amount to reflect the beneficial conversion feature of the convertible debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company recorded debt discount in the amount to reflect the beneficial conversion feature of the convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' xlink:to='lab_fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalOutstandingBalanceOfAdvance' xlink:label='fil_TotalOutstandingBalanceOfAdvance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingBalanceOfAdvance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total outstanding balance of advance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingBalanceOfAdvance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total outstanding balance of advance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalOutstandingBalanceOfAdvance' xlink:to='lab_fil_TotalOutstandingBalanceOfAdvance'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetLoss1' xlink:label='fil_NetLoss1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Loss {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net Loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetLoss1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetLoss1' xlink:to='lab_fil_NetLoss1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTransactionsAbstract1' xlink:label='fil_RelatedPartyTransactionsAbstract1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionsAbstract1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RELATED PARTY TRANSACTIONS:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyTransactionsAbstract1' xlink:to='lab_fil_RelatedPartyTransactionsAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CONVERTIBLEDEBTAbstract' xlink:label='fil_CONVERTIBLEDEBTAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CONVERTIBLEDEBTAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CONVERTIBLE DEBT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CONVERTIBLEDEBTAbstract' xlink:to='lab_fil_CONVERTIBLEDEBTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfDeferredFinanceCosts' xlink:label='fil_AmortizationOfDeferredFinanceCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfDeferredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of deferred finance costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmortizationOfDeferredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmortizationOfDeferredFinanceCosts' xlink:to='lab_fil_AmortizationOfDeferredFinanceCosts'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices1' xlink:label='fil_IssuanceOfWarrantsForServices1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServices1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants for services {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServices1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance of warrants for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServices1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForServices1' xlink:to='lab_fil_IssuanceOfWarrantsForServices1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants to board of directors</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The value of warrants issued to board of directors during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:to='lab_fil_IssuanceOfWarrantsToBoardOfDirectors'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalUnitsMember' xlink:label='us-gaap_CapitalUnitsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CapitalUnitsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock Shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CapitalUnitsMember' xlink:to='lab_us-gaap_CapitalUnitsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Stockholders&apos; Deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Current Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SubsequentEventsDetailsAbstract' xlink:label='fil_SubsequentEventsDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SubsequentEventsDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent Events Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='lab_fil_SubsequentEventsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' xlink:label='fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant for shares upon upon the Company entering into a pharmaceutical development agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrant for shares upon upon the Company entering into a pharmaceutical development agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' xlink:to='lab_fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice017' xlink:label='fil_WeightedAverageExercisePrice017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.17</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.17</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice017' xlink:to='lab_fil_WeightedAverageExercisePrice017'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice005' xlink:label='fil_WeightedAverageExercisePrice005'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice005' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.05</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice005' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.05</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice005' xlink:to='lab_fil_WeightedAverageExercisePrice005'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisableWarrantsNumberAbstract' xlink:label='fil_ExercisableWarrantsNumberAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisableWarrantsNumberAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercisable Warrants Number</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisableWarrantsNumberAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='lab_fil_ExercisableWarrantsNumberAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange008InYears' xlink:label='fil_PriceRange008InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange008InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.08 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange008InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.08, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange008InYears' xlink:to='lab_fil_PriceRange008InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N1ConvertibleNotesPayableDueApril2016' xlink:label='fil_N1ConvertibleNotesPayableDueApril2016'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_N1ConvertibleNotesPayableDueApril2016' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>1% Convertible notes payable, due April 2016</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_N1ConvertibleNotesPayableDueApril2016' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>1% Convertible notes payable, due April 2016</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_N1ConvertibleNotesPayableDueApril2016' xlink:to='lab_fil_N1ConvertibleNotesPayableDueApril2016'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleE030PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -E 0.30 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -E 0.30 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockValueScheduleE030PerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MachineryAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MachineryAndEquipmentGross' xlink:to='lab_us-gaap_MachineryAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Expected dividends</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ProceedsFromIssuanceOfConvertibleDebentures' xlink:label='fil_ProceedsFromIssuanceOfConvertibleDebentures'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedsFromIssuanceOfConvertibleDebentures' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of convertible debentures</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedsFromIssuanceOfConvertibleDebentures' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity&apos;s common stock, at the option of the issuer or the holder</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProceedsFromIssuanceOfConvertibleDebentures' xlink:to='lab_fil_ProceedsFromIssuanceOfConvertibleDebentures'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FairValueOfWarrantsEstimatedTablesAbstract' xlink:label='fil_FairValueOfWarrantsEstimatedTablesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueOfWarrantsEstimatedTablesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value of Warrants Estimated (Tables):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueOfWarrantsEstimatedTablesAbstract' xlink:to='lab_fil_FairValueOfWarrantsEstimatedTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock' xlink:label='us-gaap_ShippingAndHandlingCostPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShippingAndHandlingCostPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shipping and Handling Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShippingAndHandlingCostPolicyTextBlock' xlink:to='lab_us-gaap_ShippingAndHandlingCostPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AccountingPolicies1Abstract' xlink:label='fil_AccountingPolicies1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccountingPolicies1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='lab_fil_AccountingPolicies1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>STOCKHOLDERS&apos; DEFICIENCY {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>STOCKHOLDERS&apos; DEFICIENCY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>DUE TO RELATED PARTY {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>DUE TO RELATED PARTY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:to='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromConvertibleDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of 11% convertible debentures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromConvertibleDebt' xlink:to='lab_us-gaap_ProceedsFromConvertibleDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (decrease) in accrued liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants for services - related party {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance of warrants for services - related party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees, related party as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:to='lab_fil_IssuanceOfWarrantsForServicesRelatedParty2'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flows from Operating Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NetIncome' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NetIncome' xlink:to='lab_fil_NetIncome'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance' xlink:label='fil_Balance'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Balance' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of shares issued which are neither cancelled nor held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Balance' xlink:to='lab_fil_Balance'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>WEIGHTED AVERAGE BASIC AND DILUTED SHARES OUTSTANDING</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:to='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NET INCOME (LOSS)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net Loss</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense' xlink:label='us-gaap_NonoperatingIncomeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NonoperatingIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Other Income (Expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='lab_us-gaap_NonoperatingIncomeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, $.001 par value, 450,000,000 shares authorized; 132,156,776 and 136,745,347 issued and outstanding at December 31, 2015 and 2016, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Payable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accounts Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TermInYears1' xlink:label='fil_TermInYears1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TermInYears1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Term in years</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TermInYears1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Term in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TermInYears1' xlink:to='lab_fil_TermInYears1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' xlink:label='fil_CompanyIssuedToTheLenderForAggregateConsiderationOf'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company issued to the Lender for aggregate consideration of</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company issued to the Lender for aggregate consideration of</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' xlink:to='lab_fil_CompanyIssuedToTheLenderForAggregateConsiderationOf'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' xlink:label='fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>HEP Investments LLC (&quot;Lender&quot;) funded an additional loan</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>HEP Investments LLC (&quot;Lender&quot;) funded an additional loan</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' xlink:to='lab_fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalOutstandingDebtAsOfMarch12017' xlink:label='fil_TotalOutstandingDebtAsOfMarch12017'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingDebtAsOfMarch12017' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total outstanding debt as of March 1, 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalOutstandingDebtAsOfMarch12017' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total outstanding debt as of March 1, 2017</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalOutstandingDebtAsOfMarch12017' xlink:to='lab_fil_TotalOutstandingDebtAsOfMarch12017'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:label='fil_SettlementOfLitigationRelatedPartyDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Settlement of Litigation - Related Party Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='lab_fil_SettlementOfLitigationRelatedPartyDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice022' xlink:label='fil_WeightedAverageExercisePrice022'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice022' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.22</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice022' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.22</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice022' xlink:to='lab_fil_WeightedAverageExercisePrice022'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice033' xlink:label='fil_ExercisePrice033'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice033' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.33</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice033' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.33</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice033' xlink:to='lab_fil_ExercisePrice033'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice019' xlink:label='fil_ExercisePrice019'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice019' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.19</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice019' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.19</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice019' xlink:to='lab_fil_ExercisePrice019'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange038' xlink:label='fil_PriceRange038'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange038' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.38</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange038' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.38</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange038' xlink:to='lab_fil_PriceRange038'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange009' xlink:label='fil_PriceRange009'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange009' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.09</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange009' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.09</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange009' xlink:to='lab_fil_PriceRange009'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsCancelled' xlink:label='fil_NumberOfWarrantsCancelled'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsCancelled' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants Cancelled</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsCancelled' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Cancelled</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsCancelled' xlink:to='lab_fil_NumberOfWarrantsCancelled'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsOutstanding1' xlink:label='fil_NumberOfWarrantsOutstanding1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsOutstanding1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of Warrants Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NumberOfWarrantsOutstanding1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NumberOfWarrantsOutstanding1' xlink:to='lab_fil_NumberOfWarrantsOutstanding1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:label='fil_StockIssuancesInTheYear2016DetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issuances in the year 2016 Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm&apos;s shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='lab_fil_StockIssuancesInTheYear2016DetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:to='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrPayneSUnvestedWarrant1' xlink:label='fil_MrPayneSUnvestedWarrant1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrPayneSUnvestedWarrant1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Mr. Payne&apos;s unvested warrant</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_MrPayneSUnvestedWarrant1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Mr. Payne&apos;s unvested warrant</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_MrPayneSUnvestedWarrant1' xlink:to='lab_fil_MrPayneSUnvestedWarrant1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePricePerShare' xlink:label='fil_ExercisePricePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise price per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePricePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Exercise price per share.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePricePerShare' xlink:to='lab_fil_ExercisePricePerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CashFinanceFee' xlink:label='fil_CashFinanceFee'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashFinanceFee' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash finance fee</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CashFinanceFee' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Cash finance fee</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CashFinanceFee' xlink:to='lab_fil_CashFinanceFee'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FairValueOfWarrantsEstimatedTablesTextBlock' xlink:label='fil_FairValueOfWarrantsEstimatedTablesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueOfWarrantsEstimatedTablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value of Warrants Estimated (Tables)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueOfWarrantsEstimatedTablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueOfWarrantsEstimatedTablesTextBlock' xlink:to='lab_fil_FairValueOfWarrantsEstimatedTablesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock' xlink:label='us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenueRecognitionPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue Recognition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenueRecognitionPolicyTextBlock' xlink:to='lab_us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SUBSEQUENT EVENTS {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>SUBSEQUENT EVENTS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock' xlink:label='us-gaap_LegalMattersAndContingenciesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LegalMattersAndContingenciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SETTLEMENT OF LITIGATION - RELATED PARTY {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LegalMattersAndContingenciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>SETTLEMENT OF LITIGATION - RELATED PARTY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LegalMattersAndContingenciesTextBlock' xlink:to='lab_us-gaap_LegalMattersAndContingenciesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>INCOME TAXES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxDisclosureTextBlock' xlink:to='lab_us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash (Used) in Investing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount' xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentUnamortizedDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discount on Convertible Debenture Payable Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentUnamortizedDiscount' xlink:to='lab_us-gaap_DebtInstrumentUnamortizedDiscount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' xlink:label='fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Notes accrue interest at the rate per annum</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Convertible Notes accrue interest at the rate per annum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' xlink:to='lab_fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RestructuringAndLegalFees' xlink:label='fil_RestructuringAndLegalFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RestructuringAndLegalFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Restructuring and legal fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RestructuringAndLegalFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RestructuringAndLegalFees' xlink:to='lab_fil_RestructuringAndLegalFees'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponIdentificationOfBioActiveAgents' xlink:label='fil_WarrantForSharesUponIdentificationOfBioActiveAgents'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponIdentificationOfBioActiveAgents' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant for shares upon identification of bio-active agents</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponIdentificationOfBioActiveAgents' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrant for shares upon identification of bio-active agents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantForSharesUponIdentificationOfBioActiveAgents' xlink:to='lab_fil_WarrantForSharesUponIdentificationOfBioActiveAgents'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice033' xlink:label='fil_WeightedAverageExercisePrice033'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice033' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.33</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice033' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.33</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice033' xlink:to='lab_fil_WeightedAverageExercisePrice033'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange030InYears' xlink:label='fil_PriceRange030InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange030InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.30 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange030InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.30, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange030InYears' xlink:to='lab_fil_PriceRange030InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange019InYears' xlink:label='fil_PriceRange019InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange019InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.19 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange019InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.19, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange019InYears' xlink:to='lab_fil_PriceRange019InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange019' xlink:label='fil_PriceRange019'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange019' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.19</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange019' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.19</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange019' xlink:to='lab_fil_PriceRange019'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued warrants to purchase shares of common stock at an exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:to='lab_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfSharesOfCommonStock' xlink:label='fil_IssuanceOfSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issuance of shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfSharesOfCommonStock' xlink:to='lab_fil_IssuanceOfSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:label='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible debt consists of the following</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='lab_fil_ConvertibleDebtConsistsOfTheFollowing1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NewLendersAdvancedPaulsonNotesInterestRate' xlink:label='fil_NewLendersAdvancedPaulsonNotesInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NewLendersAdvancedPaulsonNotesInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>New Lenders advanced Paulson Notes, interest rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NewLendersAdvancedPaulsonNotesInterestRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>New Lenders advanced Paulson Notes, interest rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NewLendersAdvancedPaulsonNotesInterestRate' xlink:to='lab_fil_NewLendersAdvancedPaulsonNotesInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonInvestmentRelatedDebtAbstract' xlink:label='fil_PaulsonInvestmentRelatedDebtAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaulsonInvestmentRelatedDebtAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Paulson Investment Related Debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='lab_fil_PaulsonInvestmentRelatedDebtAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' xlink:label='fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loans were converted to Convertible Secured Promissory Notes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Loans were converted to Convertible Secured Promissory Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' xlink:to='lab_fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountAdvancedByOfficers' xlink:label='fil_AmountAdvancedByOfficers'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountAdvancedByOfficers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amount advanced by Officers</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AmountAdvancedByOfficers' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount advanced by Officers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AmountAdvancedByOfficers' xlink:to='lab_fil_AmountAdvancedByOfficers'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PropertyAndEquipmentDepreciationAbstract' xlink:label='fil_PropertyAndEquipmentDepreciationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentDepreciationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment Depreciation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentDepreciationAbstract' xlink:to='lab_fil_PropertyAndEquipmentDepreciationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PropertyAndEquipmentDetailsAbstract' xlink:label='fil_PropertyAndEquipmentDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyAndEquipmentDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='lab_fil_PropertyAndEquipmentDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsOutstandingAndExercisableTableTextBlock' xlink:label='fil_WarrantsOutstandingAndExercisableTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsOutstandingAndExercisableTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants outstanding and exercisable (Tables)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsOutstandingAndExercisableTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular Disclosure for Warrants outstanding and exercisable.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsOutstandingAndExercisableTableTextBlock' xlink:to='lab_fil_WarrantsOutstandingAndExercisableTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Esimates</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock' xlink:label='us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>OTHER INCOME (EXPENSE)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock' xlink:to='lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StocksAndWarrantsIssuedForFinancingCosts' xlink:label='fil_StocksAndWarrantsIssuedForFinancingCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StocksAndWarrantsIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stocks and warrants issued for financing costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StocksAndWarrantsIssuedForFinancingCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Stocks and warrants issued for financing costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StocksAndWarrantsIssuedForFinancingCosts' xlink:to='lab_fil_StocksAndWarrantsIssuedForFinancingCosts'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts1' xlink:label='fil_CommonStockIssuedForFinancingCosts1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued for financing costs {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Common stock issued for financing costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockIssuedForFinancingCosts1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants issued for financing costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockIssuedForFinancingCosts1' xlink:to='lab_fil_CommonStockIssuedForFinancingCosts1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseRelatedParty' xlink:label='us-gaap_InterestExpenseRelatedParty'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpenseRelatedParty' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Expense - Related Parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpenseRelatedParty' xlink:to='lab_us-gaap_InterestExpenseRelatedParty'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>General and Administrative</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_GeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Long Term Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrent' xlink:to='lab_us-gaap_LiabilitiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtCurrent' xlink:label='us-gaap_ConvertibleDebtCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConvertibleDebtCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Debentures Payable, less discount of $385,190 and $500,490 at December 31, 2015 and 2016, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConvertibleDebtCurrent' xlink:to='lab_us-gaap_ConvertibleDebtCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' xlink:label='fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>On February 27, 2017, the Company issued warrants to purchase shares of common stock at an exercise price of $.10</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>On February 27, 2017, the Company issued warrants to purchase shares of common stock at an exercise price of $.10</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' xlink:to='lab_fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' xlink:label='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrant for shares upon the Company entering into a co-development agreement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrant for shares upon the Company entering into a co-development agreement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' xlink:to='lab_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' xlink:label='fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Percent of Company&apos;s revenue that Mr. Dahl entitled to receive as monthy bonus compensation</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Percent of Company&apos;s revenue that Mr. Dahl entitled to receive as monthy bonus compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' xlink:to='lab_fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalExercisableWarrantsWeightedAverageExercisePrice' xlink:label='fil_TotalExercisableWarrantsWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalExercisableWarrantsWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Exercisable Warrants Weighted Average Exercise Price:</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TotalExercisableWarrantsWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total Exercisable Warrants Weighted Average Exercise Price:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TotalExercisableWarrantsWeightedAverageExercisePrice' xlink:to='lab_fil_TotalExercisableWarrantsWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice009' xlink:label='fil_WeightedAverageExercisePrice009'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice009' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.09</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice009' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.09</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice009' xlink:to='lab_fil_WeightedAverageExercisePrice009'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice015' xlink:label='fil_ExercisePrice015'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice015' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise Price 0.15</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisePrice015' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.15</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisePrice015' xlink:to='lab_fil_ExercisePrice015'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange033' xlink:label='fil_PriceRange033'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange033' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.33</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange033' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.33</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange033' xlink:to='lab_fil_PriceRange033'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange005' xlink:label='fil_PriceRange005'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange005' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.05</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange005' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.05</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange005' xlink:to='lab_fil_PriceRange005'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Compensation for serving as Chief Financial Officer issued warrants to purchase shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Compensation for serving as Chief Financial Officer issued warrants to purchase shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' xlink:to='lab_fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model {2}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants were valued at using the Black Scholes pricing model</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:to='lab_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' xlink:label='fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Received proceeds from the issuance of shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Received proceeds from the issuance of shares of common stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' xlink:to='lab_fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtIsConvertiblePerShare' xlink:label='fil_DebtIsConvertiblePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtIsConvertiblePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt is convertible per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DebtIsConvertiblePerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Debt is convertible per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DebtIsConvertiblePerShare' xlink:to='lab_fil_DebtIsConvertiblePerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' xlink:label='fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company shall be required to pay a prepayment premium equal to the amount repaid</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Lender Converted the debt per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' xlink:to='lab_fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleC015PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -C 0.15 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company &apos;s Restricted Common stock value- schedule -C 0.15 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockValueScheduleC015PerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Risk free rate maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageAssumptionsAbstract' xlink:label='fil_WeightedAverageAssumptionsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageAssumptionsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average assumptions:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='lab_fil_WeightedAverageAssumptionsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk' xlink:label='us-gaap_ConcentrationRiskCreditRisk'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConcentrationRiskCreditRisk' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Concentrations of Credit Risk</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConcentrationRiskCreditRisk' xlink:to='lab_us-gaap_ConcentrationRiskCreditRisk'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (Decrease) in Cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by Financing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DeferredFinanceCosts' xlink:label='fil_DeferredFinanceCosts'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Finance Costs</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredFinanceCosts' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeferredFinanceCosts' xlink:to='lab_fil_DeferredFinanceCosts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties' xlink:label='us-gaap_IncreaseDecreaseInDueFromRelatedParties'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase in due to related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInDueFromRelatedParties' xlink:to='lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors1'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants to board of directors {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Issuance of warrants to board of directors</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The value of warrants issued to board of directors during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:to='lab_fil_IssuanceOfWarrantsToBoardOfDirectors1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and Development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ResearchAndDevelopmentExpense' xlink:to='lab_us-gaap_ResearchAndDevelopmentExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>REVENUES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:label='us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Parentheticals</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies' xlink:label='us-gaap_CommitmentsAndContingencies'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingencies' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COMMITMENTS AND CONTINGENCIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingencies' xlink:to='lab_us-gaap_CommitmentsAndContingencies'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract' xlink:label='us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LONG TERM LIABILITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' xlink:label='fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issued 11% convertible note and warrants to purchase shares at exercise price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Issued 11% convertible note and warrants to purchase shares at exercise price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' xlink:to='lab_fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OtherIncomeExpenseDetailsAbstract' xlink:label='fil_OtherIncomeExpenseDetailsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherIncomeExpenseDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Income (Expense) Details</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherIncomeExpenseDetailsAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Annual base salary</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherIncomeExpenseDetailsAbstract' xlink:to='lab_fil_OtherIncomeExpenseDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice038' xlink:label='fil_WeightedAverageExercisePrice038'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice038' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Exercise Price 0.38</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageExercisePrice038' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants exercisable at Price 0.38</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageExercisePrice038' xlink:to='lab_fil_WeightedAverageExercisePrice038'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:label='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercisable Warrants Weighted Average Exercise Price:</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total exercisable warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='lab_fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange038InYears' xlink:label='fil_PriceRange038InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange038InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.38 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange038InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.38, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange038InYears' xlink:to='lab_fil_PriceRange038InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange014InYears' xlink:label='fil_PriceRange014InYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange014InYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.14 (in years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange014InYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.14, contractual life in years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange014InYears' xlink:to='lab_fil_PriceRange014InYears'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange025' xlink:label='fil_PriceRange025'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange025' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price range 0.25</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRange025' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of Warrants Outstanding at Price range 0.25</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRange025' xlink:to='lab_fil_PriceRange025'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' xlink:label='fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In addition, Mr. Rondeau entitled to receive for each annual term served</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>The amount which Mr. Rondeau entitled to receive for each annual term served.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' xlink:to='lab_fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingWarrants' xlink:label='fil_RemainingWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Remaining warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RemainingWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of warrants remaining</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RemainingWarrants' xlink:to='lab_fil_RemainingWarrants'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockPerShare' xlink:label='fil_CompanySRestrictedCommonStockPerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockPerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company&apos;s restricted common stock per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySRestrictedCommonStockPerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company&apos;s restricted common stock per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySRestrictedCommonStockPerShare' xlink:to='lab_fil_CompanySRestrictedCommonStockPerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' xlink:label='fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Related Party, the Lender reduced the principal of the debt at $.12 per share</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Related Party, the Lender reduced the principal of the debt at $.12 per share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' xlink:to='lab_fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' xlink:label='fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company valued the beneficial conversion feature as an addition to paid-in capital</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company valued the beneficial conversion feature as an addition to paid-in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' xlink:to='lab_fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyAgreedToPayInterestOnLoan' xlink:label='fil_CompanyAgreedToPayInterestOnLoan'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAgreedToPayInterestOnLoan' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company agreed to pay interest on loan</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyAgreedToPayInterestOnLoan' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company agreed to pay interest on loan</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyAgreedToPayInterestOnLoan' xlink:to='lab_fil_CompanyAgreedToPayInterestOnLoan'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' xlink:label='fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company owed HEP Investments, a related party, cumulative balances</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Company owed HEP Investments, a related party, cumulative balances</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' xlink:to='lab_fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock' xlink:label='us-gaap_AdvertisingCostsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdvertisingCostsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Advertising Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdvertisingCostsPolicyTextBlock' xlink:to='lab_us-gaap_AdvertisingCostsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SignificantAccountingPoliciesTextBlock' xlink:to='lab_us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' xlink:label='fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' xlink:to='lab_fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForDirectorsFees' xlink:label='fil_WarrantsIssuedForDirectorsFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForDirectorsFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warrants issued for Directors&apos; Fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantsIssuedForDirectorsFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Warrants issued for Directors&apos; Fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantsIssuedForDirectorsFees' xlink:to='lab_fil_WarrantsIssuedForDirectorsFees'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:label='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of common stock and warrants pursuant to private placements</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Number of</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:to='lab_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices' xlink:label='fil_IssuanceOfWarrantsForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForServices' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForServices' xlink:to='lab_fil_IssuanceOfWarrantsForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityComponentDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Component</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityComponentDomain' xlink:to='lab_us-gaap_EquityComponentDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementEquityComponentsAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Components [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='lab_us-gaap_StatementEquityComponentsAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees' xlink:label='us-gaap_ProfessionalFees'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfessionalFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Professional Fees and Consulting Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProfessionalFees' xlink:to='lab_us-gaap_ProfessionalFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional Paid-In Capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent' xlink:label='us-gaap_InterestPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued Interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPayableCurrent' xlink:to='lab_us-gaap_InterestPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>PROPERTY AND EQUIPMENT, NET</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>zivo-20161231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.zivobioscience.com/20161231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_TradingSymbol' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentType' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDBALANCESHEET"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Cash' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent' xlink:label='us-gaap_PrepaidExpenseCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PrepaidExpenseCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsAbstract' xlink:label='us-gaap_OtherAssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_OtherAssetsAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFinanceCostsNet' xlink:label='us-gaap_DeferredFinanceCostsNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherAssetsAbstract' xlink:to='us-gaap_DeferredFinanceCostsNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_Assets' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableCurrent' xlink:label='us-gaap_LoansPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LoansPayableCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtCurrent' xlink:label='us-gaap_ConvertibleDebtCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_ConvertibleDebtCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent' xlink:label='us-gaap_InterestPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_InterestPayableCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent' xlink:label='us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_OtherAccruedLiabilitiesCurrent' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract' xlink:label='us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesNoncurrentAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent' xlink:label='us-gaap_ConvertibleDebtNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='us-gaap_ConvertibleDebtNoncurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='us-gaap_LiabilitiesNoncurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies' xlink:label='us-gaap_CommitmentsAndContingencies'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_CommitmentsAndContingencies' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:label='us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount' xlink:label='us-gaap_DebtInstrumentUnamortizedDiscount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_DebtInstrumentUnamortizedDiscount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet' xlink:label='us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract' xlink:label='us-gaap_RevenuesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_Revenues' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees' xlink:label='us-gaap_ProfessionalFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ProfessionalFees' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses' xlink:label='us-gaap_CostsAndExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_CostsAndExpenses' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract' xlink:label='us-gaap_NonoperatingIncomeExpenseAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_NonoperatingIncomeExpenseAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome' xlink:label='us-gaap_OtherIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_OtherIncome' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments' xlink:label='us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_AmortizationOfDebtDiscountPremium' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfFinancingCosts' xlink:label='us-gaap_PaymentsOfFinancingCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_PaymentsOfFinancingCosts' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:label='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseRelatedParty' xlink:label='us-gaap_InterestExpenseRelatedParty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_InterestExpenseRelatedParty' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense' xlink:label='us-gaap_NonoperatingIncomeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_NonoperatingIncomeExpense' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_EarningsPerShareBasicAndDiluted' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ChangesInEquityAbstract' xlink:label='fil_ChangesInEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ChangesInEquityAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalUnitsMember' xlink:label='us-gaap_CapitalUnitsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CapitalUnitsMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_AdditionalPaidInCapitalMember' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_RetainedEarningsMember' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding' xlink:label='us-gaap_SharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesOutstanding' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance' xlink:label='fil_Balance'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance1' xlink:label='fil_Balance1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance1' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding' xlink:label='us-gaap_SharesOutstanding_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesOutstanding_1' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsToBoardOfDirectors' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices' xlink:label='fil_IssuanceOfWarrantsForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServices' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServicesRelatedParty' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' xlink:label='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' xlink:label='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' xlink:label='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountsOnIssuanceOfConvertibleDebentures' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts' xlink:label='fil_WarrantsIssuedForFinancingCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsIssuedForFinancingCosts' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts' xlink:label='fil_CommonStockIssuedForFinancingCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedForFinancingCosts' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetIncome' xlink:label='fil_NetIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetIncome' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance' xlink:label='fil_Balance_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance_1' use='optional' order='16.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsToBoardOfDirectors1' xlink:label='fil_IssuanceOfWarrantsToBoardOfDirectors1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsToBoardOfDirectors1' use='optional' order='17.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServices1' xlink:label='fil_IssuanceOfWarrantsForServices1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServices1' use='optional' order='18.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty1' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfWarrantsForServicesRelatedParty1' use='optional' order='19.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfCommonStockForServices' xlink:label='fil_IssuanceOfCommonStockForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IssuanceOfCommonStockForServices' use='optional' order='20.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DiscountsOnIssuanceOfConvertibleDebentures1' xlink:label='fil_DiscountsOnIssuanceOfConvertibleDebentures1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountsOnIssuanceOfConvertibleDebentures1' use='optional' order='21.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForFinancingCosts1' xlink:label='fil_WarrantsIssuedForFinancingCosts1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WarrantsIssuedForFinancingCosts1' use='optional' order='22.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockIssuedForFinancingCosts1' xlink:label='fil_CommonStockIssuedForFinancingCosts1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockIssuedForFinancingCosts1' use='optional' order='23.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetLoss' xlink:label='fil_NetLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NetLoss' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Balance1' xlink:label='fil_Balance1_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_Balance1_1' use='optional' order='25.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StocksAndWarrantsIssuedForServicesRendered' xlink:label='fil_StocksAndWarrantsIssuedForServicesRendered'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StocksAndWarrantsIssuedForServicesRendered' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfWarrantsForServicesRelatedParty2' xlink:label='fil_IssuanceOfWarrantsForServicesRelatedParty2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_IssuanceOfWarrantsForServicesRelatedParty2' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsIssuedForDirectorsFees' xlink:label='fil_WarrantsIssuedForDirectorsFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_WarrantsIssuedForDirectorsFees' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StocksAndWarrantsIssuedForFinancingCosts' xlink:label='fil_StocksAndWarrantsIssuedForFinancingCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StocksAndWarrantsIssuedForFinancingCosts' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfDeferredFinanceCosts' xlink:label='fil_AmortizationOfDeferredFinanceCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_AmortizationOfDeferredFinanceCosts' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfBondDiscount' xlink:label='fil_AmortizationOfBondDiscount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_AmortizationOfBondDiscount' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet' xlink:label='us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DepreciationAmortizationAndAccretionNet' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense' xlink:label='us-gaap_IncreaseDecreaseInPrepaidExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInPrepaidExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties' xlink:label='us-gaap_IncreaseDecreaseInDueFromRelatedParties'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInDueFromRelatedParties' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet' xlink:label='us-gaap_IncreaseDecreaseInInterestPayableNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInInterestPayableNet' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties' xlink:label='us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DeferredFinanceCosts' xlink:label='fil_DeferredFinanceCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='fil_DeferredFinanceCosts' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt' xlink:label='us-gaap_ProceedsFromConvertibleDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromConvertibleDebt' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock' xlink:label='us-gaap_ProceedsFromSaleOfTreasuryStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromSaleOfTreasuryStock' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='9.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue_1' use='optional' order='10.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_SupplementalCashFlowInformationAbstract' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CashPaidDuringThePeriodForAbstract' xlink:label='fil_CashPaidDuringThePeriodForAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='fil_CashPaidDuringThePeriodForAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet' xlink:label='us-gaap_InterestPaidNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CashPaidDuringThePeriodForAbstract' xlink:to='us-gaap_InterestPaidNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid' xlink:label='us-gaap_IncomeTaxesPaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CashPaidDuringThePeriodForAbstract' xlink:to='us-gaap_IncomeTaxesPaid' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureDESCRIPTIONOFBUSINESS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DescriptionOfBusinessAbstract' xlink:label='fil_DescriptionOfBusinessAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:label='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DescriptionOfBusinessAbstract' xlink:to='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureBASISOFPRESENTATION"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BasisOfPresentationAbstract' xlink:label='fil_BasisOfPresentationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationAbstract' xlink:to='us-gaap_BasisOfAccounting' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' xlink:label='fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' xlink:to='us-gaap_SignificantAccountingPoliciesTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosurePROPERTYANDEQUIPMENT"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract' xlink:label='us-gaap_PropertyPlantAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureDUETORELATEDPARTY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyDisclosuresAbstract' xlink:label='fil_RelatedPartyDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RelatedPartyDisclosuresAbstract' xlink:to='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureLOANPAYABLERELATEDPARTIES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtAbstract' xlink:label='fil_DebtAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DebtAbstract' xlink:to='us-gaap_LongTermDebtTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureCONVERTIBLEDEBT"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CONVERTIBLEDEBTAbstract' xlink:label='fil_CONVERTIBLEDEBTAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CONVERTIBLEDEBTAbstract' xlink:to='us-gaap_DebtDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSTOCKHOLDERSDEFICIENCY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockholdersDeficiency1Abstract' xlink:label='fil_StockholdersDeficiency1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockholdersDeficiency1Abstract' xlink:to='us-gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureOTHERINCOMEEXPENSE"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OtherIncomeAndExpensesAbstract1' xlink:label='fil_OtherIncomeAndExpensesAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock' xlink:label='us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OtherIncomeAndExpensesAbstract1' xlink:to='us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureCOMMITMENTSANDCONTINGENCIES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommitmentAndContingenciesAbstract' xlink:label='fil_CommitmentAndContingenciesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CommitmentAndContingenciesAbstract' xlink:to='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureRELATEDPARTYTRANSACTIONS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTransactionsAbstract1' xlink:label='fil_RelatedPartyTransactionsAbstract1'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTransactionsTextBlock' xlink:label='fil_RelatedPartyTransactionsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RelatedPartyTransactionsAbstract1' xlink:to='fil_RelatedPartyTransactionsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureINCOMETAXES"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncomeTaxesAbstract' xlink:label='fil_IncomeTaxesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxesAbstract' xlink:to='us-gaap_IncomeTaxDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementOfLitigationRelatedPartyAbstract' xlink:label='fil_SettlementOfLitigationRelatedPartyAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock' xlink:label='us-gaap_LegalMattersAndContingenciesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyAbstract' xlink:to='us-gaap_LegalMattersAndContingenciesTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureSUBSEQUENTEVENTS"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract' xlink:label='us-gaap_SubsequentEventsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SubsequentEventsAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureAccountingPoliciesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AccountingPolicies1Abstract' xlink:label='fil_AccountingPolicies1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_ConsolidationPolicyTextBlock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_CashAndCashEquivalentsPolicyTextBlock' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock' xlink:label='us-gaap_DeferredChargesPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_DeferredChargesPolicyTextBlock' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock' xlink:label='us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_RevenueRecognitionPolicyTextBlock' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock' xlink:label='us-gaap_ShippingAndHandlingCostPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_ShippingAndHandlingCostPolicyTextBlock' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy' xlink:label='us-gaap_ResearchAndDevelopmentExpensePolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_ResearchAndDevelopmentExpensePolicy' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_IncomeTaxPolicyTextBlock' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock' xlink:label='us-gaap_CompensationRelatedCostsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_CompensationRelatedCostsPolicyTextBlock' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_EarningsPerSharePolicyTextBlock' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock' xlink:label='us-gaap_AdvertisingCostsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_AdvertisingCostsPolicyTextBlock' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk' xlink:label='us-gaap_ConcentrationRiskCreditRisk'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_ConcentrationRiskCreditRisk' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:label='us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_PriorPeriodReclassificationAdjustmentDescription' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_AccountingPolicies1Abstract' xlink:to='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureFairValueOfWarrantsEstimatedTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FairValueOfWarrantsEstimatedTablesAbstract' xlink:label='fil_FairValueOfWarrantsEstimatedTablesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FairValueOfWarrantsEstimatedTablesTextBlock' xlink:label='fil_FairValueOfWarrantsEstimatedTablesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_FairValueOfWarrantsEstimatedTablesAbstract' xlink:to='fil_FairValueOfWarrantsEstimatedTablesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureScheduleOfPropertyAndEquipmentTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ScheduleOfPropertyAndEquipmentAbstract' xlink:label='fil_ScheduleOfPropertyAndEquipmentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ScheduleOfPropertyAndEquipmentAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureScheduleOfConvertibleDebtTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' xlink:label='fil_ScheduleOfConvertibleDebtTableTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock' xlink:label='us-gaap_ConvertibleDebtTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' xlink:to='us-gaap_ConvertibleDebtTableTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DisclosureStockholdersWarrantsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_STOCKHOLDERSWARRANTSAbstract' xlink:label='fil_STOCKHOLDERSWARRANTSAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' xlink:label='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_STOCKHOLDERSWARRANTSAbstract' xlink:to='us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsOutstandingAndExercisableTableTextBlock' xlink:label='fil_WarrantsOutstandingAndExercisableTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_STOCKHOLDERSWARRANTSAbstract' xlink:to='fil_WarrantsOutstandingAndExercisableTableTextBlock' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_BasisOfPresentationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BasisOfPresentationDetailsAbstract' xlink:label='fil_BasisOfPresentationDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NetLoss1' xlink:label='fil_NetLoss1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationDetailsAbstract' xlink:to='fil_NetLoss1' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WorkingCapitalDeficiency1' xlink:label='fil_WorkingCapitalDeficiency1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationDetailsAbstract' xlink:to='fil_WorkingCapitalDeficiency1' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockholdersDeficiency' xlink:label='fil_StockholdersDeficiency'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationDetailsAbstract' xlink:to='fil_StockholdersDeficiency' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ProceedsFromIssuanceOfConvertibleDebentures' xlink:label='fil_ProceedsFromIssuanceOfConvertibleDebentures'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BasisOfPresentationDetailsAbstract' xlink:to='fil_ProceedsFromIssuanceOfConvertibleDebentures' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:label='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ResearchAndDevelopmentCosts' xlink:label='fil_ResearchAndDevelopmentCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:to='fil_ResearchAndDevelopmentCosts' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockBasedCompensationExpense' xlink:label='fil_StockBasedCompensationExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:to='fil_StockBasedCompensationExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PotentiallyDilutiveSecuritiesAbstract' xlink:label='fil_PotentiallyDilutiveSecuritiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' xlink:to='fil_PotentiallyDilutiveSecuritiesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' xlink:label='fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PotentiallyDilutiveSecuritiesAbstract' xlink:to='fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonSharesFromOutstandingWarrants' xlink:label='fil_CommonSharesFromOutstandingWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PotentiallyDilutiveSecuritiesAbstract' xlink:to='fil_CommonSharesFromOutstandingWarrants' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense' xlink:label='us-gaap_AdvertisingExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PotentiallyDilutiveSecuritiesAbstract' xlink:to='us-gaap_AdvertisingExpense' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' xlink:label='fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PotentiallyDilutiveSecuritiesAbstract' xlink:to='fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_FairValueAssumptionsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageAssumptionsAbstract' xlink:label='fil_WeightedAverageAssumptionsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageAssumptionsAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PropertyAndEquipmentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PropertyAndEquipmentDetailsAbstract' xlink:label='fil_PropertyAndEquipmentDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross' xlink:label='us-gaap_FurnitureAndFixturesGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='us-gaap_FurnitureAndFixturesGross' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDetailsAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PropertyAndEquipmentDepreciationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PropertyAndEquipmentDepreciationAbstract' xlink:label='fil_PropertyAndEquipmentDepreciationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PropertyAndEquipmentDepreciationAbstract' xlink:to='us-gaap_Depreciation' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DueToRelatedPartyDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DueToRelatedPartyDetailsAbstract' xlink:label='fil_DueToRelatedPartyDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' xlink:label='fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DueToRelatedPartyDetailsAbstract' xlink:to='fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CashFinanceFee' xlink:label='fil_CashFinanceFee'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DueToRelatedPartyDetailsAbstract' xlink:to='fil_CashFinanceFee' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyIncurredFinanceCosts' xlink:label='fil_CompanyIncurredFinanceCosts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DueToRelatedPartyDetailsAbstract' xlink:to='fil_CompanyIncurredFinanceCosts' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_LoanPayableRelatedPartiesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:label='fil_LoanPayableRelatedPartiesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountAdvancedByChrisMaggioreASignificantShareholder' xlink:label='fil_AmountAdvancedByChrisMaggioreASignificantShareholder'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_AmountAdvancedByChrisMaggioreASignificantShareholder' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' xlink:label='fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalOutstandingBalanceOfAdvance' xlink:label='fil_TotalOutstandingBalanceOfAdvance'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_TotalOutstandingBalanceOfAdvance' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyAgreedToPayInterestOnLoan' xlink:label='fil_CompanyAgreedToPayInterestOnLoan'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_CompanyAgreedToPayInterestOnLoan' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AccruedInterestOnIndebtednessTotaled' xlink:label='fil_AccruedInterestOnIndebtednessTotaled'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_AccruedInterestOnIndebtednessTotaled' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountAdvancedByOfficers' xlink:label='fil_AmountAdvancedByOfficers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_AmountAdvancedByOfficers' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcLoanedTheCompany' xlink:label='fil_HepInvestmentsLlcLoanedTheCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_HepInvestmentsLlcLoanedTheCompany' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' xlink:label='fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleSecuredPromissoryNotes' xlink:label='fil_ConvertibleSecuredPromissoryNotes'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_ConvertibleSecuredPromissoryNotes' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingBalanceInLoansPayableToRelatedParties' xlink:label='fil_RemainingBalanceInLoansPayableToRelatedParties'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_LoanPayableRelatedPartiesDetailsAbstract' xlink:to='fil_RemainingBalanceInLoansPayableToRelatedParties' use='optional' order='10.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtHEPInvestmentsLLCDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcDetailsAbstract' xlink:label='fil_HepInvestmentsLlcDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdvanceAgreedUnderLoanAgreement1' xlink:label='fil_AdvanceAgreedUnderLoanAgreement1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_HepInvestmentsLlcDetailsAbstract' xlink:to='fil_AdvanceAgreedUnderLoanAgreement1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' xlink:label='fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_HepInvestmentsLlcDetailsAbstract' xlink:to='fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' xlink:label='fil_AdvancedAmountOfConvertibleSecuredPromissoryNote'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_HepInvestmentsLlcDetailsAbstract' xlink:to='fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DeferredDebtDiscountAndOtherDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:label='fil_DeferredDebtDiscountAndOtherDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' xlink:label='fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' xlink:label='fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' xlink:label='fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' xlink:label='fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmortizationOfDebtDiscounts' xlink:label='fil_AmortizationOfDebtDiscounts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_AmortizationOfDebtDiscounts' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' xlink:label='fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DeferredDebtDiscountAndOtherDetailsAbstract' xlink:to='fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_HEPInvestmentsLLCRestrictedCommonSharesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RestrictedCommonSharesDetailsAbstract' xlink:label='fil_RestrictedCommonSharesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleA010PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleB012PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleC015PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleD022PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' xlink:label='fil_CompanySRestrictedCommonStockValueScheduleE030PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleNote2BearsInterestRate' xlink:label='fil_ConvertibleNote2BearsInterestRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_ConvertibleNote2BearsInterestRate' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteTotaling' xlink:label='fil_ConvertiblePromissoryNoteTotaling'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_ConvertiblePromissoryNoteTotaling' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteTranches14Through16Totaling' xlink:label='fil_ConvertiblePromissoryNoteTranches14Through16Totaling'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_ConvertiblePromissoryNoteTranches14Through16Totaling' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingTranches17To30Totaling' xlink:label='fil_RemainingTranches17To30Totaling'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_RemainingTranches17To30Totaling' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnpaidInterestDue' xlink:label='fil_UnpaidInterestDue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_UnpaidInterestDue' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LenderConvertedTheDebt' xlink:label='fil_LenderConvertedTheDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_LenderConvertedTheDebt' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LenderConvertedTheDebtPerShare' xlink:label='fil_LenderConvertedTheDebtPerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_LenderConvertedTheDebtPerShare' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' xlink:label='fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_RestrictedCommonSharesDetailsAbstract' xlink:to='fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' use='optional' order='13.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_PaulsonInvestmentRelatedDebtDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonInvestmentRelatedDebtAbstract' xlink:label='fil_PaulsonInvestmentRelatedDebtAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' xlink:label='fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyReceivedFunding4IndividualLoans' xlink:label='fil_CompanyReceivedFunding4IndividualLoans'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_CompanyReceivedFunding4IndividualLoans' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PaulsonReceivesACashFinanceFee' xlink:label='fil_PaulsonReceivesACashFinanceFee'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_PaulsonReceivesACashFinanceFee' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtIsConvertiblePerShare' xlink:label='fil_DebtIsConvertiblePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_DebtIsConvertiblePerShare' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NewLendersAdvancedPaulsonNotes1' xlink:label='fil_NewLendersAdvancedPaulsonNotes1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_NewLendersAdvancedPaulsonNotes1' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanySRestrictedCommonStockPerShare' xlink:label='fil_CompanySRestrictedCommonStockPerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_CompanySRestrictedCommonStockPerShare' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NewLendersAdvancedPaulsonNotesInterestRate' xlink:label='fil_NewLendersAdvancedPaulsonNotesInterestRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_PaulsonInvestmentRelatedDebtAbstract' xlink:to='fil_NewLendersAdvancedPaulsonNotesInterestRate' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtConsistsOfTheFollowingDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:label='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N1ConvertibleNotesPayableDueApril2016' xlink:label='fil_N1ConvertibleNotesPayableDueApril2016'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_N1ConvertibleNotesPayableDueApril2016' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotePayableHepInvestmentsLlc' xlink:label='fil_N11ConvertibleNotePayableHepInvestmentsLlc'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_N11ConvertibleNotePayableHepInvestmentsLlc' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotePayableNewLenders' xlink:label='fil_N11ConvertibleNotePayableNewLenders'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_N11ConvertibleNotePayableNewLenders' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleNotesPayable' xlink:label='us-gaap_ConvertibleNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='us-gaap_ConvertibleNotesPayable' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LessCurrentPortion' xlink:label='fil_LessCurrentPortion'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_LessCurrentPortion' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_LongTermPortion' xlink:label='fil_LongTermPortion'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_LongTermPortion' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' xlink:label='fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' xlink:to='fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ConvertibleDebtParentheticalsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleDebtParentheticalsAbstract' xlink:label='fil_ConvertibleDebtParentheticalsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnamortizedDiscount' xlink:label='fil_UnamortizedDiscount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ConvertibleDebtParentheticalsAbstract' xlink:to='fil_UnamortizedDiscount' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_BoardOfDirectorsFeesTextualDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_BoardOfDirectorsFeesDetailsAbstract' xlink:label='fil_BoardOfDirectorsFeesDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_GrantedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_GrantedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_GrantedWarrantsToPurchaseSharesOfCommonStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePricePerShare' xlink:label='fil_ExercisePricePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_ExercisePricePerShare' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsTermInYears' xlink:label='fil_WarrantsTermInYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_WarrantsTermInYears' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsVestedOnTheGrantDate' xlink:label='fil_WarrantsVestedOnTheGrantDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_WarrantsVestedOnTheGrantDate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingWarrants' xlink:label='fil_RemainingWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_RemainingWarrants' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RemainingWarrantsShallVestQuarterly' xlink:label='fil_RemainingWarrantsShallVestQuarterly'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_RemainingWarrantsShallVestQuarterly' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' xlink:label='fil_WarrantsWereValuedUsingTheBlackScholesPricingModel'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' xlink:label='fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' xlink:label='fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrRiceSUnvestedWarrant' xlink:label='fil_MrRiceSUnvestedWarrant'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_MrRiceSUnvestedWarrant' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrCoxSUnvestedWarrant' xlink:label='fil_MrCoxSUnvestedWarrant'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_MrCoxSUnvestedWarrant' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' xlink:label='fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' xlink:label='fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MsMastersonSUnvestedWarrant1' xlink:label='fil_MsMastersonSUnvestedWarrant1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_MsMastersonSUnvestedWarrant1' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_MrPayneSUnvestedWarrant1' xlink:label='fil_MrPayneSUnvestedWarrant1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_BoardOfDirectorsFeesDetailsAbstract' xlink:to='fil_MrPayneSUnvestedWarrant1' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_DirectorsFeesDuringThePeriodDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DirectorsFeesDuringThePeriodAbstract' xlink:label='fil_DirectorsFeesDuringThePeriodAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DirectorsFees' xlink:label='fil_DirectorsFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DirectorsFeesDuringThePeriodAbstract' xlink:to='fil_DirectorsFees' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockBasedCompensationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockBasedCompensationAbstract' xlink:label='fil_StockBasedCompensationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock' xlink:label='fil_IssuedSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_IssuedSharesOfCommonStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue' xlink:label='fil_IssuedSharesOfCommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_IssuedSharesOfCommonStockValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStock' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TermInYears' xlink:label='fil_TermInYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_TermInYears' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockBasedCompensationAbstract' xlink:to='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockIssuancesInTheYear2015Details"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:label='fil_StockIssuancesInTheYear2015DetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' xlink:label='fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceOfSharesOfCommonStock' xlink:label='fil_IssuanceOfSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuanceOfSharesOfCommonStock' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' xlink:label='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock1' xlink:label='fil_IssuedSharesOfCommonStock1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuedSharesOfCommonStock1' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue1' xlink:label='fil_IssuedSharesOfCommonStockValue1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuedSharesOfCommonStockValue1' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2015DetailsAbstract' xlink:to='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_StockIssuancesInTheYear2016Details"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:label='fil_StockIssuancesInTheYear2016DetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' xlink:label='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStock2' xlink:label='fil_IssuedSharesOfCommonStock2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_IssuedSharesOfCommonStock2' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedSharesOfCommonStockValue2' xlink:label='fil_IssuedSharesOfCommonStockValue2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_IssuedSharesOfCommonStockValue2' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStock2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_StockIssuancesInTheYear2016DetailsAbstract' xlink:to='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_ExecutiveCompensationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExecutiveCompensationAbstract' xlink:label='fil_ExecutiveCompensationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExecutiveCompensationAbstract' xlink:to='fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' xlink:label='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExecutiveCompensationAbstract' xlink:to='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' xlink:label='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExecutiveCompensationAbstract' xlink:to='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsAbstract' xlink:label='fil_NumberOfWarrantsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsOutstanding1' xlink:label='fil_NumberOfWarrantsOutstanding1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_NumberOfWarrantsOutstanding1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsIssued' xlink:label='fil_NumberOfWarrantsIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_NumberOfWarrantsIssued' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsExercised' xlink:label='fil_NumberOfWarrantsExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_NumberOfWarrantsExercised' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsCancelled' xlink:label='fil_NumberOfWarrantsCancelled'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_NumberOfWarrantsCancelled' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_NumberOfWarrantsExpired' xlink:label='fil_NumberOfWarrantsExpired'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_NumberOfWarrantsExpired' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceAbstract' xlink:label='fil_WeightedAverageExercisePriceAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_NumberOfWarrantsAbstract' xlink:to='fil_WeightedAverageExercisePriceAbstract' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingBeginningOfYear' xlink:label='fil_OutstandingBeginningOfYear'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_OutstandingBeginningOfYear' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceIssued' xlink:label='fil_WeightedAverageExercisePriceIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePriceIssued' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceExercised' xlink:label='fil_WeightedAverageExercisePriceExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePriceExercised' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceCancelled' xlink:label='fil_WeightedAverageExercisePriceCancelled'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePriceCancelled' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePriceExpired' xlink:label='fil_WeightedAverageExercisePriceExpired'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePriceExpired' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingEndOfPeriod' xlink:label='fil_OutstandingEndOfPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_WeightedAverageExercisePriceAbstract' xlink:to='fil_OutstandingEndOfPeriod' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_WarrantsOutstandingAndExercisableByPriceRangeDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingWarrantsNumberAbstract' xlink:label='fil_OutstandingWarrantsNumberAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange005' xlink:label='fil_PriceRange005'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange005' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange008' xlink:label='fil_PriceRange008'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange008' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange009' xlink:label='fil_PriceRange009'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange009' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange010' xlink:label='fil_PriceRange010'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange010' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange012' xlink:label='fil_PriceRange012'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange012' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange014' xlink:label='fil_PriceRange014'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange014' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange015' xlink:label='fil_PriceRange015'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange015' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange017' xlink:label='fil_PriceRange017'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange017' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange019' xlink:label='fil_PriceRange019'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange019' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange020' xlink:label='fil_PriceRange020'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange020' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange022' xlink:label='fil_PriceRange022'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange022' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange025' xlink:label='fil_PriceRange025'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange025' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange030' xlink:label='fil_PriceRange030'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange030' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange033' xlink:label='fil_PriceRange033'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange033' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange038' xlink:label='fil_PriceRange038'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_PriceRange038' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalWarrantsOutstandingNumber' xlink:label='fil_TotalWarrantsOutstandingNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_TotalWarrantsOutstandingNumber' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:label='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange005InYears' xlink:label='fil_PriceRange005InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange005InYears' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange008InYears' xlink:label='fil_PriceRange008InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange008InYears' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange009InYears' xlink:label='fil_PriceRange009InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange009InYears' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange010InYears' xlink:label='fil_PriceRange010InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange010InYears' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange012InYears' xlink:label='fil_PriceRange012InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange012InYears' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange014InYears' xlink:label='fil_PriceRange014InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange014InYears' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange015InYears' xlink:label='fil_PriceRange015InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange015InYears' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange017InYears' xlink:label='fil_PriceRange017InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange017InYears' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange019InYears' xlink:label='fil_PriceRange019InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange019InYears' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange020InYears' xlink:label='fil_PriceRange020InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange020InYears' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange022InYears' xlink:label='fil_PriceRange022InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange022InYears' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange025InYears' xlink:label='fil_PriceRange025InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange025InYears' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange030InYears' xlink:label='fil_PriceRange030InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange030InYears' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange033InYears' xlink:label='fil_PriceRange033InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange033InYears' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PriceRange038InYears' xlink:label='fil_PriceRange038InYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_PriceRange038InYears' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' xlink:label='fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' xlink:to='fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisableWarrantsNumberAbstract' xlink:label='fil_ExercisableWarrantsNumberAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_ExercisableWarrantsNumberAbstract' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice005' xlink:label='fil_ExercisePrice005'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice005' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice008' xlink:label='fil_ExercisePrice008'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice008' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice009' xlink:label='fil_ExercisePrice009'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice009' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice010' xlink:label='fil_ExercisePrice010'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice010' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice012' xlink:label='fil_ExercisePrice012'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice012' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice014' xlink:label='fil_ExercisePrice014'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice014' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice015' xlink:label='fil_ExercisePrice015'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice015' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice017' xlink:label='fil_ExercisePrice017'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice017' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice019' xlink:label='fil_ExercisePrice019'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice019' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice020' xlink:label='fil_ExercisePrice020'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice020' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice022' xlink:label='fil_ExercisePrice022'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice022' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice025' xlink:label='fil_ExercisePrice025'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice025' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice030' xlink:label='fil_ExercisePrice030'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice030' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice033' xlink:label='fil_ExercisePrice033'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice033' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePrice038' xlink:label='fil_ExercisePrice038'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_ExercisePrice038' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalExercisableWarrants' xlink:label='fil_TotalExercisableWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsNumberAbstract' xlink:to='fil_TotalExercisableWarrants' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:label='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OutstandingWarrantsNumberAbstract' xlink:to='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice005' xlink:label='fil_WeightedAverageExercisePrice005'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice005' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice008' xlink:label='fil_WeightedAverageExercisePrice008'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice008' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice009' xlink:label='fil_WeightedAverageExercisePrice009'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice009' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice010' xlink:label='fil_WeightedAverageExercisePrice010'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice010' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice012' xlink:label='fil_WeightedAverageExercisePrice012'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice012' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice014' xlink:label='fil_WeightedAverageExercisePrice014'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice014' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice015' xlink:label='fil_WeightedAverageExercisePrice015'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice015' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice017' xlink:label='fil_WeightedAverageExercisePrice017'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice017' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice019' xlink:label='fil_WeightedAverageExercisePrice019'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice019' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice020' xlink:label='fil_WeightedAverageExercisePrice020'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice020' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice022' xlink:label='fil_WeightedAverageExercisePrice022'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice022' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice025' xlink:label='fil_WeightedAverageExercisePrice025'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice025' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice030' xlink:label='fil_WeightedAverageExercisePrice030'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice030' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice033' xlink:label='fil_WeightedAverageExercisePrice033'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice033' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WeightedAverageExercisePrice038' xlink:label='fil_WeightedAverageExercisePrice038'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_WeightedAverageExercisePrice038' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalExercisableWarrantsWeightedAverageExercisePrice' xlink:label='fil_TotalExercisableWarrantsWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' xlink:to='fil_TotalExercisableWarrantsWeightedAverageExercisePrice' use='optional' order='16.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_OtherIncomeExpenseDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OtherIncomeExpenseDetailsAbstract' xlink:label='fil_OtherIncomeExpenseDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementAgreementCallsForTheCompanyToMake10Payments' xlink:label='fil_SettlementAgreementCallsForTheCompanyToMake10Payments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OtherIncomeExpenseDetailsAbstract' xlink:to='fil_SettlementAgreementCallsForTheCompanyToMake10Payments' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalLiabilityOutOfTheGrossAmount' xlink:label='fil_TotalLiabilityOutOfTheGrossAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OtherIncomeExpenseDetailsAbstract' xlink:to='fil_TotalLiabilityOutOfTheGrossAmount' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AmountRecordedOnTheCompanySBooks' xlink:label='fil_AmountRecordedOnTheCompanySBooks'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OtherIncomeExpenseDetailsAbstract' xlink:to='fil_AmountRecordedOnTheCompanySBooks' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' xlink:label='fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_OtherIncomeExpenseDetailsAbstract' xlink:to='fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_CommitmentAndContingenciesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EmploymentAgreementDetailsAbstract' xlink:label='fil_EmploymentAgreementDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AnnualBaseSalary' xlink:label='fil_AnnualBaseSalary'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_AnnualBaseSalary' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' xlink:label='fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ExercisePricePerShareWarrantsEntitled' xlink:label='fil_ExercisePricePerShareWarrantsEntitled'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_ExercisePricePerShareWarrantsEntitled' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponIdentificationOfBioActiveAgents' xlink:label='fil_WarrantForSharesUponIdentificationOfBioActiveAgents'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_WarrantForSharesUponIdentificationOfBioActiveAgents' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' xlink:label='fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ReceivesInCashPayments' xlink:label='fil_ReceivesInCashPayments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_ReceivesInCashPayments' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' xlink:label='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PartnerProvidesAtleastInCashOrInKindOutlays' xlink:label='fil_PartnerProvidesAtleastInCashOrInKindOutlays'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_PartnerProvidesAtleastInCashOrInKindOutlays' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' xlink:label='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' use='optional' order='9.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' xlink:label='fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_EmploymentAgreementDetailsAbstract' xlink:to='fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' use='optional' order='10.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_IncomeTaxDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncomeTaxDetailsAbstract' xlink:label='fil_IncomeTaxDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards' xlink:label='us-gaap_OperatingLossCarryforwards'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='us-gaap_OperatingLossCarryforwards' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet' xlink:label='us-gaap_DeferredTaxAssetsNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='us-gaap_DeferredTaxAssetsNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_FederalAndStateStatutoryRate' xlink:label='fil_FederalAndStateStatutoryRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='fil_FederalAndStateStatutoryRate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EffectiveTaxRate' xlink:label='fil_EffectiveTaxRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='fil_EffectiveTaxRate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_IncreaseInTheValuationAllowance' xlink:label='fil_IncreaseInTheValuationAllowance'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_IncomeTaxDetailsAbstract' xlink:to='fil_IncreaseInTheValuationAllowance' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SettlementOfLitigationRelatedPartyDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:label='fil_SettlementOfLitigationRelatedPartyDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_DebtOwedToHepInvestment' xlink:label='fil_DebtOwedToHepInvestment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_DebtOwedToHepInvestment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_PayToTheShareholderSLegalCounsel' xlink:label='fil_PayToTheShareholderSLegalCounsel'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_PayToTheShareholderSLegalCounsel' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SharesOfTheCompanySCommonStock' xlink:label='fil_SharesOfTheCompanySCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_SharesOfTheCompanySCommonStock' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SharesOfTheCompanySCommonStockValued' xlink:label='fil_SharesOfTheCompanySCommonStockValued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_SharesOfTheCompanySCommonStockValued' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecordedLegalFees' xlink:label='fil_RecordedLegalFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_RecordedLegalFees' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RecordedTheSettlementAmount' xlink:label='fil_RecordedTheSettlementAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' xlink:to='fil_RecordedTheSettlementAmount' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails" xlink:type="simple" xlink:href="zivo-20161231.xsd#idr_SubsequentEventsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails">
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_SubsequentEventsDetailsAbstract' xlink:label='fil_SubsequentEventsDetailsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' xlink:label='fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalOutstandingDebtAsOfMarch12017' xlink:label='fil_TotalOutstandingDebtAsOfMarch12017'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_TotalOutstandingDebtAsOfMarch12017' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_UnpaidPrincipal' xlink:label='fil_UnpaidPrincipal'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_UnpaidPrincipal' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_InterestOutstandingAsOfFebruary282017' xlink:label='fil_InterestOutstandingAsOfFebruary282017'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_InterestOutstandingAsOfFebruary282017' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_RestructuringAndLegalFees' xlink:label='fil_RestructuringAndLegalFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_RestructuringAndLegalFees' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' xlink:label='fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' xlink:label='fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' xlink:label='fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' xlink:label='fil_CompanyIssuedToTheLenderForAggregateConsiderationOf'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_WarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_WarrantsToPurchaseSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_WarrantsToPurchaseSharesOfCommonStock' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockAtAtAnExercisePricePerShare' xlink:label='fil_CommonStockAtAtAnExercisePricePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_CommonStockAtAtAnExercisePricePerShare' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' xlink:label='fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' xlink:label='fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' xlink:label='fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' xlink:label='fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:label='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_SubsequentEventsDetailsAbstract' xlink:to='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_AdditionalAmountFundedByHepInvestmentsLlc' xlink:label='fil_AdditionalAmountFundedByHepInvestmentsLlc'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:to='fil_AdditionalAmountFundedByHepInvestmentsLlc' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' xlink:label='fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:to='fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' xlink:label='fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:to='fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='zivo-20161231.xsd#fil_TermInYears1' xlink:label='fil_TermInYears1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' xlink:to='fil_TermInYears1' use='optional' order='4.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>zivo-20161231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<schema xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2016-01-31' xmlns:fil='http://www.zivobioscience.com/20161231' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' xmlns:num='http://www.xbrl.org/dtr/type/numeric' targetNamespace='http://www.zivobioscience.com/20161231' xmlns:link='http://www.xbrl.org/2003/linkbase' elementFormDefault='qualified' attributeFormDefault='unqualified' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="zivo-20161231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zivo-20161231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zivo-20161231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="zivo-20161231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables" id="idr_DisclosureScheduleOfPropertyAndEquipmentTables">
				<link:definition>000230 - Disclosure - Schedule of Property and Equipment (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails" id="idr_IncomeTaxDetails">
				<link:definition>000490 - Statement - Income Tax (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails" id="idr_SubsequentEventsDetails">
				<link:definition>000510 - Statement - Subsequent Events (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails" id="idr_DueToRelatedPartyDetails">
				<link:definition>000310 - Statement - Due to Related Party (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails">
				<link:definition>000270 - Statement - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables" id="idr_DisclosureStockholdersWarrantsTables">
				<link:definition>000250 - Disclosure - Stockholders Warrants (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT" id="idr_DisclosureCONVERTIBLEDEBT">
				<link:definition>000130 - Disclosure - CONVERTIBLE DEBT</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails" id="idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails">
				<link:definition>000450 - Statement - Summary of the status of the Company&apos;s warrants (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES" id="idr_DisclosureINCOMETAXES">
				<link:definition>000180 - Disclosure - INCOME TAXES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables" id="idr_DisclosureScheduleOfConvertibleDebtTables">
				<link:definition>000240 - Disclosure - Schedule of Convertible debt (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails" id="idr_DirectorsFeesDuringThePeriodDetails">
				<link:definition>000400 - Statement - Directors fees- During the period (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails" id="idr_ExecutiveCompensationDetails">
				<link:definition>000440 - Statement - Executive Compensation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails" id="idr_LoanPayableRelatedPartiesDetails">
				<link:definition>000320 - Statement - Loan Payable, Related Parties (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE" id="idr_DisclosureOTHERINCOMEEXPENSE">
				<link:definition>000150 - Disclosure - OTHER INCOME (EXPENSE)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity" id="idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity">
				<link:definition>000050 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS&apos; DEFICIENCY {Stockholders&apos; Equity}</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables" id="idr_DisclosureFairValueOfWarrantsEstimatedTables">
				<link:definition>000220 - Disclosure - Fair Value of Warrants Estimated (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies" id="idr_DisclosureAccountingPoliciesPolicies">
				<link:definition>000210 - Disclosure - Accounting Policies (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails" id="idr_PaulsonInvestmentRelatedDebtDetails">
				<link:definition>000360 - Statement - Paulson Investment - Related Debt (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY" id="idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY">
				<link:definition>000190 - Disclosure - SETTLEMENT OF LITIGATION - RELATED PARTY</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails" id="idr_FairValueAssumptionsDetails">
				<link:definition>000280 - Statement - Fair value assumptions (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails" id="idr_OtherIncomeExpenseDetails">
				<link:definition>000470 - Statement - Other Income (Expense) (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails" id="idr_PropertyAndEquipmentDepreciationDetails">
				<link:definition>000300 - Statement - Property and Equipment Depreciation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails" id="idr_StockBasedCompensationDetails">
				<link:definition>000410 - Statement - Stock Based Compensation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" id="idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
				<link:definition>000090 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails" id="idr_BasisOfPresentationDetails">
				<link:definition>000260 - Statement - Basis of Presentation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS" id="idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
				<link:definition>000040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails" id="idr_BoardOfDirectorsFeesTextualDetails">
				<link:definition>000390 - Statement - Board Of Directors Fees Textual (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails" id="idr_DeferredDebtDiscountAndOtherDetails">
				<link:definition>000340 - Statement - Deferred Debt Discount and Other (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS" id="idr_DisclosureSUBSEQUENTEVENTS">
				<link:definition>000200 - Disclosure - SUBSEQUENT EVENTS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS" id="idr_DisclosureDESCRIPTIONOFBUSINESS">
				<link:definition>000070 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails" id="idr_ConvertibleDebtParentheticalsDetails">
				<link:definition>000380 - Statement - Convertible debt Parentheticals (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT" id="idr_DisclosurePROPERTYANDEQUIPMENT">
				<link:definition>000100 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION" id="idr_DisclosureBASISOFPRESENTATION">
				<link:definition>000080 - Disclosure - BASIS OF PRESENTATION</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails" id="idr_SettlementOfLitigationRelatedPartyDetails">
				<link:definition>000500 - Statement - Settlement of Litigation - Related Party (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES" id="idr_DisclosureLOANPAYABLERELATEDPARTIES">
				<link:definition>000120 - Disclosure - LOAN PAYABLE, RELATED PARTIES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY" id="idr_DisclosureSTOCKHOLDERSDEFICIENCY">
				<link:definition>000140 - Disclosure - STOCKHOLDERS&apos; DEFICIENCY</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details" id="idr_StockIssuancesInTheYear2016Details">
				<link:definition>000430 - Statement - Stock Issuances in the year 2016 (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails" id="idr_HEPInvestmentsLLCRestrictedCommonSharesDetails">
				<link:definition>000350 - Statement - HEP Investments, LLC - Restricted Common Shares (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY" id="idr_DisclosureDUETORELATEDPARTY">
				<link:definition>000110 - Disclosure - DUE TO RELATED PARTY</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details" id="idr_StockIssuancesInTheYear2015Details">
				<link:definition>000420 - Statement - Stock Issuances in the year 2015 (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails" id="idr_ConvertibleDebtHEPInvestmentsLLCDetails">
				<link:definition>000330 - Statement - Convertible Debt - HEP Investments, LLC (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES" id="idr_DisclosureCOMMITMENTSANDCONTINGENCIES">
				<link:definition>000160 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails" id="idr_ConvertibleDebtConsistsOfTheFollowingDetails">
				<link:definition>000370 - Statement - Convertible debt consists of the following (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails" id="idr_PropertyAndEquipmentDetails">
				<link:definition>000290 - Statement - Property and Equipment (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS" id="idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS">
				<link:definition>000060 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET" id="idr_CONSOLIDATEDBALANCESHEET">
				<link:definition>000020 - Statement - CONSOLIDATED BALANCE SHEET</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS" id="idr_DisclosureRELATEDPARTYTRANSACTIONS">
				<link:definition>000170 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails" id="idr_CommitmentAndContingenciesDetails">
				<link:definition>000480 - Statement - Commitment and Contingencies (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails" id="idr_WarrantsOutstandingAndExercisableByPriceRangeDetails">
				<link:definition>000460 - Statement - Warrants outstanding and exercisable by price range (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS" id="idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS">
				<link:definition>000030 - Statement - CONSOLIDATED BALANCE SHEET PARENTHETICALS</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import namespace='http://fasb.org/us-gaap/2016-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2014-01-31' schemaLocation='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DocumentAndEntityInformationAbstract' name='DocumentAndEntityInformationAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CONVERTIBLEDEBTAbstract' name='CONVERTIBLEDEBTAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' name='SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_STOCKHOLDERSWARRANTSAbstract' name='STOCKHOLDERSWARRANTSAbstract' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_WarrantsOutstandingAndExercisableTableTextBlock' name='WarrantsOutstandingAndExercisableTableTextBlock' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_AccountingPolicies1Abstract' name='AccountingPolicies1Abstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_AdvanceAgreedUnderLoanAgreement1' name='AdvanceAgreedUnderLoanAgreement1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' name='ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_AnnualBaseSalary' name='AnnualBaseSalary' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommitmentAndContingenciesAbstract' name='CommitmentAndContingenciesAbstract' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ConvertibleNote2BearsInterestRate' name='ConvertibleNote2BearsInterestRate' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FairValueOfWarrantsEstimatedTablesAbstract' name='FairValueOfWarrantsEstimatedTablesAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' name='CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' name='CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CommonSharesFromOutstandingWarrants' name='CommonSharesFromOutstandingWarrants' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StockholdersDeficiency' name='StockholdersDeficiency' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConvertibleDebtConsistsOfTheFollowing1Abstract' name='ConvertibleDebtConsistsOfTheFollowing1Abstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_AdvancedAmountOfConvertibleSecuredPromissoryNote' name='AdvancedAmountOfConvertibleSecuredPromissoryNote' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FairValueOfWarrantsEstimatedTablesTextBlock' name='FairValueOfWarrantsEstimatedTablesTextBlock' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfPropertyAndEquipmentAbstract' name='ScheduleOfPropertyAndEquipmentAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfConvertibleDebtTableTextBlockAbstract' name='ScheduleOfConvertibleDebtTableTextBlockAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LoanPayableRelatedPartiesDetailsAbstract' name='LoanPayableRelatedPartiesDetailsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_HepInvestmentsLlcDetailsAbstract' name='HepInvestmentsLlcDetailsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RestrictedCommonSharesDetailsAbstract' name='RestrictedCommonSharesDetailsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_EmploymentAgreementDetailsAbstract' name='EmploymentAgreementDetailsAbstract' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' name='PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_HepInvestmentsLlcLoanedTheCompany' name='HepInvestmentsLlcLoanedTheCompany' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes' name='LoansWereConvertedToConvertibleSecuredPromissoryNotes' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_RemainingBalanceInLoansPayableToRelatedParties' name='RemainingBalanceInLoansPayableToRelatedParties' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DeferredDebtDiscountAndOtherDetailsAbstract' name='DeferredDebtDiscountAndOtherDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' name='TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_TotalOutstandingBalanceOfAdvance' name='TotalOutstandingBalanceOfAdvance' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_LenderConvertedTheDebt' name='LenderConvertedTheDebt' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' name='CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_WorkingCapitalDeficiency1' name='WorkingCapitalDeficiency1' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PropertyAndEquipmentDetailsAbstract' name='PropertyAndEquipmentDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AmountAdvancedByChrisMaggioreASignificantShareholder' name='AmountAdvancedByChrisMaggioreASignificantShareholder' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CompanyAgreedToPayInterestOnLoan' name='CompanyAgreedToPayInterestOnLoan' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccruedInterestOnIndebtednessTotaled' name='AccruedInterestOnIndebtednessTotaled' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AmountAdvancedByOfficers' name='AmountAdvancedByOfficers' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConvertibleSecuredPromissoryNotes' name='ConvertibleSecuredPromissoryNotes' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanySRestrictedCommonStockValueScheduleA010PerShare' name='CompanySRestrictedCommonStockValueScheduleA010PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanySRestrictedCommonStockValueScheduleB012PerShare' name='CompanySRestrictedCommonStockValueScheduleB012PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanySRestrictedCommonStockValueScheduleC015PerShare' name='CompanySRestrictedCommonStockValueScheduleC015PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanySRestrictedCommonStockValueScheduleD022PerShare' name='CompanySRestrictedCommonStockValueScheduleD022PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanySRestrictedCommonStockValueScheduleE030PerShare' name='CompanySRestrictedCommonStockValueScheduleE030PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_ConvertiblePromissoryNoteTotaling' name='ConvertiblePromissoryNoteTotaling' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' name='CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantsVestedOnTheGrantDate' name='WarrantsVestedOnTheGrantDate' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_NumberOfWarrantsAbstract' name='NumberOfWarrantsAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NumberOfWarrantsIssued' name='NumberOfWarrantsIssued' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NumberOfWarrantsExercised' name='NumberOfWarrantsExercised' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NumberOfWarrantsCancelled' name='NumberOfWarrantsCancelled' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NumberOfWarrantsExpired' name='NumberOfWarrantsExpired' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_WeightedAverageExercisePriceAbstract' name='WeightedAverageExercisePriceAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NumberOfWarrantsOutstanding1' name='NumberOfWarrantsOutstanding1' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_BasisOfPresentationAbstract' name='BasisOfPresentationAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_WeightedAverageAssumptionsAbstract' name='WeightedAverageAssumptionsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_BasisOfPresentationDetailsAbstract' name='BasisOfPresentationDetailsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' name='SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ResearchAndDevelopmentCosts' name='ResearchAndDevelopmentCosts' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PropertyAndEquipmentDepreciationAbstract' name='PropertyAndEquipmentDepreciationAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AmortizationOfDebtDiscounts' name='AmortizationOfDebtDiscounts' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DebtAbstract' name='DebtAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DirectorsFees' name='DirectorsFees' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IssuedSharesOfCommonStock' name='IssuedSharesOfCommonStock' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OtherIncomeAndExpensesAbstract1' name='OtherIncomeAndExpensesAbstract1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ProceedsFromIssuanceOfConvertibleDebentures' name='ProceedsFromIssuanceOfConvertibleDebentures' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PotentiallyDilutiveSecuritiesAbstract' name='PotentiallyDilutiveSecuritiesAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_BoardOfDirectorsFeesDetailsAbstract' name='BoardOfDirectorsFeesDetailsAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_GrantedWarrantsToPurchaseSharesOfCommonStock' name='GrantedWarrantsToPurchaseSharesOfCommonStock' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePricePerShare' name='ExercisePricePerShare' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantsTermInYears' name='WarrantsTermInYears' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_RemainingWarrants' name='RemainingWarrants' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_RemainingWarrantsShallVestQuarterly' name='RemainingWarrantsShallVestQuarterly' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_WarrantsWereValuedUsingTheBlackScholesPricingModel' name='WarrantsWereValuedUsingTheBlackScholesPricingModel' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' name='InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' name='InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_MrRiceSUnvestedWarrant' name='MrRiceSUnvestedWarrant' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_MrCoxSUnvestedWarrant' name='MrCoxSUnvestedWarrant' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' name='InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DirectorsFeesDuringThePeriodAbstract' name='DirectorsFeesDuringThePeriodAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_StockBasedCompensationAbstract' name='StockBasedCompensationAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ExecutiveCompensationAbstract' name='ExecutiveCompensationAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' name='CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' name='CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded' name='ValueOfTheNotesOnWhichDebtDiscountWasRecorded' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SubsequentEventsDetailsAbstract' name='SubsequentEventsDetailsAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyDisclosuresAbstract' name='RelatedPartyDisclosuresAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StockBasedCompensationExpense' name='StockBasedCompensationExpense' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DueToRelatedPartyDetailsAbstract' name='DueToRelatedPartyDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' name='CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CashFinanceFee' name='CashFinanceFee' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanyIncurredFinanceCosts' name='CompanyIncurredFinanceCosts' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount' name='MrMaggioreAdvancedTheCompanyAnAdditionalAmount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_ConvertiblePromissoryNoteTranches14Through16Totaling' name='ConvertiblePromissoryNoteTranches14Through16Totaling' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_RemainingTranches17To30Totaling' name='RemainingTranches17To30Totaling' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_UnpaidInterestDue' name='UnpaidInterestDue' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_LenderConvertedTheDebtPerShare' name='LenderConvertedTheDebtPerShare' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PaulsonInvestmentRelatedDebtAbstract' name='PaulsonInvestmentRelatedDebtAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors' name='PaulsonCanProvideFinancingsThroughAccreditedInvestors' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanyReceivedFunding4IndividualLoans' name='CompanyReceivedFunding4IndividualLoans' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PaulsonReceivesACashFinanceFee' name='PaulsonReceivesACashFinanceFee' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_DebtIsConvertiblePerShare' name='DebtIsConvertiblePerShare' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CompanySRestrictedCommonStockPerShare' name='CompanySRestrictedCommonStockPerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_NewLendersAdvancedPaulsonNotes1' name='NewLendersAdvancedPaulsonNotes1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LessCurrentPortion' name='LessCurrentPortion' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongTermPortion' name='LongTermPortion' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConvertibleDebtParentheticalsAbstract' name='ConvertibleDebtParentheticalsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_UnamortizedDiscount' name='UnamortizedDiscount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CompanyIssuedToTheLenderForAggregateConsiderationOf' name='CompanyIssuedToTheLenderForAggregateConsiderationOf' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantsToPurchaseSharesOfCommonStock' name='WarrantsToPurchaseSharesOfCommonStock' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_CommonStockAtAtAnExercisePricePerShare' name='CommonStockAtAtAnExercisePricePerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' name='CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum' name='ConvertibleNotesAccrueInterestAtTheRatePerAnnum' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePriceIssued' name='WeightedAverageExercisePriceIssued' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePriceExercised' name='WeightedAverageExercisePriceExercised' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePriceCancelled' name='WeightedAverageExercisePriceCancelled' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePriceExpired' name='WeightedAverageExercisePriceExpired' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange005' name='PriceRange005' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' name='InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_MsMastersonSUnvestedWarrant1' name='MsMastersonSUnvestedWarrant1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_MrPayneSUnvestedWarrant1' name='MrPayneSUnvestedWarrant1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' name='WarrantsWereValuedAtUsingTheBlackScholesPricingModel2' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' name='IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DescriptionOfBusinessAbstract' name='DescriptionOfBusinessAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_StockholdersDeficiency1Abstract' name='StockholdersDeficiency1Abstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyTransactionsAbstract1' name='RelatedPartyTransactionsAbstract1' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyTransactionsTextBlock' name='RelatedPartyTransactionsTextBlock' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IncomeTaxesAbstract' name='IncomeTaxesAbstract' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SettlementOfLitigationRelatedPartyAbstract' name='SettlementOfLitigationRelatedPartyAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_NetLoss1' name='NetLoss1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' name='RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_N1ConvertibleNotesPayableDueApril2016' name='N1ConvertibleNotesPayableDueApril2016' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_N11ConvertibleNotePayableHepInvestmentsLlc' name='N11ConvertibleNotePayableHepInvestmentsLlc' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_N11ConvertibleNotePayableNewLenders' name='N11ConvertibleNotePayableNewLenders' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' name='N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IssuedSharesOfCommonStockValue' name='IssuedSharesOfCommonStockValue' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedSharesOfCommonStock1' name='IssuedSharesOfCommonStock1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStock2' name='IssuedWarrantsToPurchaseSharesOfCommonStock2' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' name='IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_NewLendersAdvancedPaulsonNotesInterestRate' name='NewLendersAdvancedPaulsonNotesInterestRate' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ChangesInEquityAbstract' name='ChangesInEquityAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_Balance' name='Balance' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_Balance1' name='Balance1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsToBoardOfDirectors' name='IssuanceOfWarrantsToBoardOfDirectors' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForServices' name='IssuanceOfWarrantsForServices' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsToBoardOfDirectors1' name='IssuanceOfWarrantsToBoardOfDirectors1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForServices1' name='IssuanceOfWarrantsForServices1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForServicesRelatedParty' name='IssuanceOfWarrantsForServicesRelatedParty' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForServicesRelatedParty1' name='IssuanceOfWarrantsForServicesRelatedParty1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' name='IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IssuanceOfCommonStockForServices' name='IssuanceOfCommonStockForServices' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockIssuedOnConversionOf1ConvertibleDebt' name='CommonStockIssuedOnConversionOf1ConvertibleDebt' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DiscountsOnIssuanceOfConvertibleDebentures' name='DiscountsOnIssuanceOfConvertibleDebentures' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DiscountsOnIssuanceOfConvertibleDebentures1' name='DiscountsOnIssuanceOfConvertibleDebentures1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_WarrantsIssuedForFinancingCosts' name='WarrantsIssuedForFinancingCosts' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockIssuedForFinancingCosts' name='CommonStockIssuedForFinancingCosts' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_WarrantsIssuedForFinancingCosts1' name='WarrantsIssuedForFinancingCosts1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockIssuedForFinancingCosts1' name='CommonStockIssuedForFinancingCosts1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_NetLoss' name='NetLoss' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_NetIncome' name='NetIncome' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StocksAndWarrantsIssuedForServicesRendered' name='StocksAndWarrantsIssuedForServicesRendered' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForServicesRelatedParty2' name='IssuanceOfWarrantsForServicesRelatedParty2' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_WarrantsIssuedForDirectorsFees' name='WarrantsIssuedForDirectorsFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StocksAndWarrantsIssuedForFinancingCosts' name='StocksAndWarrantsIssuedForFinancingCosts' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AmortizationOfDeferredFinanceCosts' name='AmortizationOfDeferredFinanceCosts' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_AmortizationOfBondDiscount' name='AmortizationOfBondDiscount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DeferredFinanceCosts' name='DeferredFinanceCosts' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CashPaidDuringThePeriodForAbstract' name='CashPaidDuringThePeriodForAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel' name='WarrantsWereValuedAtUsingTheBlackScholesPricingModel' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStock' name='IssuedWarrantsToPurchaseSharesOfCommonStock' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TermInYears' name='TermInYears' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_StockIssuancesInTheYear2015DetailsAbstract' name='StockIssuancesInTheYear2015DetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' name='ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuanceOfSharesOfCommonStock' name='IssuanceOfSharesOfCommonStock' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture' name='IssuanceInPrincipalOfAn11ConvertibleDebenture' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IssuedSharesOfCommonStockValue1' name='IssuedSharesOfCommonStockValue1' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' name='IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' name='WarrantsWereValuedAtUsingTheBlackScholesPricingModel1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStock1' name='IssuedWarrantsToPurchaseSharesOfCommonStock1' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_StockIssuancesInTheYear2016DetailsAbstract' name='StockIssuancesInTheYear2016DetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1' name='IssuanceInPrincipalOfAn11ConvertibleDebenture1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedSharesOfCommonStock2' name='IssuedSharesOfCommonStock2' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IssuedSharesOfCommonStockValue2' name='IssuedSharesOfCommonStockValue2' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' name='WarrantsWereValuedAtUsingTheBlackScholesPricingModel3' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' name='IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_OutstandingBeginningOfYear' name='OutstandingBeginningOfYear' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_OutstandingEndOfPeriod' name='OutstandingEndOfPeriod' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OutstandingWarrantsNumberAbstract' name='OutstandingWarrantsNumberAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange008' name='PriceRange008' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange009' name='PriceRange009' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange010' name='PriceRange010' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange012' name='PriceRange012' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange014' name='PriceRange014' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange015' name='PriceRange015' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange017' name='PriceRange017' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange019' name='PriceRange019' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange020' name='PriceRange020' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange022' name='PriceRange022' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange025' name='PriceRange025' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange030' name='PriceRange030' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange033' name='PriceRange033' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange038' name='PriceRange038' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TotalWarrantsOutstandingNumber' name='TotalWarrantsOutstandingNumber' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' name='OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange005InYears' name='PriceRange005InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange008InYears' name='PriceRange008InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange009InYears' name='PriceRange009InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange010InYears' name='PriceRange010InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange012InYears' name='PriceRange012InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange014InYears' name='PriceRange014InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange015InYears' name='PriceRange015InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange017InYears' name='PriceRange017InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange019InYears' name='PriceRange019InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange020InYears' name='PriceRange020InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange022InYears' name='PriceRange022InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange025InYears' name='PriceRange025InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange030InYears' name='PriceRange030InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange033InYears' name='PriceRange033InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_PriceRange038InYears' name='PriceRange038InYears' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' name='TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ExercisableWarrantsNumberAbstract' name='ExercisableWarrantsNumberAbstract' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice005' name='ExercisePrice005' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice008' name='ExercisePrice008' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice009' name='ExercisePrice009' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice010' name='ExercisePrice010' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice012' name='ExercisePrice012' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice014' name='ExercisePrice014' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice015' name='ExercisePrice015' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice017' name='ExercisePrice017' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice019' name='ExercisePrice019' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice020' name='ExercisePrice020' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice022' name='ExercisePrice022' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice025' name='ExercisePrice025' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice030' name='ExercisePrice030' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice033' name='ExercisePrice033' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePrice038' name='ExercisePrice038' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TotalExercisableWarrants' name='TotalExercisableWarrants' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract' name='ExercisableWarrantsWeightedAverageExercisePriceAbstract' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice005' name='WeightedAverageExercisePrice005' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice008' name='WeightedAverageExercisePrice008' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice009' name='WeightedAverageExercisePrice009' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice010' name='WeightedAverageExercisePrice010' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice012' name='WeightedAverageExercisePrice012' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice014' name='WeightedAverageExercisePrice014' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice015' name='WeightedAverageExercisePrice015' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice017' name='WeightedAverageExercisePrice017' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice019' name='WeightedAverageExercisePrice019' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice020' name='WeightedAverageExercisePrice020' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice022' name='WeightedAverageExercisePrice022' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice025' name='WeightedAverageExercisePrice025' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice030' name='WeightedAverageExercisePrice030' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice033' name='WeightedAverageExercisePrice033' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageExercisePrice038' name='WeightedAverageExercisePrice038' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TotalExercisableWarrantsWeightedAverageExercisePrice' name='TotalExercisableWarrantsWeightedAverageExercisePrice' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ExercisePricePerShareWarrantsEntitled' name='ExercisePricePerShareWarrantsEntitled' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantForSharesUponIdentificationOfBioActiveAgents' name='WarrantForSharesUponIdentificationOfBioActiveAgents' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' name='WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_ReceivesInCashPayments' name='ReceivesInCashPayments' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' name='WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_PartnerProvidesAtleastInCashOrInKindOutlays' name='PartnerProvidesAtleastInCashOrInKindOutlays' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' name='WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' name='WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OtherIncomeExpenseDetailsAbstract' name='OtherIncomeExpenseDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_SettlementAgreementCallsForTheCompanyToMake10Payments' name='SettlementAgreementCallsForTheCompanyToMake10Payments' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_TotalLiabilityOutOfTheGrossAmount' name='TotalLiabilityOutOfTheGrossAmount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_AmountRecordedOnTheCompanySBooks' name='AmountRecordedOnTheCompanySBooks' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' name='RecognizedAsOtherIncomeForThePeriodEndingSeptember302014' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IncomeTaxDetailsAbstract' name='IncomeTaxDetailsAbstract' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_FederalAndStateStatutoryRate' name='FederalAndStateStatutoryRate' />
	<element nillable='true' type='num:percentItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_EffectiveTaxRate' name='EffectiveTaxRate' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_IncreaseInTheValuationAllowance' name='IncreaseInTheValuationAllowance' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SettlementOfLitigationRelatedPartyDetailsAbstract' name='SettlementOfLitigationRelatedPartyDetailsAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_DebtOwedToHepInvestment' name='DebtOwedToHepInvestment' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_PayToTheShareholderSLegalCounsel' name='PayToTheShareholderSLegalCounsel' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_SharesOfTheCompanySCommonStock' name='SharesOfTheCompanySCommonStock' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_SharesOfTheCompanySCommonStockValued' name='SharesOfTheCompanySCommonStockValued' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_RecordedLegalFees' name='RecordedLegalFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_RecordedTheSettlementAmount' name='RecordedTheSettlementAmount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' name='EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_TotalOutstandingDebtAsOfMarch12017' name='TotalOutstandingDebtAsOfMarch12017' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_UnpaidPrincipal' name='UnpaidPrincipal' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_InterestOutstandingAsOfFebruary282017' name='InterestOutstandingAsOfFebruary282017' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_RestructuringAndLegalFees' name='RestructuringAndLegalFees' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' name='ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' name='TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan' name='HepInvestmentsLlcLenderFundedAnAdditionalLoan' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' name='CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' name='OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_N11ConvertibleDebtHepInvestmentsLlcAbstract' name='N11ConvertibleDebtHepInvestmentsLlcAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_AdditionalAmountFundedByHepInvestmentsLlc' name='AdditionalAmountFundedByHepInvestmentsLlc' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' name='Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_TermInYears1' name='TermInYears1' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' name='Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817773360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Mar. 29, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zivo Bioscience, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Entity Trading Symbol</a></td>
<td class="text">zivo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001101026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,995,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,967,207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820714448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEET - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 506,986<span></span>
</td>
<td class="nump">$ 16,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expenses</a></td>
<td class="nump">13,437<span></span>
</td>
<td class="nump">12,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">520,423<span></span>
</td>
<td class="nump">28,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="nump">18,750<span></span>
</td>
<td class="nump">43,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred Finance Costs, net</a></td>
<td class="nump">198,119<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">737,292<span></span>
</td>
<td class="nump">72,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">666,365<span></span>
</td>
<td class="nump">1,114,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to Related Party</a></td>
<td class="nump">319,234<span></span>
</td>
<td class="nump">211,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans Payable, Related Parties</a></td>
<td class="nump">245,979<span></span>
</td>
<td class="nump">337,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible Debentures Payable, less discount of $385,190 and $500,490 at December 31, 2015 and 2016, respectively</a></td>
<td class="nump">6,886,710<span></span>
</td>
<td class="nump">1,224,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued Interest</a></td>
<td class="nump">2,659,574<span></span>
</td>
<td class="nump">1,673,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued Liabilities - Other</a></td>
<td class="nump">404,618<span></span>
</td>
<td class="nump">410,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">11,182,480<span></span>
</td>
<td class="nump">4,970,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG TERM LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible Debenture Payable, less discount of $1,458,741 and $ 73,953 at December 31, 2015 and 2016, respectively</a></td>
<td class="nump">3,176,047<span></span>
</td>
<td class="nump">4,598,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long Term Liabilities</a></td>
<td class="nump">3,176,047<span></span>
</td>
<td class="nump">4,598,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">14,358,527<span></span>
</td>
<td class="nump">9,569,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 450,000,000 shares authorized; 132,156,776 and 136,745,347 issued and outstanding at December 31, 2015 and 2016, respectively</a></td>
<td class="nump">136,745<span></span>
</td>
<td class="nump">132,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-In Capital</a></td>
<td class="nump">40,016,059<span></span>
</td>
<td class="nump">38,085,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">(53,774,039)<span></span>
</td>
<td class="num">(47,714,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Deficit</a></td>
<td class="num">(13,621,235)<span></span>
</td>
<td class="num">(9,496,989)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</a></td>
<td class="nump">$ 737,292<span></span>
</td>
<td class="nump">$ 72,680<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820718320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEET PARENTHETICALS - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract', window );"><strong>Parentheticals</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on Convertible Debenture Payable Current</a></td>
<td class="nump">$ 500,490<span></span>
</td>
<td class="nump">$ 385,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount on Convertible Debenture Payable Non-Current</a></td>
<td class="nump">$ 73,953<span></span>
</td>
<td class="nump">$ 1,458,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">136,745,347<span></span>
</td>
<td class="nump">132,156,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">136,745,347<span></span>
</td>
<td class="nump">132,156,776<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28567-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockTransactionsParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823449216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUES:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>COSTS AND EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
<td class="nump">832,239<span></span>
</td>
<td class="nump">963,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees and Consulting Expense</a></td>
<td class="nump">1,869,234<span></span>
</td>
<td class="nump">1,059,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="nump">788,971<span></span>
</td>
<td class="nump">1,033,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">3,490,444<span></span>
</td>
<td class="nump">3,056,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(3,490,444)<span></span>
</td>
<td class="num">(3,056,280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other Income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of Bond Discount</a></td>
<td class="num">(1,376,182)<span></span>
</td>
<td class="num">(1,866,842)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Deferred Finance Costs</a></td>
<td class="num">(26,813)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Financing Costs</a></td>
<td class="num">(108,000)<span></span>
</td>
<td class="num">(84,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Finance Costs Paid in Stocks and Warrants</a></td>
<td class="num">(72,000)<span></span>
</td>
<td class="num">(95,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseRelatedParty', window );">Interest Expense - Related Parties</a></td>
<td class="num">(950,698)<span></span>
</td>
<td class="num">(718,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(35,490)<span></span>
</td>
<td class="num">(2,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (Expense)</a></td>
<td class="num">(2,569,183)<span></span>
</td>
<td class="num">(2,732,851)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS)</a></td>
<td class="num">$ (6,059,627)<span></span>
</td>
<td class="num">$ (5,789,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">BASIC AND DILUTED LOSS PER SHARE</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">WEIGHTED AVERAGE BASIC AND DILUTED SHARES OUTSTANDING</a></td>
<td class="nump">133,844,254<span></span>
</td>
<td class="nump">130,945,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense incurred on a debt or other obligation to related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=6488370&amp;loc=d3e13550-115849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6818474336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY {Stockholders' Equity} - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock Shares</div></th>
<th class="th"><div>Common Stock Amount</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at Jan. 01, 2015</a></td>
<td class="nump">128,773,859<span></span>
</td>
<td class="nump">128,774<span></span>
</td>
<td class="nump">35,427,339<span></span>
</td>
<td class="num">(41,925,281)<span></span>
</td>
<td class="num">(6,369,168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of warrants to board of directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 126,679<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 126,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForServices', window );">Issuance of warrants for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">321,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">321,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForServicesRelatedParty', window );">Issuance of warrants for services - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,053<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services</a></td>
<td class="nump">961,539<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="nump">75,190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements', window );">Issuance of common stock and warrants pursuant to private placements</a></td>
<td class="nump">970,000<span></span>
</td>
<td class="nump">970<span></span>
</td>
<td class="nump">47,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued on conversion of 1% Convertible Debt</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt', window );">Common stock issued on conversion of 11% Convertible Debt</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">59,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DiscountsOnIssuanceOfConvertibleDebentures', window );">Discounts on issuance of convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,916,501<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,916,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedForFinancingCosts', window );">Warrants issued for financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 21,150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 21,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockIssuedForFinancingCosts', window );">Common stock issued for financing costs</a></td>
<td class="nump">851,378<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">73,579<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">74,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (5,789,131)<span></span>
</td>
<td class="num">$ (5,789,131)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Balance', window );">Balance at Dec. 31, 2015</a></td>
<td class="nump">132,156,776<span></span>
</td>
<td class="nump">132,157<span></span>
</td>
<td class="nump">38,085,266<span></span>
</td>
<td class="num">(47,714,412)<span></span>
</td>
<td class="num">(9,496,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsToBoardOfDirectors1', window );">Issuance of warrants to board of directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69,712<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForServices1', window );">Issuance of warrants for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,116,444<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,116,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForServicesRelatedParty1', window );">Issuance of warrants for services - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,601<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfCommonStockForServices', window );">Issuance of common stock for services</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">171,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DiscountsOnIssuanceOfConvertibleDebentures1', window );">Discounts on issuance of convertible debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 106,693<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 106,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedForFinancingCosts1', window );">Warrants issued for financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99,931<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockIssuedForFinancingCosts1', window );">Common stock issued for financing costs</a></td>
<td class="nump">1,088,571<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">70,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (6,059,627)<span></span>
</td>
<td class="num">$ (6,059,627)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Balance1', window );">Balance at Dec. 31, 2016</a></td>
<td class="nump">136,745,347<span></span>
</td>
<td class="nump">136,745<span></span>
</td>
<td class="nump">40,016,059<span></span>
</td>
<td class="num">(53,774,039)<span></span>
</td>
<td class="num">(13,621,235)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Balance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_Balance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Balance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_Balance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockIssuedForFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued for financing costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockIssuedForFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockIssuedForFinancingCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued for financing costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockIssuedForFinancingCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockIssuedOnConversionOf1ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockIssuedOnConversionOf1ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DiscountsOnIssuanceOfConvertibleDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discounts on issuance of convertible debentures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DiscountsOnIssuanceOfConvertibleDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DiscountsOnIssuanceOfConvertibleDebentures1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discounts on issuance of convertible debentures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DiscountsOnIssuanceOfConvertibleDebentures1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfCommonStockAndWarrantsPursuantToPrivatePlacements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfCommonStockForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock and warrants issued pursuant to private placements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfCommonStockForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForServices1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForServices1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForServicesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees, related parties as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForServicesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForServicesRelatedParty1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees, related parties as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForServicesRelatedParty1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of warrants issued to board of directors during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsToBoardOfDirectors1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of warrants issued to board of directors during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsToBoardOfDirectors1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedForFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued for financing costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsIssuedForFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedForFinancingCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued for financing costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsIssuedForFinancingCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CapitalUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CapitalUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762864992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (6,059,627)<span></span>
</td>
<td class="num">$ (5,789,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StocksAndWarrantsIssuedForServicesRendered', window );">Stocks and warrants issued for services rendered</a></td>
<td class="nump">1,291,444<span></span>
</td>
<td class="nump">397,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForServicesRelatedParty2', window );">Issuance of warrants for services - related party</a></td>
<td class="nump">15,601<span></span>
</td>
<td class="nump">16,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedForDirectorsFees', window );">Warrants issued for Directors' Fees</a></td>
<td class="nump">69,713<span></span>
</td>
<td class="nump">126,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StocksAndWarrantsIssuedForFinancingCosts', window );">Stocks and warrants issued for financing costs</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">95,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmortizationOfDeferredFinanceCosts', window );">Amortization of deferred finance costs</a></td>
<td class="nump">26,813<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmortizationOfBondDiscount', window );">Amortization of bond discount</a></td>
<td class="nump">1,376,181<span></span>
</td>
<td class="nump">1,866,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation expense</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">(Increase) decrease in prepaid expenses</a></td>
<td class="num">(1,096)<span></span>
</td>
<td class="nump">19,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">(Decrease) in accounts payable</a></td>
<td class="num">(448,061)<span></span>
</td>
<td class="num">(21,430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Increase in due to related party</a></td>
<td class="nump">108,001<span></span>
</td>
<td class="nump">121,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Increase in accrued interest</a></td>
<td class="nump">986,188<span></span>
</td>
<td class="nump">720,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase (decrease) in accrued liabilities</a></td>
<td class="num">(5,630)<span></span>
</td>
<td class="nump">123,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash (Used) in Operating Activities</a></td>
<td class="num">(2,543,473)<span></span>
</td>
<td class="num">(2,296,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash (Used) in Investing Activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flow from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties', window );">Proceeds (payments) from loans payable, related parties</a></td>
<td class="num">(91,130)<span></span>
</td>
<td class="nump">196,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeferredFinanceCosts', window );">Deferred Finance Costs</a></td>
<td class="num">(125,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of 11% convertible debentures</a></td>
<td class="nump">3,250,000<span></span>
</td>
<td class="nump">2,067,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTreasuryStock', window );">Proceeds from sale of common stock and exercise of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">3,033,870<span></span>
</td>
<td class="nump">2,312,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase (Decrease) in Cash</a></td>
<td class="nump">490,397<span></span>
</td>
<td class="nump">15,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at Beginning of Period</a></td>
<td class="nump">16,589<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at End of Period</a></td>
<td class="nump">506,986<span></span>
</td>
<td class="nump">16,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmortizationOfBondDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmortizationOfBondDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmortizationOfDeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmortizationOfDeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForServicesRelatedParty2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees, related party as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForServicesRelatedParty2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StocksAndWarrantsIssuedForFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stocks and warrants issued for financing costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StocksAndWarrantsIssuedForFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StocksAndWarrantsIssuedForServicesRendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StocksAndWarrantsIssuedForServicesRendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedForDirectorsFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued for Directors' Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsIssuedForDirectorsFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow or outflow associated with long-term loans for related parties where one party can exercise control or significant influence over another party, including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from (Payments for) Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForLongTermLoansForRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of an equity stock that has been previously reacquired by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813401808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfBusinessAbstract', window );"><strong>DESCRIPTION OF BUSINESS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 1 &#150; DESCRIPTION OF BUSINESS</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The business model of Zivo Bioscience, Inc. and Subsidiaries (Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc.) (collectively the &#147;Company&#148;) is as follows: 1) to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement and medical food manufacturers (currently, the Company's focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially), and 2) developing, manufacturing, marketing, and selling tests that the Company believes will allow people to optimize their health and identify future health risks.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6741014544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BasisOfPresentationAbstract', window );"><strong>BASIS OF PRESENTATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 2 &#150; BASIS OF PRESENTATION </b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Going Concern</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company had a net loss of $6,059,627 and $5,789,131 during the years ended December 31, 2016 and 2015, respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>In addition, the Company had a working capital deficiency of $10,662,057 and a stockholders&#146; deficiency of $13,621,235 at December 31, 2016. These factors raise substantial doubt about the Company's ability to continue as a going concern.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company&#146;s existing stockholders.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company is attempting to address its lack of liquidity by raising additional funds, either in the form of debt or equity or some combination thereof. &nbsp;There can be no assurances that the Company will be able to raise the additional funds it requires.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>During the year ended December 31, 2016, the Company received proceeds of $3,250,000 from the issuance of 11% convertible debt.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813516896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt'><b>NOTE 3 &#150; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Principles of Consolidation</u></b><b> -</b> The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Accounting Estimates</u></b><b> - </b>The Company&#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates. &nbsp;Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. &nbsp;&nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Cash and Cash Equivalents</u></b><b> -</b> For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31, 2016, the Company did not have any cash equivalents.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Property and Equipment</u></b><b> &#150; </b>Property and equipment consists of furniture and office equipment, and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets, generally five to seven years. &nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Deferred Financing Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &nbsp;Amortization of deferred financing costs amounted to $26,813 and $-0- for the years ended December 31, 2016 and 2015.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Revenue Recognition</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104, &#147;Revenue Recognition&#148; (&#147;SAB No. 104&#148;), which superseded Staff Accounting Bulletin No. 101, &#147;Revenue Recognition in Financial Statements&#148; (&#147;SAB No. 101&#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Shipping and Handling Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Shipping and handling costs are expensed as incurred. For the years ended December 31, 2016 and 2015 no shipping and handling costs were incurred.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Research and Development</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Research and development costs are expensed as incurred. The majority of the Company's research and development costs consist of clinical study expenses. These consist of fees, charges, and related expenses incurred in the conduct of clinical studies conducted with Company products by independent outside contractors. External clinical studies expenses were approximately $789,000 and $1,033,000 for the years ended December 31, 2016 and 2015, respectively. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Income Taxes</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses, and it is more likely than not that some portion or all of the deferred tax assets will not be realized, a full valuation allowance has been established. In addition, utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &#147;change in ownership&#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Stock Based Compensation</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>We account for stock-based compensation in accordance with FASB ASC 718, <i>Compensation &#150; Stock Compensation. &nbsp;</i>Under the provisions of FASB ASC 718, stock-based compensation cost is estimated at the grant date based on the award&#146;s fair value and is recognized as expense over the requisite service period. &nbsp;The Company generally issues grants to its employees, consultants and board members. &nbsp;At the date of grant, the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>During 2016 and 2015, warrants were granted to employees, directors and consultants of the Company. &nbsp;As a result of these grants, the Company recorded compensation expense of $1,201,758 and $464,577 during the years ended December 31, 2016 and 2015 respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="206" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Year Ended December 31,</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected volatility</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>158.53% to 173.53%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>128.36% to 155.43%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected dividends</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected term</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>5 years</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>3 to 5 years</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Risk free rate</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.71% to 1.04%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.51% to 1.75%</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company&#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Income (Loss) Per Share</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Basic loss per share is computed by dividing the Company&#146;s net loss by the weighted average number of common shares outstanding during the period presented. Diluted loss per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &nbsp;Potentially dilutive securities as of December 31, 2016, consisted of 111,086,456 common shares from convertible debentures and related accrued interest and 32,071,901 common shares from outstanding warrants. Potentially dilutive securities as of December 31, 2015, consisted of 73,883,330 common shares from convertible debentures and related accrued interest and 14,705,818 common shares from outstanding warrants. &nbsp;&nbsp;For 2016 and 2015, diluted and basic weighted average shares were the same, as potentially dilutive shares are anti-dilutive.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Advertising Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Advertising costs are charged to operations when incurred. &nbsp;There were no Advertising Costs during the years 2016 and 2015.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Concentrations of Credit Risk</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&#147;FDIC&#148;) limit of $250,000 at times during the year.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Reclassifications</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Future Impact of Recently Issued Accounting Standards</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>In May 2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), &#147;<i>Revenue from Contracts with Customers.</i>&#148;<i> </i>ASU 2014-09 superseded the revenue recognition requirements in &#147;Revenue Recognition (Topic 605),&#148; and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&#146;s financial position or results of operations.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) &#147;Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40).&#148; &nbsp;The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. &nbsp;Early application is permitted. &nbsp;This Update had no effect on the Company&#146;s financial position and results of operations for the year ended December 31, 2016.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued, but not yet effective, accounting standards been adopted in the current period.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746767856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 4 &#150; PROPERTY AND EQUIPMENT</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Property and equipment at December 31, 2016 and 2015 consist of the following:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Furniture &amp; fixtures</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Equipment</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>80,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>80,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Less accumulated depreciation and amortization</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(81,250)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(56,250)</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,750</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>43,750</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Depreciation and amortization was $25,000 and $25,000 for the years ended December 31, 2016 and 2015, respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813446032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DUE TO RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyDisclosuresAbstract', window );"><strong>DUE TO RELATED PARTY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">DUE TO RELATED PARTY</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt'><b>NOTE 5 &#150; DUE TO RELATED PARTY</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As of December 31, 2016 and 2015, the Company owed HEP Investments, a related party, cumulative balances of $319,234 and $211,234, respectively. &nbsp;The basis for the payable is a 5.4% cash finance fee for monies invested in the Company in the form of convertible debt. &nbsp;For the years ended December 31, 2016 and 2015, the Company incurred finance costs related to these transactions of $108,000 and $111,820, respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6731165248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOAN PAYABLE, RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtAbstract', window );"><strong>LOAN PAYABLE, RELATED PARTIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LOAN PAYABLE, RELATED PARTIES</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 6 &#150; LOAN PAYABLE, RELATED PARTIES</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>During the year ended December 31, 2015, Mr. Christopher Maggiore, a director and a significant shareholder of the Company, had advanced the Company a total of $156,405, which remained unpaid as of December 31, 2015. &nbsp;During 2016, Mr. Maggiore advanced the Company an additional $20,000, for a total advanced as of December 31, 2016 of $176,405. &nbsp;The Company has agreed to pay 11% interest on this loan. During the years ended December 31, 2016 and 2015, the Company recorded interest on this indebtedness of $20,396 and $19,835, respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>For the year ended December 31, 2015, Officers had advanced the Company $2,000, which amount remained unpaid as of December 31, 2015. &nbsp;This amount was repaid in 2016.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>During the year ended December 31, 2015, HEP Investments, LLC loaned the Company $2,246,202 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,067,500 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $178,702 as of December 31, 2015. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>During the year ended December 31, 2016, HEP Investments loaned the Company $1,890,872 (see Note 7 - Convertible Debt). Pursuant to the terms of the agreement with HEP Investments, $2,000,000 of these loans were recorded as 11% Convertible Secured Promissory Notes, leaving a remaining balance of $69,574 as of December 31, 2016. &nbsp;&nbsp;</p> <p style='margin:0in 0in 12pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813458240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CONVERTIBLEDEBTAbstract', window );"><strong>CONVERTIBLE DEBT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONVERTIBLE DEBT</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 7 &#150; CONVERTIBLE DEBT</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>HEP Investments, LLC &#150; Related Party</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On December 2, 2011, the Company and HEP Investments, LLC, a Michigan limited liability company (&#147;Lender&#148;), entered into the following documents, effective as of December 1, 2011, as amended through September 30, 2016:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>(i) a Loan Agreement under which the Lender has agreed to advance up to $17,500,000 to the Company, subject to certain conditions, (ii) a Convertible Secured Promissory Note in the principal amount of $17,500,000 (&#147;Note&#148;) and (iii) a Security Agreement, under which the Company granted the Lender a security interest in all of its assets, (iv) an Intellectual Property security agreement under which the Company and its subsidiaries granted the Lender a security interest in all their respective intellectual properties, including patents, in each case order to secure their respective obligations to the Lender under the Note and related documents and &nbsp;(v) enter into a Registration Rights Agreement with respect to all the shares of common stock issuable to the Lender in connection with the Loan transaction. &nbsp;In addition, the Company&#146;s subsidiaries have guaranteed the Company&#146;s obligations under the Note. The Company has also made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Company&#146;s senior management, without the prior written consent of the Lender. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>During the year ended December 31, 2015, the Company recorded a debt discount, related to the $2,067,500 of Notes described previously (Note 6), in the amount of $1,916,501, to reflect the beneficial conversion feature of the convertible debt and fair value of the warrants pursuant to Emerging Issues Task Force (&#147;EITF&#148;) 00-27: Application of EITF 98-5, &#147;Accounting for Convertible Securities with Beneficial Conversion Features on Contingently Adjustable Conversion Rates,&#148; to certain convertible instruments. In accordance with EITF 00-27, the Company valued the beneficial conversion feature and recorded the amount of $1,773,078 as a reduction to the carrying amount of the convertible debt and as an addition to paid-in capital. Additionally, the relative fair value of the warrants was calculated and recorded at $143,423 as a further reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of discounts was $1,866,842 for the year ended December 31, 2015. &nbsp;The $2,067,500 of Notes are convertible at $.10 per share.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>During the year ended December 31, 2016, the Company recorded debt discounts, related to the $2,000,000 of Notes described previously (Note 6), in the amount of $106,693, to reflect the relative fair value of the related warrants as a reduction to the carrying amount of the convertible debt and an addition to additional paid-in capital. The Company is amortizing the debt discount over the term of the debt. Amortization of the debt discounts was $1,376,181 for the years ended December 31, 2016. &nbsp;The $2,000,000 of Notes are convertible at $.10 per share. As discussed in Note 13 &#150; Settlement of Litigation &#150; Related Party, the Lender reduced the principal of the debt by $280,000 (at $.12 per share) relating to a settlement with the Company.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As of December 31, 2016, amounts advanced under the Note are convertible into the Company&#146;s restricted common stock according to the following schedule: (A) $4,152,200 at $.10 per share, (B) $2,320,000 at $.12 per share, (C) $1,285,000 at $.15 per share, (D) $640,000 at $.22 per share, and (E) $750,000 at $.30 per share, (ii) bear interest at the rate of 11% per annum. &nbsp;The Seventh Amended and Restated Senior Secured Convertible Promissory Note (effective December 31, 2015) resets the Due Dates of Tranches 1 through 13 (totaling $3,740,000) to October 14, 2017. The Eighth Amended and Restated Senior Secured Convertible Promissory Note (effective September 30, 2016) resets the Due Dates of Tranches 14 through 16 (totaling $1,369,700) to January 31, 2017. The remaining Tranches 17 to 30, totaling $4,067,500, are due on varying anniversary dates ranging from February 28, 2017 through August 25, 2018. &nbsp;Accrued interest must be paid on the first and second anniversary of the Note. &nbsp;&nbsp;The Company determined that the modification of these Notes was not a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148; As of December 31, 2016 and December 31, 2015, unpaid interest due was $2,502,367 and $1,572,065, respectively and is included in accrued liabilities. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>In 2015, the Lender converted $60,000 of the debt (at $.12 per share). Any Note that has not yet matured may be prepaid upon sixty days written notice, provided that the Company shall be required to pay a prepayment premium equal to 5% of the amount repaid.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'><b>Paulson Investment Company, LLC - Related Debt</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On August 24, 2016, the Company entered into a Placement Agent Agreement with Paulson Investment Company, LLC (Paulson). &nbsp;This agreement provides that Paulson can provide up to $2 million in financings through &#147;accredited investors&#148; (as defined by Regulation D of the Securities Act of 1933, as amended). &nbsp;As of December 31, 2016, the Company received funding of $1,250,000 through seven (7) individual loans (the &#147;New Lenders&#148;). &nbsp;Each loan includes a (i) a Loan Agreement of the individual loan, (ii) a Convertible Secured Promissory Note (&#147;New Lenders Notes&#148;) in the principal amount of the loan, (iii) a Security Agreement under which the Company granted the Lender a security interest in all of its assets and (iv) an Intercreditor Agreement with HEP Investments, LLC (HEP) whereby HEP and the New Lenders agree to participate in all collateral a <i>pari passu </i>basis. &nbsp;The loans have a two year term and mature in September 2018 ($600,000) and October 2018 ($650,000). &nbsp;Paulson receives a 10% cash finance fee for monies invested in the Company in the form of convertible debt, along with 5 year, $.10 warrants equal to 15% of the number of common shares for which the debt is convertible into at $.10 per share.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>The New Lenders Notes are convertible into the Company&#146;s restricted common stock at $.10 per share and bear interest at the rate of 11% per annum. &nbsp;The New Lenders Notes must be repaid as follows: &nbsp;accrued interest must be paid on the first and second anniversary of the Note and unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Other Debt</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>In September 2014, the Lender of the 1% convertible debentures agreed to rolling 30 day extensions until notice is given to the Company to the contrary. &nbsp;The Company determined that the modification of these Notes is not a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Convertible debt consists of the following:</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>1% Convertible notes payable, due January 2017</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>240,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>240,000</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>11% Convertible note payable &#150; HEP Investments, LLC, a related party, net of unamortized discount of $574,443 and $1,843,931, respectively, due at various dates ranging from January 2017 to October 2018</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>8,572,757</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>5,583,269</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>11% Convertible note payable &#150; New Lenders; placed by Paulson, due at various dates ranging from September 2018 to October 2018</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>10,062,757</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>5,823,269</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Less: Current portion</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>6,886,710</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,224,510</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long term portion</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3,176,047</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4,598,759</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 12pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CONVERTIBLEDEBTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CONVERTIBLEDEBTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6758514848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' DEFICIENCY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockholdersDeficiency1Abstract', window );"><strong>STOCKHOLDERS' DEFICIENCY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' DEFICIENCY</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 8 - STOCKHOLDERS&#146; DEFICIENCY</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Board of Directors fees</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2015, at an exercise price of $.09 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $3,664 using the Black Scholes pricing model relying on the following assumptions: volatility 128.38%; annual rate of dividends 0%; discount rate 0.68%. &nbsp;In addition, Mr. Rice is entitled to receive $10,000 for each annual term served.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2015, at an exercise price of $.15 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $6,185 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 1.09%. &nbsp;In addition, Mr. Cox is entitled to receive $10,000 for each annual term served.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to John B. Payne in July, 2015, at an exercise price of $.09 per share. &nbsp;The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter). &nbsp;The warrants were valued at $4,876 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 0. 109%. &nbsp;In addition, Mr. Payne is entitled to receive $10,000 for each annual term served.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On September 10, 2015, the board of directors amended its policy for the compensation of its directors. The Board granted to each of its five (5) Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.10 per share. The warrants have a term of five years and vest immediately. The unvested portion of the previously granted warrants were cancelled due to the Company&#146;s change to a program where all director warrant grants are made once per year at the same time. In addition, each director is entitled to receive $10,000 for each annual term served. &nbsp;As such, Mr. Cox&#146;s unvested warrant of 36,986 shares, Ms. Masterson&#146;s warrant of 959 shares, Mr. Payne&#146;s warrant of 42,740 shares and Mr. Rice&#146;s unvested warrant of 15,890 shares, were cancelled.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 125,000 shares of common stock to Robert O. Rondeau, a new Director, in March 2016, at an exercise price of $.09 per share. &nbsp;The warrants have a term of five years and vest immediately. &nbsp;The warrants were valued at $10,588 using the Black Scholes pricing model relying on the following assumptions: volatility 168.01%; annual rate of dividends 0%; discount rate 0.97%. &nbsp;In addition, Mr. Rondeau will receive $10,000 for each annual term served, paid quarterly.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On September 10, 2016, the board of directors granted to each of its Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.05 per share. The warrants have a term of five years and vest immediately. The warrants were valued at $59,125 using the Black Scholes pricing model relying on the following assumptions: volatility 171.58%; annual rate of dividends 0%; discount rate 0.79%. &nbsp;In addition, each director is entitled to receive $10,000 for each annual term served.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>The Company recorded directors&#146; fees of $109,713 and $166,679 for the years ended December 31, 2016 and 2015, respectively, representing the cash fees and the value of the vested warrants described above.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'><b>Stock Based Compensation</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On April 23, 2015, the Company issued 500,000 shares of common stock valued at $30,000, to an investor relations consulting firm. On April 15, 2015, the Company issued warrants to purchase 1,875,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &nbsp;The warrants were valued at $133,862 using the Black Scholes pricing model relying on the following assumptions: volatility 143.36%; annual rate of dividends 0%; discount rate 0.15%. On June 26, 2015, the Company issued warrants to purchase 1,250,000 shares of common stock at an exercise price of $.08 with a term of five years pursuant to an agreement with a financial consultant. &nbsp;The warrants were valued at $151,443 using the Black Scholes pricing model relying on the following assumptions: volatility 150.93%; annual rate of dividends 0%; discount rate 1.75%. On August 1, 2015, the Company issued 461,539 shares of common stock valued at $46,154, to an investor relations consulting firm. On September 10, 2015, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.10 with a term of five years to four of its consultants (100,000 warrants per consultant) working in research and development. &nbsp;The warrants have a term of five years and are fully vested. &nbsp;The warrants were valued at $36,540 using the Black Scholes pricing model relying on the following assumptions: volatility 152.53%; annual rate of dividends 0%; discount rate 0. 075%.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On May 19, 2016, the Company issued warrants to purchase 14,500,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to agreements with financial consultants. &nbsp;The warrants were valued at $1,095,063 using the Black Scholes pricing model relying on the following assumptions: volatility 170.07%; annual rate of dividends 0%; discount rate 0.89%. &nbsp;On September 19, 2016, the Company issued 3,500,000 shares of common stock, valued at $175,000, to an investor relations consulting firm. &nbsp;On November 17, 2016, the Company issued warrants to purchase 400,000 shares of common stock at an exercise price of $.09 with a term of 5 years pursuant to agreements with financial consultants. &nbsp;The warrants were valued at $21,381 using the Black Scholes pricing model relying on the following assumptions: volatility 173.41%; annual rate of dividends 0%; discount rate 1.04%.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'><b>Stock Issuances</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On January 14, 2015, the Company received proceeds of $30,000 from the issuance of 600,000 shares of common stock. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On January 23, 2015, the Company received proceeds of $13,500 from the issuance of 270,000 shares of common stock. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On February 17, 2015, the Company received proceeds of $5,000 from the issuance of 100,000 shares of common stock. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On February 27, 2015, in connection with the issuance of $227,500 in principal of an 11% Convertible Debenture, the Company issued 81,900 shares of common stock valued at $8,190 and a warrant to purchase 227,500 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.3%; annual rate of dividends 0%; discount rate 0.63%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On March 27, 2015, in connection with the issuance of $135,000 in principal of an 11% Convertible Debenture, the Company issued 151,329 shares of common stock valued at $13,050 and a warrant to purchase 135,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $21,150 using the Black Scholes pricing model relying on the following assumptions: volatility 138.9%; annual rate of dividends 0%; discount rate 0.61%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On April 17, 2015, in connection with the issuance of $217,800 in principal of an 11% Convertible Debenture, the Company issued 112,011 shares of common stock valued at $7,841 and a warrant to purchase 217,800 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $13,326 using the Black Scholes pricing model relying on the following assumptions: volatility 143.3%; annual rate of dividends 0%; discount rate 1.31%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On May 1, 2015, in connection with the issuance of $237,200 in principal of an 11% Convertible Debenture, the Company issued 121,989 shares of common stock valued at $8,539 and a warrant to purchase 237,200 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $14,531 using the Black Scholes pricing model relying on the following assumptions: volatility 143.7%; annual rate of dividends 0%; discount rate 1.50%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On June 26, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 69,231 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $30,012 using the Black Scholes pricing model relying on the following assumptions: volatility 150.9%; annual rate of dividends 0%; discount rate 1.75%. See Note 7 &#150; Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On July 7, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 90,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $22,972 using the Black Scholes pricing model relying on the following assumptions: volatility 150.8%; annual rate of dividends 0%; discount rate 1.55%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On September 2, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 81,818 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $25,221 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.72%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On October 8, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.8%; annual rate of dividends 0%; discount rate 0.65%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On October 29, 2015, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,065 using the Black Scholes pricing model relying on the following assumptions: volatility 152.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On January 27, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $8,018 using the Black Scholes pricing model relying on the following assumptions: volatility 158.1%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On March 1, 2016, in connection with the issuance of $750,000 in principal of an 11% Convertible Debenture, the Company issued 337,500 shares of common stock valued at $27,000 and a warrant to purchase 750,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $44,371 using the Black Scholes pricing model relying on the following assumptions: volatility 167.7%; annual rate of dividends 0%; discount rate 0.85%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On May 16, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 112,500 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $18,746 using the Black Scholes pricing model relying on the following assumptions: volatility 170.1%; annual rate of dividends 0%; discount rate 0.79%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On July 26, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 180,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $11,523 using the Black Scholes pricing model relying on the following assumptions: volatility 170.3%; annual rate of dividends 0%; discount rate 0.75%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On August 25, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 150,000 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $13,939 using the Black Scholes pricing model relying on the following assumptions: volatility 170.8%; annual rate of dividends 0%; discount rate 0.78%. See Note 7 - Convertible Debt. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On October 20, 2016, in connection with the issuance of $250,000 in principal of an 11% Convertible Debenture, the Company issued 128,571 shares of common stock valued at $9,000 and a warrant to purchase 250,000 shares of common stock at an exercise price of $.10 per share. &nbsp;The warrants were valued at $16,419 using the Black Scholes pricing model relying on the following assumptions: volatility 173.2%; annual rate of dividends 0%; discount rate 0.84%. See Note 7 - Convertible Debt.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Executive Compensation</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>As compensation for serving as Chief Financial Officer, the Company, quarterly, will issue warrants to purchase 50,000 shares of common stock to Philip M. Rice at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and compliant manner, at which time such warrants would vest. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>On April 6, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.085. The warrants were valued at $3,800 using the Black Scholes pricing model relying on the following assumptions: volatility 143.17%; annual rate of dividends 0%; discount rate 1.31%. On May 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. The warrants were valued at $3,582 using the Black Scholes pricing model relying on the following assumptions: volatility 143.464%; annual rate of dividends 0%; discount rate 1.57%. &nbsp;On August 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.11. The warrants were valued at $5,019 using the Black Scholes pricing model relying on the following assumptions: volatility 152.05%; annual rate of dividends 0%; discount rate 0.72%. &nbsp;On November 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,652 using the Black Scholes pricing model relying on the following assumptions: volatility 151.81%; annual rate of dividends 0%; discount rate 1.2%.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On March 29, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,771 using the Black Scholes pricing model relying on the following assumptions: volatility 169.28%; annual rate of dividends 0%; discount rate 0.78%. &nbsp;On May 13, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08. &nbsp;The warrants were valued at $3,777 using the Black Scholes pricing model relying on the following assumptions: volatility 170.23%; annual rate of dividends 0%; discount rate 0.76%. &nbsp;On August 12, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.07. &nbsp;The warrants were valued at $3,307 using the Black Scholes pricing model relying on the following assumptions: volatility 170.83%; annual rate of dividends 0%; discount rate 0.71%. &nbsp;On November 14, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.10. &nbsp;The warrants were valued at $4,745 using the Black Scholes pricing model relying on the following assumptions: volatility 173.53%; annual rate of dividends 0%; discount rate 1.00%. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'><b>Common Stock Warrants</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>A summary of the status of the Company&#146;s warrants is presented below.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="160" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:120pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>December 31, 2016</b></p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="166" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:124.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>December 31, 2015</b></p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number of</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number of</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Warrants</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Warrants</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Outstanding, beginning of year</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>14,705,818</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>9,053,005</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.16</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Issued</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,350,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,192,500</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Exercised</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Cancelled</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(96,575)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expired</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(2,983,917)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(1,443,112)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Outstanding, end of period</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>14,705,818</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Warrants outstanding and exercisable by price range as of December 31, 2016 were as follows:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="227" colspan="5" style='border-top:#f0f0f0;border-right:#f0f0f0;width:170.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>Outstanding Warrants</b></p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="196" colspan="5" style='border-top:#f0f0f0;border-right:#f0f0f0;width:147pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>Exercisable Warrants</b></p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Remaining</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Range of</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Contractual Life in Years</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td></tr> <tr> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4.70</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,625,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4.23</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,625,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>309,110</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3.11</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>309,110</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,327,200</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3.99</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,327,200</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>99,041</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.17</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>99,041</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.62</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2,485,274</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.30</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2,485,274</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.25</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.46</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>269,276</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.75</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>269,276</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>707,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.52</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>707,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.90</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.50</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.01</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.79</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockholdersDeficiency1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockholdersDeficiency1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813481920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INCOME (EXPENSE)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OtherIncomeAndExpensesAbstract1', window );"><strong>OTHER INCOME (EXPENSE): {1}</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">OTHER INCOME (EXPENSE)</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt'><b>NOTE 9 - OTHER INCOME (EXPENSE)</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>On July 15, 2014, the Company settled a dispute with one of its vendors. &nbsp;The settlement agreement calls for the Company to make 10 payments of $6,250. &nbsp;If the payments are not made timely, a total liability of $97,463 out of the gross amount recorded on the Company&#146;s books of $191,146 will be due. &nbsp;During the year ended December 31, 2015, the Company met its obligation for timely payments and recognized an additional $34,963 (the difference between the $97,463 remaining liability and the agreed upon payments of $62,500) as "Other Income" on its Statement of Operations the year ended December 31, 2015.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OtherIncomeAndExpensesAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OtherIncomeAndExpensesAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3,6,7,9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6629856112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommitmentAndContingenciesAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES {1}</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 10- COMMITMENTS AND CONTINGENCIES</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Employment Agreement</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>The Company&#146;s Chief Executive Officer, Andrew Dahl, is serving under the terms of an employment agreement dated December 16, 2011 as amended August 11, 2016. Under the agreement Mr. Dahl serves as CEO for one year terms, subject to automatic renewal, unless either party terminates the Agreement on sixty days&#146; notice prior to the expiration of the term of the agreement. &nbsp;Mr. Dahl is compensated as follows: &nbsp;he receives an annual base salary of $240,000. &nbsp;In addition, Mr. Dahl is entitled to monthly bonus compensation equal to 2% of the Company&#146;s revenue, but only to the extent that such bonus amount exceeds his base salary for the month in question. &nbsp;In addition, Mr. Dahl will be entitled to warrants having an exercise price of $.25 per share, upon the attainment of specified milestones as follows: 1) Warrants for 500,000 shares upon identification of bio-active agents in the Company&#146;s product and filing of a patent with respect thereto, 2) Warrants for 500,000 shares upon entering into a business contract under which the Company receives at least $500,000 in cash payments, 3) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement with a research company to develop &nbsp;medicinal or pharmaceutical applications (where the partner provides at least $2 million in cash or in-kind outlays), 4) Warrants for 1,000,000 shares upon the Company entering into a co-development agreement for nutraceutical or dietary supplement applications (where the partner provides at least $2 million in cash or in-kind outlays), 5) Warrants for 1,000,000 shares upon the Company entering into a pharmaceutical development agreement. &nbsp;Further, as it relates to Company&#146;s wholly-owned subsidiary, WellMetris, LLC (&#147;WellMetris&#148;), in the event the Company ceases to own a controlling interest in WellMetris for any reason whatsoever, the Company shall cause WellMetris to grant Mr. Dahl warrants to purchase a seven percent (7%) equity interest in WellMetris at the time outside funding is closed and/or at the time an event occurs whereby the Company relinquishes majority control of WellMetris. &nbsp;Such Warrant shall be priced at the per-unit or per-share price at the time of the applicable closing or change of control with respect to WellMetris. &nbsp;As of December 31, 2016, none of the milestones referred to had been achieved and there has been no notice of contract termination.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Legal Contingencies</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>We may become a party to litigation in the normal course of business. &nbsp;In the opinion of management, there are no legal matters involving us that would have a material adverse effect upon our financial condition, results of operation or cash flows.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Workers&#146; Compensation</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company does not carry workers&#146; compensation insurance, which covers on the job injury.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommitmentAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommitmentAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6629858448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyTransactionsAbstract1', window );"><strong>RELATED PARTY TRANSACTIONS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyTransactionsTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 11 - RELATED PARTY TRANSACTIONS</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Due to Related Party</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>See Note 5 Due to Related Party for disclosure of payable to related Party. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Loan Payable &#150; Related Party</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>See Note 6 Loan Payable &#150; Related Parties for disclosure of loans payable to related Parties </p> <p style='margin:0in 0in 12pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Executive Compensation</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>See Note 8 &#150; Stockholder&#146; Deficiency for disclosure of compensation to the Chief Financial Officer. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Employment Agreement</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>See Note 10 &#150; Commitments and Contingencies for disclosure of the Employment Agreement with the Chief Executive Officer.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyTransactionsAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyTransactionsAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyTransactionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyTransactionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622495232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncomeTaxesAbstract', window );"><strong>INCOME TAXES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 12 - INCOME TAXES</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>At December 31, 2016 the Company had available net-operating loss carry-forwards for Federal tax purposes of approximately $39,732,000, which may be applied against future taxable income, if any, at various dates from 2016 through 2036. Certain significant changes in ownership of the Company may restrict the future utilization of these tax loss carry-forwards.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>At December 31, 2016 the Company had a deferred tax asset of approximately $15,893,000 representing the benefit of its net operating loss carry-forwards. The Company has not recognized the tax benefit because realization of the tax benefit is uncertain and thus a valuation allowance has been fully provided against the deferred tax asset. &nbsp;The difference between the Federal and State Statutory Rate of 40% and the Company&#146;s effective tax rate of 0% is due to an increase in the valuation allowance of approximately $3,693,000 in 2016.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747390064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SETTLEMENT OF LITIGATION - RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SettlementOfLitigationRelatedPartyAbstract', window );"><strong>SETTLEMENT OF LITIGATION - RELATED PARTY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">SETTLEMENT OF LITIGATION - RELATED PARTY</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt'><b>NOTE 13 &#150; SETTLEMENT OF LITIGATION - RELATED PARTY</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>On July 15, 2015, a shareholder of the Company (&#147;Shareholder&#148;) brought action against HEP Investment alleging certain technical violations of Section 16(b) of the Securities Act of 1934, as amended. &nbsp;On March 3, 2017, without admitting any liability whatsoever, HEP Investment settled with the Shareholder by agreeing to reduce the Company&#146;s debt owed to HEP Investment by $280,000. Related to this debt reduction, the Company will pay to the Shareholder&#146;s legal counsel $60,000 and 250,000 shares of the Company&#146;s common stock valued at $22,500. &nbsp;The Company considered the settlement to be a Type 1 subsequent event and recorded legal fees of $82,500 on the Statement of Operations and recorded the settlement amount of $280,000 as a reduction of convertible debt owed to HEP Investments and an increase to Additional Paid-In Capital.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SettlementOfLitigationRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SettlementOfLitigationRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619725648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>NOTE 14 &#150; SUBSEQUENT EVENTS </b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>CONVERTIBLE DEBT: HEP Investments, LLC</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b>Debt Modification</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>On March 1, 2017, the Company and HEP Investments, LLC (&#147;Lender&#148;), entered into the following documents, effective as of March 1, 2017: (i) Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total of $17,500,000 to the Company, subject to certain conditions, and (ii) a Ninth Amended and Restated Senior Secured Convertible Promissory Note. &nbsp;The Eighth Amendment to Loan Agreement amends and restates the Seventh Amendment to Loan Agreement, which was entered into with the Lender on December 31, 2015 and disclosed in the Company&#146;s Form 8-K Current Report filed on January 7, 2016. &nbsp;The Ninth Amended and Restated Senior Secured Convertible Promissory Note resets the total outstanding debt as of March 1, 2017 and provides for a maturity date of September 30, 2018. &nbsp;The total outstanding debt as of March 1, 2017 is $12,982,203. &nbsp;This amount includes unpaid principal of $9,427,200, interest outstanding as of February 28, 2017 of $2,955,003 and restructuring and legal fees of $600,000.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company, as consideration for the extension of the maturity date to September 30, 2018, agreed to provide for the conversion of the $12,982,203 Convertible Promissory Note into the Company&#146;s restricted common stock at $.10 per share, with interest at the rate of 11% per annum.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The related indebtedness represented by this note shall be paid to the Lender in monthly installments of interest only beginning on July 1, 2017 and continuing on the first day of each month thereafter.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Based on the above, the total shares of common stock, if the Lender converted the complete $12,982,203 convertible debt, would be 129,822,030 shares, not including any future interest charges which may be converted into common stock.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Amounts advanced under the Note are secured by all the Company&#146;s assets.</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company has agreed to pay the following fees in connection with the Loan transaction (when the final $4,517,797 in funding is achieved): (i) a $361,602 closing fee, consisting of $216,961 in cash, and $144,641 paid in shares of common stock, which will be accomplished by the issuance of common stock valued at various amounts based on the timing of the funding and the related stock price. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company has made certain agreements with the Lender which shall remain in effect as long as any amount is outstanding under the Loan. These agreements include an agreement not to make any change in the Registrant&#146;s senior management. Two representatives of the Lender will have the right to attend Board of Director meetings as non-voting observers.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company determined that the modification of these Notes was a substantial modification in accordance with ASC 470-50, &#147;Modifications and Extinguishments.&#148; &nbsp;As such, the Company will recognize a loss on extinguishment.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='text-align:justify;margin:0in 0in 0pt'><b>11% Convertible Debt - HEP Investments, LLC</b></p> <p style='text-align:justify;margin:0in 0in 0pt'>&nbsp;</p> <p style='text-align:justify;margin:0in 0in 0pt'>On March 31, 2017, HEP Investments LLC (&#147;Lender&#148;) funded an additional of $1,000,000. &nbsp;Due to this additional funding, the Company issued to the Lender a $1,000,000, an 11% convertible note and warrants to purchase 1,000,000 shares of common stock, at an exercise price of $.10 for a term of five years. &nbsp;The terms of the debt are in described in Note 7 - Convertible Debt.</p> <p style='text-align:justify;margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'><b>Stock Based Compensation</b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>On February 27, 2017, the Company issued warrants to purchase 500,000 shares of common stock at an exercise price of $.10 with a term of 5 years pursuant to an agreement with a financial consultant. &nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820799088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccountingPolicies1Abstract', window );"><strong>Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Principles of Consolidation</u></b><b> -</b> The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Accounting Esimates</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Accounting Estimates</u></b><b> - </b>The Company&#146;s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. &nbsp;Actual results could differ from those estimates. &nbsp;Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. &nbsp;&nbsp;</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Cash and Cash Equivalents</u></b><b> -</b> For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances in certain bank accounts may exceed the FDIC insured limits. Cash equivalents consist of highly liquid investments with an original maturity of three months or less when purchased. At December 31, 2016, the Company did not have any cash equivalents.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Property and Equipment</u></b><b> &#150; </b>Property and equipment consists of furniture and office equipment, and are carried at cost less allowances for depreciation and amortization. Depreciation and amortization is determined by using the straight-line method over the estimated useful lives of the related assets, generally five to seven years. &nbsp;Repair and maintenance costs that do not improve service potential or extend the economic life of an existing fixed asset are expensed as incurred. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Financing Costs</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Deferred Financing Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company follows authoritative guidance for accounting for financing costs as it relates to convertible debt issuance cost. &nbsp;These costs are deferred and amortized over the term of the debt period or until redemption of the convertible debentures. &nbsp;Amortization of deferred financing costs amounted to $26,813 and $-0- for the years ended December 31, 2016 and 2015.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Revenue Recognition</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>For revenue from product sales, the Company recognizes revenue in accordance with Staff Accounting Bulletin No. 104, &#147;Revenue Recognition&#148; (&#147;SAB No. 104&#148;), which superseded Staff Accounting Bulletin No. 101, &#147;Revenue Recognition in Financial Statements&#148; (&#147;SAB No. 101&#148;). SAB No. 104 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#146;s judgment regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Shipping and Handling Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Shipping and handling costs are expensed as incurred. For the years ended December 31, 2016 and 2015 no shipping and handling costs were incurred.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Research and Development</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Research and development costs are expensed as incurred. The majority of the Company's research and development costs consist of clinical study expenses. These consist of fees, charges, and related expenses incurred in the conduct of clinical studies conducted with Company products by independent outside contractors. External clinical studies expenses were approximately $789,000 and $1,033,000 for the years ended December 31, 2016 and 2015, respectively. </p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes, Policy</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Income Taxes</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The Company follows the authoritative guidance for accounting for income taxes. Deferred income taxes are determined using the asset and liability method. &nbsp;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The tax effects of temporary differences that gave rise to the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 were primarily attributable to net operating loss carry forwards. Since the Company has a history of losses, and it is more likely than not that some portion or all of the deferred tax assets will not be realized, a full valuation allowance has been established. In addition, utilization of net operating loss carry-forwards are subject to a substantial annual limitation due to the &#147;change in ownership&#148; provisions of the Internal Revenue Code. The annual limitation may result in the expiration of net operating loss carry-forwards before utilization.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock Based Compensation</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Stock Based Compensation</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>We account for stock-based compensation in accordance with FASB ASC 718, <i>Compensation &#150; Stock Compensation. &nbsp;</i>Under the provisions of FASB ASC 718, stock-based compensation cost is estimated at the grant date based on the award&#146;s fair value and is recognized as expense over the requisite service period. &nbsp;The Company generally issues grants to its employees, consultants and board members. &nbsp;At the date of grant, the Company determines the fair value of the stock option award and recognizes compensation expense over the requisite service period. &nbsp;The fair value of the stock option or warrant award is calculated using the Black Scholes option pricing model.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>During 2016 and 2015, warrants were granted to employees, directors and consultants of the Company. &nbsp;As a result of these grants, the Company recorded compensation expense of $1,201,758 and $464,577 during the years ended December 31, 2016 and 2015 respectively.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="206" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Year Ended December 31,</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected volatility</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>158.53% to 173.53%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>128.36% to 155.43%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected dividends</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected term</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>5 years</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>3 to 5 years</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Risk free rate</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.71% to 1.04%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.51% to 1.75%</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Because the Company&#146;s employee warrants have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&#146;s opinion the existing models may not necessarily provide a reliable single measure of the fair value of its employee options.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Income (Loss) Per Share</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Basic loss per share is computed by dividing the Company&#146;s net loss by the weighted average number of common shares outstanding during the period presented. Diluted loss per share is based on the treasury stock method and includes the effect from potential issuance of common stock such as shares issuable pursuant to the exercise of warrants and conversions of debentures. &nbsp;Potentially dilutive securities as of December 31, 2016, consisted of 111,086,456 common shares from convertible debentures and related accrued interest and 32,071,901 common shares from outstanding warrants. Potentially dilutive securities as of December 31, 2015, consisted of 73,883,330 common shares from convertible debentures and related accrued interest and 14,705,818 common shares from outstanding warrants. &nbsp;&nbsp;For 2016 and 2015, diluted and basic weighted average shares were the same, as potentially dilutive shares are anti-dilutive.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Advertising Costs</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Advertising costs are charged to operations when incurred. &nbsp;There were no Advertising Costs during the years 2016 and 2015.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Concentrations of Credit Risk</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. &nbsp;The Company has historically maintained cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation (&#147;FDIC&#148;) limit of $250,000 at times during the year.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Reclassifications</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Certain items in these consolidated financial statements have been reclassified to conform to the current period presentation.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Future Impact of Recently Issued Accounting Standards</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'><b><u>Future Impact of Recently Issued Accounting Standards</u></b></p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>In May 2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), &#147;<i>Revenue from Contracts with Customers.</i>&#148;<i> </i>ASU 2014-09 superseded the revenue recognition requirements in &#147;Revenue Recognition (Topic 605),&#148; and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflect the consideration to which the entity expects to be entitled to in exchange for those goods or services. &nbsp;ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. ASU 2014-09 is not expected to have a material impact on the Company&#146;s financial position or results of operations.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt'>In August 2014, the FASB issued Accounting Standards Update 2014-15 (ASU 2014-15) &#147;Presentation of Financial Statements &#150; Going Concern (Subtopic 205-40).&#148; &nbsp;The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. &nbsp;Early application is permitted. &nbsp;This Update had no effect on the Company&#146;s financial position and results of operations for the year ended December 31, 2016.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Management does not believe there would have been a material effect on the accompanying financial statements had any other recently issued, but not yet effective, accounting standards been adopted in the current period.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccountingPolicies1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccountingPolicies1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054294&amp;loc=d3e8384-108330<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68072981&amp;loc=d3e8275-108329<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Shipping Costs<br> -URI http://asc.fasb.org/extlink&amp;oid=51575562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6408413&amp;loc=d3e221937-122793<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68075638&amp;loc=d3e60635-111653<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68080631&amp;loc=d3e61069-111654<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Handling Costs<br> -URI http://asc.fasb.org/extlink&amp;oid=51575068<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShippingAndHandlingCostPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746699584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Warrants Estimated (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfWarrantsEstimatedTablesAbstract', window );"><strong>Fair Value of Warrants Estimated (Tables):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfWarrantsEstimatedTablesTextBlock', window );">Fair Value of Warrants Estimated (Tables)</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'>The fair value of warrants was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted average assumptions:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="206" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:154.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Year Ended December 31,</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected volatility</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>158.53% to 173.53%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>128.36% to 155.43%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected dividends</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>0%</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expected term</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>5 years</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>3 to 5 years</p></td></tr> <tr> <td valign="bottom" width="130" style='border-top:#f0f0f0;border-right:#f0f0f0;width:97.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Risk free rate</p></td> <td valign="bottom" width="100" style='border-top:#f0f0f0;border-right:#f0f0f0;width:75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.71% to 1.04%</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="93" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>.51% to 1.75%</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfWarrantsEstimatedTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FairValueOfWarrantsEstimatedTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfWarrantsEstimatedTablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FairValueOfWarrantsEstimatedTablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6758405616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfPropertyAndEquipmentAbstract', window );"><strong>Schedule of Property and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Property and equipment at December 31, 2016 and 2015 consist of the following:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Furniture &amp; fixtures</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Equipment</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>80,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>80,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Less accumulated depreciation and amortization</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(81,250)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(56,250)</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,750</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="86" style='border-top:#f0f0f0;border-right:#f0f0f0;width:64.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>43,750</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfPropertyAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfPropertyAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813523440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Convertible debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfConvertibleDebtTableTextBlockAbstract', window );"><strong>Schedule of Convertible debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Convertible debt</a></td>
<td class="text"><!--egx--><div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Convertible debt consists of the following:</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2016</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>December 31,</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>2015</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>1% Convertible notes payable, due January 2017</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>240,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>240,000</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>11% Convertible note payable &#150; HEP Investments, LLC, a related party, net of unamortized discount of $574,443 and $1,843,931, respectively, due at various dates ranging from January 2017 to October 2018</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>8,572,757</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>5,583,269</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>11% Convertible note payable &#150; New Lenders; placed by Paulson, due at various dates ranging from September 2018 to October 2018</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>10,062,757</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>5,823,269</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Less: Current portion</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>6,886,710</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,224,510</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="286" style='border-top:#f0f0f0;border-right:#f0f0f0;width:214.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long term portion</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="80" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3,176,047</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4,598,759</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 12pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfConvertibleDebtTableTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfConvertibleDebtTableTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6648841504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_STOCKHOLDERSWARRANTSAbstract', window );"><strong>Stockholders Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of the status of warrants (Tables)</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'>A summary of the status of the Company&#146;s warrants is presented below.</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="160" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:120pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>December 31, 2016</b></p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="166" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:124.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>December 31, 2015</b></p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number of</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number of</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Warrants</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Warrants</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Outstanding, beginning of year</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>14,705,818</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>9,053,005</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.16</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Issued</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>20,350,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,192,500</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Exercised</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Cancelled</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>-</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(96,575)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Expired</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(2,983,917)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>(1,443,112)</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="177" style='border-top:#f0f0f0;border-right:#f0f0f0;width:132.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Outstanding, end of period</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="79" style='border-top:#f0f0f0;border-right:#f0f0f0;width:59.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="64" style='border-top:#f0f0f0;border-right:#f0f0f0;width:48pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>14,705,818</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="84" style='border-top:#f0f0f0;border-right:#f0f0f0;width:63pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.13</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsOutstandingAndExercisableTableTextBlock', window );">Warrants outstanding and exercisable (Tables)</a></td>
<td class="text"><!--egx--><p style='margin:0in 0in 0pt;text-indent:-0.5pt'>Warrants outstanding and exercisable by price range as of December 31, 2016 were as follows:</p> <p style='margin:0in 0in 0pt'>&nbsp;</p> <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="227" colspan="5" style='border-top:#f0f0f0;border-right:#f0f0f0;width:170.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>Outstanding Warrants</b></p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="196" colspan="5" style='border-top:#f0f0f0;border-right:#f0f0f0;width:147pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'><b>Exercisable Warrants</b></p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Weighted</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Remaining</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Average</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Range of</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Contractual Life in Years</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Number</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="center" style='text-align:center;margin:0in 0in 0pt'>Exercise Price</p></td></tr> <tr> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td> <td valign="top" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt;text-indent:-0.5pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4.70</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1,250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.05</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,625,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>4.23</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>18,625,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.08</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>309,110</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3.11</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>309,110</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.09</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,327,200</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>3.99</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>7,327,200</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>99,041</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.17</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>99,041</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.12</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.62</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.14</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2,485,274</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.30</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2,485,274</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.15</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>2.25</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.17</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.46</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>100,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.19</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.20</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>269,276</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.75</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>269,276</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.22</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>707,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.52</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>707,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.25</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.90</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.30</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.50</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>250,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.33</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.01</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>50,000</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.38</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="67" style='border-top:#f0f0f0;border-right:#f0f0f0;width:50.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="12" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="76" style='border-top:#f0f0f0;border-right:#f0f0f0;width:57pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>1.79</p></td> <td valign="bottom" width="20" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="52" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="13" style='border-top:#f0f0f0;border-right:#f0f0f0;width:9.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p style='margin:0in 0in 0pt'>&nbsp;</p></td> <td valign="bottom" width="60" style='border-top:#f0f0f0;border-right:#f0f0f0;width:45pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>32,071,901</p></td> <td valign="bottom" width="16" style='border-top:#f0f0f0;border-right:#f0f0f0;width:12pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>$</p></td> <td valign="bottom" width="53" style='border-top:#f0f0f0;border-right:#f0f0f0;width:39.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> <p align="right" style='text-align:right;margin:0in 0in 0pt'>0.10</p></td></tr></table></div> <p style='margin:0in 0in 0pt'>&nbsp;</p> <p style='margin:0in 0in 12pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_STOCKHOLDERSWARRANTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_STOCKHOLDERSWARRANTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular Disclosure for Warrants outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6758661632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BasisOfPresentationDetailsAbstract', window );"><strong>Basis of Presentation Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NetLoss1', window );">Net Loss</a></td>
<td class="nump">$ 6,059,627<span></span>
</td>
<td class="nump">$ 5,789,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WorkingCapitalDeficiency1', window );">Working capital deficiency</a></td>
<td class="nump">10,662,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockholdersDeficiency', window );">Stockholders' deficiency</a></td>
<td class="nump">13,621,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfConvertibleDebentures', window );">Proceeds from issuance of convertible debentures</a></td>
<td class="nump">$ 3,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BasisOfPresentationDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_BasisOfPresentationDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NetLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NetLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedsFromIssuanceOfConvertibleDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ProceedsFromIssuanceOfConvertibleDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockholdersDeficiency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockholdersDeficiency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WorkingCapitalDeficiency1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital deficiency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WorkingCapitalDeficiency1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811519360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract', window );"><strong>Summary of Significant Accounting Policies (Narrative) Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ResearchAndDevelopmentCosts', window );">Research and development costs</a></td>
<td class="nump">$ 789,000<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">1,201,758<span></span>
</td>
<td class="nump">464,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PotentiallyDilutiveSecuritiesAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest', window );">Common shares from convertible debentures and related accrued interest</a></td>
<td class="nump">111,086,456<span></span>
</td>
<td class="nump">73,883,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonSharesFromOutstandingWarrants', window );">Common shares from outstanding warrants</a></td>
<td class="nump">32,071,901<span></span>
</td>
<td class="nump">14,705,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1', window );">Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation ("FDIC") limit.</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares from convertible debentures and related accrued interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonSharesFromConvertibleDebenturesAndRelatedAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonSharesFromOutstandingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares from convertible debentures and related accrued interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonSharesFromOutstandingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ConcentrationsOfCreditRiskAbstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyMaintainsCashBalancesAtFinancialInstitutionsWhichExceedTheCurrentFederalDepositInsuranceCorporationFdicLimit1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PotentiallyDilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PotentiallyDilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company raised net proceeds from from the issuance of convertible debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SummaryOfSignificantAccountingPoliciesNarrativeDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760573536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility minimum</a></td>
<td class="nump">158.53%<span></span>
</td>
<td class="nump">128.36%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility maximum</a></td>
<td class="nump">173.53%<span></span>
</td>
<td class="nump">155.43%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free rate minimum</a></td>
<td class="nump">0.71%<span></span>
</td>
<td class="nump">0.51%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free rate maximum</a></td>
<td class="nump">1.04%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811653712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyAndEquipmentDetailsAbstract', window );"><strong>Property and Equipment Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(81,250)<span></span>
</td>
<td class="num">(56,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="nump">$ 18,750<span></span>
</td>
<td class="nump">$ 43,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyAndEquipmentDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PropertyAndEquipmentDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6595451008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment Depreciation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyAndEquipmentDepreciationAbstract', window );"><strong>Property and Equipment Depreciation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyAndEquipmentDepreciationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PropertyAndEquipmentDepreciationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622904336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Due to Related Party (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DueToRelatedPartyDetailsAbstract', window );"><strong>Due to Related Party Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances', window );">Company owed HEP Investments, a related party, cumulative balances</a></td>
<td class="nump">$ 319,234<span></span>
</td>
<td class="nump">$ 211,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CashFinanceFee', window );">Cash finance fee</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyIncurredFinanceCosts', window );">Company incurred finance costs</a></td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="nump">$ 111,820<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CashFinanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash finance fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CashFinanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyIncurredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company incurred finance costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyIncurredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company owed HEP Investments, a related party, cumulative balances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyOwedHepInvestmentsARelatedPartyCumulativeBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DueToRelatedPartyDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DueToRelatedPartyDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823450112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Payable, Related Parties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LoanPayableRelatedPartiesDetailsAbstract', window );"><strong>Loan Payable, Related Parties Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountAdvancedByChrisMaggioreASignificantShareholder', window );">Amount advanced by Chris Maggiore, a significant shareholder</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 156,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount', window );">Mr. Maggiore advanced the Company an additional amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalOutstandingBalanceOfAdvance', window );">Total outstanding balance of advance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 176,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyAgreedToPayInterestOnLoan', window );">Company agreed to pay interest on loan</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccruedInterestOnIndebtednessTotaled', window );">Accrued interest on indebtedness totaled</a></td>
<td class="nump">$ 20,396<span></span>
</td>
<td class="nump">$ 19,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountAdvancedByOfficers', window );">Amount advanced by Officers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_HepInvestmentsLlcLoanedTheCompany', window );">HEP Investments, LLC loaned the Company</a></td>
<td class="nump">1,890,872<span></span>
</td>
<td class="nump">2,246,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes', window );">Loans were converted to Convertible Secured Promissory Notes</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,067,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleSecuredPromissoryNotes', window );">Convertible Secured Promissory Notes</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RemainingBalanceInLoansPayableToRelatedParties', window );">Remaining balance in loans payable to related parties</a></td>
<td class="nump">$ 69,574<span></span>
</td>
<td class="nump">$ 178,702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccruedInterestOnIndebtednessTotaled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued interest on indebtedness totaled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccruedInterestOnIndebtednessTotaled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountAdvancedByChrisMaggioreASignificantShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount advanced by Chris Maggiore, a significant shareholder</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmountAdvancedByChrisMaggioreASignificantShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountAdvancedByOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount advanced by Officers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmountAdvancedByOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyAgreedToPayInterestOnLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company agreed to pay interest on loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyAgreedToPayInterestOnLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleSecuredPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Secured Promissory Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleSecuredPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_HepInvestmentsLlcLoanedTheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>HEP Investments, LLC loaned the Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_HepInvestmentsLlcLoanedTheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LoanPayableRelatedPartiesDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LoanPayableRelatedPartiesDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans were converted to Convertible Secured Promissory Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LoansWereConvertedToConvertibleSecuredPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mr. Maggiore advanced the Company an additional amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_MrMaggioreAdvancedTheCompanyAnAdditionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RemainingBalanceInLoansPayableToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining balance in loans payable to related parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RemainingBalanceInLoansPayableToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalOutstandingBalanceOfAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total outstanding balance of advance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalOutstandingBalanceOfAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738248720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Debt - HEP Investments, LLC (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_HepInvestmentsLlcDetailsAbstract', window );"><strong>HEP Investments, LLC Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvanceAgreedUnderLoanAgreement1', window );">Advance agreed under the loan agreement</a></td>
<td class="nump">$ 17,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1', window );">Convertible Secured Promissory Note in the initial principal amount</a></td>
<td class="nump">17,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote', window );">Advanced amount of Convertible Secured Promissory Note</a></td>
<td class="nump">$ 8,677,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvanceAgreedUnderLoanAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance agreed under loan agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AdvanceAgreedUnderLoanAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdvancedAmountOfConvertibleSecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advances of Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AdvancedAmountOfConvertibleSecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Secured Promissory Note in the initial principal amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleSecuredPromissoryNoteInTheInitialPrincipalAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_HepInvestmentsLlcDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance agreed under loan agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_HepInvestmentsLlcDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823558640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Debt Discount and Other (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeferredDebtDiscountAndOtherDetailsAbstract', window );"><strong>Deferred Debt Discount and Other details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt', window );">Company recorded debt discount in the amount to reflect the beneficial conversion feature of the convertible debt</a></td>
<td class="nump">$ 106,693<span></span>
</td>
<td class="nump">$ 1,916,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded', window );">Value of the notes on which debt discount was recorded</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,067,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital', window );">Company valued the beneficial conversion feature as an addition to paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,773,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded', window );">The relative fair value of the warrants was calculated and recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">143,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmortizationOfDebtDiscounts', window );">Amortization of debt discounts</a></td>
<td class="nump">1,376,181<span></span>
</td>
<td class="nump">1,866,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare', window );">Related Party, the Lender reduced the principal of the debt at $.12 per share</a></td>
<td class="nump">$ 280,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmortizationOfDebtDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmortizationOfDebtDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company recorded debt discount in the amount to reflect the beneficial conversion feature of the convertible debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRecordedDebtDiscountInTheAmountToReflectTheBeneficialConversionFeatureOfTheConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company valued the beneficial conversion feature as an addition to paid-in capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyValuedTheBeneficialConversionFeatureAsAnAdditionToPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeferredDebtDiscountAndOtherDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeferredDebtDiscountAndOtherDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party, the Lender reduced the principal of the debt at $.12 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyTheLenderReducedThePrincipalOfTheDebtAt12PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company valued the beneficial conversion feature and recorded the amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TheRelativeFairValueOfTheWarrantsWasCalculatedAndRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the notes on which debt discount was recorded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ValueOfTheNotesOnWhichDebtDiscountWasRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817874992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>HEP Investments, LLC - Restricted Common Shares (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RestrictedCommonSharesDetailsAbstract', window );"><strong>Restricted Common Shares Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockValueScheduleA010PerShare', window );">Company 's Restricted Common stock value- schedule A 0.10 per share</a></td>
<td class="nump">$ 4,152,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockValueScheduleB012PerShare', window );">Company 's Restricted Common stock value- schedule B 0.12 per share</a></td>
<td class="nump">2,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockValueScheduleC015PerShare', window );">Company 's Restricted Common stock value- schedule -C 0.15 per share</a></td>
<td class="nump">1,285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockValueScheduleD022PerShare', window );">Company 's Restricted Common stock value- schedule -D 0.22 per share</a></td>
<td class="nump">640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockValueScheduleE030PerShare', window );">Company 's Restricted Common stock value- schedule -E 0.30 per share</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleNote2BearsInterestRate', window );">Convertible note (2) bears interest rate</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePromissoryNoteTotaling', window );">Convertible Promissory Note Totaling</a></td>
<td class="nump">$ 3,740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePromissoryNoteTranches14Through16Totaling', window );">Convertible Promissory Note Tranches 14 through 16 Totaling</a></td>
<td class="nump">1,369,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RemainingTranches17To30Totaling', window );">Remaining Tranches 17 to 30, totaling</a></td>
<td class="nump">4,067,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnpaidInterestDue', window );">Unpaid interest due</a></td>
<td class="nump">2,502,367<span></span>
</td>
<td class="nump">$ 1,572,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LenderConvertedTheDebt', window );">Lender Converted the debt</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LenderConvertedTheDebtPerShare', window );">Lender Converted the debt per share</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid', window );">Company shall be required to pay a prepayment premium equal to the amount repaid</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockValueScheduleA010PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company 's Restricted Common stock value- schedule A 0.10 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockValueScheduleA010PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockValueScheduleB012PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company 's Restricted Common stock value- schedule B 0.12 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockValueScheduleB012PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockValueScheduleC015PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company 's Restricted Common stock value- schedule -C 0.15 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockValueScheduleC015PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockValueScheduleD022PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company 's Restricted Common stock value- schedule -D 0.22 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockValueScheduleD022PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockValueScheduleE030PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company 's Restricted Common stock value- schedule -E 0.30 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockValueScheduleE030PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lender Converted the debt per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyShallBeRequiredToPayAPrepaymentPremiumEqualToTheAmountRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleNote2BearsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ConvertibleNote2BearsInterestRate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleNote2BearsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertiblePromissoryNoteTotaling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Promissory Note Totaling</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertiblePromissoryNoteTotaling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertiblePromissoryNoteTranches14Through16Totaling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Promissory Note Tranches 14 through 16 Totaling</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertiblePromissoryNoteTranches14Through16Totaling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LenderConvertedTheDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lender Converted the debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LenderConvertedTheDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LenderConvertedTheDebtPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lender Converted the debt per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LenderConvertedTheDebtPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RemainingTranches17To30Totaling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining Tranches 17 to 30, totaling</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RemainingTranches17To30Totaling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RestrictedCommonSharesDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RestrictedCommonSharesDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnpaidInterestDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid interest due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_UnpaidInterestDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760134736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Paulson Investment - Related Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Aug. 24, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaulsonInvestmentRelatedDebtAbstract', window );"><strong>Paulson Investment Related Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors', window );">Paulson can provide financings through accredited investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyReceivedFunding4IndividualLoans', window );">Company received funding (4) individual loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaulsonReceivesACashFinanceFee', window );">Paulson receives a cash finance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtIsConvertiblePerShare', window );">Debt is convertible per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NewLendersAdvancedPaulsonNotes1', window );">New Lenders advanced Paulson Notes</a></td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySRestrictedCommonStockPerShare', window );">Company's restricted common stock per share</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NewLendersAdvancedPaulsonNotesInterestRate', window );">New Lenders advanced Paulson Notes, interest rate</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyReceivedFunding4IndividualLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company received funding (4) individual loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyReceivedFunding4IndividualLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySRestrictedCommonStockPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company's restricted common stock per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySRestrictedCommonStockPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtIsConvertiblePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt is convertible per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DebtIsConvertiblePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NewLendersAdvancedPaulsonNotes1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Lenders advanced Paulson Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NewLendersAdvancedPaulsonNotes1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NewLendersAdvancedPaulsonNotesInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Lenders advanced Paulson Notes, interest rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NewLendersAdvancedPaulsonNotesInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Paulson can provide financings through "accredited investors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PaulsonCanProvideFinancingsThroughAccreditedInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaulsonInvestmentRelatedDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PaulsonInvestmentRelatedDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaulsonReceivesACashFinanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Paulson receives a cash finance fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PaulsonReceivesACashFinanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817690608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible debt consists of the following (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleDebtConsistsOfTheFollowing1Abstract', window );"><strong>Convertible debt consists of the following</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_N1ConvertibleNotesPayableDueApril2016', window );">1% Convertible notes payable, due April 2016</a></td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_N11ConvertibleNotePayableHepInvestmentsLlc', window );">11% Convertible note payable - HEP Investments, LLC,</a></td>
<td class="nump">8,572,757<span></span>
</td>
<td class="nump">5,583,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_N11ConvertibleNotePayableNewLenders', window );">11% Convertible note payable - New Lenders</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total Convertible notes payable</a></td>
<td class="nump">10,062,757<span></span>
</td>
<td class="nump">5,823,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LessCurrentPortion', window );">Less: Current portion</a></td>
<td class="nump">6,886,710<span></span>
</td>
<td class="nump">1,224,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPortion', window );">Long term portion</a></td>
<td class="nump">3,176,047<span></span>
</td>
<td class="nump">4,598,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc', window );">11% Convertible notes payable unamortized discount HEP Investments, LLC</a></td>
<td class="nump">$ 574,443<span></span>
</td>
<td class="nump">$ 1,843,931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleDebtConsistsOfTheFollowing1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleDebtConsistsOfTheFollowing1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LessCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LessCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongTermPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongTermPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_N11ConvertibleNotePayableHepInvestmentsLlc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_N11ConvertibleNotePayableHepInvestmentsLlc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_N11ConvertibleNotePayableNewLenders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_N11ConvertibleNotePayableNewLenders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_N11ConvertibleNotesPayableUnamortizedDiscountHepInvestmentsLlc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_N1ConvertibleNotesPayableDueApril2016">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>1% Convertible notes payable, due April 2016</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_N1ConvertibleNotesPayableDueApril2016</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811668080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible debt Parentheticals (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleDebtParentheticalsAbstract', window );"><strong>Convertible debt Parentheticals</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="nump">$ 574,443<span></span>
</td>
<td class="nump">$ 1,843,931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleDebtParentheticalsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleDebtParentheticalsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_UnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820704480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Board Of Directors Fees Textual (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 10, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 10, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BoardOfDirectorsFeesDetailsAbstract', window );"><strong>Board Of Directors Fees Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrantedWarrantsToPurchaseSharesOfCommonStock', window );">Granted warrants to purchase shares of common stock</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePricePerShare', window );">Exercise price per share | $ / shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsTermInYears', window );">Warrants term (in years)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsVestedOnTheGrantDate', window );">Warrants vested on the grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RemainingWarrants', window );">Remaining warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RemainingWarrantsShallVestQuarterly', window );">Remaining warrants shall vest quarterly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWereValuedUsingTheBlackScholesPricingModel', window );">Warrants were valued using the Black Scholes pricing model | $</a></td>
<td class="nump">$ 59,125<span></span>
</td>
<td class="nump">$ 10,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,876<span></span>
</td>
<td class="nump">$ 6,185<span></span>
</td>
<td class="nump">$ 3,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed', window );">In addition, Mr. Rice entitled to receive for each annual term served | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed', window );">In addition, Mr. Cox is entitled to receive $10,000 for each annual term served | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MrRiceSUnvestedWarrant', window );">Mr. Rice's unvested warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MrCoxSUnvestedWarrant', window );">Mr. Cox's unvested warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed', window );">In addition, Mr. Rondeau entitled to receive for each annual term served | $</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed', window );">In addition, each director is entitled to receive each annual term served | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MsMastersonSUnvestedWarrant1', window );">Ms. Masterson's unvested warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MrPayneSUnvestedWarrant1', window );">Mr. Payne's unvested warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BoardOfDirectorsFeesDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount advanced by Chris Maggiore, a significant shareholder</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_BoardOfDirectorsFeesDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GrantedWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants granted to purchase shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GrantedWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In addition, each director is entitled to receive each annual term served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_InAdditionEachDirectorIsEntitledToReceiveEachAnnualTermServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mr. Cox is entitled to receive $10,000 for each annual term served.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_InAdditionMrCoxIsEntitledToReceive10000ForEachAnnualTermServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount which Mr. Rice entitled to receive for each annual term served.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_InAdditionMrRiceEntitledToReceiveForEachAnnualTermServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount which Mr. Rondeau entitled to receive for each annual term served.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_InAdditionMrRondeauEntitledToReceiveForEachAnnualTermServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MrCoxSUnvestedWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mr. Cox's unvested warrant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_MrCoxSUnvestedWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MrPayneSUnvestedWarrant1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mr. Payne's unvested warrant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_MrPayneSUnvestedWarrant1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MrRiceSUnvestedWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mr. Rice's unvested warrant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_MrRiceSUnvestedWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MsMastersonSUnvestedWarrant1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ms. Masterson's unvested warrant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_MsMastersonSUnvestedWarrant1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RemainingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RemainingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RemainingWarrantsShallVestQuarterly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants remaining that shall vest quarterly.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RemainingWarrantsShallVestQuarterly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsTermInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of warrants in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsTermInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsVestedOnTheGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants vested on the grant date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsVestedOnTheGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWereValuedUsingTheBlackScholesPricingModel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants were valued using the Black Scholes pricing model</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsWereValuedUsingTheBlackScholesPricingModel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746112352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Directors fees- During the period (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DirectorsFeesDuringThePeriodAbstract', window );"><strong>Directors fees- During the period</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DirectorsFees', window );">Directors' fees</a></td>
<td class="nump">$ 109,713<span></span>
</td>
<td class="nump">$ 166,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DirectorsFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense incurred during the period as Director's fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DirectorsFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DirectorsFeesDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount which Mr. Rondeau entitled to receive for each annual term served.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DirectorsFeesDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823694240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Based Compensation (Details)<br></strong></div></th>
<th class="th">
<div>Nov. 17, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 19, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 19, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 29, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 08, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 10, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 02, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 07, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 01, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 23, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 17, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 27, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 27, 2015 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockBasedCompensationAbstract', window );"><strong>Stock Based Compensation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedSharesOfCommonStockValue', window );">Issued shares of common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock', window );">Issued warrants to purchase shares of common stock | shares</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">237,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,800<span></span>
</td>
<td class="nump">1,875,000<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">227,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice', window );">Issued warrants to purchase shares of common stock at an exercise price | $ / shares</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TermInYears', window );">Term (in years)</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel', window );">Warrants were valued at using the Black Scholes pricing model</a></td>
<td class="nump">$ 21,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,095,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedSharesOfCommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedSharesOfCommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock at an exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TermInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term (in years)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TermInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants were valued at using the Black Scholes pricing model</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820629360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Issuances in the year 2015 (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 19, 2016</div></th>
<th class="th"><div>Oct. 29, 2015</div></th>
<th class="th"><div>Oct. 08, 2015</div></th>
<th class="th"><div>Sep. 02, 2015</div></th>
<th class="th"><div>Aug. 01, 2015</div></th>
<th class="th"><div>Jul. 07, 2015</div></th>
<th class="th"><div>Jun. 26, 2015</div></th>
<th class="th"><div>May 01, 2015</div></th>
<th class="th"><div>Apr. 23, 2015</div></th>
<th class="th"><div>Apr. 17, 2015</div></th>
<th class="th"><div>Mar. 27, 2015</div></th>
<th class="th"><div>Feb. 27, 2015</div></th>
<th class="th"><div>Feb. 17, 2015</div></th>
<th class="th"><div>Jan. 23, 2015</div></th>
<th class="th"><div>Jan. 14, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockIssuancesInTheYear2015DetailsAbstract', window );"><strong>Stock Issuances in the year 2015 Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock', window );">Received proceeds from the issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfSharesOfCommonStock', window );">Issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture', window );">Issuance in principal of an 11% Convertible Debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 237,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,800<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 227,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedSharesOfCommonStock1', window );">Issued shares of common stock</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">81,818<span></span>
</td>
<td class="nump">461,539<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">69,231<span></span>
</td>
<td class="nump">121,989<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">112,011<span></span>
</td>
<td class="nump">151,329<span></span>
</td>
<td class="nump">81,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedSharesOfCommonStockValue1', window );">Issued shares of common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 8,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,841<span></span>
</td>
<td class="nump">$ 13,050<span></span>
</td>
<td class="nump">$ 8,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1', window );">Issued warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">237,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,800<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
<td class="nump">227,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1', window );">Issued warrants to purchase shares of common stock at an exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1', window );">Warrants were valued at using the Black Scholes pricing model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,065<span></span>
</td>
<td class="nump">$ 18,065<span></span>
</td>
<td class="nump">$ 25,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,972<span></span>
</td>
<td class="nump">$ 30,012<span></span>
</td>
<td class="nump">$ 14,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,326<span></span>
</td>
<td class="nump">$ 21,150<span></span>
</td>
<td class="nump">$ 21,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance in principal of an 11% Convertible Debenture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceInPrincipalOfAn11ConvertibleDebenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedSharesOfCommonStock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedSharesOfCommonStock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedSharesOfCommonStockValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued shares of common stock value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedSharesOfCommonStockValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock at an exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Received proceeds from the issuance of shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ReceivedProceedsFromTheIssuanceOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockIssuancesInTheYear2015DetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockIssuancesInTheYear2015DetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants were valued at using the Black Scholes pricing model</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812273072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Issuances in the year 2016 (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 17, 2016</div></th>
<th class="th"><div>Oct. 20, 2016</div></th>
<th class="th"><div>Aug. 25, 2016</div></th>
<th class="th"><div>Jul. 26, 2016</div></th>
<th class="th"><div>May 19, 2016</div></th>
<th class="th"><div>May 16, 2016</div></th>
<th class="th"><div>Mar. 01, 2016</div></th>
<th class="th"><div>Jan. 27, 2016</div></th>
<th class="th"><div>Sep. 10, 2015</div></th>
<th class="th"><div>Jun. 26, 2015</div></th>
<th class="th"><div>Apr. 15, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockIssuancesInTheYear2016DetailsAbstract', window );"><strong>Stock Issuances in the year 2016 Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1', window );">Issuance in principal of an 11% Convertible Debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedSharesOfCommonStock2', window );">Issued shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,571<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">337,500<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedSharesOfCommonStockValue2', window );">Issued shares of common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2', window );">Issued warrants to purchase shares of common stock</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,875,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2', window );">Issued warrants to purchase shares of common stock at an exercise price</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2', window );">Warrants were valued at using the Black Scholes pricing model</a></td>
<td class="nump">$ 21,381<span></span>
</td>
<td class="nump">$ 16,419<span></span>
</td>
<td class="nump">$ 13,939<span></span>
</td>
<td class="nump">$ 11,523<span></span>
</td>
<td class="nump">$ 1,095,063<span></span>
</td>
<td class="nump">$ 18,746<span></span>
</td>
<td class="nump">$ 44,371<span></span>
</td>
<td class="nump">$ 8,018<span></span>
</td>
<td class="nump">$ 36,540<span></span>
</td>
<td class="nump">$ 151,443<span></span>
</td>
<td class="nump">$ 133,862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance in principal of an 11% Convertible Debenture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceInPrincipalOfAn11ConvertibleDebenture1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedSharesOfCommonStock2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedSharesOfCommonStock2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedSharesOfCommonStockValue2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedSharesOfCommonStockValue2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStock2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStock2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock at an exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockIssuancesInTheYear2016DetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockIssuancesInTheYear2016DetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants were valued at using the Black Scholes pricing model</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817950624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Executive Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 20, 2016</div></th>
<th class="th"><div>Aug. 25, 2016</div></th>
<th class="th"><div>Jul. 26, 2016</div></th>
<th class="th"><div>May 16, 2016</div></th>
<th class="th"><div>May 13, 2016</div></th>
<th class="th"><div>Mar. 29, 2016</div></th>
<th class="th"><div>Mar. 01, 2016</div></th>
<th class="th"><div>Jan. 27, 2016</div></th>
<th class="th"><div>May 13, 2015</div></th>
<th class="th"><div>Apr. 06, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExecutiveCompensationAbstract', window );"><strong>Executive Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock', window );">Compensation for serving as Chief Financial Officer issued warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3', window );">Issued warrants to purchase shares of common stock at an exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3', window );">Warrants were valued at using the Black Scholes pricing model</a></td>
<td class="nump">$ 16,419<span></span>
</td>
<td class="nump">$ 13,939<span></span>
</td>
<td class="nump">$ 11,523<span></span>
</td>
<td class="nump">$ 18,746<span></span>
</td>
<td class="nump">$ 3,777<span></span>
</td>
<td class="nump">$ 3,771<span></span>
</td>
<td class="nump">$ 44,371<span></span>
</td>
<td class="nump">$ 8,018<span></span>
</td>
<td class="nump">$ 3,582<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation for serving as Chief Financial Officer issued warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompensationForServingAsChiefFinancialOfficerIssuedWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExecutiveCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExecutiveCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants to purchase shares of common stock at an exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePrice3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants were valued at using the Black Scholes pricing model</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsWereValuedAtUsingTheBlackScholesPricingModel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820662544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of the status of the Company's warrants (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsAbstract', window );"><strong>Number of Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsOutstanding1', window );">Number of Warrants Outstanding</a></td>
<td class="nump">32,071,901<span></span>
</td>
<td class="nump">14,705,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsIssued', window );">Number of Warrants Issued</a></td>
<td class="nump">20,350,000<span></span>
</td>
<td class="nump">7,192,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsExercised', window );">Number of Warrants Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsCancelled', window );">Number of Warrants Cancelled</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(96,575)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfWarrantsExpired', window );">Number of Warrants Expired</a></td>
<td class="num">(2,983,917)<span></span>
</td>
<td class="num">(1,443,112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingBeginningOfYear', window );">Outstanding Beginning Of Year</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePriceIssued', window );">Issued</a></td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePriceExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePriceCancelled', window );">Cancelled</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePriceExpired', window );">Expired</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingEndOfPeriod', window );">Outstanding End Of Period</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Cancelled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfWarrantsOutstanding1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NumberOfWarrantsOutstanding1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OutstandingBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OutstandingEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePriceCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePriceCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6818317680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants outstanding and exercisable by price range (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingWarrantsNumberAbstract', window );"><strong>Outstanding Warrants Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange005', window );">Price range 0.05</a></td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange008', window );">Price range 0.08</a></td>
<td class="nump">18,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange009', window );">Price range 0.09</a></td>
<td class="nump">309,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange010', window );">Price range 0.10</a></td>
<td class="nump">7,327,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange012', window );">Price range 0.12</a></td>
<td class="nump">99,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange014', window );">Price range 0.14</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange015', window );">Price range 0.15</a></td>
<td class="nump">2,485,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange017', window );">Price range 0.17</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange019', window );">Price range 0.19</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange020', window );">Price range 0.20</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange022', window );">Price range 0.22</a></td>
<td class="nump">269,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange025', window );">Price range 0.25</a></td>
<td class="nump">707,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange030', window );">Price range 0.30</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange033', window );">Price range 0.33</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange038', window );">Price range 0.38</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalWarrantsOutstandingNumber', window );">Total Warrants outstanding number</a></td>
<td class="nump">32,071,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract', window );"><strong>Outstanding Warrants Average Weighted Remaining Contractual Life in Years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange005InYears', window );">Price range 0.05 (in years)</a></td>
<td class="nump">4.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange008InYears', window );">Price range 0.08 (in years)</a></td>
<td class="nump">4.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange009InYears', window );">Price range 0.09 (in years)</a></td>
<td class="nump">3.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange010InYears', window );">Price range 0.10 (in years)</a></td>
<td class="nump">3.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange012InYears', window );">Price range 0.12 (in years)</a></td>
<td class="nump">2.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange014InYears', window );">Price range 0.14 (in years)</a></td>
<td class="nump">2.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange015InYears', window );">Price range 0.15 (in years)</a></td>
<td class="nump">1.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange017InYears', window );">Price range 0.17 (in years)</a></td>
<td class="nump">2.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange019InYears', window );">Price range 0.19 (in years)</a></td>
<td class="nump">1.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange020InYears', window );">Price range 0.20 (in years)</a></td>
<td class="nump">0.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange022InYears', window );">Price range 0.22 (in years)</a></td>
<td class="nump">1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange025InYears', window );">Price range 0.25 (in years)</a></td>
<td class="nump">1.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange030InYears', window );">Price range 0.30 (in years)</a></td>
<td class="nump">1.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange033InYears', window );">Price range 0.33 (in years)</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRange038InYears', window );">Price range 0.38 (in years)</a></td>
<td class="nump">0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears', window );">Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</a></td>
<td class="nump">1.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisableWarrantsNumberAbstract', window );"><strong>Exercisable Warrants Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice005', window );">Exercise Price 0.05</a></td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice008', window );">Exercise Price 0.08</a></td>
<td class="nump">18,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice009', window );">Exercise Price 0.09</a></td>
<td class="nump">309,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice010', window );">Exercise Price 0.10</a></td>
<td class="nump">7,327,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice012', window );">Exercise Price 0.12</a></td>
<td class="nump">99,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice014', window );">Exercise Price 0.14</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice015', window );">Exercise Price 0.15</a></td>
<td class="nump">2,485,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice017', window );">Exercise Price 0.17</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice019', window );">Exercise Price 0.19</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice020', window );">Exercise Price 0.20</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice022', window );">Exercise Price 0.22</a></td>
<td class="nump">269,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice025', window );">Exercise Price 0.25</a></td>
<td class="nump">707,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice030', window );">Exercise Price 0.30</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice033', window );">Exercise Price 0.33</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePrice038', window );">Exercise Price 0.38</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalExercisableWarrants', window );">Total exercisable warrants</a></td>
<td class="nump">32,071,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract', window );"><strong>Exercisable Warrants Weighted Average Exercise Price:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice005', window );">Weighted Average Exercise Price 0.05 | $ / shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice008', window );">Weighted Average Exercise Price 0.08 | $ / shares</a></td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice009', window );">Weighted Average Exercise Price 0.09 | $ / shares</a></td>
<td class="nump">0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice010', window );">Weighted Average Exercise Price 0.10 | $ / shares</a></td>
<td class="nump">0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice012', window );">Weighted Average Exercise Price 0.12 | $ / shares</a></td>
<td class="nump">0.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice014', window );">Weighted Average Exercise Price 0.14 | $ / shares</a></td>
<td class="nump">0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice015', window );">Weighted Average Exercise Price 0.15 | $ / shares</a></td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice017', window );">Weighted Average Exercise Price 0.17 | $ / shares</a></td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice019', window );">Weighted Average Exercise Price 0.19 | $ / shares</a></td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice020', window );">Weighted Average Exercise Price 0.20 | $ / shares</a></td>
<td class="nump">0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice022', window );">Weighted Average Exercise Price 0.22 | $ / shares</a></td>
<td class="nump">0.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice025', window );">Weighted Average Exercise Price 0.25 | $ / shares</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice030', window );">Weighted Average Exercise Price 0.30 | $ / shares</a></td>
<td class="nump">0.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice033', window );">Weighted Average Exercise Price 0.33 | $ / shares</a></td>
<td class="nump">0.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageExercisePrice038', window );">Weighted Average Exercise Price 0.38 | $ / shares</a></td>
<td class="nump">0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalExercisableWarrantsWeightedAverageExercisePrice', window );">Total Exercisable Warrants Weighted Average Exercise Price: | $ / shares</a></td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisableWarrantsNumberAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisableWarrantsNumberAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total exercisable warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisableWarrantsWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice005">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.05</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice005</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice008">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.08</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice008</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice009">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.09</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice009</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice010">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.10</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice010</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice012">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.12</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice012</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice014">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.14</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice014</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.15</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.17</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.20</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice022">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.22</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice022</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.25</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice030">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.30</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice030</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice033">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.33</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice033</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePrice038">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.38</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePrice038</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Number of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OutstandingWarrantsAverageWeightedRemainingContractualLifeInYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingWarrantsNumberAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OutstandingWarrantsNumberAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange005">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.05</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange005</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange005InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.05, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange005InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange008">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.08</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange008</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange008InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.08, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange008InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange009">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.09</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange009</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange009InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.09, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange009InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange010">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.10</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange010</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange010InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.10, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange010InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange012">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.12</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange012</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange012InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.12, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange012InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange014">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.14</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange014</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange014InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.14, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange014InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.15</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange015InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.15, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange015InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.17</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange017InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.17, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange017InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange019InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.19, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange019InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.20</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange020InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.20, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange020InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange022">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.22</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange022</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange022InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.22, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange022InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.25</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange025InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.25, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange025InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange030">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.30</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange030</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange030InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.30, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange030InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange033">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.33</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange033</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange033InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.33, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange033InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange038">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.38</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange038</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRange038InYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants Outstanding at Price range 0.38, contractual life in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRange038InYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalExercisableWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total exercisable warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalExercisableWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalExercisableWarrantsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Exercisable Warrants Weighted Average Exercise Price:</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalExercisableWarrantsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Warrants outstanding Average Weighted Remaining Contractual Life in Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalWarrantsOutstandingAverageWeightedRemainingContractualLifeInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalWarrantsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Number of Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalWarrantsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice005">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.05</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice005</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice008">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.05</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice008</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice009">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.09</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice009</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice010">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.10</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice010</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice012">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.12</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice012</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice014">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.14</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice014</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.15</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.17</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.20</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice022">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.22</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice022</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.25</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice030">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.30</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice030</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice033">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.33</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice033</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageExercisePrice038">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants exercisable at Price 0.38</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageExercisePrice038</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813431472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Income (Expense) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jul. 15, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OtherIncomeExpenseDetailsAbstract', window );"><strong>Other Income (Expense) Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SettlementAgreementCallsForTheCompanyToMake10Payments', window );">Settlement agreement calls for the Company to make 10 payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalLiabilityOutOfTheGrossAmount', window );">Total liability out of the gross amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountRecordedOnTheCompanySBooks', window );">Amount recorded on the Company's books</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014', window );">Recognized as other income for the period ending September 30, 2014</a></td>
<td class="nump">$ 34,963<span></span>
</td>
<td class="nump">$ 93,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountRecordedOnTheCompanySBooks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recorded on the Company's books</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AmountRecordedOnTheCompanySBooks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OtherIncomeExpenseDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual base salary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OtherIncomeExpenseDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognized as other income for the period ending September 30, 2014</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RecognizedAsOtherIncomeForThePeriodEndingSeptember302014</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SettlementAgreementCallsForTheCompanyToMake10Payments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settlement agreement calls for the Company to make 10 payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SettlementAgreementCallsForTheCompanyToMake10Payments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalLiabilityOutOfTheGrossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total liability out of the gross amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalLiabilityOutOfTheGrossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6736899776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 16, 2011 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EmploymentAgreementDetailsAbstract', window );"><strong>Employment Agreement Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AnnualBaseSalary', window );">Annual base salary | $</a></td>
<td class="nump">$ 240,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation', window );">Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExercisePricePerShareWarrantsEntitled', window );">Exercise price per share warrants entitled | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantForSharesUponIdentificationOfBioActiveAgents', window );">Warrant for shares upon identification of bio-active agents</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract', window );">Warrant for shares to be issued upon upon entering into a business contract</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ReceivesInCashPayments', window );">Receives in cash payments | $</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement', window );">Warrant for shares upon the Company entering into a co-development agreement</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PartnerProvidesAtleastInCashOrInKindOutlays', window );">Partner provides atleast in cash or in-kind outlays | $</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1', window );">Warrant for shares upon the Company entering into a co-development agreement</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement', window );">Warrant for shares upon upon the Company entering into a pharmaceutical development agreement</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AnnualBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual base salary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AnnualBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EmploymentAgreementDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_EmploymentAgreementDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExercisePricePerShareWarrantsEntitled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share warrants entitled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExercisePricePerShareWarrantsEntitled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PartnerProvidesAtleastInCashOrInKindOutlays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partner provides atleast in cash or in-kind outlays</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PartnerProvidesAtleastInCashOrInKindOutlays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PercentOfCompanySRevenueThatMrDahlEntitledToReceiveAsMonthyBonusCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ReceivesInCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receives in cash payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ReceivesInCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant for shares to be issued upon upon entering into a business contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantForSharesToBeIssuedUponUponEnteringIntoABusinessContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantForSharesUponIdentificationOfBioActiveAgents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant for shares upon identification of bio-active agents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantForSharesUponIdentificationOfBioActiveAgents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant for shares upon the Company entering into a co-development agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant for shares upon the Company entering into a co-development agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantForSharesUponTheCompanyEnteringIntoACoDevelopmentAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant for shares upon upon the Company entering into a pharmaceutical development agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantForSharesUponUponTheCompanyEnteringIntoAPharmaceuticalDevelopmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6758606144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncomeTaxDetailsAbstract', window );"><strong>INCOME TAX Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net-operating loss carry-forwards for Federal tax</a></td>
<td class="nump">$ 39,732,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Company had a deferred tax asset</a></td>
<td class="nump">$ 15,893,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FederalAndStateStatutoryRate', window );">Federal and State Statutory Rate</a></td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncreaseInTheValuationAllowance', window );">Increase in the valuation allowance</a></td>
<td class="nump">$ 3,693,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_EffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FederalAndStateStatutoryRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FederalAndStateStatutoryRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncomeTaxDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settlement agreement calls for the Company to make 10 payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IncomeTaxDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncreaseInTheValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IncreaseInTheValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812582480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Settlement of Litigation - Related Party (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 03, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SettlementOfLitigationRelatedPartyDetailsAbstract', window );"><strong>Settlement of Litigation - Related Party Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtOwedToHepInvestment', window );">Debt owed to HEP Investment</a></td>
<td class="nump">$ 280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PayToTheShareholderSLegalCounsel', window );">Pay to the Shareholder's legal counsel</a></td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SharesOfTheCompanySCommonStock', window );">Shares of the Company's common stock | shares</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SharesOfTheCompanySCommonStockValued', window );">Shares of the Company's common stock valued</a></td>
<td class="nump">$ 22,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RecordedLegalFees', window );">Recorded legal fees</a></td>
<td class="nump">82,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RecordedTheSettlementAmount', window );">Recorded the settlement amount</a></td>
<td class="nump">$ 280,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtOwedToHepInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt owed to HEP Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DebtOwedToHepInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PayToTheShareholderSLegalCounsel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pay to the Shareholder's legal counsel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PayToTheShareholderSLegalCounsel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RecordedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RecordedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RecordedTheSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded the settlement amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RecordedTheSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SettlementOfLitigationRelatedPartyDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SettlementOfLitigationRelatedPartyDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SharesOfTheCompanySCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares of the Company's common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SharesOfTheCompanySCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SharesOfTheCompanySCommonStockValued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares of the Company's common stock valued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SharesOfTheCompanySCommonStockValued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817747040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SubsequentEventsDetailsAbstract', window );"><strong>Subsequent Events Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal', window );">Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalOutstandingDebtAsOfMarch12017', window );">Total outstanding debt as of March 1, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,982,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnpaidPrincipal', window );">Unpaid principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,427,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InterestOutstandingAsOfFebruary282017', window );">Interest outstanding as of February 28, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,955,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RestructuringAndLegalFees', window );">Restructuring and legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare', window );">Convertible Promissory Note into the Company's restricted common stock at $.10 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,982,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt', window );">Total shares of common stock, if the Lender converted the complete convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,822,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan', window );">HEP Investments LLC ("Lender") funded an additional loan</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyIssuedToTheLenderForAggregateConsiderationOf', window );">Company issued to the Lender for aggregate consideration of</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsToPurchaseSharesOfCommonStock', window );">Warrants to purchase shares of common stock</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockAtAtAnExercisePricePerShare', window );">Common stock, at at an exercise price per share</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt', window );">Common stock as financing cost related to the issuance of the 11% convertible debt</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum', window );">Convertible Notes accrue interest at the rate per annum</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount', window );">Company recorded a deferred debt discount, related to the $1,000,000 Note, in the amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10', window );">On February 27, 2017, the Company issued warrants to purchase shares of common stock at an exercise price of $.10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_N11ConvertibleDebtHepInvestmentsLlcAbstract', window );"><strong>11% Convertible Debt - HEP Investments, LLC</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdditionalAmountFundedByHepInvestmentsLlc', window );">Additional amount funded by HEP Investments LLC</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock', window );">Issued $1,000,000 11% convertible note and warrants to purchase shares of common stock</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice', window );">Issued 11% convertible note and warrants to purchase shares at exercise price</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TermInYears1', window );">Term in years</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdditionalAmountFundedByHepInvestmentsLlc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional amount funded by HEP Investments LLC</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AdditionalAmountFundedByHepInvestmentsLlc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock as financing cost related to the issuance of the 11% convertible debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockAsFinancingCostRelatedToTheIssuanceOfThe11ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockAtAtAnExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, at at an exercise price per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockAtAtAnExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyIssuedToTheLenderForAggregateConsiderationOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company issued to the Lender for aggregate consideration of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyIssuedToTheLenderForAggregateConsiderationOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company recorded a deferred debt discount, related to the $1,000,000 Note, in the amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRecordedADeferredDebtDiscountRelatedToThe1000000NoteInTheAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Notes accrue interest at the rate per annum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertibleNotesAccrueInterestAtTheRatePerAnnum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Promissory Note into the Company's restricted common stock at $.10 per share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertiblePromissoryNoteIntoTheCompanySRestrictedCommonStockAt10PerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Eighth Amendment to Loan Agreement under which the Lender has agreed to advance up to a total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_EighthAmendmentToLoanAgreementUnderWhichTheLenderHasAgreedToAdvanceUpToATotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>HEP Investments LLC ("Lender") funded an additional loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_HepInvestmentsLlcLenderFundedAnAdditionalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InterestOutstandingAsOfFebruary282017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest outstanding as of February 28, 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_InterestOutstandingAsOfFebruary282017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued $1,000,000 11% convertible note and warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_Issued100000011ConvertibleNoteAndWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued 11% convertible note and warrants to purchase shares at exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_Issued11ConvertibleNoteAndWarrantsToPurchaseSharesAtExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_N11ConvertibleDebtHepInvestmentsLlcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Paulson can provide financings through "accredited investors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_N11ConvertibleDebtHepInvestmentsLlcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On February 27, 2017, the Company issued warrants to purchase shares of common stock at an exercise price of $.10</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OnFebruary272017TheCompanyIssuedWarrantsToPurchaseSharesOfCommonStockAtAnExercisePriceOf10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RestructuringAndLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RestructuringAndLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SubsequentEventsDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_SubsequentEventsDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TermInYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TermInYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalOutstandingDebtAsOfMarch12017">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total outstanding debt as of March 1, 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalOutstandingDebtAsOfMarch12017</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total shares of common stock, if the Lender converted the complete convertible debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TotalSharesOfCommonStockIfTheLenderConvertedTheCompleteConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnpaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid principal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_UnpaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants to purchase shares of common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M<: ,HA; NGEB/$Y]"Q? #"-,/G\7T*[$I?HG=ND .R6G[-;4.([U*)=<V4'
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M[HN^-.D'BG>N[$)#[;?Z!U!+ P04    " !(:']* X$2;M4#  #)$   &
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M'JZO#T-[GC\<%+>O%ZM_ 5!+ P04    " !(:']*;:_FL"T"  "I!@  &
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MQM8FTA(PUB2V!GYK%!$ "H^77RGS*HUM\:D(:"R"$.<BH*$C5A 9_#CB.=P
M"IE(D=3 8*0!C)*4T50#^"0$- I!B+,0^,.0'TD99*%,G$"$0]XMY-@<'XJ
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M,^[IC!==?9[VJY+KIMGZ/U!+ P04    " !(:']*9?]@^+(!  #2 P  &
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MZ/S+QOY7B Z\E,V5'Z'&?[#9D%"Y<+SQ9S..V6@X[*8?Q.9OG/\&4$L#!!0
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M_C?&>$ IR0V.4(<?;#44-#X<7^/9SF,V&]X,RP]BZS<N?P)02P,$%     @
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MGXRWR,Q2<PG*<JV0@:; M]O#,0OQ,> 'A]$NSBA4<M;Z.1A?ZP)O@B 04+G
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MQI^)D\XI W!Y?F7_&FO'6L["P9U1C[+T34;WE)10B5[Y!S-\@ZF>:TJFXG_
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M/YMIR";#Z7[^/V3YQ.5O4$L#!!0    ( $AH?TJS48ZCM $  -(#   9
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M&'\5%:72>VN;3NS\2LI^&P2BK&A+Q!/K::>>G!EOB51'?@E$SRDYF:2V"1
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MY?A[C846_71SX/GZRO\"4$L#!!0    ( $AH?TK&IQ3FJ (  %X)   9
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MEA#D!<)%B0I76 %"0I*,H!L% =\H:QB \NH:!A8+ ;\2*,SR].9,@87P 1,
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M1VGLR?'[VTIIP')&3Y:TLQ=X<3BTQIF9M54XQL$Q<IQO*%F>B>H?4$L#!!0
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M;RY;XT;/:U*C97'VCB;-PZ@AMYJWBDVJH/\EA0O@&@4!HR#!GKZ) L,.*.B
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M4SA$]DI9Z1RB.^?PZ.X5UTXK]]8W*]?6X^$Z=JP:IHM#<;V]K/\!4$L#!!0
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M_V[3'S3E27^3\JX?QB;_ U!+ P04    " !(:']*=*7&74L#  !T#P  &0
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M@E[?@7H5)7!%";#+:6_/"3%W%(2)?IXR*12'2"O\%*#P &O4#*!0%&@GKSE
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M!^J1$(Z%H3<0CF?QOM,T<GSD\C86][3^UZ\;G%3ZA08T;U63_U!+ P04
M" !(:']*01B)[)D"  "<"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6R%EMN.VC 0AE\ERGV)#PE)5H!4J*I6:B6T5=MK P:B3>+4-K!]^]J.EX(S
M6;@@MO//S#<39^+91<@7=>1<1Z]-W:IY?-2Z>TH2M3WRAJF)Z'AK[NR%;)@V
M4WE(5"<YVSFCIDX(0M.D854;+V9N;2T7,W'2==7RM8S4J6F8_+ODM;C,8QR_
M+3Q7AZ.V"\EBUK$#_\'USVXMS2RY>ME5#6]5)=I(\OT\_HB?5CBU!D[QJ^(7
M=3..;"H;(5[LY.MN'B-+Q&N^U=8%,Y<S7_&ZMIX,QQ_O-+[&M(:WXS?OGUWR
M)ID-4WPEZM_53A_G<1%'.[YGIUH_B\L7[A/*XLAG_XV?>6WDEL3$V(I:N?]H
M>U):--Z+06G8:W^M6G>]]'=R[,U@ ^(-R-6@+\ZH ?4&-#!(>C*7ZB>FV6(F
MQ262_=/JF-T4^(F:8F[MHJN=NV>R56;UO$AQ.4O.UI'7+'L-N=&0>\5JJ*#_
M)8D!N%(0D((X>WI+01#L@((.J'.0WCG 01J])G.:UD.B')<H$*Z&0ISF*"MP
M 2.E(%(*( 5U6Z:#2 31#)E?@#04&G"2H9$B92!1!A#1@"@;! I1WE/<04Q!
MB"D D080TX<00\6'<IKE&4R2@R0Y0)(%)/DP#BD+6N(\  *$.$TIQB/O00$B
M%<![,(4=E*"#$L@I0%WVFN*VNA,<[(,5*!I!P0AN+0B *<+>THO*NT"H"/L+
MJ"I'<$8Z'09P!JT./]QZ[TKN0>!FA\D0A*(0A#P&(4!1<#K" O=-##1.&C9.
M+QH-Y'% %1W!@7LF!IHF#9NF%P5[,Z0!12%-<O.9M.>6[TP>JE9%&Z'-%]=]
M%_=":&X\HHEY%D=S5+I.:K[7=IB;L>S/"_U$B\Z?A9+K@6SQ#U!+ P04
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M\-)<:F4"J,Q[>H%OH+[W!Z%/:%(Y-2UTLN%=(.!<A!_B[9X8O 7\:&"0=_O
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MF>U*[\7XT8\'Q7OWGJ'I42W_ %!+ P04    " !(:']*CQHZK2$"   .!P
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M&*:8TZY'9>'6#K(LQ%FSKH>##-29<RK_[H&)<8<VZ'WAI3NUVB[@LACH"7Z
M_CD<I(GPXE)W''K5B3Z0T.S0Q\UVGUN]$_SJ8%17\\!V<A3BU09?ZQT*;4'
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M:G7T,4F?X RB,$^3:.F=YWD998U881[Z&7QI359O*=#(V?;LEX:%79?S5;P
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MQ6O,Y$LY:;AS*0.S54((F=Q)Z6;6Q7P2.007&(FS-),MU%1:$4!!9J9-EL)
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MR3Y8-W1I5YSRUE%4T*L0,@@D1Y]21IDYB9Y9#>._I(#L;UD\EHLF6#J2LG+
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MTGK=J!ZV6 3-"0J%7D P/!3S7QN@HSA/A\-+*IL_IDRS\!D.(/]M.2] OEO
MD,.C0?=0QL>0"B^#A 7^Q6HQ9/)2H=G2 "E4?H%/D8C*PA!"(^^'RIQ-60[2
MK-HK%U(+"JQK]9T9BS@+*5.M?O-."=30R%J(0L]ZF?AZ"HBUMKDYA#A]AXA(
MD'V&PV"M5ZMYQ9C=I,MV #&E!*U?K,Y!$HXXT K9B'Y6RT^)]=O:ZF(Y>@Z6
M2X9G]W5?4H 8^Z(R>7<8HSA3!\[_#+*J@IAOFK-SA6F\E"6(WH:SH4(D''0!
M1?B_2!%>9S%3FOG!'0J-=NA)ZX[MWC+^RU+PZI8"R]*V>(R6Y8J.L2%FI0GX
MN[ON'RD3J5FW&YD-[UL%@-^WRKIX5F9)3 SKW\/UY@?T8+,4_@8S''(F//%!
M'X-X223^HU+#B?]>8% X7,AR7;(0O\2@3;CGBAB%9DS*P82R[AUZ!\,1?WB#
MR?7&0YQZT*</V\[[I!Y[TP9(]4ZMP&-/)<X^_\+#KT5=)A0V*IZ5^V3)5A63
M,. =(#%0,!&?ZI&;%-NXJ3YH=X5Q^FS-(/A05@:?[=7W7IGH@"25+11EQ^%X
M@,DHI4-T,L!Z"$'5P\FKMEXK8_P'47R4)RI[@MNHJQ. 0H>5 GH \[$W](>@
M.O9&TU9[O(R>1/QG_H.W :+'YH[KL%SE:%_;O2RCH" NI+XPG1KR"##=[X[D
M*B<]7B6B_??J"9!TLHQ  1[Y8TS&Z?=Z&-8.%P1CK(F$R59OO+X?C$=^=X!0
MAE93O !3MS. 'SGFFL<T(KRKM=6H*<?KTX[A&W34?R6-_1^7-+:.,JV2R.Z%
M-?]*2_NOM+3_2DO[U=+26C<6/0,Y"Z>&9GUP&A5AO,H/@;1\N#WU#MY8+,3=
M4?2SZ$*:?21+)#\ QY "D<IF&V?Z=DL[$(@YU2)QZ*IEWV4[WL+<;@T+H/-1
MP252 91B#ML<S!>.W'!RVR/\W"$!#F^]\&!;I[C=EF];<K^&I;[%J"Y+_39+
MN?,P= (;-K3FOYF=]1LTL7XCK*L=ISV E7?3?ZE0R[H\V]3M>F.7;KT&_K0N
MU_6F0N6VOF:UN]7 X6?GP*S V_.1$M\XL-+IZRVZ6(O NAA5=;YACU3@P?YR
M:']9'Z]A:V@ML+\<#ZTOF^P$NPE(0\\& J'5=$ZF^ME)[IJL#4V&!4JB;3FD
M]U+?6V_+&.,EIZ.'L1X.N1+'M9C*V:\!#)+84((42ZVV-&IQADAN)3URON!B
M A5A]'3]=[A,]JU0+_ID)+4<P$DAS1QWOI7=KL4);1^@X:CXY;E^> [2^\DC
M)O-\'SX\Q"EF'P@K;CDCZU)]+$PH*KOI$4T77_5%*0?WUD>YLQ)7"*!06"J/
MVG32U9?N1H8"R@5HD8K 1<N.Z[YLBJ\S$BE0^H%HV>(D14(]Z]"=#W9QA=7C
M<@%8>+F-M 9IQ>@BDY'4LE XKLC^?;1V)2$2)\U)%C>,>-LFWO9^N9$#@RK9
M46IDPU5HR"SDO@$B 8],SZ_>S>/.]'O8+SA Z<R(\4T8>GI4[A0WYA]+U-'I
MH%K,TO@RDT[W5)H&D4)S<8$VQ';7&,OMA%=%;I+Y59DGQ7F([1&NW*]D&  G
MZY,OC66RE?NH\DJK_H*SO@#EV<'&;*A-93!]=2WHGI'+;-J&R NQ>W5A;I(V
MIC_Q\H@269"291$Y^1"+')G5X,7'J.I$6H2KA>#Q9@XQ!_VIO2 UMNNXRP8?
M]<UW^9P@;BF>OQG9?O1;>,I0T].18:VNWQ$E3A(9;V0I*U8S6F!D8]\=(L"W
MN6-:(^O'D9=+?\,Q*^6-N_J"(=^QO>5K#GETPI:7KSKF*=M/ONJ8,[:E;!FS
MYBK MZ9S\?Y%L%Z4_K?UJQ-<DAV 0>W5!W5&3"H>##R9I#48-0ZEF:#N2/X1
MS")5-'3ZD(CL-6)?R]+:EKA])Y5\12X2U]AP-_A4IB<1L*PDI1#-^J*B GY<
MQ^5:%^8P:#:VBBW2,W3)4<*G8V:1/%)2*?&5%M?^N'SH>#U1!;#%#.;X3<TQ
M-EFE]Y*OZW,%>[208)P9B8 X<&H+<+4Z%4N5# C?)(.PB,HS/4-!X:AI';K(
MA4A*WJQ>!$ZM^Y13&%288B,.&)XW+:/*I32(B,835&>JLA=,YK>_Y-M=N&VP
MJ/UHUL'O=/UR-6D7>F[UA[JE7G_/,8QS=JM1C8MWF1,LMZBM@-0\HFV6JY4#
MI\O:=0P[X0=2"^:3C*B\1ROY8<<0-L&VEVH9W2FV[THGJLJ],\RF=A=])O=2
MHP9S&VTPOT-%@WGC?2>,KOROI5MCT&=-Z]G5QYQGV++/G\J5FJ=]GZ0CDRBV
M[H,YR?:<I^G &T3 '\4[-6<F)7<&)=L<6DFEI)]"_%]/+[;1[THWY0"4 (IY
MLDW)LATBOP[MXM"PI8,H:M&CR0QOMQ \'Z?P@)^#P)"M+,/"SY7W?4+K:5?_
M%@ZB/II51.L&SRXRBF<)SD=QC93[401CTH&1KWG9:N"3]'.]T)@<^DW057D
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M8T7\:T-78T#_+DS;HEC4D:Y]TVGKID&W?=->^Z:#]DW;GT P;M^T_0GTVI]
MK_T)]-IOJ]]^ ?U^^Z;;T&7+=?@:..Y\+N,FO+6'+2[::S>QKK?=Q*)@5A.;
M"-M-+#IF-[%(L=UD]XYL@FPWV;TCFRS;37;OR";.5A.;/MM-+!)M-VF@TJ9<
MT.1A<&+8ON+4CO9,GK>Z6'8/,'GI -,7#@ $_H4#]%XZP."E [P4"L X7CC
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M=%CLB#2@:"1IV=4_?I?GQ1__'U!+ P04    " !(:']*K$XIA#P"  " "@
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MY1T*TQCAOV^27*U <[.>V';KB>.E=X-1F:$E7N@(@2VPO#/9K"9QK))%%J9
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M0,8Y/PEAS==: -?"]UH V,(76P#9PC=; -K"5UL V\)W6P#<PI=; -W"MUL
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M/,QGW3_ATR]02P$"% ,4    " !(:']*'R// \     3 @  "P
M    @ $     7W)E;',O+G)E;'-02P$"% ,4    " !(:']*9O,+8((   "Q
M    $               @ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( $AH?TJT< "][0   "L"   1              "  9D!  !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( $AH?TJ97)PC$ 8  )PG   3
M      "  ;4"  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 2&A_
M2KY#U'BK @  !PH  !@              ( !]@@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( $AH?TH#@1)NU0,  ,D0   8
M      "  =<+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M" !(:']*;:_FL"T"  "I!@  &               @ 'B#P  >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 2&A_2O]-Q@=Z P  _@T  !@
M             ( !11(  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( $AH?TKT4C=&F00  #L8   8              "  ?45  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !(:']*N/%*N#,$  !
M$P  &               @ '$&@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ 2&A_2F7_8/BR 0  T@,  !@              ( !+1\
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( $AH?TK2YA&E
MLP$  -(#   8              "  14A  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    " !(:']*>O*>HK0!  #2 P  &
M@ '^(@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 2&A_
M2C$,2DNT 0  T@,  !D              ( !Z"0  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    " !(:']*/V=# +0!  #2 P  &0
M        @ '3)@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( $AH?TH+H<?/LP$  -(#   9              "  ;XH  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 2&A_2G"#IG:S 0  T@,
M !D              ( !J"H  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    " !(:']*!/0P![0!  #2 P  &0              @ &2+
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( $AH?TIFG^V\
MM0$  -(#   9              "  7TN  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ 2&A_2@S+))2U 0  T ,  !D
M ( !:3   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !(
M:']*LU&.H[0!  #2 P  &0              @ %5,@  >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $AH?TK9G7LXM $  -(#   9
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M970R,BYX;6Q02P$"% ,4    " !(:']*P@.R ;8!  #2 P  &0
M    @ &;/@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M $AH?TJ4[RF>M0$  -(#   9              "  8A   !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ 2&A_2@)P&E7$ 0  -P0  !D
M             ( !=$(  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    " !(:']*RA%K01\"  "G!0  &0              @ %O1   >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( $AH?TK^OZF@; (
M '4'   9              "  <5&  !X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ 2&A_2A+M&UL? @  A@8  !D              ( !
M:$D  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !(:']*
MK0'>=@D"   +!@  &0              @ &^2P  >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $AH?TJJ[T'MVP$  &8$   9
M      "  ?Y-  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ 2&A_2K%3D,7? 0  R@0  !D              ( !$%   'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !(:']*QJ<4YJ@"  !>"0
M&0              @ $F4@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( $AH?THFS/EOP0$  #($   9              "  055  !X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ 2&A_2AS)2CI7
M @  *@<  !D              ( !_58  'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    " !(:']*QW>EXX$"  #)"   &0
M@ &+60  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( $AH
M?TIN5'_N" (  !8&   9              "  4-<  !X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ 2&A_2M%"_ 5. @  -@<  !D
M         ( !@EX  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
M    " !(:']*1R>AU+<!  #7 P  &0              @ $'80  >&PO=V]R
M:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( $AH?THD3CLU+@,  'P.
M   9              "  ?5B  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL
M4$L! A0#%     @ 2&A_2M@^[MO@ 0  : 0  !D              ( !6F8
M 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !(:']*R;(>
MJB\#  #B#0  &0              @ %Q:   >&PO=V]R:W-H965T<R]S:&5E
M=#0Q+GAM;%!+ 0(4 Q0    ( $AH?TK$9/5BS@,  "03   9
M  "  ==K  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
M2&A_2G2EQEU+ P  = \  !D              ( !W&\  'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    " !(:']*(F)]/X,"  !A"0  &0
M            @ %><P  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( $AH?TI!&(GLF0(  )P)   9              "  1AV  !X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ 2&A_2MB?-Y-N!0
M*!X  !D              ( !Z'@  'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    " !(:']*A8AN(/L!  !@!0  &0              @ &-
M?@  >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( $AH?TJ/
M&CJM(0(   X'   9              "  ;^   !X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ 2&A_2GL*@+'@ 0  _ 0  !D
M     ( !%X,  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
M" !(:']*LH%5B.H!  !B!0  &0              @ $NA0  >&PO=V]R:W-H
M965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( $AH?TI?;+$LU@(  +H+   9
M              "  4^'  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L!
M A0#%     @ 2&A_2C]("=.?2P  >DT! !0              ( !7(H  'AL
M+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ 2&A_2JQ.*80\ @  @ H
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;72YX;6Q02P4&     #P / !6$   %N(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>67</ContextCount>
  <ElementCount>366</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - CONSOLIDATED BALANCE SHEET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEET</Role>
      <ShortName>CONSOLIDATED BALANCE SHEET</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - CONSOLIDATED BALANCE SHEET PARENTHETICALS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDBALANCESHEETPARENTHETICALS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEET PARENTHETICALS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY {Stockholders' Equity}</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICIENCYStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY {Stockholders' Equity}</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CONSOLIDATEDSTATEMENTOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000070 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureDESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureBASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosurePROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - DUE TO RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureDUETORELATEDPARTY</Role>
      <ShortName>DUE TO RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - LOAN PAYABLE, RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureLOANPAYABLERELATEDPARTIES</Role>
      <ShortName>LOAN PAYABLE, RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - CONVERTIBLE DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureCONVERTIBLEDEBT</Role>
      <ShortName>CONVERTIBLE DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - STOCKHOLDERS' DEFICIENCY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureSTOCKHOLDERSDEFICIENCY</Role>
      <ShortName>STOCKHOLDERS' DEFICIENCY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - OTHER INCOME (EXPENSE)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureOTHERINCOMEEXPENSE</Role>
      <ShortName>OTHER INCOME (EXPENSE)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureCOMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureRELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureINCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - SETTLEMENT OF LITIGATION - RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureSETTLEMENTOFLITIGATIONRELATEDPARTY</Role>
      <ShortName>SETTLEMENT OF LITIGATION - RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureSUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureAccountingPoliciesPolicies</Role>
      <ShortName>Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - Fair Value of Warrants Estimated (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureFairValueOfWarrantsEstimatedTables</Role>
      <ShortName>Fair Value of Warrants Estimated (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - Schedule of Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfPropertyAndEquipmentTables</Role>
      <ShortName>Schedule of Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000240 - Disclosure - Schedule of Convertible debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureScheduleOfConvertibleDebtTables</Role>
      <ShortName>Schedule of Convertible debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000250 - Disclosure - Stockholders Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DisclosureStockholdersWarrantsTables</Role>
      <ShortName>Stockholders Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000260 - Statement - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_BasisOfPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000270 - Statement - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000280 - Statement - Fair value assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_FairValueAssumptionsDetails</Role>
      <ShortName>Fair value assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000290 - Statement - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000300 - Statement - Property and Equipment Depreciation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_PropertyAndEquipmentDepreciationDetails</Role>
      <ShortName>Property and Equipment Depreciation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000310 - Statement - Due to Related Party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DueToRelatedPartyDetails</Role>
      <ShortName>Due to Related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000320 - Statement - Loan Payable, Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_LoanPayableRelatedPartiesDetails</Role>
      <ShortName>Loan Payable, Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000330 - Statement - Convertible Debt - HEP Investments, LLC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtHEPInvestmentsLLCDetails</Role>
      <ShortName>Convertible Debt - HEP Investments, LLC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>000340 - Statement - Deferred Debt Discount and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DeferredDebtDiscountAndOtherDetails</Role>
      <ShortName>Deferred Debt Discount and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>000350 - Statement - HEP Investments, LLC - Restricted Common Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_HEPInvestmentsLLCRestrictedCommonSharesDetails</Role>
      <ShortName>HEP Investments, LLC - Restricted Common Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>000360 - Statement - Paulson Investment - Related Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_PaulsonInvestmentRelatedDebtDetails</Role>
      <ShortName>Paulson Investment - Related Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>000370 - Statement - Convertible debt consists of the following (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtConsistsOfTheFollowingDetails</Role>
      <ShortName>Convertible debt consists of the following (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>000380 - Statement - Convertible debt Parentheticals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_ConvertibleDebtParentheticalsDetails</Role>
      <ShortName>Convertible debt Parentheticals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>000390 - Statement - Board Of Directors Fees Textual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_BoardOfDirectorsFeesTextualDetails</Role>
      <ShortName>Board Of Directors Fees Textual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>000400 - Statement - Directors fees- During the period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_DirectorsFeesDuringThePeriodDetails</Role>
      <ShortName>Directors fees- During the period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>000410 - Statement - Stock Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_StockBasedCompensationDetails</Role>
      <ShortName>Stock Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>000420 - Statement - Stock Issuances in the year 2015 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2015Details</Role>
      <ShortName>Stock Issuances in the year 2015 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>000430 - Statement - Stock Issuances in the year 2016 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_StockIssuancesInTheYear2016Details</Role>
      <ShortName>Stock Issuances in the year 2016 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>000440 - Statement - Executive Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_ExecutiveCompensationDetails</Role>
      <ShortName>Executive Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>000450 - Statement - Summary of the status of the Company's warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_SummaryOfTheStatusOfTheCompanySWarrantsDetails</Role>
      <ShortName>Summary of the status of the Company's warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>000460 - Statement - Warrants outstanding and exercisable by price range (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_WarrantsOutstandingAndExercisableByPriceRangeDetails</Role>
      <ShortName>Warrants outstanding and exercisable by price range (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>000470 - Statement - Other Income (Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_OtherIncomeExpenseDetails</Role>
      <ShortName>Other Income (Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>000480 - Statement - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_CommitmentAndContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>000490 - Statement - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>000500 - Statement - Settlement of Litigation - Related Party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_SettlementOfLitigationRelatedPartyDetails</Role>
      <ShortName>Settlement of Litigation - Related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="zivo-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>000510 - Statement - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zivobioscience.com/20161231/role/idr_SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zivo-20161231.xml</File>
    <File>zivo-20161231.xsd</File>
    <File>zivo-20161231_cal.xml</File>
    <File>zivo-20161231_def.xml</File>
    <File>zivo-20161231_lab.xml</File>
    <File>zivo-20161231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001078782-17-000387-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001078782-17-000387-xbrl.zip
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M,4OB&1 E\Y([X857GA3C/,3.4NS>BY!?''&=3[V(.O+ULVD^FX6*=/CU%+H
M*L'P8_C#B_()= ^M)$!M;7F%=PX1H9PZKB5.>)RG./DX$L@77C*^IB8#7/@
M)"HM"BYO %-8/C%Z/A51G(FRMY(F^!I,T\_'\"MH<9F, R\,[]ZIM6N] [K
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MCJHOR4!X6!870CC38ES)S?NB*2@C;D$9A7='\6TDZ^$51[Q$>$4< ^^;.C7
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M)'PP1:T/K< JPW-H") =K-A._Z)8"<3K=7!U#4RLK$!ESV$2<)*K7HG7XR0
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M=)R\-CC\6&V03'&#4:K*,%@1)<;Z$X$J.T![EXJ7)9 ]G@9C&-]$%O5BONL
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M?X0[G(MN7 U)V;9G0L?7CNL#^L)6E?3U!Y^6/H"\-B0-T<AAX(I0B91-/K7
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M!=-[VB9*SG^C)WK'L:J+;SB[:8 V/#X:10&>?5@P!3XBC5]XKG-80!ON'8O
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M/M1]Y"U\ST96]*RIV!2%3@9BV=R+@EBOSFD;QOU5@M6)._Z]XDP0K09*)X[
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MOIDU6^<3-,6FD^^0;$:0-\K#T J +3IUI3V50LU.]G=]B/P@(+)=][A"S)6
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M'QMTR*<+O-ZBG?73G_\/4$L#!!0    ( $AH?TJ^DGM?BP(  -4,   5
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MLW9<\-/'#Q^BLE=+BC?*/Y_%I3OM'[=#PWY$<ZN%/9#DV:MZ%%_1Z.TAL:V
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M@)\I87U<F_U@_RKWZ\?_ U!+ P04    " !(:']*EB9%_71Y  "N604 %0
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MQ)0U6R83UI09N-25*A[$>$^];(S#E$S$HG%#+H37O,6G1-F#OL%=;X4LGC7
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M4UGZ1_HKC*\5V\=XDFR+_/W<5!)'&^TTEFZRV:,K6;,*.[Z*^DG<42[O0=R
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MIJD9 :7Q/_F=_NGFE8Y4YNGU[M;>V3.C]\!'* K"'0PC/Z9EP"CQ??4[F*E
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M!?'?J<^6A>&6.IE4^ KT:;V*)X'2UP_'#"7:)^\<*>D]A$=:0ACQ!DNYT<1
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M43:+YG]OJ@"%D?FS4)7!U.396D_C=2:&-'^66J6JBH2IF3.))$SL=97$_Y8
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MB>>O5&I8 3/56UBH:6J%@9L4P=<]>2$#@YFF+8I0:S)$_<$M,]>*\$0QXU;
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MNGTQIG?==Y4#=V6#OAT88\=\95,D^-N[+R].'V5"C1^HB*@H\='J9S&.J-0
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M'1'&77PI<0#5&YT1QNVU,1(-5TD8=_&E#\*X9KTQ1[-5V[M!$<;M+:1-&%>
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M=>-I$[' X6JJ?H,@GBF^F)Y)2EK&24D768K&!43/#13E\;IE0:4_O"+*0/Q
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M/YKJ&&_5;^_?%/]1/V 5_/[-'U!+ P04    " !(:']*W+UG2\TO   V P,
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M)"D.8U6H%.KNDPX"E,M/C,J*F>;Z/,B7J=(/-]LP2!]-?X4L$X=?I^N(-]I
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M %XZ.T< ,.ZI*F4LAIVB< L7@FF79$$\Q@.SXFQYI2\ =RH(_.M"_69U\H3
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MI5];R4%9P8;)Q_:_(/]YPES]\^__!U!+ 0(4 Q0    ( $AH?TH@RWR'+94
M *(@"0 1              "  0    !Z:79O+3(P,38Q,C,Q+GAM;%!+ 0(4
M Q0    ( $AH?TJZ> Z5'!T  "-7 0 1              "  5R5  !Z:79O
M+3(P,38Q,C,Q+GAS9%!+ 0(4 Q0    ( $AH?TJ^DGM?BP(  -4,   5
M          "  :>R  !Z:79O+3(P,38Q,C,Q7V-A;"YX;6Q02P$"% ,4
M" !(:']*PTI=1FP*  #.>   %0              @ %EM0  >FEV;RTR,#$V
M,3(S,5]D968N>&UL4$L! A0#%     @ 2&A_2I8F1?UT>0  KED% !4
M         ( !!,   'II=F\M,C Q-C$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M $AH?TK<O6=+S2\  #8# P 5              "  :LY 0!Z:79O+3(P,38Q
A,C,Q7W!R92YX;6Q02P4&      8 !@"* 0  JVD!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
